LitCovid-sample-Enju  

PMC:7205724 JSONTXT 40 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
T0 0-7 IN denotes Towards
T1 8-17 NN denotes treatment
T2 18-26 NN denotes planning
T3 27-29 IN denotes of
T4 30-38 NN denotes COVID-19
T5 38-39 -COLON- denotes :
T6 40-49 NN denotes Rationale
T7 50-53 CC denotes and
T8 54-64 NN denotes hypothesis
T9 65-68 IN denotes for
T10 69-72 DT denotes the
T11 73-76 NN denotes use
T12 77-79 IN denotes of
T13 80-88 JJ denotes multiple
T14 89-106 JJ denotes immunosuppressive
T15 107-113 NNS denotes agents
T16 113-114 -COLON- denotes :
T17 115-130 NNS denotes Anti-antibodies
T18 130-131 -COMMA- denotes ,
T19 132-147 NNS denotes immunoglobulins
T20 147-148 -COMMA- denotes ,
T21 149-152 CC denotes and
T22 153-168 NNS denotes corticosteroids
T23 170-180 NNS denotes Highlights
T24 181-182 IN denotes •
T25 184-188 NNP denotes IVIG
T26 188-189 -COMMA- denotes ,
T27 190-198 VBN denotes combined
T28 199-203 IN denotes with
T29 204-217 NN denotes moderate-dose
T30 218-220 IN denotes of
T31 221-236 NNS denotes corticosteroids
T32 236-237 -COMMA- denotes ,
T33 238-243 MD denotes might
T34 244-251 VB denotes improve
T35 252-259 NN denotes patient
T36 260-268 NNS denotes outcomes
T37 270-271 PDT denotes •
T38 273-276 DT denotes The
T39 277-280 NN denotes use
T40 281-283 IN denotes of
T41 284-299 NNS denotes corticosteroids
T42 300-305 MD denotes might
T43 306-316 VB denotes accelerate
T44 317-325 NN denotes recovery
T45 326-330 IN denotes from
T46 331-339 NN denotes COVID-19
T47 341-342 PDT denotes •
T48 344-346 DT denotes No
T49 347-357 VBN denotes controlled
T50 358-366 JJ denotes clinical
T51 367-373 NNS denotes trials
T52 374-379 VBP denotes exist
T53 380-382 IN denotes on
T54 383-386 DT denotes the
T55 387-390 NN denotes use
T56 391-393 IN denotes of
T57 394-409 NNS denotes corticosteroids
T58 410-413 IN denotes for
T59 414-422 NN denotes COVID-19
T60 424-425 LS denotes •
T61 427-430 NN denotes IL6
T62 431-441 VBZ denotes correlates
T63 442-446 IN denotes with
T64 447-455 NN denotes severity
T65 455-456 -COMMA- denotes ,
T66 457-468 NN denotes criticality
T67 468-469 -COMMA- denotes ,
T68 470-475 JJ denotes viral
T69 476-480 NN denotes load
T70 480-481 -COMMA- denotes ,
T71 482-485 CC denotes and
T72 486-495 NN denotes prognosis
T73 496-498 IN denotes of
T74 499-507 NN denotes COVID-19
T75 509-510 IN denotes •
T76 512-523 NNP denotes Tocilizumab
T77 523-524 -COMMA- denotes ,
T78 525-527 DT denotes an
T79 528-536 NN denotes anti-IL6
T80 536-537 -COMMA- denotes ,
T81 538-541 MD denotes can
T82 542-548 VB denotes confer
T83 549-556 NN denotes benefit
T84 557-559 IN denotes in
T85 560-568 NNS denotes patients
T86 569-573 IN denotes with
T87 574-582 NN denotes COVID-19
T88 583-586 CC denotes and
T89 587-591 JJ denotes high
T90 592-595 NN denotes IL6
T91 598-606 NN denotes Abstract
T92 607-610 DT denotes The
T93 611-616 JJ denotes novel
T94 617-628 NN denotes coronavirus
T95 628-629 -COMMA- denotes ,
T96 630-639 NN denotes SARS-CoV2
T97 639-640 -COMMA- denotes ,
T98 641-644 MD denotes can
T99 645-650 VB denotes cause
T100 651-652 DT denotes a
T101 653-664 RB denotes potentially
T102 665-670 JJ denotes fatal
T103 671-678 NN denotes disease
T104 678-679 -COMMA- denotes ,
T105 680-688 NN denotes COVID-19
T106 688-689 -COMMA- denotes ,
T107 690-692 IN denotes in
T108 693-699 NNS denotes humans
T109 701-705 RB denotes Here
T110 705-706 -COMMA- denotes ,
T111 707-709 PRP denotes we
T112 710-714 MD denotes will
T113 715-722 VB denotes provide
T114 723-725 DT denotes an
T115 726-734 NN denotes overview
T116 735-737 IN denotes of
T117 738-749 JJ denotes therapeutic
T118 750-757 NNS denotes options
T119 758-761 IN denotes for
T120 762-770 NN denotes COVID-19
T121 772-778 NN denotes Plasma
T122 779-783 IN denotes from
T123 784-792 NNS denotes patients
T124 793-802 VBN denotes recovered
T125 803-807 IN denotes from
T126 808-816 NN denotes COVID-19
T127 817-821 WDT denotes that
T128 822-830 VBZ denotes contains
T129 831-841 NNS denotes antibodies
T130 842-849 IN denotes against
T131 850-859 NN denotes SARS-CoV2
T132 860-863 VBZ denotes has
T133 864-869 VBN denotes shown
T134 870-879 JJ denotes promising
T135 880-887 NNS denotes results
T136 888-890 IN denotes in
T137 891-899 NNS denotes patients
T138 900-904 IN denotes with
T139 905-911 JJ denotes severe
T140 912-920 NN denotes COVID-19
T141 922-926 RB denotes Also
T142 926-927 -COMMA- denotes ,
T143 928-932 NNP denotes IVIG
T144 932-933 -COMMA- denotes ,
T145 934-942 VBN denotes combined
T146 943-947 IN denotes with
T147 948-961 NN denotes moderate-dose
T148 962-964 IN denotes of
T149 965-980 NNS denotes corticosteroids
T150 980-981 -COMMA- denotes ,
T151 982-987 MD denotes might
T152 988-995 VB denotes improve
T153 996-1003 NN denotes patient
T154 1004-1012 NNS denotes outcomes
T155 1014-1022 NN denotes Evidence
T156 1023-1028 VBZ denotes links
T157 1029-1037 NN denotes COVID-19
T158 1038-1040 TO denotes to
T159 1041-1049 JJ denotes variable
T160 1050-1057 NNS denotes degrees
T161 1058-1060 IN denotes of
T162 1061-1073 NN denotes inflammation
T163 1075-1082 NNS denotes Studies
T164 1083-1087 VBP denotes show
T165 1088-1092 IN denotes that
T166 1093-1096 DT denotes the
T167 1097-1100 NN denotes use
T168 1101-1103 IN denotes of
T169 1104-1119 NNS denotes corticosteroids
T170 1120-1125 MD denotes might
T171 1126-1136 VB denotes accelerate
T172 1137-1145 NN denotes recovery
T173 1146-1150 IN denotes from
T174 1151-1159 NN denotes COVID-19
T175 1161-1166 EX denotes There
T176 1167-1170 VBP denotes are
T177 1170-1171 -COMMA- denotes ,
T178 1172-1179 RB denotes however
T179 1179-1180 -COMMA- denotes ,
T180 1181-1183 DT denotes no
T181 1184-1194 JJ denotes controlled
T182 1195-1203 JJ denotes clinical
T183 1204-1210 NNS denotes trials
T184 1211-1215 WDT denotes that
T185 1216-1220 VBP denotes show
T186 1221-1228 IN denotes whether
T187 1229-1232 DT denotes the
T188 1233-1236 NN denotes use
T189 1237-1239 IN denotes of
T190 1240-1255 NNS denotes corticosteroids
T191 1256-1259 MD denotes can
T192 1260-1266 VB denotes reduce
T193 1267-1283 JJ denotes COVID-19-related
T194 1284-1289 NN denotes death
T195 1291-1295 RB denotes Also
T196 1295-1296 -COMMA- denotes ,
T197 1297-1300 DT denotes the
T198 1301-1317 JJ denotes pro-inflammatory
T199 1318-1326 NN denotes cytokine
T200 1327-1330 NN denotes IL6
T201 1331-1333 VBZ denotes is
T202 1334-1337 DT denotes the
T203 1338-1353 JJ denotes best-documented
T204 1354-1362 NN denotes cytokine
T205 1363-1365 IN denotes in
T206 1366-1374 NN denotes COVID-19
T207 1375-1385 VBD denotes correlated
T208 1386-1390 IN denotes with
T209 1391-1399 NN denotes severity
T210 1399-1400 -COMMA- denotes ,
T211 1401-1412 NN denotes criticality
T212 1412-1413 -COMMA- denotes ,
T213 1414-1419 JJ denotes viral
T214 1420-1424 NN denotes load
T215 1424-1425 -COMMA- denotes ,
T216 1426-1429 CC denotes and
T217 1430-1439 NN denotes prognosis
T218 1440-1442 IN denotes of
T219 1443-1451 NNS denotes patients
T220 1452-1456 IN denotes with
T221 1457-1465 NN denotes COVID-19
T222 1467-1478 NNP denotes Tocilizumab
T223 1478-1479 -COMMA- denotes ,
T224 1480-1481 DT denotes a
T225 1482-1492 JJ denotes monoclonal
T226 1493-1501 NN denotes antibody
T227 1502-1509 IN denotes against
T228 1510-1513 NN denotes IL6
T229 1513-1514 -COMMA- denotes ,
T230 1515-1520 MD denotes could
T231 1521-1527 VB denotes confer
T232 1528-1536 JJ denotes clinical
T233 1537-1544 NN denotes benefit
T234 1545-1547 IN denotes in
T235 1548-1556 NNS denotes patients
T236 1557-1561 IN denotes with
T237 1562-1566 JJ denotes high
T238 1567-1570 NN denotes IL6
T239 1571-1577 NNS denotes levels
T240 1579-1588 JJ denotes Essential
T241 1589-1597 NNS denotes elements
T242 1598-1602 IN denotes that
T243 1603-1610 NN denotes process
T244 1611-1620 NN denotes SARS-CoV2
T245 1621-1625 NN denotes cell
T246 1626-1631 NN denotes entry
T247 1632-1635 CC denotes and
T248 1636-1644 JJ denotes specific
T249 1645-1660 NNS denotes characteristics
T250 1661-1665 WDT denotes that
T251 1666-1671 VBP denotes allow
T252 1672-1681 NN denotes SARS-CoV2
T253 1682-1684 TO denotes to
T254 1685-1691 VB denotes escape
T255 1692-1695 DT denotes the
T256 1696-1702 JJ denotes immune
T257 1703-1709 NN denotes system
T258 1710-1714 VBP denotes have
T259 1715-1718 DT denotes the
T260 1719-1728 NN denotes potential
T261 1729-1731 IN denotes as
T262 1732-1739 NNS denotes targets
T263 1740-1743 IN denotes for
T264 1744-1752 NN denotes COVID-19
T265 1753-1760 NN denotes therapy
T266 1763-1764 CD denotes 1
T267 1766-1778 NN denotes Introduction
T268 1779-1786 JJ denotes Several
T269 1787-1798 NNS denotes generations
T270 1799-1803 VBP denotes have
T271 1804-1808 VBN denotes been
T272 1809-1816 VBN denotes exposed
T273 1817-1819 TO denotes to
T274 1820-1828 NN denotes COVID-19
T275 1829-1834 IN denotes under
T276 1835-1844 JJ denotes different
T277 1845-1855 NNS denotes conditions
T278 1856-1858 IN denotes of
T279 1859-1863 NN denotes life
T280 1864-1866 IN denotes at
T281 1867-1874 VBG denotes varying
T282 1875-1884 NNS denotes locations
T283 1885-1891 IN denotes around
T284 1892-1895 DT denotes the
T285 1896-1901 NN denotes world
T286 1903-1905 RB denotes As
T287 1906-1910 RB denotes long
T288 1911-1913 IN denotes as
T289 1914-1917 DT denotes the
T290 1918-1926 NN denotes COVID-19
T291 1927-1936 VBZ denotes continues
T292 1937-1939 TO denotes to
T293 1940-1946 VB denotes spread
T294 1946-1947 -COMMA- denotes ,
T295 1948-1951 PRP-DOLLAR- denotes its
T296 1952-1957 NN denotes power
T297 1958-1960 IN denotes of
T298 1961-1967 NN denotes genome
T299 1968-1980 NN denotes modification
T300 1981-1986 MD denotes would
T301 1987-1995 RB denotes probably
T302 1996-1998 VB denotes be
T303 1999-2008 VBN denotes increased
T304 2010-2014 WP denotes What
T305 2015-2023 VBZ denotes concerns
T306 2024-2026 PRP denotes us
T307 2027-2031 RBR denotes more
T308 2032-2034 VBZ denotes is
T309 2035-2039 IN denotes that
T310 2040-2043 DT denotes the
T311 2044-2053 NN denotes 2019-nCoV
T312 2053-2054 -COMMA- denotes ,
T313 2055-2057 IN denotes by
T314 2058-2061 DT denotes the
T315 2062-2069 NN denotes process
T316 2070-2072 IN denotes of
T317 2073-2085 NN denotes modification
T318 2086-2088 IN denotes of
T319 2089-2095 NN denotes genome
T320 2096-2105 NN denotes structure
T321 2105-2106 -COMMA- denotes ,
T322 2107-2112 MD denotes might
T323 2113-2119 VB denotes become
T324 2120-2124 RBR denotes more
T325 2125-2128 CC denotes and
T326 2129-2133 RBR denotes more
T327 2134-2140 VBN denotes fitted
T328 2141-2143 TO denotes to
T329 2144-2150 NNS denotes humans
T330 2151-2153 TO denotes to
T331 2154-2164 RB denotes profoundly
T332 2165-2171 VB denotes affect
T333 2172-2177 DT denotes those
T334 2178-2181 WP denotes who
T335 2182-2186 VBP denotes have
T336 2187-2194 RB denotes already
T337 2195-2202 VBN denotes escaped
T338 2203-2204 NN denotes –
T339 2205-2213 NNS denotes children
T340 2214-2217 CC denotes and
T341 2218-2223 JJ denotes young
T342 2224-2230 NNS denotes people
T343 2231-2238 IN denotes without
T344 2239-2240 DT denotes a
T345 2241-2253 JJ denotes pre-existing
T346 2254-2263 NN denotes condition
T347 2265-2267 DT denotes No
T348 2268-2271 NN denotes one
T349 2272-2275 MD denotes can
T350 2276-2280 VB denotes tell
T351 2281-2284 WRB denotes how
T352 2285-2289 JJ denotes much
T353 2290-2294 NN denotes time
T354 2295-2297 PRP denotes it
T355 2298-2303 VBZ denotes takes
T356 2304-2306 TO denotes to
T357 2307-2312 VB denotes reach
T358 2313-2314 DT denotes a
T359 2315-2318 JJ denotes new
T360 2319-2324 NN denotes level
T361 2325-2327 IN denotes of
T362 2328-2338 NN denotes perfection
T363 2338-2339 -COMMA- denotes ,
T364 2340-2343 CC denotes and
T365 2344-2348 IN denotes that
T366 2349-2352 DT denotes the
T367 2353-2364 NN denotes development
T368 2365-2367 IN denotes of
T369 2368-2376 NNS denotes vaccines
T370 2377-2380 IN denotes for
T371 2381-2387 JJ denotes active
T372 2388-2400 NN denotes immunization
T373 2401-2403 VBZ denotes is
T374 2404-2405 DT denotes a
T375 2406-2410 JJ denotes long
T376 2411-2418 NN denotes process
T377 2420-2428 RB denotes Moreover
T378 2428-2429 -COMMA- denotes ,
T379 2430-2434 JJS denotes most
T380 2435-2437 IN denotes of
T381 2438-2441 DT denotes the
T382 2442-2446 JJS denotes best
T383 2447-2456 JJ denotes available
T384 2457-2467 JJ denotes anti-viral
T385 2468-2474 NNS denotes agents
T386 2475-2478 VBP denotes are
T387 2479-2482 RB denotes not
T388 2483-2490 JJ denotes helpful
T389 2491-2493 IN denotes in
T390 2494-2497 DT denotes the
T391 2498-2507 NN denotes treatment
T392 2508-2510 IN denotes of
T393 2511-2519 NN denotes COVID-19
T394 2521-2522 DT denotes A
T395 2523-2533 VBN denotes randomized
T396 2534-2544 VBN denotes controlled
T397 2545-2550 NN denotes trial
T398 2551-2553 IN denotes of
T399 2554-2557 CD denotes 199
T400 2558-2570 VBN denotes hospitalized
T401 2571-2577 NNS denotes adults
T402 2578-2582 IN denotes with
T403 2583-2592 VBN denotes confirmed
T404 2593-2601 NN denotes COVID-19
T405 2602-2614 VBD denotes demonstrated
T406 2615-2617 DT denotes no
T407 2618-2624 JJ denotes actual
T408 2625-2635 NN denotes difference
T409 2636-2643 IN denotes between
T410 2644-2652 NNS denotes patients
T411 2653-2656 WP denotes who
T412 2657-2665 VBD denotes received
T413 2666-2685 NN denotes lopinavir-ritonavir
T414 2686-2689 CC denotes and
T415 2690-2698 NNS denotes patients
T416 2699-2702 WP denotes who
T417 2703-2711 VBD denotes received
T418 2712-2720 JJ denotes standard
T419 2721-2725 NN denotes care
T420 2726-2731 RB denotes alone
T421 2732-2734 IN denotes in
T422 2735-2743 JJ denotes clinical
T423 2744-2755 NN denotes improvement
T424 2755-2756 -COMMA- denotes ,
T425 2757-2762 NN denotes death
T426 2763-2767 NN denotes rate
T427 2767-2768 -COMMA- denotes ,
T428 2769-2772 CC denotes and
T429 2773-2781 JJ denotes positive
T430 2782-2787 NN denotes virus
T431 2788-2792 NN denotes test
T432 2793-2797 NN denotes rate
T433 2798-2800 IN denotes at
T434 2801-2804 NN denotes day
T435 2805-2807 CD denotes 28
T436 2808-2809 -LRB- denotes [
T437 2809-2810 CD denotes 1
T438 2810-2811 -RRB- denotes ]
T439 2813-2817 RB denotes Here
T440 2818-2820 PRP denotes we
T441 2821-2827 VBP denotes review
T442 2828-2840 JJ denotes intermediate
T443 2841-2851 NNS denotes indicators
T444 2852-2854 IN denotes of
T445 2855-2858 DT denotes the
T446 2859-2871 NN denotes pathogenesis
T447 2872-2874 IN denotes of
T448 2875-2883 NN denotes COVID-19
T449 2884-2888 WDT denotes that
T450 2889-2893 VBP denotes have
T451 2894-2897 DT denotes the
T452 2898-2907 NN denotes potential
T453 2908-2910 IN denotes of
T454 2911-2916 VBG denotes being
T455 2917-2927 VBN denotes considered
T456 2928-2931 IN denotes for
T457 2932-2935 DT denotes the
T458 2936-2945 NN denotes treatment
T459 2946-2948 IN denotes of
T460 2949-2957 NN denotes COVID-19
T461 2960-2961 CD denotes 2
T462 2963-2972 NN denotes SARS-CoV2
T463 2973-2977 NN denotes cell
T464 2978-2983 NN denotes entry
T465 2984-2986 VBZ denotes is
T466 2987-2990 RB denotes not
T467 2991-2998 JJ denotes complex
T468 2999-3003 NNP denotes Fig.
T469 3004-3005 CD denotes 1
T470 3006-3008 VBZ denotes is
T471 3009-3010 DT denotes a
T472 3011-3020 JJ denotes schematic
T473 3021-3033 NN denotes illustration
T474 3034-3036 IN denotes of
T475 3037-3040 DT denotes the
T476 3041-3048 JJ denotes minimum
T477 3049-3057 NNS denotes proteins
T478 3058-3066 VBN denotes required
T479 3067-3069 TO denotes to
T480 3070-3077 VB denotes mediate
T481 3078-3081 DT denotes the
T482 3082-3091 NN denotes SARS-CoV2
T483 3092-3096 NN denotes cell
T484 3097-3102 NN denotes entry
T485 3104-3107 DT denotes The
T486 3108-3116 JJ denotes trimeric
T487 3116-3117 -COMMA- denotes ,
T488 3118-3131 JJ denotes transmembrane
T489 3132-3137 NN denotes spike
T490 3138-3139 -LRB- denotes (
T491 3139-3140 NN denotes S
T492 3140-3141 -RRB- denotes )
T493 3142-3154 NN denotes glycoprotein
T494 3155-3157 IN denotes of
T495 3158-3161 DT denotes the
T496 3162-3167 NN denotes virus
T497 3167-3168 -COMMA- denotes ,
T498 3169-3177 NN denotes SARS-2-S
T499 3177-3178 -COMMA- denotes ,
T500 3179-3187 VBZ denotes includes
T501 3188-3191 CD denotes two
T502 3192-3196 JJ denotes main
T503 3197-3207 JJ denotes functional
T504 3208-3216 NNS denotes subunits
T505 3216-3217 -COLON- denotes :
T506 3218-3220 NN denotes S1
T507 3221-3224 CC denotes and
T508 3225-3227 NN denotes S2
T509 3229-3232 DT denotes The
T510 3233-3239 JJ denotes former
T511 3239-3240 -COMMA- denotes ,
T512 3241-3243 IN denotes in
T513 3244-3248 NN denotes turn
T514 3248-3249 -COMMA- denotes ,
T515 3250-3258 VBZ denotes consists
T516 3259-3261 IN denotes of
T517 3262-3265 DT denotes the
T518 3266-3270 CD denotes four
T519 3271-3275 NN denotes core
T520 3276-3283 NNS denotes domains
T521 3283-3284 -COMMA- denotes ,
T522 3285-3288 NN denotes S1A
T523 3288-3289 -COMMA- denotes ,
T524 3290-3293 NN denotes S1B
T525 3293-3294 -COMMA- denotes ,
T526 3295-3298 NN denotes S1C
T527 3298-3299 -COMMA- denotes ,
T528 3300-3303 CC denotes and
T529 3304-3307 NN denotes S1D
T530 3307-3308 -COMMA- denotes ,
T531 3309-3313 WDT denotes that
T532 3314-3324 VBP denotes contribute
T533 3325-3327 TO denotes to
T534 3328-3331 DT denotes the
T535 3332-3342 NN denotes attachment
T536 3343-3345 TO denotes to
T537 3346-3349 DT denotes the
T538 3350-3357 NN denotes surface
T539 3358-3366 NN denotes receptor
T540 3367-3369 IN denotes of
T541 3370-3376 NN denotes target
T542 3377-3382 NNS denotes cells
T543 3384-3388 RB denotes Then
T544 3388-3389 -COMMA- denotes ,
T545 3390-3393 DT denotes the
T546 3394-3400 JJ denotes latter
T547 3401-3412 VBZ denotes coordinates
T548 3413-3416 DT denotes the
T549 3417-3423 NN denotes fusion
T550 3424-3426 IN denotes of
T551 3427-3432 JJ denotes viral
T552 3433-3436 CC denotes and
T553 3437-3445 JJ denotes cellular
T554 3446-3455 NNS denotes membranes
T555 3457-3465 NN denotes Receptor
T556 3466-3473 NN denotes binding
T557 3474-3483 VBZ denotes activates
T558 3484-3493 NNS denotes proteases
T559 3494-3498 WDT denotes that
T560 3499-3502 MD denotes can
T561 3503-3508 VB denotes carry
T562 3509-3512 RP denotes out
T563 3513-3524 JJ denotes proteolytic
T564 3525-3533 NN denotes cleavage
T565 3534-3536 IN denotes of
T566 3537-3540 DT denotes the
T567 3541-3542 NN denotes S
T568 3543-3550 NN denotes protein
T569 3552-3554 IN denotes In
T570 3555-3568 NNS denotes coronaviruses
T571 3568-3569 -COMMA- denotes ,
T572 3570-3578 NN denotes cleavage
T573 3579-3585 VBZ denotes occurs
T574 3586-3588 IN denotes at
T575 3589-3592 CD denotes two
T576 3593-3598 NNS denotes sites
T577 3598-3599 -COLON- denotes :
T578 3600-3603 DT denotes the
T579 3604-3609 NN denotes S1/S2
T580 3610-3618 NN denotes junction
T581 3619-3622 CC denotes and
T582 3623-3625 IN denotes at
T583 3626-3629 DT denotes the
T584 3630-3633 NN denotes S2′
T585 3633-3634 -COMMA- denotes ,
T586 3635-3636 DT denotes a
T587 3637-3643 NN denotes region
T588 3644-3649 JJ denotes close
T589 3650-3652 TO denotes to
T590 3653-3656 DT denotes the
T591 3657-3662 JJ denotes viral
T592 3663-3669 NN denotes fusion
T593 3670-3677 NN denotes peptide
T594 3678-3679 -LRB- denotes [
T595 3679-3680 CD denotes 2
T596 3680-3681 -RRB- denotes ]
T597 3683-3694 JJ denotes Proteolytic
T598 3695-3703 NN denotes cleavage
T599 3704-3706 IN denotes of
T600 3707-3710 DT denotes the
T601 3711-3712 NN denotes S
T602 3713-3720 NN denotes protein
T603 3721-3727 VBZ denotes causes
T604 3728-3742 JJ denotes conformational
T605 3743-3750 NNS denotes changes
T606 3751-3753 IN denotes so
T607 3754-3758 IN denotes that
T608 3759-3763 PRP denotes they
T609 3764-3767 MD denotes can
T610 3767-3770 RB denotes not
T611 3771-3777 VB denotes revert
T612 3778-3780 TO denotes to
T613 3781-3784 DT denotes the
T614 3785-3793 JJ denotes original
T615 3794-3803 NN denotes structure
T616 3804-3807 CC denotes and
T617 3808-3816 JJ denotes profound
T618 3817-3823 RB denotes enough
T619 3824-3826 TO denotes to
T620 3827-3832 VB denotes prime
T621 3833-3836 DT denotes the
T622 3837-3839 NN denotes S2
T623 3840-3847 NN denotes subunit
T624 3848-3851 IN denotes for
T625 3852-3855 DT denotes the
T626 3856-3862 NN denotes fusion
T627 3863-3865 IN denotes of
T628 3866-3871 JJ denotes viral
T629 3872-3875 CC denotes and
T630 3876-3884 JJ denotes cellular
T631 3885-3894 NNS denotes membranes
T632 3896-3900 NNP denotes Fig.
T633 3901-3902 CD denotes 1
T634 3903-3911 NNS denotes Proteins
T635 3912-3920 VBN denotes required
T636 3921-3924 IN denotes for
T637 3925-3928 DT denotes the
T638 3929-3943 NN denotes SARS-CoV2-cell
T639 3944-3949 NN denotes entry
T640 3952-3953 CD denotes 3
T641 3955-3962 JJ denotes Certain
T642 3963-3978 NNS denotes characteristics
T643 3979-3981 IN denotes of
T644 3982-3991 NN denotes SARS-CoV2
T645 3993-3996 CD denotes 3.1
T646 3998-4007 NN denotes SARS-CoV2
T647 4008-4011 VBZ denotes has
T648 4012-4020 VBN denotes acquired
T649 4021-4023 DT denotes an
T650 4024-4025 NN denotes S
T651 4026-4038 NN denotes glycoprotein
T652 4039-4043 WDT denotes that
T653 4044-4050 RB denotes highly
T654 4051-4060 VBD denotes underwent
T655 4061-4068 JJ denotes genetic
T656 4069-4078 NN denotes variation
T657 4079-4082 CC denotes and
T658 4083-4096 NN denotes glycosylation
T659 4098-4103 CD denotes 3.1.1
T660 4105-4114 JJ denotes Polybasic
T661 4115-4123 NN denotes cleavage
T662 4124-4128 NN denotes site
T663 4129-4131 IN denotes As
T664 4132-4141 VBN denotes evidenced
T665 4142-4144 IN denotes by
T666 4145-4153 NN denotes sequence
T667 4154-4162 NN denotes analysis
T668 4162-4163 -COMMA- denotes ,
T669 4164-4169 EX denotes there
T670 4170-4172 VBZ denotes is
T671 4173-4174 DT denotes a
T672 4175-4182 NN denotes residue
T673 4183-4192 NN denotes insertion
T674 4193-4199 VBN denotes formed
T675 4200-4202 IN denotes of
T676 4203-4207 CD denotes four
T677 4208-4213 NN denotes amino
T678 4214-4219 NNS denotes acids
T679 4220-4221 -LRB- denotes (
T680 4221-4223 CD denotes 12
T681 4224-4235 NNS denotes nucleotides
T682 4235-4236 -RRB- denotes )
T683 4237-4239 IN denotes at
T684 4240-4243 DT denotes the
T685 4244-4252 NN denotes boundary
T686 4253-4260 IN denotes between
T687 4261-4263 NN denotes S1
T688 4264-4267 CC denotes and
T689 4268-4270 NN denotes S2
T690 4271-4279 NNS denotes subunits
T691 4280-4282 IN denotes of
T692 4283-4286 DT denotes the
T693 4287-4295 NN denotes SARS-CoV
T694 4296-4297 CD denotes 2
T695 4298-4300 NNP denotes S.
T696 4301-4303 PRP denotes It
T697 4304-4311 VBZ denotes defines
T698 4312-4313 DT denotes a
T699 4314-4323 JJ denotes polybasic
T700 4324-4329 NN denotes furin
T701 4330-4338 NN denotes cleavage
T702 4339-4343 NN denotes site
T703 4344-4346 IN denotes of
T704 4347-4351 NN denotes RRAR
T705 4352-4355 IN denotes for
T706 4356-4359 DT denotes the
T707 4360-4365 JJ denotes human
T708 4366-4374 NN denotes SARS-CoV
T709 4375-4376 CD denotes 2
T710 4377-4381 WDT denotes that
T711 4382-4385 VBD denotes was
T712 4386-4392 JJ denotes absent
T713 4393-4395 IN denotes in
T714 4396-4401 JJ denotes human
T715 4402-4410 NN denotes SARS-CoV
T716 4410-4411 -COMMA- denotes ,
T717 4412-4415 NN denotes bat
T718 4416-4425 JJ denotes SARS-like
T719 4426-4430 NNS denotes CoVs
T720 4430-4431 -COMMA- denotes ,
T721 4432-4435 CC denotes and
T722 4436-4444 NN denotes pangolin
T723 4445-4454 JJ denotes SARS-like
T724 4455-4458 NN denotes CoV
T725 4459-4464 NN denotes while
T726 4465-4470 MD denotes might
T727 4471-4473 VB denotes be
T728 4474-4481 JJ denotes present
T729 4482-4484 IN denotes in
T730 4485-4490 JJ denotes other
T731 4491-4498 NNS denotes species
T732 4499-4500 -LRB- denotes [
T733 4500-4501 CD denotes 3
T734 4501-4502 -RRB- denotes ]
T735 4504-4509 IN denotes After
T736 4510-4513 DT denotes the
T737 4514-4526 NN denotes introduction
T738 4527-4529 IN denotes of
T739 4530-4538 NN denotes mutation
T740 4539-4541 TO denotes to
T741 4542-4545 DT denotes the
T742 4546-4553 NN denotes residue
T743 4554-4563 NN denotes insertion
T744 4564-4567 CC denotes and
T745 4568-4573 NN denotes furin
T746 4574-4582 NN denotes cleavage
T747 4583-4587 NN denotes site
T748 4587-4588 -COMMA- denotes ,
T749 4589-4592 DT denotes the
T750 4593-4598 NN denotes S1/S2
T751 4599-4607 NN denotes cleavage
T752 4608-4610 IN denotes of
T753 4611-4614 DT denotes the
T754 4615-4623 JJ denotes SARS-CoV
T755 4624-4625 CD denotes 2
T756 4626-4627 NN denotes S
T757 4628-4631 VBD denotes did
T758 4632-4635 RB denotes not
T759 4636-4642 RBR denotes longer
T760 4643-4647 VB denotes take
T761 4648-4653 NN denotes place
T762 4655-4662 RB denotes However
T763 4662-4663 -COMMA- denotes ,
T764 4664-4667 DT denotes the
T765 4668-4676 JJ denotes SARS-CoV
T766 4677-4678 CD denotes 2
T767 4679-4680 NN denotes S
T768 4681-4686 NN denotes entry
T769 4687-4693 VBN denotes raised
T770 4694-4697 IN denotes for
T771 4698-4704 NN denotes VeroE6
T772 4705-4710 NNS denotes cells
T773 4711-4714 CC denotes and
T774 4715-4723 VBD denotes remained
T775 4724-4728 JJ denotes high
T776 4729-4731 IN denotes in
T777 4732-4735 NN denotes BHK
T778 4736-4741 NNS denotes cells
T779 4742-4746 WDT denotes that
T780 4747-4754 VBP denotes express
T781 4755-4760 JJ denotes human
T782 4761-4764 NN denotes ACE
T783 4766-4775 RB denotes Therefore
T784 4775-4776 -COMMA- denotes ,
T785 4777-4779 PRP denotes it
T786 4780-4785 VBZ denotes seems
T787 4786-4790 IN denotes that
T788 4791-4800 NN denotes SARS-CoV2
T789 4801-4817 NN denotes transmissibility
T790 4818-4822 VBZ denotes does
T791 4823-4826 RB denotes not
T792 4827-4833 VB denotes depend
T793 4834-4836 IN denotes on
T794 4837-4840 DT denotes the
T795 4841-4846 NN denotes S1/S2
T796 4847-4855 NN denotes cleavage
T797 4857-4858 DT denotes A
T798 4859-4868 JJ denotes polybasic
T799 4869-4877 NN denotes cleavage
T800 4878-4882 NN denotes site
T801 4883-4891 VBZ denotes explains
T802 4892-4893 DT denotes a
T803 4894-4899 NN denotes virus
T804 4900-4904 WDT denotes that
T805 4905-4907 VBZ denotes is
T806 4908-4925 JJ denotes highly-pathogenic
T807 4926-4929 IN denotes for
T808 4930-4936 NNS denotes humans
T809 4937-4942 IN denotes while
T810 4943-4945 PRP denotes it
T811 4946-4948 VBZ denotes is
T812 4949-4963 JJ denotes low-pathogenic
T813 4964-4967 IN denotes for
T814 4968-4973 JJ denotes other
T815 4974-4981 NNS denotes species
T816 4983-4986 IN denotes For
T817 4987-4994 NN denotes example
T818 4994-4995 -COMMA- denotes ,
T819 4996-5001 VBG denotes using
T820 5002-5009 JJ denotes reverse
T821 5010-5017 JJ denotes genetic
T822 5018-5023 NNS denotes tools
T823 5023-5024 -COMMA- denotes ,
T824 5025-5027 DT denotes an
T825 5028-5033 JJ denotes avian
T826 5034-5047 NN denotes paramyxovirus
T827 5048-5052 NN denotes type
T828 5053-5054 CD denotes 7
T829 5055-5056 -LRB- denotes (
T830 5056-5062 NN denotes APMV-7
T831 5062-5063 -RRB- denotes )
T832 5064-5067 VBD denotes was
T833 5068-5077 VBN denotes developed
T834 5078-5080 IN denotes by
T835 5081-5089 VBG denotes mutating
T836 5090-5093 DT denotes the
T837 5094-5100 NN denotes fusion
T838 5101-5102 -LRB- denotes (
T839 5102-5103 NN denotes F
T840 5103-5104 -RRB- denotes )
T841 5105-5112 NN denotes protein
T842 5113-5121 NN denotes cleavage
T843 5122-5126 NN denotes site
T844 5127-5128 -LRB- denotes [
T845 5128-5129 CD denotes 4
T846 5129-5130 -RRB- denotes ]
T847 5132-5135 DT denotes The
T848 5136-5147 VBN denotes constructed
T849 5148-5154 NN denotes APMV-7
T850 5155-5161 VBD denotes showed
T851 5162-5167 NN denotes furin
T852 5168-5176 NN denotes cleavage
T853 5177-5180 CC denotes and
T854 5181-5190 VBD denotes increased
T855 5191-5202 NN denotes replication
T856 5203-5206 CC denotes and
T857 5207-5216 NN denotes syncytium
T858 5217-5226 NN denotes formation
T859 5227-5229 IN denotes in
T860 5230-5234 NN denotes cell
T861 5235-5243 NNS denotes cultures
T862 5245-5252 RB denotes However
T863 5252-5253 -COMMA- denotes ,
T864 5254-5261 NN denotes chicken
T865 5262-5269 VBN denotes exposed
T866 5270-5272 TO denotes to
T867 5273-5276 DT denotes the
T868 5277-5282 NN denotes virus
T869 5283-5286 VBD denotes did
T870 5287-5290 RB denotes not
T871 5291-5298 VB denotes exhibit
T872 5299-5308 NN denotes infection
T873 5311-5316 CD denotes 3.1.2
T874 5318-5331 NN denotes Glycosylation
T875 5332-5345 NN denotes Glycosylation
T876 5346-5349 CC denotes and
T877 5350-5353 PRP-DOLLAR- denotes its
T878 5354-5361 JJ denotes related
T879 5362-5370 NNS denotes products
T880 5370-5371 -COMMA- denotes ,
T881 5372-5376 FW denotes i.e.
T882 5376-5377 -COMMA- denotes ,
T883 5378-5385 NNS denotes glycans
T884 5385-5386 -COMMA- denotes ,
T885 5387-5396 VBP denotes introduce
T886 5397-5404 NNS denotes changes
T887 5405-5407 TO denotes to
T888 5408-5411 DT denotes the
T889 5412-5417 JJ denotes viral
T890 5418-5426 NN denotes envelope
T891 5427-5431 WDT denotes that
T892 5432-5436 VBP denotes make
T893 5437-5440 DT denotes the
T894 5441-5446 NN denotes virus
T895 5447-5453 VBN denotes fitted
T896 5454-5457 IN denotes for
T897 5458-5469 NN denotes interaction
T898 5470-5474 IN denotes with
T899 5475-5478 DT denotes the
T900 5479-5483 NN denotes host
T901 5484-5488 NN denotes cell
T902 5489-5497 NN denotes membrane
T903 5498-5499 -LRB- denotes [
T904 5499-5500 CD denotes 5
T905 5500-5501 -RRB- denotes ]
T906 5503-5512 RB denotes Generally
T907 5512-5513 -COMMA- denotes ,
T908 5514-5521 NNS denotes glycans
T909 5522-5525 VBP denotes are
T910 5526-5542 NNS denotes oligosaccharides
T911 5543-5549 VBN denotes linked
T912 5550-5552 TO denotes to
T913 5553-5556 DT denotes the
T914 5557-5562 JJ denotes dense
T915 5563-5573 NN denotes decoration
T916 5574-5576 IN denotes of
T917 5577-5580 DT denotes the
T918 5581-5586 NN denotes spike
T919 5587-5599 NN denotes glycoprotein
T920 5601-5603 IN denotes In
T921 5604-5614 JJ denotes particular
T922 5614-5615 -COMMA- denotes ,
T923 5616-5621 DT denotes these
T924 5622-5638 NNS denotes oligosaccharides
T925 5639-5643 VBP denotes have
T926 5644-5649 VBN denotes shown
T927 5650-5652 TO denotes to
T928 5653-5662 VB denotes influence
T929 5663-5666 DT denotes the
T930 5667-5674 NN denotes folding
T931 5675-5677 IN denotes of
T932 5678-5681 DT denotes the
T933 5682-5683 NN denotes S
T934 5684-5691 NN denotes protein
T935 5692-5695 CC denotes and
T936 5696-5707 JJ denotes proteolytic
T937 5708-5715 NN denotes process
T938 5716-5718 IN denotes so
T939 5719-5723 IN denotes that
T940 5724-5728 PRP denotes they
T941 5729-5739 VBP denotes facilitate
T942 5740-5743 DT denotes the
T943 5744-5749 NN denotes virus
T944 5750-5754 NN denotes cell
T945 5755-5760 NN denotes entry
T946 5762-5770 RB denotes Moreover
T947 5770-5771 -COMMA- denotes ,
T948 5772-5773 DT denotes a
T949 5774-5779 NN denotes virus
T950 5780-5784 IN denotes with
T951 5785-5788 DT denotes the
T952 5789-5801 VBN denotes glycosylated
T953 5802-5814 NN denotes glycoprotein
T954 5815-5820 VBZ denotes gains
T955 5821-5823 DT denotes an
T956 5824-5829 JJ denotes extra
T957 5830-5837 NN denotes feature
T958 5838-5841 IN denotes for
T959 5842-5844 DT denotes an
T960 5845-5851 NN denotes escape
T961 5852-5856 IN denotes from
T962 5857-5860 DT denotes the
T963 5861-5867 JJ denotes immune
T964 5868-5877 NNS denotes responses
T965 5879-5888 RB denotes Therefore
T966 5888-5889 -COMMA- denotes ,
T967 5890-5897 NNS denotes glycans
T968 5898-5901 VBP denotes are
T969 5902-5903 DT denotes a
T970 5904-5908 JJ denotes good
T971 5909-5915 NN denotes target
T972 5916-5919 IN denotes for
T973 5920-5927 NN denotes vaccine
T974 5928-5934 NN denotes design
T975 5936-5939 CD denotes Two
T976 5940-5944 JJ denotes main
T977 5945-5950 NNS denotes types
T978 5951-5953 IN denotes of
T979 5954-5961 NNS denotes glycans
T980 5962-5965 VBP denotes are
T981 5966-5974 VBN denotes N-linked
T982 5975-5978 CC denotes and
T983 5979-5987 JJ denotes O-linked
T984 5988-5995 NNS denotes glycans
T985 5997-6001 DT denotes Both
T986 6002-6005 VBP denotes are
T987 6006-6014 VBN denotes released
T988 6015-6019 IN denotes from
T989 6020-6033 NNS denotes glycoproteins
T990 6035-6042 IN denotes Whereas
T991 6043-6050 NNS denotes enzymes
T992 6051-6058 VBP denotes fulfill
T993 6059-6062 DT denotes the
T994 6063-6075 NN denotes construction
T995 6076-6078 IN denotes of
T996 6079-6088 NNS denotes N-glycans
T997 6088-6089 -COMMA- denotes ,
T998 6090-6098 JJ denotes chemical
T999 6099-6106 NNS denotes methods
T1000 6107-6114 VBP denotes perform
T1001 6115-6118 DT denotes the
T1002 6119-6126 NN denotes release
T1003 6127-6129 IN denotes of
T1004 6130-6139 NNS denotes O-glycans
T1005 6141-6150 NNS denotes N-glycans
T1006 6151-6154 VBP denotes are
T1007 6155-6161 VBN denotes linked
T1008 6162-6164 TO denotes to
T1009 6165-6168 DT denotes the
T1010 6169-6174 JJ denotes amino
T1011 6175-6179 NN denotes acid
T1012 6180-6190 NN denotes asparagine
T1013 6191-6192 -LRB- denotes (
T1014 6192-6195 NN denotes Asn
T1015 6195-6196 -RRB- denotes )
T1016 6197-6205 NNS denotes residues
T1017 6206-6207 -LRB- denotes (
T1018 6207-6214 JJ denotes Asn-any
T1019 6215-6220 NN denotes amino
T1020 6221-6226 NNS denotes acids
T1021 6227-6233 IN denotes except
T1022 6234-6237 IN denotes for
T1023 6238-6246 NN denotes proline-
T1024 6247-6250 NN denotes Ser
T1025 6251-6253 CC denotes or
T1026 6254-6257 NN denotes Thr
T1027 6257-6258 -RRB- denotes )
T1028 6259-6268 VBG denotes utilizing
T1029 6269-6271 DT denotes an
T1030 6272-6284 JJ denotes N-glycosidic
T1031 6285-6289 NN denotes bond
T1032 6289-6290 -COMMA- denotes ,
T1033 6291-6297 RB denotes mostly
T1034 6298-6317 NN denotes N-acetylglucosamine
T1035 6319-6328 NNS denotes O-glycans
T1036 6329-6332 VBP denotes are
T1037 6333-6341 VBN denotes attached
T1038 6342-6344 TO denotes to
T1039 6345-6348 DT denotes the
T1040 6349-6354 JJ denotes amino
T1041 6355-6359 NN denotes acid
T1042 6360-6366 NN denotes serine
T1043 6367-6368 -LRB- denotes (
T1044 6368-6371 NN denotes Ser
T1045 6371-6372 -RRB- denotes )
T1046 6373-6376 CC denotes and
T1047 6377-6386 NN denotes threonine
T1048 6387-6388 -LRB- denotes (
T1049 6388-6391 NN denotes Thr
T1050 6391-6392 -RRB- denotes )
T1051 6393-6401 NNS denotes residues
T1052 6402-6404 IN denotes by
T1053 6405-6408 DT denotes the
T1054 6409-6417 NN denotes addition
T1055 6418-6420 IN denotes of
T1056 6421-6423 DT denotes an
T1057 6424-6432 NN denotes N-acetyl
T1058 6433-6446 NN denotes galactosamine
T1059 6447-6448 -LRB- denotes (
T1060 6448-6454 NN denotes GalNAc
T1061 6454-6455 -RRB- denotes )
T1062 6457-6460 IN denotes For
T1063 6461-6468 NN denotes example
T1064 6468-6469 -COMMA- denotes ,
T1065 6470-6479 NNS denotes N-glycans
T1066 6480-6485 VBP denotes exist
T1067 6486-6488 IN denotes in
T1068 6489-6495 NNP denotes Hendra
T1069 6496-6501 NN denotes virus
T1070 6501-6502 -COMMA- denotes ,
T1071 6503-6511 NN denotes SARS-CoV
T1072 6511-6512 -COMMA- denotes ,
T1073 6513-6522 NN denotes influenza
T1074 6523-6528 NN denotes virus
T1075 6528-6529 -COMMA- denotes ,
T1076 6530-6539 NN denotes hepatitis
T1077 6540-6545 NN denotes virus
T1078 6545-6546 -COMMA- denotes ,
T1079 6547-6552 NN denotes HIV-1
T1080 6552-6553 -COMMA- denotes ,
T1081 6554-6557 CC denotes and
T1082 6558-6562 NNP denotes West
T1083 6563-6567 NNP denotes Nile
T1084 6568-6573 NN denotes virus
T1085 6574-6575 -LRB- denotes [
T1086 6575-6576 CD denotes 6
T1087 6576-6577 -RRB- denotes ]
T1088 6577-6578 -COMMA- denotes ,
T1089 6579-6582 CC denotes and
T1090 6583-6592 NNS denotes O-glycans
T1091 6593-6597 VBP denotes have
T1092 6598-6606 VBN denotes occurred
T1093 6607-6609 IN denotes in
T1094 6610-6613 DT denotes the
T1095 6614-6619 NNP denotes Ebola
T1096 6620-6625 NN denotes virus
T1097 6627-6630 DT denotes The
T1098 6631-6640 JJ denotes 2019-nCoV
T1099 6641-6642 NN denotes S
T1100 6643-6650 NN denotes protein
T1101 6651-6659 VBZ denotes includes
T1102 6660-6662 CD denotes 13
T1103 6663-6666 CC denotes and
T1104 6667-6676 JJ denotes 9N-linked
T1105 6677-6690 NN denotes glycosylation
T1106 6691-6698 NNS denotes sequons
T1107 6699-6701 IN denotes in
T1108 6702-6705 DT denotes the
T1109 6706-6708 NN denotes S1
T1110 6709-6712 CC denotes and
T1111 6713-6715 NN denotes S2
T1112 6716-6723 NN denotes subunit
T1113 6723-6724 -COMMA- denotes ,
T1114 6725-6737 RB denotes respectively
T1115 6738-6739 -LRB- denotes [
T1116 6739-6740 CD denotes 3
T1117 6740-6741 -RRB- denotes ]
T1118 6743-6746 DT denotes All
T1119 6747-6749 IN denotes of
T1120 6750-6755 DT denotes these
T1121 6756-6760 VBP denotes have
T1122 6761-6771 RB denotes previously
T1123 6772-6780 VBD denotes occurred
T1124 6781-6783 IN denotes in
T1125 6784-6787 DT denotes the
T1126 6788-6796 JJ denotes SARS-CoV
T1127 6797-6798 NN denotes S
T1128 6799-6811 NN denotes glycoprotein
T1129 6811-6812 -COMMA- denotes ,
T1130 6813-6819 IN denotes except
T1131 6820-6823 IN denotes for
T1132 6824-6835 JJ denotes four-linked
T1133 6836-6849 NN denotes glycosylation
T1134 6850-6857 NNS denotes sequons
T1135 6858-6860 IN denotes in
T1136 6861-6864 DT denotes the
T1137 6865-6867 NN denotes S1
T1138 6869-6873 RB denotes Also
T1139 6873-6874 -COMMA- denotes ,
T1140 6875-6878 JJ denotes due
T1141 6879-6881 TO denotes to
T1142 6882-6885 DT denotes the
T1143 6886-6895 NN denotes existence
T1144 6896-6898 IN denotes of
T1145 6899-6901 DT denotes an
T1146 6902-6907 JJ denotes amino
T1147 6908-6912 NN denotes acid
T1148 6913-6920 NN denotes proline
T1149 6921-6923 IN denotes in
T1150 6924-6927 DT denotes the
T1151 6928-6937 JJ denotes polybasic
T1152 6938-6946 NN denotes cleavage
T1153 6947-6951 NN denotes site
T1154 6951-6952 -COMMA- denotes ,
T1155 6953-6958 WDT denotes which
T1156 6959-6964 VBZ denotes makes
T1157 6965-6968 DT denotes the
T1158 6969-6977 VBN denotes inserted
T1159 6978-6986 NN denotes sequence
T1160 6987-6991 NN denotes PRRA
T1161 6991-6992 -COMMA- denotes ,
T1162 6993-6998 EX denotes there
T1163 6999-7002 VBP denotes are
T1164 7003-7008 CD denotes three
T1165 7009-7017 JJ denotes O-linked
T1166 7018-7025 NNS denotes glycans
T1167 7026-7036 VBN denotes introduced
T1168 7037-7039 TO denotes to
T1169 7040-7043 DT denotes the
T1170 7044-7053 JJ denotes 2019-nCoV
T1171 7054-7057 NN denotes RBD
T1172 7058-7066 NNS denotes residues
T1173 7067-7071 NN denotes S673
T1174 7071-7072 -COMMA- denotes ,
T1175 7073-7077 NN denotes T678
T1176 7077-7078 -COMMA- denotes ,
T1177 7079-7082 CC denotes and
T1178 7083-7087 NN denotes S686
T1179 7088-7089 -LRB- denotes [
T1180 7089-7090 CD denotes 7
T1181 7090-7091 -RRB- denotes ]
T1182 7094-7099 CD denotes 3.1.3
T1183 7101-7110 NN denotes SARS-CoV2
T1184 7111-7119 NN denotes receptor
T1185 7120-7127 NN denotes binding
T1186 7128-7134 NN denotes domain
T1187 7135-7143 VBZ denotes contains
T1188 7144-7147 CD denotes six
T1189 7148-7153 NN denotes amino
T1190 7154-7159 NNS denotes acids
T1191 7160-7169 VBG denotes providing
T1192 7170-7179 JJ denotes favorable
T1193 7180-7189 NNS denotes positions
T1194 7190-7193 IN denotes for
T1195 7194-7201 VBG denotes binding
T1196 7202-7204 TO denotes to
T1197 7205-7210 JJ denotes human
T1198 7211-7215 NN denotes ACE2
T1199 7216-7220 WRB denotes When
T1200 7221-7229 VBN denotes compared
T1201 7230-7232 TO denotes to
T1202 7233-7241 NNP denotes SARS-CoV
T1203 7242-7244 NNP denotes SB
T1204 7244-7245 -COMMA- denotes ,
T1205 7246-7249 DT denotes the
T1206 7250-7255 NN denotes motif
T1207 7256-7263 VBG denotes binding
T1208 7264-7267 DT denotes the
T1209 7268-7273 JJ denotes human
T1210 7274-7278 NN denotes ACE2
T1211 7279-7281 TO denotes to
T1212 7282-7285 DT denotes the
T1213 7286-7294 JJ denotes SARS-CoV
T1214 7295-7296 CD denotes 2
T1215 7297-7299 NN denotes SB
T1216 7300-7306 VBD denotes showed
T1217 7307-7308 DT denotes a
T1218 7309-7319 RB denotes relatively
T1219 7320-7326 JJR denotes higher
T1220 7327-7334 NN denotes binding
T1221 7335-7343 NN denotes affinity
T1222 7344-7347 IN denotes for
T1223 7348-7353 JJ denotes human
T1224 7354-7358 NN denotes ACE2
T1225 7359-7361 IN denotes as
T1226 7362-7371 VBN denotes indicated
T1227 7372-7374 IN denotes in
T1228 7375-7382 JJR denotes smaller
T1229 7383-7394 NN denotes equilibrium
T1230 7395-7407 NN denotes dissociation
T1231 7408-7416 NN denotes constant
T1232 7417-7418 -LRB- denotes (
T1233 7418-7424 NN denotes 2.9 nM
T1234 7425-7428 IN denotes vs.
T1235 7429-7435 NN denotes 7.7 nM
T1236 7435-7436 -RRB- denotes )
T1237 7437-7438 -LRB- denotes [
T1238 7438-7439 CD denotes 3
T1239 7439-7440 -RRB- denotes ]
T1240 7442-7452 JJ denotes Structural
T1241 7453-7461 NN denotes analysis
T1242 7462-7465 VBZ denotes has
T1243 7466-7478 VBN denotes demonstrated
T1244 7479-7483 IN denotes that
T1245 7484-7492 CD denotes fourteen
T1246 7493-7502 NNS denotes positions
T1247 7503-7513 RB denotes critically
T1248 7514-7518 VBP denotes take
T1249 7519-7523 NN denotes part
T1250 7524-7526 IN denotes in
T1251 7527-7530 DT denotes the
T1252 7531-7547 JJ denotes receptor-binding
T1253 7548-7554 NN denotes domain
T1254 7555-7557 IN denotes of
T1255 7558-7561 DT denotes the
T1256 7562-7570 NN denotes SARS-CoV
T1257 7571-7573 NN denotes SB
T1258 7574-7578 WDT denotes that
T1259 7579-7586 VBP denotes contain
T1260 7587-7592 CD denotes eight
T1261 7593-7602 VBN denotes conserved
T1262 7603-7604 -LRB- denotes (
T1263 7604-7608 NN denotes T402
T1264 7608-7609 -COMMA- denotes ,
T1265 7610-7614 NN denotes Y436
T1266 7614-7615 -COMMA- denotes ,
T1267 7616-7620 NN denotes Y440
T1268 7620-7621 -COMMA- denotes ,
T1269 7622-7626 NN denotes N473
T1270 7626-7627 -COMMA- denotes ,
T1271 7628-7632 NN denotes Y475
T1272 7632-7633 -COMMA- denotes ,
T1273 7634-7638 NN denotes T486
T1274 7638-7639 -COMMA- denotes ,
T1275 7640-7644 NN denotes G488
T1276 7644-7645 -COMMA- denotes ,
T1277 7646-7649 CC denotes and
T1278 7650-7654 NN denotes Y491
T1279 7654-7655 -RRB- denotes )
T1280 7656-7665 NNS denotes positions
T1281 7666-7669 CC denotes and
T1282 7670-7673 CD denotes six
T1283 7674-7688 JJ denotes semi-conserved
T1284 7689-7690 -LRB- denotes (
T1285 7690-7694 NN denotes R426
T1286 7695-7697 TO denotes to
T1287 7698-7702 NN denotes N448
T1288 7702-7703 -COMMA- denotes ,
T1289 7704-7708 NN denotes Y442
T1290 7709-7711 TO denotes to
T1291 7712-7716 NN denotes L464
T1292 7716-7717 -COMMA- denotes ,
T1293 7718-7722 NN denotes L472
T1294 7723-7725 TO denotes to
T1295 7726-7730 NN denotes F495
T1296 7730-7731 -COMMA- denotes ,
T1297 7732-7736 NN denotes N479
T1298 7737-7739 TO denotes to
T1299 7740-7744 NN denotes Q502
T1300 7744-7745 -COMMA- denotes ,
T1301 7746-7750 NN denotes Y484
T1302 7751-7753 TO denotes to
T1303 7754-7758 NN denotes Q507
T1304 7758-7759 -COMMA- denotes ,
T1305 7760-7763 CC denotes and
T1306 7764-7768 NN denotes T487
T1307 7769-7771 TO denotes to
T1308 7772-7776 NN denotes N510
T1309 7776-7777 -RRB- denotes )
T1310 7778-7791 NNS denotes substitutions
T1311 7792-7796 IN denotes with
T1312 7797-7804 NN denotes respect
T1313 7805-7807 TO denotes to
T1314 7808-7811 DT denotes the
T1315 7812-7820 JJ denotes SARS-CoV
T1316 7821-7822 CD denotes 2
T1317 7823-7825 NN denotes SB
T1318 7828-7833 CD denotes 3.1.4
T1319 7835-7844 NN denotes SARS-CoV2
T1320 7845-7853 NN denotes receptor
T1321 7854-7861 NN denotes binding
T1322 7862-7868 NN denotes domain
T1323 7869-7877 VBZ denotes contains
T1324 7878-7884 JJ denotes cyclic
T1325 7885-7892 NNS denotes regions
T1326 7893-7897 WDT denotes that
T1327 7898-7901 MD denotes can
T1328 7902-7906 VB denotes make
T1329 7907-7918 NN denotes interaction
T1330 7919-7923 IN denotes with
T1331 7924-7936 JJ denotes cell-surface
T1332 7937-7942 NN denotes GRP78
T1333 7943-7948 NN denotes Pep42
T1334 7949-7951 VBZ denotes is
T1335 7952-7953 DT denotes a
T1336 7954-7960 JJ denotes cyclic
T1337 7961-7973 NN denotes oligopeptide
T1338 7974-7978 IN denotes that
T1339 7978-7979 -COMMA- denotes ,
T1340 7980-7984 IN denotes with
T1341 7985-7988 PRP-DOLLAR- denotes its
T1342 7989-8000 JJ denotes hydrophobic
T1343 8001-8010 NN denotes character
T1344 8010-8011 -COMMA- denotes ,
T1345 8012-8015 MD denotes can
T1346 8016-8027 RB denotes selectively
T1347 8028-8036 VB denotes interact
T1348 8037-8041 IN denotes with
T1349 8042-8046 NN denotes cell
T1350 8047-8054 NN denotes surface
T1351 8055-8072 VBN denotes glucose‐regulated
T1352 8073-8080 NN denotes protein
T1353 8081-8083 CD denotes 78
T1354 8084-8085 -LRB- denotes (
T1355 8085-8090 NN denotes GRP78
T1356 8090-8091 -RRB- denotes )
T1357 8091-8092 -COMMA- denotes ,
T1358 8093-8094 DT denotes a
T1359 8095-8101 NN denotes member
T1360 8102-8104 IN denotes of
T1361 8105-8111 NN denotes 70 kDa
T1362 8112-8116 NN denotes heat
T1363 8117-8122 NN denotes shock
T1364 8123-8131 NNS denotes proteins
T1365 8133-8138 NN denotes GRP78
T1366 8138-8139 -COMMA- denotes ,
T1367 8140-8144 RB denotes also
T1368 8145-8150 VBN denotes known
T1369 8151-8153 IN denotes as
T1370 8154-8157 NN denotes BiP
T1371 8158-8160 CC denotes or
T1372 8161-8166 NN denotes HSPA5
T1373 8166-8167 -COMMA- denotes ,
T1374 8168-8173 IN denotes under
T1375 8174-8185 JJ denotes endoplasmic
T1376 8186-8195 NN denotes reticulum
T1377 8196-8202 NN denotes stress
T1378 8202-8203 -COMMA- denotes ,
T1379 8204-8207 MD denotes can
T1380 8208-8210 VB denotes be
T1381 8211-8223 VBN denotes translocated
T1382 8224-8228 IN denotes from
T1383 8229-8232 DT denotes the
T1384 8233-8244 JJ denotes endoplasmic
T1385 8245-8254 NN denotes reticulum
T1386 8255-8257 TO denotes to
T1387 8258-8261 DT denotes the
T1388 8262-8270 NN denotes membrane
T1389 8271-8274 CC denotes and
T1390 8275-8280 VBZ denotes helps
T1391 8281-8283 TO denotes to
T1392 8284-8292 VB denotes maintain
T1393 8293-8301 JJ denotes cellular
T1394 8302-8311 NN denotes integrity
T1395 8312-8317 IN denotes under
T1396 8318-8329 JJ denotes physiologic
T1397 8330-8333 CC denotes and
T1398 8334-8346 JJ denotes pathological
T1399 8347-8353 NN denotes stress
T1400 8355-8357 PRP denotes It
T1401 8358-8368 RB denotes critically
T1402 8369-8380 VBZ denotes contributes
T1403 8381-8383 TO denotes to
T1404 8384-8391 JJ denotes various
T1405 8392-8401 NNS denotes functions
T1406 8402-8409 VBG denotes ranging
T1407 8410-8414 IN denotes from
T1408 8415-8422 NN denotes protein
T1409 8423-8430 NN denotes folding
T1410 8430-8431 -COMMA- denotes ,
T1411 8432-8446 NN denotes transportation
T1412 8446-8447 -COMMA- denotes ,
T1413 8448-8451 CC denotes and
T1414 8452-8463 NN denotes degradation
T1415 8464-8466 TO denotes to
T1416 8467-8481 JJ denotes cell-signaling
T1417 8481-8482 -COMMA- denotes ,
T1418 8483-8496 NN denotes proliferation
T1419 8496-8497 -COMMA- denotes ,
T1420 8498-8506 NN denotes survival
T1421 8506-8507 -COMMA- denotes ,
T1422 8508-8517 NN denotes apoptosis
T1423 8517-8518 -COMMA- denotes ,
T1424 8519-8531 NN denotes inflammation
T1425 8531-8532 -COMMA- denotes ,
T1426 8533-8536 CC denotes and
T1427 8537-8545 NN denotes immunity
T1428 8547-8550 DT denotes The
T1429 8551-8561 NN denotes expression
T1430 8562-8564 IN denotes of
T1431 8565-8570 NN denotes GRP78
T1432 8571-8580 VBZ denotes decreases
T1433 8581-8585 IN denotes with
T1434 8586-8589 NN denotes age
T1435 8591-8593 IN denotes On
T1436 8594-8597 DT denotes the
T1437 8598-8607 JJ denotes 2019-nCoV
T1438 8608-8613 NN denotes spike
T1439 8614-8621 NN denotes protein
T1440 8621-8622 -COMMA- denotes ,
T1441 8623-8625 CD denotes 13
T1442 8626-8635 NN denotes disulfide
T1443 8636-8641 NNS denotes bonds
T1444 8642-8645 VBP denotes are
T1445 8646-8659 VBG denotes corresponding
T1446 8660-8662 TO denotes to
T1447 8663-8665 CD denotes 13
T1448 8666-8675 JJ denotes different
T1449 8676-8682 JJ denotes cyclic
T1450 8683-8690 NNS denotes regions
T1451 8691-8698 VBN denotes thought
T1452 8699-8701 TO denotes to
T1453 8702-8704 VB denotes be
T1454 8705-8712 JJ denotes similar
T1455 8713-8715 TO denotes to
T1456 8716-8719 DT denotes the
T1457 8720-8726 JJ denotes cyclic
T1458 8727-8731 NN denotes form
T1459 8732-8734 IN denotes of
T1460 8735-8740 NN denotes Pep42
T1461 8741-8742 -LRB- denotes [
T1462 8742-8743 CD denotes 8
T1463 8743-8744 -RRB- denotes ]
T1464 8746-8751 IN denotes Among
T1465 8752-8757 DT denotes these
T1466 8757-8758 -COMMA- denotes ,
T1467 8759-8763 CD denotes four
T1468 8764-8771 NNS denotes regions
T1469 8772-8776 NN denotes I-IV
T1470 8777-8781 VBP denotes take
T1471 8782-8787 NN denotes place
T1472 8788-8790 IN denotes in
T1473 8791-8794 DT denotes the
T1474 8795-8800 JJ denotes outer
T1475 8801-8808 NN denotes surface
T1476 8809-8811 IN denotes of
T1477 8812-8813 DT denotes a
T1478 8814-8822 JJ denotes putative
T1479 8823-8839 JJ denotes receptor-binding
T1480 8840-8846 NN denotes domain
T1481 8847-8848 -LRB- denotes (
T1482 8848-8851 NN denotes RBD
T1483 8851-8852 -RRB- denotes )
T1484 8853-8855 IN denotes on
T1485 8856-8859 DT denotes the
T1486 8860-8865 JJ denotes viral
T1487 8866-8872 NN denotes spike.
T1488 8872-8873 -COMMA- denotes ,
T1489 8874-8883 VBG denotes including
T1490 8884-8888 NN denotes C361
T1491 8888-8889 -COMMA- denotes ,
T1492 8890-8894 NN denotes C379
T1493 8894-8895 -COMMA- denotes ,
T1494 8896-8900 NN denotes C391
T1495 8900-8901 -COMMA- denotes ,
T1496 8902-8905 CC denotes and
T1497 8906-8910 NN denotes C480
T1498 8912-8917 DT denotes These
T1499 8918-8925 NNS denotes regions
T1500 8926-8931 VBP denotes share
T1501 8932-8940 NN denotes sequence
T1502 8941-8951 NN denotes similarity
T1503 8952-8956 IN denotes with
T1504 8957-8962 NN denotes Pep42
T1505 8962-8963 -COMMA- denotes ,
T1506 8964-8971 VBG denotes ranging
T1507 8972-8976 IN denotes from
T1508 8977-8982 CD denotes 15.38
T1509 8982-8983 NN denotes %
T1510 8984-8986 TO denotes to
T1511 8987-8992 CD denotes 46.15
T1512 8992-8993 NN denotes %
T1513 8995-9002 RB denotes However
T1514 9002-9003 -COMMA- denotes ,
T1515 9004-9008 RB denotes only
T1516 9009-9012 CD denotes one
T1517 9013-9015 IN denotes of
T1518 9016-9020 PRP denotes them
T1519 9020-9021 -COMMA- denotes ,
T1520 9022-9026 FW denotes i.e.
T1521 9026-9027 -COMMA- denotes ,
T1522 9028-9034 NN denotes region
T1523 9035-9037 CD denotes IV
T1524 9038-9039 -LRB- denotes (
T1525 9039-9051 NN denotes GRAVY = 0.08
T1526 9051-9052 -RRB- denotes )
T1527 9052-9053 -COMMA- denotes ,
T1528 9054-9056 VBZ denotes is
T1529 9057-9058 DT denotes a
T1530 9059-9070 JJ denotes hydrophobic
T1531 9071-9077 NN denotes region
T1532 9077-9078 -COMMA- denotes ,
T1533 9079-9083 IN denotes like
T1534 9084-9089 NN denotes Pep42
T1535 9090-9091 -LRB- denotes (
T1536 9091-9102 NN denotes GRAVY = 1.1
T1537 9102-9103 -RRB- denotes )
T1538 9105-9115 JJ denotes Structural
T1539 9116-9122 NNS denotes models
T1540 9123-9131 VBP denotes evaluate
T1541 9132-9135 DT denotes the
T1542 9136-9142 NN denotes energy
T1543 9143-9155 NN denotes contribution
T1544 9156-9159 IN denotes for
T1545 9160-9166 NN denotes region
T1546 9167-9169 CD denotes IV
T1547 9170-9172 IN denotes as
T1548 9173-9174 DT denotes a
T1549 9175-9179 NN denotes part
T1550 9180-9182 IN denotes of
T1551 9183-9189 NN denotes region
T1552 9190-9193 CD denotes III
T1553 9194-9196 TO denotes to
T1554 9197-9200 DT denotes the
T1555 9201-9206 NN denotes GRP78
T1556 9207-9209 TO denotes to
T1557 9210-9212 VB denotes be
T1558 9213-9218 IN denotes about
T1559 9219-9220 -LRB- denotes (
T1560 9220-9224 CD denotes −9.8
T1561 9225-9228 IN denotes out
T1562 9229-9231 IN denotes of
T1563 9232-9246 NN denotes −14.0 kcal/mol
T1564 9246-9247 -RRB- denotes )
T1565 9247-9248 -COMMA- denotes ,
T1566 9249-9252 CC denotes and
T1567 9253-9256 DT denotes the
T1568 9257-9264 NN denotes docking
T1569 9265-9273 NN denotes platform
T1570 9274-9282 VBZ denotes proposes
T1571 9283-9289 NN denotes region
T1572 9290-9292 CD denotes IV
T1573 9293-9295 IN denotes as
T1574 9296-9299 DT denotes the
T1575 9300-9304 JJS denotes best
T1576 9305-9311 NN denotes region
T1577 9312-9319 VBG denotes binding
T1578 9320-9322 TO denotes to
T1579 9323-9328 NN denotes GRP78
T1580 9330-9333 DT denotes The
T1581 9334-9340 NN denotes region
T1582 9341-9343 CD denotes IV
T1583 9344-9347 MD denotes can
T1584 9348-9350 VB denotes be
T1585 9351-9357 VBN denotes linked
T1586 9358-9360 TO denotes to
T1587 9361-9364 DT denotes the
T1588 9365-9382 JJ denotes substrate-binding
T1589 9383-9389 NN denotes domain
T1590 9390-9391 NN denotes β
T1591 9392-9393 -LRB- denotes (
T1592 9393-9397 NN denotes SBDB
T1593 9397-9398 -RRB- denotes )
T1594 9399-9401 IN denotes of
T1595 9402-9407 NN denotes GRP78
T1596 9408-9413 VBG denotes using
T1597 9414-9418 CD denotes five
T1598 9419-9426 NNS denotes H-bonds
T1599 9427-9428 -LRB- denotes (
T1600 9428-9435 IN denotes through
T1601 9436-9440 NN denotes P479
T1602 9440-9441 -COMMA- denotes ,
T1603 9442-9446 NN denotes N481
T1604 9446-9447 -COMMA- denotes ,
T1605 9448-9452 NN denotes E484
T1606 9452-9453 -COMMA- denotes ,
T1607 9454-9457 CC denotes and
T1608 9458-9462 NN denotes N487
T1609 9462-9463 -RRB- denotes )
T1610 9464-9467 CC denotes and
T1611 9468-9472 CD denotes four
T1612 9473-9484 JJ denotes hydrophobic
T1613 9485-9497 NNS denotes interactions
T1614 9498-9499 -LRB- denotes (
T1615 9499-9506 IN denotes through
T1616 9507-9511 NN denotes T478
T1617 9511-9512 -COMMA- denotes ,
T1618 9513-9517 NN denotes E484
T1619 9517-9518 -COMMA- denotes ,
T1620 9519-9522 CC denotes and
T1621 9523-9527 NN denotes F486
T1622 9527-9528 -RRB- denotes )
T1623 9531-9532 CD denotes 4
T1624 9534-9541 JJ denotes Passive
T1625 9542-9554 NN denotes immunization
T1626 9555-9560 EX denotes There
T1627 9561-9564 VBP denotes are
T1628 9565-9568 CD denotes two
T1629 9569-9573 JJ denotes main
T1630 9574-9578 NNS denotes ways
T1631 9579-9581 TO denotes to
T1632 9582-9588 VB denotes induce
T1633 9589-9599 NN denotes protection
T1634 9600-9607 IN denotes against
T1635 9608-9618 NNS denotes infections
T1636 9618-9619 -COLON- denotes :
T1637 9620-9626 JJ denotes active
T1638 9627-9630 CC denotes and
T1639 9631-9638 JJ denotes passive
T1640 9639-9651 NN denotes immunization
T1641 9653-9659 JJ denotes Active
T1642 9660-9672 NN denotes immunization
T1643 9673-9678 VBZ denotes comes
T1644 9679-9681 TO denotes to
T1645 9682-9687 VB denotes exist
T1646 9688-9692 WRB denotes when
T1647 9693-9696 DT denotes the
T1648 9697-9701 NN denotes body
T1649 9701-9703 POS denotes 's
T1650 9704-9707 JJ denotes own
T1651 9708-9714 JJ denotes immune
T1652 9715-9721 NN denotes system
T1653 9722-9725 MD denotes can
T1654 9726-9733 VB denotes produce
T1655 9734-9744 NNS denotes antibodies
T1656 9745-9753 RB denotes actively
T1657 9754-9763 VBG denotes following
T1658 9764-9772 NN denotes exposure
T1659 9773-9775 TO denotes to
T1660 9776-9777 DT denotes a
T1661 9778-9783 JJ denotes viral
T1662 9784-9791 NN denotes antigen
T1663 9793-9795 IN denotes On
T1664 9796-9799 DT denotes the
T1665 9800-9808 NN denotes contrary
T1666 9808-9809 -COMMA- denotes ,
T1667 9810-9815 EX denotes there
T1668 9816-9818 VBZ denotes is
T1669 9819-9820 DT denotes a
T1670 9821-9828 NN denotes passive
T1671 9829-9836 VBG denotes working
T1672 9837-9841 NN denotes mode
T1673 9842-9844 IN denotes of
T1674 9845-9848 DT denotes the
T1675 9849-9855 JJ denotes immune
T1676 9856-9862 NN denotes system
T1677 9863-9867 WDT denotes that
T1678 9868-9873 MD denotes would
T1679 9874-9880 VB denotes appear
T1680 9881-9890 VBG denotes following
T1681 9891-9894 DT denotes the
T1682 9895-9903 NN denotes transfer
T1683 9904-9906 IN denotes of
T1684 9907-9917 NNS denotes antibodies
T1685 9918-9922 WDT denotes that
T1686 9923-9926 VBP denotes act
T1687 9927-9935 RB denotes directly
T1688 9936-9938 TO denotes to
T1689 9939-9949 VB denotes neutralize
T1690 9950-9955 JJ denotes viral
T1691 9956-9967 NN denotes infectivity
T1692 9970-9973 CD denotes 4.1
T1693 9975-9980 NN denotes Serum
T1694 9981-9988 NN denotes therapy
T34096 9990-9995 CD denotes 4.1.1
T81207 9997-10009 JJ denotes Convalescent
T7654 10010-10016 NN denotes plasma
T71050 10017-10021 IN denotes from
T25890 10022-10030 NNS denotes patients
T44174 10031-10040 VBN denotes recovered
T26910 10041-10045 IN denotes from
T41378 10046-10054 NN denotes COVID-19
T88463 10056-10063 CD denotes 4.1.1.1
T5371 10065-10075 NN denotes Hypothesis
T65084 10075-10076 -COLON- denotes :
T11805 10077-10083 NN denotes Plasma
T86158 10084-10088 IN denotes from
T7828 10089-10097 NNS denotes patients
T20215 10098-10107 VBN denotes recovered
T19523 10108-10112 IN denotes from
T35336 10113-10121 NN denotes COVID-19
T99442 10122-10129 VBP denotes contain
T6188 10130-10140 NNS denotes antibodies
T80510 10141-10148 IN denotes against
T57397 10149-10158 NN denotes 2019-nCoV
T57607 10159-10160 DT denotes A
T47460 10161-10165 NN denotes look
T44003 10166-10168 IN denotes at
T20122 10169-10172 DT denotes the
T89678 10173-10180 NN denotes history
T33850 10181-10183 IN denotes of
T21640 10184-10189 JJ denotes viral
T53029 10190-10199 NNS denotes outbreaks
T73113 10200-10206 VBZ denotes offers
T71269 10207-10219 JJ denotes convalescent
T26722 10220-10226 NN denotes plasma
T32817 10227-10229 IN denotes as
T73367 10230-10233 DT denotes the
T23573 10234-10238 JJ denotes only
T80270 10239-10245 NN denotes remedy
T50380 10246-10248 TO denotes to
T14621 10249-10254 VB denotes avoid
T15138 10255-10262 JJ denotes further
T77639 10263-10273 NNS denotes fatalities
T94916 10275-10278 DT denotes The
T85352 10279-10283 RBS denotes most
T26901 10284-10290 JJ denotes recent
T70143 10291-10299 NNS denotes examples
T49434 10300-10307 VBP denotes include
T54973 10308-10311 DT denotes the
T39553 10312-10320 NN denotes pandemic
T56433 10321-10323 IN denotes of
T99958 10324-10333 NN denotes influenza
T27857 10334-10335 NN denotes A
T52981 10336-10340 NN denotes H1N1
T85532 10341-10342 -LRB- denotes (
T70555 10342-10351 NN denotes H1N1pdm09
T58026 10351-10352 -RRB- denotes )
T49738 10353-10355 IN denotes in
T7553 10356-10361 NN denotes virus
T41345 10362-10371 NN denotes infection
T46256 10372-10376 CD denotes 2009
T28857 10376-10377 -COMMA- denotes ,
T13934 10378-10381 DT denotes the
T20739 10382-10389 NNP denotes Western
T80018 10390-10397 NNP denotes African
T70659 10398-10403 NNP denotes Ebola
T34284 10404-10409 NN denotes virus
T92495 10410-10418 JJ denotes epidemic
T36003 10419-10421 IN denotes in
T12982 10422-10426 CD denotes 2014
T49803 10426-10427 -COMMA- denotes ,
T90021 10428-10431 CC denotes and
T16664 10432-10435 DT denotes the
T58899 10436-10444 NN denotes outbreak
T11963 10445-10447 IN denotes of
T71906 10448-10456 NN denotes MERS-CoV
T74174 10457-10459 IN denotes in
T70278 10460-10464 CD denotes 2015
T44828 10465-10466 -LRB- denotes [
T58846 10466-10467 CD denotes 9
T98769 10467-10468 -RRB- denotes ]
T44041 10470-10483 NN denotes Meta-analysis
T92755 10484-10491 NNS denotes studies
T83388 10492-10496 VBP denotes have
T75238 10497-10502 VBN denotes shown
T72067 10503-10504 DT denotes a
T19254 10505-10512 VBN denotes reduced
T86955 10513-10517 NN denotes risk
T79896 10518-10520 IN denotes of
T13682 10521-10530 NN denotes mortality
T55812 10531-10533 IN denotes in
T18322 10534-10542 NNS denotes patients
T80297 10543-10547 IN denotes with
T10571 10548-10556 NN denotes SARS-CoV
T28781 10557-10560 CC denotes and
T12582 10561-10570 NN denotes influenza
T82834 10571-10580 VBG denotes receiving
T84690 10581-10593 JJ denotes convalescent
T47738 10594-10600 NN denotes plasma
T87902 10601-10602 -LRB- denotes [
T15127 10602-10604 CD denotes 10
T21677 10604-10605 -RRB- denotes ]
T51845 10608-10615 CD denotes 4.1.1.2
T81264 10617-10626 NNP denotes Rationale
T56248 10626-10627 -COLON- denotes :
T77485 10628-10640 JJ denotes Convalescent
T80710 10641-10647 NN denotes plasma
T37520 10648-10652 IN denotes from
T57657 10653-10661 NNS denotes patients
T22774 10662-10671 VBN denotes recovered
T85435 10672-10676 IN denotes from
T50571 10677-10685 NN denotes COVID-19
T48141 10686-10689 MD denotes can
T93212 10690-10695 VB denotes treat
T48287 10696-10704 NNS denotes patients
T91679 10705-10709 IN denotes with
T80666 10710-10716 JJ denotes severe
T17217 10717-10725 NN denotes COVID-19
T94687 10726-10727 DT denotes A
T22655 10728-10733 NN denotes pilot
T19573 10734-10739 NN denotes study
T23972 10740-10741 -LRB- denotes [
T55337 10741-10743 CD denotes 11
T96728 10743-10744 -RRB- denotes ]
T92410 10745-10753 RB denotes recently
T26265 10754-10757 VBZ denotes has
T35997 10758-10770 VBN denotes investigated
T92380 10771-10774 DT denotes the
T38590 10775-10781 NN denotes safety
T37156 10782-10785 CC denotes and
T24661 10786-10792 NN denotes effect
T94632 10793-10795 IN denotes of
T56352 10796-10808 JJ denotes convalescent
T65134 10809-10815 NN denotes plasma
T64844 10816-10820 WDT denotes that
T95987 10821-10828 VBP denotes contain
T86655 10829-10837 NN denotes antibody
T45118 10838-10844 NNS denotes levels
T26321 10845-10851 JJR denotes higher
T17226 10852-10856 IN denotes than
T2522 10857-10858 CD denotes 1
T48589 10858-10859 -COLON- denotes :
T90182 10859-10862 CD denotes 640
T89317 10863-10871 VBN denotes combined
T28925 10872-10876 IN denotes with
T68950 10877-10884 JJ denotes regular
T58621 10885-10895 JJ denotes anti-viral
T22929 10896-10902 NNS denotes agents
T50644 10903-10906 CC denotes and
T63224 10907-10915 JJ denotes standard
T22041 10916-10926 JJ denotes supportive
T89053 10927-10931 NN denotes care
T94835 10932-10934 IN denotes on
T20257 10935-10943 JJ denotes clinical
T49329 10944-10952 NNS denotes outcomes
T91601 10953-10955 IN denotes of
T6238 10956-10959 CD denotes ten
T3048 10960-10968 NNS denotes patients
T18696 10969-10973 IN denotes with
T93206 10974-10980 JJ denotes severe
T71443 10981-10989 NN denotes COVID-19
T46997 10991-10994 DT denotes The
T7672 10995-11000 NN denotes study
T83098 11001-11007 VBD denotes showed
T5017 11008-11016 JJ denotes clinical
T96870 11017-11028 NN denotes improvement
T42442 11029-11031 IN denotes of
T61149 11032-11035 PDT denotes all
T89276 11036-11039 DT denotes the
T53728 11040-11043 CD denotes ten
T50396 11044-11052 NNS denotes patients
T59179 11053-11064 VBN denotes accompanied
T83510 11065-11067 IN denotes by
T2183 11068-11070 DT denotes an
T4240 11071-11079 NN denotes increase
T18383 11080-11082 IN denotes in
T99269 11083-11093 NN denotes lymphocyte
T12131 11094-11099 NN denotes count
T36613 11100-11103 CC denotes and
T91622 11104-11105 DT denotes a
T39579 11106-11114 NN denotes decrease
T72559 11115-11117 IN denotes in
T31686 11118-11121 NN denotes CRP
T20580 11123-11132 VBG denotes Following
T23341 11133-11144 NN denotes transfusion
T23846 11145-11147 IN denotes of
T23496 11148-11160 JJ denotes convalescent
T68740 11161-11167 NN denotes plasma
T74721 11167-11168 -COMMA- denotes ,
T3255 11169-11172 PDT denotes all
T47829 11173-11176 DT denotes the
T16466 11177-11182 CD denotes seven
T26913 11183-11191 NNS denotes patients
T47643 11192-11195 WP denotes who
T10299 11196-11200 VBD denotes were
T19318 11201-11210 NN denotes SARS-CoV2
T2642 11211-11214 NN denotes RNA
T76428 11215-11223 JJ denotes positive
T59448 11224-11230 IN denotes before
T49967 11231-11242 NN denotes transfusion
T2352 11243-11245 IN denotes of
T3020 11246-11258 JJ denotes convalescent
T57517 11259-11265 NN denotes plasma
T55829 11266-11272 VBD denotes turned
T39392 11273-11282 NN denotes SARS-CoV2
T26456 11283-11291 JJ denotes negative
T52249 11293-11298 EX denotes There
T13795 11299-11303 VBD denotes were
T15563 11304-11306 DT denotes no
T53693 11307-11314 NN denotes control
T35357 11315-11321 NNS denotes groups
T16756 11322-11331 VBG denotes receiving
T53621 11332-11344 JJ denotes convalescent
T81904 11345-11351 NN denotes plasma
T11852 11352-11357 RB denotes alone
T58859 11358-11360 CC denotes or
T35171 11361-11369 JJ denotes standard
T39367 11370-11377 NN denotes therapy
T20306 11378-11385 IN denotes without
T63670 11386-11398 JJ denotes convalescent
T44856 11399-11406 NN denotes therapy
T15733 11407-11409 TO denotes to
T71428 11410-11418 VB denotes evaluate
T29390 11419-11422 DT denotes the
T54708 11423-11427 JJ denotes main
T64138 11428-11434 NN denotes effect
T21425 11435-11437 IN denotes of
T75685 11438-11450 JJ denotes convalescent
T78861 11451-11457 NN denotes plasma
T16328 11460-11465 CD denotes 4.1.2
T3323 11467-11472 NN denotes Serum
T79102 11473-11477 IN denotes from
T73342 11478-11482 NNS denotes bats
T89375 11483-11487 IN denotes with
T36397 11488-11497 JJ denotes SARS-like
T22412 11498-11501 NN denotes CoV
T58124 11503-11510 CD denotes 4.1.2.1
T5376 11512-11522 NN denotes Hypothesis
T34741 11522-11523 -COLON- denotes :
T62090 11524-11536 JJ denotes whole-genome
T52998 11537-11547 NN denotes sequencing
T20323 11548-11551 CC denotes and
T7728 11552-11564 JJ denotes phylogenetic
T67504 11565-11573 NN denotes analysis
T76343 11574-11578 VBD denotes shed
T36219 11579-11584 NN denotes light
T40337 11585-11587 IN denotes on
T54452 11588-11591 DT denotes the
T33856 11592-11598 NN denotes origin
T37831 11599-11601 IN denotes of
T28355 11602-11605 DT denotes the
T31802 11606-11615 JJ denotes 2019-nCoV
T95515 11616-11621 NN denotes virus
T64814 11622-11623 VBP denotes –
T87875 11624-11626 PRP denotes It
T46333 11627-11630 VBZ denotes has
T28188 11631-11635 VBN denotes been
T22492 11636-11644 RB denotes probably
T62169 11645-11655 VBN denotes introduced
T13328 11656-11660 IN denotes from
T96521 11661-11665 NNS denotes bats
T30811 11666-11668 TO denotes to
T52514 11669-11672 NNS denotes men
T28843 11673-11679 NN denotes Genome
T46450 11680-11690 NN denotes sequencing
T27748 11691-11693 IN denotes of
T27295 11694-11695 DT denotes a
T62671 11696-11701 JJ denotes fecal
T93555 11702-11705 NN denotes bat
T52375 11706-11712 NN denotes sample
T30106 11712-11713 -COMMA- denotes ,
T79240 11714-11717 NN denotes Rp3
T51658 11717-11718 -COMMA- denotes ,
T48337 11719-11724 MD denotes could
T23533 11725-11731 VB denotes detect
T45372 11732-11734 DT denotes an
T48569 11735-11742 NN denotes isolate
T20680 11743-11745 IN denotes of
T19302 11746-11759 NNS denotes coronaviruses
T18234 11759-11760 -COMMA- denotes ,
T77212 11761-11766 WDT denotes which
T37427 11767-11770 VBD denotes was
T90838 11771-11777 RB denotes almost
T69281 11778-11787 JJ denotes identical
T30703 11788-11790 TO denotes to
T45933 11791-11794 DT denotes the
T53102 11795-11804 JJ denotes causative
T21161 11805-11810 NN denotes agent
T31651 11811-11813 IN denotes of
T24092 11814-11817 DT denotes the
T76932 11818-11826 JJ denotes SARS-CoV
T42133 11827-11835 NN denotes outbreak
T26029 11836-11838 IN denotes of
T7676 11839-11848 CD denotes 2002–2003
T55417 11850-11855 RB denotes Hence
T40490 11855-11856 -COMMA- denotes ,
T99577 11857-11859 PRP denotes it
T85900 11860-11868 VBD denotes attained
T84303 11869-11872 DT denotes the
T99794 11873-11877 NN denotes name
T28667 11878-11887 JJ denotes SARS-like
T13194 11888-11899 NN denotes coronavirus
T40481 11900-11907 NN denotes isolate
T51053 11908-11911 NN denotes Rp3
T84085 11912-11913 -LRB- denotes (
T37600 11913-11919 NN denotes SL-CoV
T96263 11920-11923 NN denotes Rp3
T15140 11923-11924 -RRB- denotes )
T87895 11925-11926 -LRB- denotes [
T40198 11926-11928 CD denotes 12
T79787 11928-11929 -RRB- denotes ]
T87849 11931-11934 DT denotes The
T82417 11935-11950 JJ denotes bronchoalveolar
T31054 11951-11957 NN denotes lavage
T37752 11958-11963 NN denotes fluid
T74238 11964-11965 -LRB- denotes (
T3228 11965-11969 NN denotes BALF
T70930 11969-11970 -RRB- denotes )
T9092 11971-11973 IN denotes of
T49696 11974-11975 DT denotes a
T42278 11976-11983 NN denotes patient
T77065 11984-11988 IN denotes with
T56445 11989-11993 NNS denotes SARS
T91231 11994-12003 VBD denotes contained
T55260 12004-12007 DT denotes the
T14876 12008-12017 NN denotes 2019-nCoV
T41253 12019-12022 NN denotes RNA
T76927 12023-12033 NN denotes sequencing
T21523 12034-12039 MD denotes could
T61033 12040-12046 VB denotes reveal
T57735 12047-12052 RB denotes about
T17027 12053-12055 CD denotes 90
T88762 12055-12056 NN denotes %
T56862 12057-12067 NN denotes similarity
T58084 12068-12070 IN denotes in
T42893 12071-12082 NNS denotes nucleotides
T28737 12083-12085 IN denotes of
T98581 12086-12089 DT denotes the
T54378 12090-12095 JJ denotes novel
T41408 12096-12107 NN denotes coronavirus
T8820 12108-12111 CC denotes and
T82233 12112-12114 IN denotes of
T87395 12115-12124 JJ denotes SARS-like
T25315 12125-12136 NN denotes coronavirus
T40001 12137-12141 WDT denotes that
T50563 12142-12145 VBD denotes had
T73327 12146-12156 RB denotes previously
T43308 12157-12164 VBN denotes related
T87528 12165-12167 TO denotes to
T18784 12168-12172 NNS denotes bats
T21998 12173-12174 -LRB- denotes [
T45109 12174-12176 CD denotes 13
T62980 12176-12177 -RRB- denotes ]
T34259 12177-12178 -COMMA- denotes ,
T56176 12179-12180 -LRB- denotes [
T43975 12180-12182 CD denotes 14
T89437 12182-12183 -RRB- denotes ]
T32040 12185-12187 IN denotes In
T92103 12188-12198 JJ denotes particular
T46259 12198-12199 -COMMA- denotes ,
T37699 12200-12203 DT denotes the
T72545 12204-12205 NN denotes S
T24131 12206-12213 NN denotes protein
T44437 12214-12216 IN denotes of
T20264 12217-12220 DT denotes the
T45006 12221-12230 NN denotes 2019-nCoV
T85613 12231-12234 VBZ denotes has
T77820 12235-12236 DT denotes a
T51362 12237-12241 JJ denotes high
T86629 12242-12250 NN denotes sequence
T85333 12251-12259 NN denotes identity
T4126 12260-12262 IN denotes of
T23106 12263-12268 CD denotes 80–98
T47986 12268-12269 NN denotes %
T62529 12270-12274 IN denotes with
T47180 12275-12278 DT denotes the
T64906 12279-12280 NN denotes S
T55893 12281-12288 NN denotes protein
T84276 12289-12291 IN denotes of
T27337 12292-12295 NN denotes bat
T65227 12296-12305 JJ denotes SARS-like
T48841 12306-12310 NNS denotes CoVs
T43941 12310-12311 -COMMA- denotes ,
T76487 12312-12316 JJ denotes such
T69082 12317-12319 IN denotes as
T24341 12320-12329 JJ denotes SARSr-CoV
T77949 12330-12335 NN denotes ZXC21
T33016 12336-12337 NNP denotes S
T45981 12337-12338 -COMMA- denotes ,
T58714 12339-12343 NNP denotes ZC45
T47242 12344-12345 NNP denotes S
T24128 12345-12346 -COMMA- denotes ,
T33217 12347-12350 CC denotes and
T49688 12351-12357 NN denotes RaTG13
T48117 12358-12359 -LRB- denotes [
T8349 12359-12360 CD denotes 3
T82587 12360-12361 -RRB- denotes ]
T26826 12363-12371 RB denotes Moreover
T40424 12371-12372 -COMMA- denotes ,
T82603 12373-12375 IN denotes in
T83961 12376-12388 JJ denotes phylogenomic
T26439 12389-12394 NNS denotes trees
T36143 12394-12395 -COMMA- denotes ,
T1931 12396-12404 NNS denotes branches
T94548 12405-12408 IN denotes for
T9564 12409-12412 DT denotes the
T82190 12413-12422 NN denotes 2019-nCoV
T51998 12423-12426 VBP denotes are
T48884 12427-12429 IN denotes of
T84416 12430-12437 JJR denotes greater
T46091 12438-12444 NN denotes length
T44026 12445-12449 IN denotes than
T19745 12450-12455 DT denotes those
T66697 12456-12459 IN denotes for
T66659 12460-12463 DT denotes the
T22981 12464-12468 CD denotes 2003
T47496 12469-12477 NN denotes SARS-CoV
T18117 12477-12478 -COMMA- denotes ,
T90160 12479-12482 CC denotes and
T86256 12483-12492 RB denotes therefore
T89702 12493-12497 RBR denotes more
T19375 12498-12507 JJ denotes favorable
T58982 12508-12510 TO denotes to
T17546 12511-12515 NNS denotes bats
T69872 12518-12525 CD denotes 4.1.2.2
T72014 12527-12536 NNP denotes Rationale
T36633 12536-12537 -COLON- denotes :
T95726 12538-12541 NN denotes Bat
T12601 12542-12547 NN denotes serum
T14267 12548-12550 VBZ denotes is
T39971 12551-12554 RB denotes not
T40602 12555-12559 JJ denotes able
T35003 12560-12562 TO denotes to
T99887 12563-12574 RB denotes efficiently
T76540 12575-12585 VB denotes neutralize
T13120 12586-12594 NN denotes SARS-CoV
T35896 12595-12598 DT denotes The
T64598 12599-12604 NN denotes range
T32273 12605-12607 IN denotes of
T17280 12608-12612 NNS denotes bats
T96367 12612-12613 -COMMA- denotes ,
T68610 12614-12623 VBG denotes belonging
T26256 12624-12626 TO denotes to
T16732 12627-12630 DT denotes the
T46544 12631-12636 NN denotes genus
T77475 12637-12648 NN denotes Rhinolophus
T40616 12649-12650 -LRB- denotes (
T58340 12650-12659 NN denotes horseshoe
T54336 12660-12664 NNS denotes bats
T12834 12664-12665 -RRB- denotes )
T98779 12666-12669 CC denotes and
T38088 12670-12673 DT denotes the
T30678 12674-12680 NN denotes family
T95468 12681-12694 NNP denotes Rhinolophidae
T49538 12694-12695 -COMMA- denotes ,
T57549 12696-12703 VBP denotes produce
T22931 12704-12707 DT denotes the
T96372 12708-12716 JJ denotes SARS-CoV
T96617 12717-12725 NN denotes antibody
T26331 12726-12727 -LRB- denotes [
T79958 12727-12729 CD denotes 12
T94954 12729-12730 -RRB- denotes ]
T31150 12732-12742 NN denotes Polymerase
T34558 12743-12748 NN denotes chain
T29624 12749-12757 NN denotes reaction
T20040 12758-12759 -LRB- denotes (
T66963 12759-12762 NN denotes PCR
T86417 12762-12763 -RRB- denotes )
T74170 12764-12768 MD denotes will
T58244 12769-12776 VB denotes confirm
T34209 12777-12780 DT denotes the
T81644 12781-12789 NN denotes presence
T94659 12790-12792 IN denotes of
T93490 12793-12801 NN denotes SARS-CoV
T60580 12802-12814 NN denotes nucleocapsid
T19399 12815-12816 -LRB- denotes (
T43412 12816-12817 NN denotes N
T97174 12817-12818 -RRB- denotes )
T57901 12819-12822 CC denotes and
T74666 12823-12833 NN denotes polymerase
T46614 12834-12835 -LRB- denotes (
T2670 12835-12836 NN denotes P
T11868 12836-12837 -RRB- denotes )
T4452 12838-12846 NNS denotes proteins
T18709 12847-12849 IN denotes in
T53625 12850-12855 JJ denotes fecal
T33015 12856-12863 NNS denotes samples
T22237 12864-12866 IN denotes if
T47566 12867-12869 DT denotes an
T64813 12870-12880 JJ denotes individual
T7157 12881-12884 NN denotes bat
T16625 12885-12890 VBG denotes being
T28791 12891-12903 JJ denotes seropositive
T57534 12904-12907 IN denotes for
T8160 12908-12916 NN denotes SARS-CoV
T13336 12917-12918 -LRB- denotes [
T37204 12918-12920 CD denotes 12
T59200 12920-12921 -RRB- denotes ]
T53492 12923-12928 EX denotes There
T25066 12929-12931 VBZ denotes is
T54103 12932-12933 DT denotes a
T67673 12934-12945 JJ denotes significant
T81378 12946-12952 NN denotes degree
T78835 12953-12955 IN denotes of
T5389 12956-12967 NN denotes resemblance
T55726 12968-12970 IN denotes of
T9133 12971-12978 JJR denotes greater
T51866 12979-12983 IN denotes than
T67947 12984-12986 CD denotes 90
T67121 12986-12987 NN denotes %
T42920 12988-12990 IN denotes in
T98118 12991-12994 DT denotes the
T35947 12995-13005 NN denotes nucleotide
T39927 13006-13014 NN denotes sequence
T7432 13015-13017 IN denotes of
T69163 13018-13021 DT denotes the
T80745 13022-13027 JJ denotes viral
T20946 13028-13035 NNS denotes genomes
T60639 13036-13043 IN denotes between
T51508 13044-13050 NN denotes SL-CoV
T38342 13051-13054 NN denotes Rp3
T27996 13055-13056 -LRB- denotes [
T68906 13056-13058 CD denotes 12
T31717 13058-13059 -RRB- denotes ]
T45580 13060-13063 CC denotes and
T28138 13064-13067 DT denotes the
T93675 13068-13072 NN denotes Tor2
T7628 13073-13079 NN denotes strain
T18229 13080-13082 IN denotes of
T74591 13083-13091 NN denotes SARS-CoV
T32520 13092-13093 NN denotes –
T53721 13094-13099 WDT denotes which
T18272 13100-13103 VBD denotes was
T81326 13104-13112 VBN denotes isolated
T85814 13113-13115 IN denotes in
T8090 13116-13123 NNP denotes Toronto
T96099 13124-13125 -LRB- denotes [
T48626 13125-13127 CD denotes 15
T63640 13127-13128 -RRB- denotes ]
T47685 13130-13133 DT denotes The
T95952 13134-13145 NNS denotes differences
T83153 13146-13148 IN denotes in
T89898 13149-13152 DT denotes the
T5455 13153-13159 NN denotes genome
T57783 13160-13169 NNS denotes sequences
T32904 13170-13172 IN denotes of
T64654 13173-13181 NN denotes SARS-CoV
T33080 13182-13184 IN denotes in
T20399 13185-13188 DT denotes the
T6021 13189-13192 CD denotes two
T91889 13193-13200 NNS denotes species
T16420 13201-13206 VBP denotes occur
T17928 13207-13213 RB denotes merely
T18957 13214-13216 IN denotes in
T30016 13217-13220 DT denotes the
T55882 13221-13222 NN denotes S
T98573 13223-13227 NN denotes gene
T52934 13228-13229 NN denotes –
T45076 13230-13235 WDT denotes which
T16269 13236-13243 VBZ denotes encodes
T35597 13244-13247 DT denotes the
T87578 13248-13250 NN denotes S1
T90762 13251-13257 NN denotes domain
T47778 13258-13260 IN denotes of
T34405 13261-13264 DT denotes the
T12863 13265-13276 NN denotes coronavirus
T32427 13277-13282 NN denotes spike
T45316 13283-13290 NN denotes protein
T15815 13291-13294 CC denotes and
T13365 13295-13303 VBZ denotes contains
T22966 13304-13311 NNS denotes regions
T35366 13312-13316 IN denotes with
T87135 13317-13321 JJ denotes high
T71483 13322-13330 NN denotes mutation
T52732 13331-13336 NNS denotes rates
T42165 13337-13338 -LRB- denotes [
T12526 13338-13340 CD denotes 12
T31829 13340-13341 -RRB- denotes ]
T48594 13343-13346 DT denotes The
T43996 13347-13360 NNS denotes coronaviruses
T64690 13361-13369 RB denotes commonly
T94005 13370-13377 VBP denotes possess
T52748 13378-13382 CD denotes five
T25177 13383-13387 JJ denotes open
T13269 13388-13395 NN denotes reading
T8033 13396-13402 NNS denotes frames
T6150 13403-13404 -LRB- denotes (
T75001 13404-13407 NN denotes ORF
T23258 13407-13408 -RRB- denotes )
T31588 13409-13413 WDT denotes that
T98349 13414-13423 VBP denotes correlate
T84544 13424-13428 IN denotes with
T88926 13429-13432 DT denotes the
T71973 13433-13443 NN denotes production
T7216 13444-13446 IN denotes of
T15921 13447-13450 DT denotes the
T20599 13451-13460 NN denotes replicase
T83272 13461-13472 NN denotes polyprotein
T61529 13473-13474 -LRB- denotes (
T58827 13474-13475 NN denotes P
T90447 13475-13476 -RRB- denotes )
T70573 13476-13477 -COMMA- denotes ,
T42366 13478-13481 DT denotes the
T58682 13482-13487 NN denotes spike
T13646 13488-13489 -LRB- denotes (
T70419 13489-13490 NN denotes S
T16399 13490-13491 -RRB- denotes )
T28149 13491-13492 -COMMA- denotes ,
T93891 13493-13501 NN denotes envelope
T12498 13502-13503 -LRB- denotes (
T49731 13503-13504 NN denotes E
T56677 13504-13505 -RRB- denotes )
T64104 13505-13506 -COMMA- denotes ,
T31208 13507-13510 CC denotes and
T67550 13511-13519 NN denotes membrane
T28810 13520-13521 -LRB- denotes (
T38106 13521-13522 NN denotes M
T30434 13522-13523 -RRB- denotes )
T87007 13524-13537 NNS denotes glycoproteins
T95580 13538-13541 CC denotes and
T76152 13542-13545 DT denotes the
T84704 13546-13558 NN denotes nucleocapsid
T19426 13559-13560 -LRB- denotes (
T15241 13560-13561 NN denotes N
T55062 13561-13562 -RRB- denotes )
T28738 13563-13570 NN denotes protein
T87202 13572-13575 DT denotes The
T16130 13576-13581 JJ denotes human
T9407 13582-13590 NN denotes SARS-CoV
T28228 13591-13595 NN denotes Tor2
T71564 13596-13599 CC denotes and
T14942 13600-13603 NN denotes bat
T87890 13604-13610 NN denotes SL-CoV
T92515 13611-13614 NN denotes Rp3
T40210 13615-13622 NNS denotes strains
T99566 13623-13629 VBP denotes remain
T25851 13630-13634 JJR denotes more
T93008 13635-13639 IN denotes than
T9385 13640-13642 CD denotes 90
T64424 13642-13643 NN denotes %
T39551 13644-13653 JJ denotes identical
T74931 13654-13656 IN denotes at
T24944 13657-13660 DT denotes the
T54178 13661-13669 NNS denotes proteins
T40259 13670-13671 NN denotes P
T38116 13671-13672 -COMMA- denotes ,
T14257 13673-13674 NN denotes E
T31483 13674-13675 -COMMA- denotes ,
T90324 13676-13677 NN denotes M
T13349 13677-13678 -COMMA- denotes ,
T43323 13679-13682 CC denotes and
T37619 13683-13685 NNP denotes N.
T58268 13686-13689 DT denotes the
T53333 13690-13697 NN denotes protein
T21482 13698-13699 NN denotes S
T15154 13700-13708 VBZ denotes consists
T15378 13709-13711 IN denotes of
T8893 13712-13715 CD denotes two
T80047 13716-13720 JJ denotes main
T39154 13721-13728 NNS denotes domains
T63966 13728-13729 -COLON- denotes :
T14525 13730-13731 LS denotes 1
T24485 13731-13732 -RRB- denotes )
T14573 13733-13736 DT denotes the
T2720 13737-13739 NN denotes S1
T53057 13740-13746 NN denotes domain
T52808 13747-13754 VBZ denotes conveys
T40693 13755-13758 DT denotes the
T99923 13759-13763 NN denotes role
T37838 13764-13766 IN denotes of
T16526 13767-13775 NN denotes receptor
T67511 13776-13783 NN denotes binding
T34590 13784-13787 CC denotes and
T11269 13788-13789 LS denotes 2
T5490 13789-13790 -RRB- denotes )
T64378 13791-13794 DT denotes the
T5826 13795-13797 NN denotes S2
T79439 13798-13804 NN denotes domain
T56787 13805-13812 VBZ denotes assumes
T43097 13813-13816 DT denotes the
T86961 13817-13821 NN denotes role
T18963 13822-13824 IN denotes of
T97770 13825-13828 DT denotes the
T77887 13829-13835 NN denotes fusion
T55259 13836-13838 IN denotes of
T85369 13839-13844 JJ denotes viral
T77390 13845-13848 CC denotes and
T15313 13849-13858 NN denotes host-cell
T74327 13859-13868 NNS denotes membranes
T22912 13870-13872 IN denotes In
T58392 13873-13883 JJ denotes particular
T84749 13883-13884 -COMMA- denotes ,
T94019 13885-13888 DT denotes the
T82008 13889-13894 JJ denotes human
T43891 13895-13903 NN denotes SARS-CoV
T54296 13904-13908 NN denotes Tor2
T34731 13909-13915 NN denotes strain
T75489 13916-13921 VBZ denotes shows
T56235 13922-13923 DT denotes a
T89657 13924-13934 JJ denotes noticeable
T75815 13935-13941 NN denotes degree
T92988 13942-13944 IN denotes of
T77130 13945-13955 NN denotes difference
T40843 13956-13958 IN denotes in
T41545 13959-13962 DT denotes the
T39219 13963-13965 NN denotes S1
T50007 13966-13972 NN denotes domain
T5367 13973-13977 IN denotes from
T8711 13978-13981 DT denotes the
T66860 13982-13985 NN denotes bat
T62453 13986-13992 NN denotes SL-CoV
T71117 13993-13996 NN denotes Rp3
T88382 13997-14003 NN denotes strain
T88085 14005-14009 DT denotes This
T48832 14010-14019 NN denotes diversity
T76304 14020-14025 MD denotes would
T15359 14026-14033 VB denotes suffice
T62259 14034-14036 TO denotes to
T18888 14037-14044 VB denotes produce
T72744 14045-14055 JJ denotes functional
T24144 14056-14067 NNS denotes differences
T88673 14068-14075 IN denotes between
T38511 14076-14079 DT denotes the
T76844 14080-14087 NNS denotes species
T33948 14087-14088 -COMMA- denotes ,
T64840 14089-14092 CC denotes and
T43993 14093-14095 VBZ denotes is
T4517 14096-14098 DT denotes an
T84855 14099-14107 JJ denotes apparent
T42902 14108-14114 NN denotes reason
T40921 14115-14118 WRB denotes why
T70648 14119-14122 NN denotes bat
T53907 14123-14127 NNS denotes sera
T57340 14128-14134 VBG denotes having
T85409 14135-14139 JJ denotes high
T54783 14140-14146 NNS denotes levels
T45640 14147-14149 IN denotes of
T58628 14150-14164 JJ denotes cross-reactive
T52676 14165-14175 NNS denotes antibodies
T45941 14176-14179 RB denotes not
T27008 14180-14185 VBD denotes acted
T78461 14186-14197 RB denotes efficiently
T42258 14198-14200 TO denotes to
T33747 14201-14211 VB denotes neutralize
T77904 14212-14220 NN denotes SARS-CoV
T98558 14223-14228 CD denotes 4.1.3
T38385 14230-14235 NN denotes Serum
T65035 14236-14240 IN denotes from
T20625 14241-14253 JJ denotes convalescent
T20197 14254-14258 NN denotes SARS
T37092 14259-14267 NNS denotes patients
T79043 14269-14276 CD denotes 4.1.3.1
T13076 14278-14288 NN denotes Hypothesis
T75604 14288-14289 -COLON- denotes :
T99993 14290-14298 NN denotes SARS-CoV
T3009 14299-14302 CC denotes and
T80950 14303-14312 NN denotes SARS-CoV2
T92082 14313-14316 VBP denotes are
T32575 14317-14324 RB denotes ideally
T79226 14325-14332 JJ denotes similar
T33377 14333-14335 IN denotes in
T59896 14336-14339 DT denotes the
T19520 14340-14349 NN denotes structure
T87934 14350-14353 CC denotes and
T72009 14354-14357 DT denotes the
T96172 14358-14362 NN denotes cell
T92132 14363-14368 NN denotes entry
T55153 14369-14377 NN denotes receptor
T65675 14378-14381 CC denotes and
T29199 14382-14390 NN denotes protease
T27640 14391-14399 NN denotes SARS-CoV
T74776 14400-14403 CC denotes and
T21368 14404-14413 NN denotes SARS-CoV2
T82506 14414-14419 NN denotes share
T68425 14420-14430 RB denotes absolutely
T18098 14431-14434 DT denotes the
T56482 14435-14439 JJ denotes same
T5709 14440-14448 NN denotes cleavage
T53777 14449-14458 NNS denotes junctions
T48942 14458-14459 -COMMA- denotes ,
T23620 14460-14466 RB denotes almost
T31417 14467-14470 DT denotes the
T14679 14471-14475 JJ denotes same
T16845 14476-14484 NN denotes sequence
T94095 14485-14486 -LRB- denotes (
T72721 14486-14488 CD denotes 96
T51290 14488-14489 NN denotes %
T3648 14489-14490 -RRB- denotes )
T81238 14491-14493 IN denotes of
T80974 14494-14499 PRP-DOLLAR- denotes their
T24041 14500-14504 JJ denotes main
T97737 14505-14513 NN denotes protease
T89215 14513-14514 -COMMA- denotes ,
T68838 14515-14516 DT denotes a
T10566 14517-14521 JJ denotes high
T25132 14522-14528 NN denotes degree
T56803 14529-14530 -LRB- denotes (
T85670 14530-14532 CD denotes 76
T72732 14532-14533 NN denotes %
T51047 14533-14534 -RRB- denotes )
T87365 14535-14537 IN denotes of
T31118 14538-14548 NN denotes similarity
T29516 14549-14551 IN denotes in
T55756 14552-14555 DT denotes the
T19117 14556-14561 JJ denotes amino
T38328 14562-14566 NN denotes acid
T71701 14567-14575 NN denotes sequence
T52612 14576-14578 IN denotes of
T55072 14579-14584 PRP-DOLLAR- denotes their
T61270 14585-14586 NN denotes S
T71641 14587-14594 NN denotes protein
T35396 14594-14595 -COMMA- denotes ,
T5992 14596-14597 DT denotes a
T7278 14598-14605 JJ denotes similar
T86199 14606-14609 NN denotes S2′
T47005 14610-14618 NN denotes cleavage
T82402 14619-14623 NN denotes site
T47763 14623-14624 -COMMA- denotes ,
T84821 14625-14626 DT denotes a
T82586 14627-14634 JJ denotes similar
T33761 14635-14643 NN denotes spectrum
T77477 14644-14646 IN denotes of
T52803 14647-14652 NNS denotes cells
T10303 14653-14657 PRP denotes they
T7764 14658-14661 MD denotes can
T28508 14662-14667 VB denotes enter
T62400 14667-14668 -COMMA- denotes ,
T63048 14669-14672 CC denotes and
T36374 14673-14676 DT denotes the
T14538 14677-14687 NN denotes similarity
T20437 14688-14690 IN denotes of
T68062 14691-14694 DT denotes the
T38190 14695-14699 JJS denotes most
T74458 14700-14708 NNS denotes residues
T87029 14709-14718 JJ denotes essential
T85323 14719-14722 IN denotes for
T99917 14723-14730 VBG denotes binding
T21537 14731-14735 NN denotes ACE2
T6014 14736-14737 -LRB- denotes [
T41035 14737-14739 CD denotes 16
T8340 14739-14740 -RRB- denotes ]
T30067 14740-14741 -COMMA- denotes ,
T62375 14742-14743 -LRB- denotes [
T93474 14743-14745 CD denotes 17
T91627 14745-14746 -RRB- denotes ]
T61038 14746-14747 -COMMA- denotes ,
T23050 14748-14749 -LRB- denotes [
T2153 14749-14751 CD denotes 18
T12115 14751-14752 -RRB- denotes ]
T92800 14754-14758 RB denotes Also
T47629 14758-14759 -COMMA- denotes ,
T61968 14760-14764 DT denotes both
T81337 14765-14767 IN denotes of
T3352 14768-14772 PRP denotes them
T94564 14773-14780 VBP denotes utilize
T79549 14781-14784 DT denotes the
T81034 14785-14789 JJ denotes same
T66440 14790-14796 NN denotes domain
T64350 14797-14799 IN denotes of
T84214 14800-14803 NN denotes S1B
T9559 14804-14806 TO denotes to
T41916 14807-14815 VB denotes interact
T92667 14816-14820 IN denotes with
T6335 14821-14824 DT denotes the
T19773 14825-14829 NN denotes ACE2
T62479 14830-14838 NN denotes receptor
T90671 14840-14847 RB denotes However
T39710 14847-14848 -COMMA- denotes ,
T81474 14849-14853 PRP denotes they
T56686 14854-14860 VBP denotes differ
T68640 14861-14863 IN denotes in
T87109 14864-14875 JJ denotes proteolytic
T98211 14876-14886 NN denotes processing
T71821 14887-14889 TO denotes to
T76662 14890-14894 DT denotes some
T50781 14895-14901 NN denotes degree
T10243 14903-14908 NN denotes Study
T47759 14909-14910 -LRB- denotes [
T98110 14910-14912 CD denotes 16
T87807 14912-14913 -RRB- denotes ]
T21860 14914-14916 IN denotes of
T41284 14917-14920 DT denotes the
T98832 14921-14926 JJ denotes human
T59673 14927-14936 JJ denotes embryonic
T56471 14937-14943 NN denotes kidney
T99239 14944-14945 -LRB- denotes (
T14503 14945-14948 NN denotes HEK
T28717 14948-14949 -RRB- denotes )
T37299 14950-14954 NN denotes cell
T7184 14955-14959 NN denotes line
T85187 14959-14960 -COMMA- denotes ,
T92189 14961-14966 NN denotes 293 T
T15543 14966-14967 -COMMA- denotes ,
T94164 14968-14971 VBZ denotes has
T43431 14972-14977 VBN denotes shown
T43613 14978-14982 IN denotes that
T18285 14983-14984 DT denotes a
T61673 14985-14991 NN denotes signal
T89124 14992-14995 IN denotes for
T39220 14996-14999 DT denotes the
T95765 15000-15002 NN denotes S2
T75829 15003-15010 NN denotes subunit
T59345 15011-15013 VBZ denotes is
T37161 15014-15021 JJ denotes present
T63565 15022-15024 IN denotes in
T66184 15025-15030 NNS denotes cells
T20519 15031-15041 VBN denotes inoculated
T83162 15042-15046 IN denotes with
T31219 15047-15055 NN denotes SARS-2-S
T44086 15055-15056 -COMMA- denotes ,
T88144 15057-15060 CC denotes but
T98702 15061-15064 RB denotes not
T7566 15065-15067 IN denotes in
T55250 15068-15073 NNS denotes cells
T72973 15074-15084 VBN denotes inoculated
T20341 15085-15089 IN denotes with
T62455 15090-15096 NN denotes SARS-S
T10680 15098-15101 CD denotes Two
T43316 15102-15106 JJ denotes main
T55924 15107-15116 NNS denotes proteases
T2463 15117-15120 IN denotes for
T44465 15121-15125 DT denotes both
T77880 15126-15132 NN denotes SARS-S
T81456 15133-15136 CC denotes and
T6788 15137-15145 NN denotes SARS-2-S
T40938 15146-15149 VBP denotes are
T56973 15150-15159 JJ denotes endosomal
T42812 15160-15168 NN denotes cysteine
T96337 15169-15178 VBZ denotes proteases
T16443 15179-15188 NN denotes cathepsin
T42466 15189-15190 NN denotes B
T71562 15191-15194 CC denotes and
T46478 15195-15196 NN denotes L
T46398 15197-15198 -LRB- denotes (
T65344 15198-15204 NN denotes CatB/L
T41087 15204-15205 -RRB- denotes )
T20678 15206-15209 CC denotes and
T62149 15210-15213 DT denotes the
T68064 15214-15227 JJ denotes transmembrane
T32448 15228-15236 NN denotes protease
T6092 15236-15237 -COMMA- denotes ,
T91380 15238-15244 NN denotes serine
T21495 15245-15253 NN denotes 2TMPRSS2
T43810 15254-15255 -LRB- denotes [
T10431 15255-15257 CD denotes 16
T63388 15257-15258 -RRB- denotes ]
T22680 15260-15262 IN denotes In
T74423 15263-15268 NN denotes 293 T
T35266 15269-15274 NNS denotes cells
T64338 15275-15282 VBG denotes lacking
T10485 15283-15291 NN denotes 2TMPRSS2
T85298 15291-15292 -COMMA- denotes ,
T71577 15293-15301 VBG denotes blocking
T94566 15302-15308 NN denotes CatB/L
T53535 15309-15317 NN denotes activity
T97443 15318-15325 IN denotes through
T35988 15326-15336 VBG denotes increasing
T24686 15337-15340 DT denotes the
T21828 15341-15350 JJ denotes endosomal
T57882 15351-15353 NN denotes pH
T2438 15354-15356 IN denotes by
T55605 15357-15365 NN denotes ammonium
T50104 15366-15374 NN denotes chloride
T36913 15375-15380 MD denotes could
T77508 15381-15394 RB denotes significantly
T70941 15395-15400 VB denotes limit
T75185 15401-15404 DT denotes the
T35511 15405-15410 NN denotes entry
T1792 15411-15413 IN denotes of
T53436 15414-15418 CC denotes both
T60629 15419-15425 NN denotes SARS-S
T78080 15426-15429 CC denotes and
T63658 15430-15439 JJ denotes SARS-2-S.
T98368 15440-15442 IN denotes In
T93115 15443-15459 NN denotes TMPRSS2 + Caco-2
T76285 15460-15465 NNS denotes cells
T31590 15465-15466 -COMMA- denotes ,
T25862 15467-15470 DT denotes the
T10314 15471-15477 NN denotes effect
T77548 15478-15480 IN denotes of
T48002 15481-15489 NN denotes ammonium
T31059 15490-15498 NN denotes chloride
T96902 15499-15506 VBD denotes existed
T81416 15507-15509 TO denotes to
T58350 15510-15511 DT denotes a
T53199 15512-15518 JJR denotes lesser
T72133 15519-15525 NN denotes extent
T12695 15527-15528 DT denotes A
T69785 15529-15540 NN denotes combination
T73262 15541-15543 IN denotes of
T77261 15544-15552 NN denotes camostat
T41765 15553-15561 NN denotes mesylate
T55852 15561-15562 -COMMA- denotes ,
T81348 15563-15564 DT denotes a
T88599 15565-15572 NN denotes blocker
T30022 15573-15575 IN denotes of
T40170 15576-15583 NN denotes TMPRSS2
T89506 15583-15584 -COMMA- denotes ,
T96381 15585-15588 CC denotes and
T31415 15589-15594 NN denotes E-64d
T14631 15594-15595 -COMMA- denotes ,
T42969 15596-15598 DT denotes an
T53416 15599-15608 NN denotes inhibitor
T3946 15609-15611 IN denotes of
T26871 15612-15618 NN denotes CatB/L
T27079 15618-15619 -COMMA- denotes ,
T56133 15620-15627 VBD denotes yielded
T87218 15628-15631 DT denotes the
T70471 15632-15640 JJ denotes complete
T11646 15641-15651 NN denotes inhibition
T91858 15652-15654 IN denotes of
T75023 15655-15663 NN denotes SARS-2-S
T21695 15664-15669 NN denotes entry
T17052 15670-15672 IN denotes in
T24463 15673-15689 NN denotes TMPRSS2 + Caco-2
T57029 15690-15695 NNS denotes cells
T57582 15697-15699 IN denotes In
T21513 15700-15704 CC denotes both
T67184 15705-15708 DT denotes the
T39137 15709-15714 JJ denotes human
T99828 15715-15719 NN denotes lung
T68094 15720-15726 NN denotes cancer
T76607 15727-15731 NN denotes cell
T55102 15732-15736 NN denotes line
T50829 15737-15743 NN denotes Calu-3
T53491 15744-15747 CC denotes and
T43867 15748-15751 DT denotes the
T21723 15752-15759 JJ denotes primary
T29104 15760-15765 JJ denotes human
T3411 15766-15770 NN denotes lung
T60390 15771-15776 NNS denotes cells
T81391 15776-15777 -COMMA- denotes ,
T33129 15778-15783 EX denotes there
T59040 15784-15787 VBD denotes was
T39475 15788-15789 DT denotes a
T15256 15790-15799 NN denotes reduction
T39714 15800-15802 IN denotes of
T49107 15803-15806 DT denotes the
T3461 15807-15812 NN denotes entry
T40063 15813-15815 IN denotes of
T3764 15816-15820 CC denotes both
T3726 15821-15827 NN denotes SARS-S
T74021 15828-15831 CC denotes and
T38308 15832-15840 NN denotes SARS-2-S
T3019 15841-15843 IN denotes by
T41127 15844-15852 NN denotes camostat
T6987 15853-15861 NN denotes mesylate
T21310 15861-15862 -COMMA- denotes ,
T88073 15863-15873 VBG denotes indicating
T47825 15874-15878 IN denotes that
T44262 15879-15885 NN denotes SARS-S
T25723 15886-15889 CC denotes and
T39073 15890-15898 NN denotes SARS-2-S
T85073 15899-15908 RB denotes partially
T75386 15909-15916 VBP denotes require
T13575 15917-15924 NN denotes TMPRSS2
T81091 15925-15928 IN denotes for
T10997 15929-15930 DT denotes a
T93402 15931-15935 NN denotes lung
T86423 15936-15945 NN denotes infection
T22068 15948-15955 CD denotes 4.1.3.2
T96302 15957-15965 NNP denotes Rational
T46108 15965-15966 -COLON- denotes :
T36509 15967-15972 NN denotes Serum
T11172 15973-15977 IN denotes from
T88528 15978-15990 JJ denotes convalescent
T76648 15991-15995 NN denotes SARS
T87601 15996-16004 NNS denotes patients
T31307 16005-16007 VBZ denotes is
T95865 16008-16012 JJ denotes able
T8130 16013-16015 TO denotes to
T87404 16016-16026 VB denotes neutralize
T83073 16027-16036 NN denotes SARS-CoV2
T56983 16037-16048 RB denotes efficiently
T85498 16049-16058 NN denotes Antiserum
T54727 16059-16063 WDT denotes that
T58025 16064-16072 VBZ denotes contains
T31794 16073-16083 NNS denotes antibodies
T72017 16084-16091 IN denotes against
T23410 16092-16097 JJ denotes human
T51011 16098-16102 NN denotes ACE2
T21969 16103-16108 MD denotes could
T10956 16109-16115 VB denotes hinder
T54161 16116-16119 DT denotes the
T78002 16120-16125 NN denotes entry
T48418 16126-16128 IN denotes of
T60794 16129-16133 CC denotes both
T68393 16134-16140 NN denotes SARS-S
T60207 16141-16144 CC denotes and
T37089 16145-16153 NN denotes SARS-2-S
T99631 16154-16165 NNS denotes pseudotypes
T70219 16166-16171 IN denotes while
T16218 16172-16175 RB denotes not
T76542 16176-16184 VBN denotes affected
T34278 16185-16188 DT denotes the
T2430 16189-16194 NN denotes entry
T98023 16195-16197 IN denotes of
T1819 16198-16203 NN denotes VSV-G
T13278 16204-16207 CC denotes and
T45315 16208-16214 NN denotes MERS-S
T32075 16215-16226 NNS denotes pseudotypes
T4602 16228-16230 PRP denotes It
T44962 16231-16239 VBZ denotes supports
T87111 16240-16243 DT denotes the
T50457 16244-16250 NN denotes notion
T41218 16251-16255 IN denotes that
T5721 16256-16262 NN denotes SARS-S
T21671 16263-16266 CC denotes and
T31105 16267-16275 NN denotes SARS-2-S
T49586 16276-16283 VBP denotes utilize
T31036 16284-16287 DT denotes the
T80074 16288-16292 JJ denotes same
T64684 16293-16300 JJ denotes primary
T36069 16301-16306 NN denotes entry
T27754 16307-16315 NN denotes receptor
T79207 16315-16316 -COMMA- denotes ,
T14629 16317-16321 FW denotes i.e.
T9665 16321-16322 -COMMA- denotes ,
T94116 16323-16327 NN denotes ACE2
T13974 16327-16328 -COMMA- denotes ,
T82487 16329-16334 WDT denotes which
T59931 16335-16337 VBZ denotes is
T21885 16338-16347 JJ denotes different
T2868 16348-16352 IN denotes from
T75369 16353-16356 DT denotes the
T44853 16357-16364 JJ denotes primary
T60868 16365-16374 NNS denotes receptors
T62157 16375-16380 NN denotes VSV-G
T53624 16381-16384 CC denotes and
T83630 16385-16391 NN denotes MERS-S
T67890 16392-16398 NN denotes engage
T48926 16399-16402 IN denotes for
T62543 16403-16407 NN denotes cell
T63733 16408-16413 NN denotes entry
T54619 16414-16418 WDT denotes that
T50860 16419-16421 VBZ denotes is
T99869 16422-16426 NN denotes LDLR
T6180 16427-16430 CC denotes and
T74051 16431-16435 NN denotes DPP4
T7846 16435-16436 -COMMA- denotes ,
T3162 16437-16449 RB denotes respectively
T66548 16451-16455 NN denotes Sera
T80239 16456-16460 IN denotes from
T68000 16461-16466 CD denotes three
T48403 16467-16479 JJ denotes convalescent
T51594 16480-16484 NN denotes SARS
T70519 16485-16493 NNS denotes patients
T59987 16494-16501 VBD denotes reduced
T66409 16502-16505 DT denotes the
T72671 16506-16512 JJ denotes SARS-S
T28601 16513-16518 NN denotes entry
T35673 16519-16522 CC denotes and
T3889 16522-16523 -COMMA- denotes ,
T61995 16524-16526 TO denotes to
T2565 16527-16528 VB denotes e
T43059 16529-16535 JJR denotes lesser
T78742 16536-16542 NN denotes degree
T89272 16542-16543 -COMMA- denotes ,
T22714 16544-16547 DT denotes the
T31064 16548-16556 NN denotes SARS-2-S
T32416 16557-16562 NN denotes entry
T56518 16564-16567 DT denotes The
T9724 16568-16575 NN denotes patient
T98703 16576-16581 NN denotes serum
T27055 16582-16588 NN denotes effect
T61320 16589-16592 VBD denotes was
T14991 16593-16595 IN denotes in
T7555 16596-16597 DT denotes a
T3238 16598-16612 JJ denotes dose-dependent
T1832 16613-16619 NN denotes manner
T4817 16620-16621 -LRB- denotes [
T18384 16621-16623 CD denotes 16
T62562 16623-16624 -RRB- denotes ]
T84996 16627-16632 CD denotes 4.1.4
T68842 16634-16639 NN denotes Serum
T82613 16640-16644 IN denotes from
T24477 16645-16652 NNS denotes rabbits
T81104 16653-16662 VBN denotes immunized
T21841 16663-16667 IN denotes with
T30838 16668-16672 NNS denotes SARS
T35613 16674-16681 CD denotes 4.1.4.1
T83832 16683-16693 NNS denotes Hypotheses
T16280 16693-16694 -COLON- denotes :
T65972 16695-16700 NN denotes Serum
T73609 16701-16705 IN denotes from
T96815 16706-16713 NNS denotes rabbits
T6431 16714-16723 VBN denotes immunized
T54166 16724-16728 IN denotes with
T55032 16729-16733 NN denotes SARS
T95142 16734-16736 VBZ denotes is
T10678 16737-16741 RBR denotes more
T7214 16742-16751 JJ denotes effective
T72082 16752-16756 IN denotes than
T89782 16757-16762 NN denotes serum
T96392 16763-16767 IN denotes from
T87687 16768-16780 JJ denotes convalescent
T5869 16781-16785 NN denotes SARS
T64875 16786-16794 NNS denotes patients
T2963 16795-16807 NNS denotes Paraoxonases
T18623 16808-16809 -LRB- denotes (
T27053 16809-16812 NN denotes PON
T42842 16812-16813 -RRB- denotes )
T5339 16814-16817 VBP denotes are
T35148 16818-16827 JJ denotes mammalian
T14128 16828-16835 NNS denotes enzymes
T4681 16836-16846 VBN denotes associated
T2648 16847-16851 IN denotes with
T63688 16852-16864 JJ denotes anti-oxidant
T88373 16865-16868 CC denotes and
T98716 16869-16886 JJ denotes anti-inflammatory
T71072 16887-16894 NNS denotes effects
T76904 16895-16896 -LRB- denotes [
T27198 16896-16898 CD denotes 19
T48276 16898-16899 -RRB- denotes ]
T62798 16901-16907 NN denotes Rabbit
T34931 16908-16911 NN denotes PON
T82559 16912-16919 VBZ denotes differs
T8248 16920-16924 IN denotes from
T26023 16925-16930 JJ denotes human
T64809 16931-16934 NN denotes PON
T83097 16935-16937 IN denotes in
T94817 16938-16943 NNS denotes terms
T39961 16944-16946 IN denotes of
T83536 16947-16951 JJR denotes more
T49542 16952-16960 NN denotes activity
T61619 16961-16964 CC denotes and
T61844 16965-16969 JJR denotes more
T24171 16970-16979 NN denotes stability
T99497 16980-16985 IN denotes under
T93581 16986-16989 DT denotes the
T23558 16990-17003 NNS denotes circumstances
T47798 17004-17005 -LRB- denotes [
T59949 17005-17007 CD denotes 20
T86756 17007-17008 -RRB- denotes ]
T78823 17011-17018 CD denotes 4.1.4.2
T89333 17020-17028 NNP denotes Rational
T87452 17028-17029 -COLON- denotes :
T28611 17030-17035 NN denotes Serum
T66778 17036-17040 IN denotes from
T92001 17041-17048 NNS denotes rabbits
T54331 17049-17058 VBN denotes immunized
T18102 17059-17063 IN denotes with
T49296 17064-17067 DT denotes the
T69690 17068-17070 NN denotes S1
T51504 17071-17078 NN denotes subunit
T98332 17079-17081 IN denotes of
T14000 17082-17088 NN denotes SARS-S
T69045 17089-17091 VBZ denotes is
T53543 17092-17096 JJ denotes able
T27081 17097-17099 TO denotes to
T20769 17100-17110 VB denotes neutralize
T66488 17111-17120 NN denotes SARS-CoV2
T92493 17121-17125 RB denotes very
T43055 17126-17137 RB denotes efficiently
T32795 17138-17142 NN denotes Sera
T88629 17143-17147 IN denotes from
T14011 17148-17155 NNS denotes rabbits
T36351 17156-17165 VBN denotes immunized
T2907 17166-17170 IN denotes with
T56297 17171-17174 DT denotes the
T15332 17175-17177 NN denotes S1
T42640 17178-17185 NN denotes subunit
T11917 17186-17188 IN denotes of
T11280 17189-17195 NN denotes SARS-S
T18675 17196-17201 MD denotes could
T31387 17202-17213 RB denotes effectively
T89944 17214-17220 VB denotes reduce
T32181 17221-17224 DT denotes the
T20355 17225-17230 NN denotes entry
T50423 17231-17233 IN denotes of
T12207 17234-17238 CC denotes both
T17436 17239-17245 NN denotes SARS-S
T17683 17246-17249 CC denotes and
T60936 17250-17258 NN denotes SARS-2-S
T11032 17259-17260 -LRB- denotes [
T73993 17260-17262 CD denotes 16
T40781 17262-17263 -RRB- denotes ]
T44829 17265-17269 WRB denotes When
T16892 17270-17278 VBN denotes compared
T48251 17279-17283 IN denotes with
T63812 17284-17291 NN denotes patient
T14554 17292-17297 NN denotes serum
T79753 17297-17298 -COMMA- denotes ,
T23241 17299-17305 NN denotes rabbit
T96424 17306-17311 NN denotes serum
T15191 17312-17320 VBD denotes revealed
T24898 17321-17323 TO denotes to
T77150 17324-17326 PRP denotes us
T91525 17327-17333 JJR denotes higher
T71552 17334-17344 NN denotes efficiency
T68477 17345-17347 IN denotes in
T44667 17348-17358 NN denotes inhibition
T25201 17359-17361 IN denotes of
T77635 17362-17370 NN denotes SARS-2-S
T92600 17371-17376 NN denotes entry
T81647 17377-17379 IN denotes at
T93940 17380-17383 DT denotes the
T15244 17384-17388 JJ denotes same
T33265 17389-17402 NN denotes concentration
T55819 17405-17408 CD denotes 4.2
T56180 17410-17421 JJ denotes Intravenous
T2182 17422-17437 NNS denotes immunoglobulins
T41175 17438-17439 -LRB- denotes (
T97867 17439-17443 NN denotes IVIG
T16816 17443-17444 -RRB- denotes )
T56020 17446-17451 CD denotes 4.2.1
T95212 17453-17463 NN denotes Hypothesis
T84611 17463-17464 -COLON- denotes :
T95417 17465-17469 NN denotes IVIG
T50853 17470-17478 VBZ denotes contains
T65863 17479-17480 DT denotes a
T68527 17481-17486 JJ denotes large
T83960 17487-17491 NN denotes pool
T57480 17492-17494 IN denotes of
T98962 17495-17500 JJ denotes human
T50450 17501-17511 NNS denotes antibodies
T12037 17512-17516 NN denotes IVIG
T52317 17517-17519 VBZ denotes is
T83276 17520-17522 DT denotes an
T47689 17523-17539 JJ denotes immunomodulatory
T32201 17540-17549 NN denotes treatment
T26744 17550-17559 RB denotes currently
T6595 17560-17566 JJ denotes useful
T61951 17567-17570 IN denotes for
T78252 17571-17572 DT denotes a
T96672 17573-17580 NN denotes variety
T75647 17581-17583 IN denotes of
T64366 17584-17589 JJ denotes human
T37666 17590-17598 NNS denotes diseases
T30663 17599-17603 WDT denotes that
T71611 17604-17609 VBP denotes share
T4369 17610-17612 DT denotes an
T95969 17613-17623 JJ denotes idiopathic
T35011 17624-17630 NN denotes origin
T94518 17630-17631 -COMMA- denotes ,
T34533 17632-17639 VBG denotes ranging
T57537 17640-17644 IN denotes from
T47481 17645-17655 JJ denotes autoimmune
T10634 17656-17665 NNS denotes disorders
T96539 17666-17668 TO denotes to
T18270 17669-17676 JJ denotes primary
T92790 17677-17685 NN denotes antibody
T91348 17686-17698 NNS denotes deficiencies
T23275 17700-17704 RB denotes Also
T97483 17704-17705 -COMMA- denotes ,
T12179 17706-17710 NNP denotes IVIG
T44219 17711-17714 VBZ denotes has
T10629 17715-17720 VBN denotes shown
T45168 17721-17730 JJ denotes promising
T67208 17731-17738 NNS denotes results
T77083 17739-17741 IN denotes in
T72909 17742-17746 NN denotes case
T84121 17747-17749 IN denotes of
T92712 17750-17756 JJ denotes severe
T79863 17757-17758 -LRB- denotes (
T66824 17758-17762 JJ denotes such
T43956 17763-17765 IN denotes as
T9832 17766-17772 NN denotes sepsis
T13628 17772-17773 -COMMA- denotes ,
T62406 17774-17784 NN denotes Parvovirus
T99835 17785-17788 NN denotes B19
T14835 17789-17798 NN denotes infection
T15497 17798-17799 -COMMA- denotes ,
T90831 17800-17804 NNP denotes West
T76795 17805-17809 NNP denotes Nile
T72325 17810-17815 NN denotes virus
T62294 17816-17828 NN denotes encephalitis
T79163 17828-17829 -COMMA- denotes ,
T42313 17830-17833 NN denotes HIV
T73958 17833-17834 -COMMA- denotes ,
T29310 17835-17846 NNP denotes Clostridium
T49447 17847-17856 JJ denotes difficile
T8038 17857-17867 NNS denotes infections
T10219 17867-17868 -COMMA- denotes ,
T3443 17869-17882 NN denotes Mycobacterium
T55185 17883-17888 NN denotes avium
T2677 17888-17889 -COMMA- denotes ,
T67405 17890-17903 NN denotes Mycobacterium
T65630 17904-17916 NN denotes tuberculosis
T60726 17916-17917 -COMMA- denotes ,
T52785 17918-17921 CC denotes and
T44446 17922-17930 NNP denotes Nocardia
T90848 17931-17941 NNS denotes infections
T80386 17941-17942 -RRB- denotes )
T6178 17943-17946 CC denotes and
T68317 17947-17956 JJ denotes recurrent
T17705 17957-17967 NNS denotes infections
T68999 17968-17970 IN denotes in
T18422 17971-17978 JJ denotes primary
T52471 17979-17989 NNS denotes antibodies
T62247 17990-18002 NNS denotes deficiencies
T55724 18003-18004 -LRB- denotes [
T27007 18004-18006 CD denotes 21
T97422 18006-18007 -RRB- denotes ]
T8813 18009-18013 JJS denotes Most
T48684 18014-18022 NNS denotes patients
T37814 18023-18030 VBP denotes develop
T41895 18031-18041 NNS denotes antibodies
T32237 18042-18049 IN denotes against
T55833 18050-18053 DT denotes the
T23466 18054-18056 NN denotes NP
T51386 18057-18060 CC denotes and
T97267 18061-18064 NN denotes RBD
T48238 18065-18067 IN denotes of
T17626 18068-18077 NN denotes 2019-nCoV
T87676 18078-18084 IN denotes during
T56543 18085-18088 DT denotes the
T74019 18089-18095 JJ denotes second
T36179 18096-18100 NN denotes week
T61939 18101-18106 IN denotes after
T53819 18107-18116 NN denotes infection
T47949 18117-18122 NN denotes onset
T10621 18123-18124 -LRB- denotes [
T31327 18124-18126 CD denotes 22
T53799 18126-18127 -RRB- denotes ]
T76985 18129-18137 NN denotes Analysis
T6758 18138-18140 IN denotes of
T88720 18141-18146 NN denotes serum
T73739 18147-18154 NNS denotes samples
T20072 18155-18164 VBD denotes collected
T30704 18165-18167 CD denotes 14
T66398 18168-18170 CC denotes or
T43796 18171-18175 JJR denotes more
T64515 18176-18180 NNS denotes days
T88119 18181-18186 IN denotes after
T33297 18187-18194 NN denotes symptom
T78997 18195-18200 NN denotes onset
T69102 18201-18209 VBD denotes revealed
T51393 18210-18219 NN denotes detection
T49412 18220-18222 IN denotes of
T86080 18223-18226 NN denotes IgG
T42365 18227-18230 CC denotes and
T24248 18231-18234 NN denotes IgM
T84785 18235-18245 NNS denotes antibodies
T33598 18246-18253 IN denotes against
T65176 18254-18256 NN denotes NP
T29543 18257-18259 IN denotes in
T67075 18260-18262 CD denotes 94
T4274 18262-18263 NN denotes %
T73088 18264-18267 CC denotes and
T74097 18268-18270 CD denotes 88
T71868 18270-18271 NN denotes %
T54079 18272-18275 CC denotes and
T73098 18276-18279 NN denotes RBD
T69539 18280-18282 IN denotes in
T87988 18283-18286 CD denotes 100
T78691 18286-18287 NN denotes %
T18580 18288-18291 CC denotes and
T46489 18292-18294 CD denotes 94
T64615 18294-18295 NN denotes %
T60810 18296-18301 IN denotes among
T38563 18302-18310 NNS denotes patients
T93829 18311-18315 IN denotes with
T24980 18316-18323 NN denotes COVID19
T89545 18325-18332 NNS denotes Studies
T44838 18333-18345 RB denotes consistently
T54246 18346-18350 VBP denotes show
T20581 18351-18355 IN denotes that
T54967 18356-18365 VBN denotes increased
T27422 18366-18380 NN denotes immunoglobulin
T48431 18381-18387 NNS denotes levels
T7060 18388-18397 VBP denotes accompany
T92743 18398-18401 DT denotes the
T24866 18402-18412 NN denotes transition
T9522 18413-18417 IN denotes from
T69120 18418-18423 JJ denotes early
T81312 18424-18426 TO denotes to
T7048 18427-18431 JJ denotes late
T25388 18432-18438 NN denotes course
T44741 18439-18441 IN denotes of
T20679 18442-18449 NN denotes COVID19
T6735 18451-18453 PRP denotes It
T32751 18454-18459 VBZ denotes poses
T41840 18460-18463 DT denotes the
T21434 18464-18475 NN denotes possibility
T75450 18476-18480 IN denotes that
T55251 18481-18485 NN denotes IVIG
T48129 18486-18493 NN denotes therapy
T90120 18494-18499 MD denotes might
T91321 18500-18504 VB denotes help
T89890 18505-18507 TO denotes to
T64443 18508-18518 VB denotes accelerate
T5150 18519-18527 NN denotes recovery
T43666 18528-18532 IN denotes from
T85289 18533-18541 NN denotes COVID-19
T72940 18544-18549 CD denotes 4.2.2
T31699 18551-18560 NNP denotes Rationale
T6254 18560-18561 -COLON- denotes :
T80516 18562-18566 NN denotes IVIG
T69063 18567-18572 MD denotes might
T22631 18573-18577 VB denotes help
T88012 18578-18580 TO denotes to
T98862 18581-18588 VB denotes improve
T98671 18589-18592 DT denotes the
T20348 18593-18600 NN denotes outcome
T65200 18601-18603 IN denotes of
T90061 18604-18612 NNS denotes patients
T66297 18613-18617 IN denotes with
T53417 18618-18626 NN denotes COVID-19
T18993 18627-18630 DT denotes The
T21718 18631-18636 NN denotes study
T64168 18637-18638 -LRB- denotes [
T66430 18638-18640 CD denotes 23
T95152 18640-18641 -RRB- denotes ]
T31198 18642-18650 VBD denotes included
T55004 18651-18654 CD denotes ten
T65830 18655-18663 NNS denotes patients
T56952 18664-18668 IN denotes with
T98815 18669-18677 NN denotes COVID-19
T69048 18678-18681 WP denotes who
T75376 18682-18694 VBD denotes demonstrated
T59786 18695-18704 VBG denotes worsening
T24326 18705-18713 NNS denotes symptoms
T13700 18713-18714 -COMMA- denotes ,
T79561 18715-18719 FW denotes e.g.
T83448 18719-18720 -COMMA- denotes ,
T77014 18721-18730 VBD denotes decreased
T40148 18731-18741 NN denotes lymphocyte
T31095 18742-18747 NN denotes count
T13833 18748-18751 CC denotes and
T80531 18752-18761 VBD denotes decreased
T26060 18762-18771 NN denotes PaO2/FIO2
T3471 18772-18777 NN denotes ratio
T11859 18778-18781 CC denotes and
T6067 18782-18788 NN denotes oxygen
T65980 18789-18799 NN denotes saturation
T58632 18799-18800 -COMMA- denotes ,
T52543 18801-18810 VBG denotes following
T84435 18811-18820 NN denotes treatment
T44273 18821-18825 IN denotes with
T99668 18826-18827 DT denotes a
T65524 18828-18838 JJ denotes short-term
T66169 18839-18852 JJ denotes moderate-dose
T25963 18853-18867 NN denotes corticosteroid
T54040 18868-18869 -LRB- denotes (
T15835 18869-18887 NN denotes methylprednisolone
T75851 18888-18895 NN denotes 80 mg/d
T55858 18895-18896 -RRB- denotes )
T6426 18897-18901 CC denotes plus
T60445 18902-18916 NN denotes immunoglobulin
T91733 18917-18918 -LRB- denotes (
T10263 18918-18924 CD denotes 10 g/d
T89099 18924-18925 -RRB- denotes )
T32422 18927-18932 IN denotes After
T38661 18933-18942 VBG denotes switching
T47400 18943-18945 TO denotes to
T27854 18946-18949 DT denotes the
T88178 18950-18956 JJ denotes double
T22917 18957-18961 NN denotes dose
T27562 18962-18964 IN denotes of
T69861 18965-18974 NN denotes 1600 mg/d
T26688 18975-18993 NN denotes methylprednisolone
T91618 18994-18998 CC denotes plus
T63033 18999-19005 NN denotes 20 g/d
T82872 19006-19020 NN denotes immunoglobulin
T48110 19020-19021 -COMMA- denotes ,
T64285 19022-19025 DT denotes all
T67888 19026-19028 IN denotes of
T16788 19029-19032 DT denotes the
T67776 19033-19041 NNS denotes patients
T6163 19042-19050 VBN denotes improved
T27596 19051-19053 IN denotes in
T10929 19054-19057 DT denotes the
T87507 19058-19066 JJ denotes clinical
T10805 19066-19067 -COMMA- denotes ,
T49266 19068-19078 NN denotes laboratory
T95692 19078-19079 -COMMA- denotes ,
T51590 19080-19083 CC denotes and
T63732 19084-19096 JJ denotes paraclinical
T58895 19097-19105 NNS denotes outcomes
T85504 19107-19114 JJ denotes Passive
T86520 19115-19127 NN denotes immunization
T22143 19128-19136 VBZ denotes protects
T80547 19137-19144 IN denotes against
T21735 19145-19152 NN denotes disease
T15590 19152-19153 -COMMA- denotes ,
T4169 19154-19157 CC denotes and
T50400 19158-19160 IN denotes so
T4187 19161-19163 PRP denotes it
T38504 19164-19170 MD denotes should
T8453 19171-19173 VB denotes be
T27914 19174-19186 VBN denotes administered
T25991 19187-19189 RB denotes as
T54707 19190-19195 RB denotes early
T29802 19196-19198 IN denotes as
T24869 19199-19207 JJ denotes possible
T10896 19208-19212 WRB denotes when
T25638 19213-19216 DT denotes the
T29960 19217-19224 NN denotes patient
T20464 19225-19227 VBZ denotes is
T3036 19228-19237 VBN denotes diagnosed
T87261 19239-19246 NNS denotes Studies
T96660 19247-19251 VBP denotes show
T29990 19252-19256 IN denotes that
T81080 19257-19260 DT denotes the
T36950 19261-19266 JJ denotes viral
T53426 19267-19270 NN denotes RNA
T78293 19271-19273 IN denotes of
T18048 19274-19283 NN denotes 2019-nCoV
T93176 19284-19291 VBZ denotes reaches
T83675 19292-19295 PRP-DOLLAR- denotes its
T2594 19296-19300 NN denotes peak
T62926 19301-19307 IN denotes during
T35185 19308-19311 DT denotes the
T47524 19312-19317 JJ denotes first
T79772 19318-19322 NN denotes week
T85972 19323-19326 CC denotes and
T60597 19327-19331 RB denotes then
T18711 19332-19341 RB denotes gradually
T40522 19342-19351 VBZ denotes decreases
T67874 19352-19355 CC denotes and
T80013 19356-19360 IN denotes that
T48373 19361-19364 NN denotes IgG
T85015 19365-19368 CC denotes and
T48892 19369-19372 NN denotes IgM
T97802 19373-19378 VBP denotes begin
T54813 19379-19381 TO denotes to
T87582 19382-19386 VB denotes rise
T15243 19387-19391 IN denotes from
T79089 19392-19395 DT denotes the
T92830 19396-19400 JJ denotes 10th
T91091 19401-19404 NN denotes day
T75308 19405-19407 IN denotes so
T98992 19408-19412 IN denotes that
T91226 19413-19417 JJS denotes most
T66875 19418-19426 NNS denotes patients
T44373 19427-19431 VBP denotes have
T45012 19432-19442 JJ denotes anti-viral
T2304 19443-19453 NNS denotes antibodies
T90719 19454-19456 IN denotes by
T66178 19457-19460 DT denotes the
T38757 19461-19465 JJ denotes 14th
T73930 19466-19469 NN denotes day
T52733 19472-19473 CD denotes 5
T83488 19475-19486 JJ denotes Recombinant
T93217 19487-19491 NN denotes type
T64716 19492-19493 CD denotes I
T68579 19494-19497 NN denotes IFN
T12001 19499-19502 CD denotes 5.1
T9969 19504-19514 NN denotes Hypothesis
T15939 19514-19515 -COLON- denotes :
T64893 19516-19520 NNS denotes IFNs
T64532 19521-19525 VBP denotes play
T66496 19526-19527 DT denotes a
T99130 19528-19532 NN denotes role
T16405 19533-19535 IN denotes in
T11399 19536-19546 JJ denotes anti-viral
T89696 19547-19555 NN denotes immunity
T96681 19556-19560 NN denotes Type
T4789 19561-19562 CD denotes I
T85645 19563-19567 NNS denotes IFNs
T76626 19568-19572 VBP denotes play
T51847 19573-19574 DT denotes a
T51548 19575-19582 JJ denotes primary
T78533 19583-19587 NN denotes role
T65875 19588-19590 IN denotes in
T16934 19591-19594 DT denotes the
T59480 19595-19605 NN denotes inhibition
T64120 19606-19608 IN denotes of
T42209 19609-19614 JJ denotes viral
T92412 19615-19626 NN denotes replication
T19053 19627-19634 IN denotes through
T85138 19635-19638 DT denotes the
T89603 19639-19651 NN denotes coordination
T52542 19652-19654 IN denotes of
T13645 19655-19665 JJ denotes anti-viral
T39632 19666-19672 JJ denotes immune
T42144 19673-19682 NNS denotes responses
T54149 19683-19686 CC denotes and
T13001 19687-19697 NN denotes modulation
T2287 19698-19700 IN denotes of
T72730 19701-19713 JJ denotes inflammatory
T37912 19714-19723 NNS denotes responses
T64464 19724-19725 -LRB- denotes [
T89396 19725-19727 CD denotes 24
T17915 19727-19728 -RRB- denotes ]
T44068 19731-19734 CD denotes 5.2
T95208 19736-19744 NNP denotes Rational
T91019 19744-19745 -COLON- denotes :
T95927 19746-19757 JJ denotes Recombinant
T3712 19758-19762 NN denotes type
T46872 19763-19764 CD denotes I
T95232 19765-19768 NN denotes IFN
T83801 19769-19772 MD denotes can
T31121 19773-19784 RB denotes effectively
T50200 19785-19792 VB denotes inhibit
T51383 19793-19802 NN denotes SARS-CoV2
T97492 19803-19814 NN denotes replication
T96177 19815-19817 IN denotes In
T72452 19818-19825 NN denotes 24–48 h
T50493 19826-19831 IN denotes after
T17096 19832-19841 NN denotes infection
T97012 19841-19842 -COMMA- denotes ,
T67170 19843-19852 NN denotes SARS-CoV2
T9761 19853-19864 NN denotes replication
T69880 19865-19872 VBZ denotes reaches
T9709 19873-19878 NN denotes titer
T49785 19879-19883 WDT denotes that
T71708 19884-19890 VBZ denotes causes
T52777 19891-19894 DT denotes the
T56623 19895-19905 JJ denotes cytopathic
T87850 19906-19912 NN denotes effect
T47272 19913-19915 IN denotes in
T71726 19916-19920 NN denotes Vero
T42629 19921-19923 NN denotes E6
T73531 19924-19929 NNS denotes cells
T60353 19929-19930 -COMMA- denotes ,
T83400 19931-19936 WDT denotes which
T80948 19937-19944 VBP denotes express
T12338 19945-19949 NN denotes ACE2
T60658 19950-19953 CC denotes and
T41368 19954-19958 RB denotes thus
T89464 19959-19962 VBP denotes are
T62340 19963-19974 JJ denotes susceptible
T6873 19975-19977 TO denotes to
T68175 19978-19987 NN denotes SARS-CoV2
T16296 19988-19997 NN denotes infection
T12529 19998-19999 -LRB- denotes [
T55131 19999-20001 CD denotes 25
T28678 20001-20002 -RRB- denotes ]
T52876 20004-20006 PRP denotes It
T21084 20007-20009 VBZ denotes is
T70918 20010-20017 JJ denotes similar
T20327 20018-20020 TO denotes to
T13471 20021-20024 DT denotes the
T26039 20025-20030 JJ denotes viral
T64125 20031-20042 NN denotes replication
T62855 20043-20051 NNS denotes kinetics
T68614 20052-20055 IN denotes for
T64958 20056-20064 NN denotes SARS-CoV
T62199 20065-20066 -LRB- denotes [
T27403 20066-20068 CD denotes 25
T34963 20068-20069 -RRB- denotes ]
T49689 20071-20083 NN denotes Pretreatment
T74739 20084-20088 IN denotes with
T62356 20089-20100 JJ denotes recombinant
T67333 20101-20105 NN denotes type
T31833 20106-20107 CD denotes I
T78772 20108-20111 NN denotes IFN
T57406 20112-20117 MD denotes could
T5100 20118-20129 RB denotes effectively
T32529 20130-20137 VB denotes inhibit
T31501 20138-20147 NN denotes SARS-CoV2
T43668 20148-20159 NN denotes replication
T86722 20160-20162 IN denotes at
T26971 20163-20167 CC denotes both
T35627 20168-20170 CD denotes 24
T29701 20171-20174 CC denotes and
T48153 20175-20179 NN denotes 48 h
T93874 20180-20185 IN denotes after
T7550 20186-20195 NN denotes infection
T23827 20196-20197 -LRB- denotes [
T6071 20197-20199 CD denotes 25
T91011 20199-20200 -RRB- denotes ]
T51029 20202-20205 IN denotes For
T64526 20206-20214 NN denotes SARS-CoV
T41819 20214-20215 -COMMA- denotes ,
T5764 20216-20220 PDT denotes such
T79954 20221-20223 DT denotes an
T48924 20224-20230 NN denotes effect
T40034 20231-20234 VBD denotes was
T1935 20235-20242 JJ denotes present
T31311 20243-20245 IN denotes at
T94385 20246-20250 CD denotes 24 h
T84543 20251-20254 CC denotes but
T64490 20255-20261 JJ denotes absent
T33679 20262-20264 IN denotes at
T68271 20265-20269 NN denotes 48 h
T69307 20270-20275 IN denotes after
T51672 20276-20285 NN denotes infection
T85433 20286-20287 -LRB- denotes [
T72350 20287-20289 CD denotes 25
T63406 20289-20290 -RRB- denotes ]
T46096 20292-20295 DT denotes The
T71403 20296-20306 NN denotes difference
T17651 20307-20314 IN denotes between
T77482 20315-20324 NN denotes SARS-CoV2
T6733 20325-20328 CC denotes and
T6622 20329-20337 NN denotes SARS-CoV
T66580 20338-20340 IN denotes in
T74975 20341-20349 NN denotes response
T1853 20350-20352 TO denotes to
T87892 20353-20357 NN denotes type
T83308 20358-20359 CD denotes I
T81934 20360-20363 NN denotes IFN
T42652 20364-20373 NN denotes treatment
T91527 20374-20377 MD denotes may
T42839 20378-20380 VB denotes be
T98810 20381-20384 JJ denotes due
T31126 20385-20387 TO denotes to
T23141 20388-20399 NNS denotes differences
T45488 20400-20402 IN denotes in
T39296 20403-20413 JJ denotes structural
T12723 20414-20422 NNS denotes proteins
T40582 20423-20425 IN denotes of
T48639 20426-20431 DT denotes these
T20513 20432-20439 NNS denotes viruses
T37519 20439-20440 -COMMA- denotes ,
T18237 20441-20450 VBG denotes including
T17094 20451-20455 NN denotes NSP3
T86991 20455-20456 -COMMA- denotes ,
T14810 20457-20462 NN denotes ORF3b
T9269 20462-20463 -COMMA- denotes ,
T18064 20464-20467 CC denotes and
T40695 20468-20472 NN denotes ORF6
T59456 20473-20474 -LRB- denotes [
T34145 20474-20476 CD denotes 25
T98303 20476-20477 -RRB- denotes ]
T22399 20480-20481 CD denotes 6
T82716 20483-20494 NN denotes Development
T5151 20495-20497 IN denotes of
T20950 20498-20499 DT denotes a
T64967 20500-20505 JJ denotes human
T94716 20506-20516 JJ denotes monoclonal
T29466 20517-20525 NN denotes antibody
T27300 20526-20527 -LRB- denotes (
T65405 20527-20530 NN denotes mAb
T53967 20530-20531 -RRB- denotes )
T20998 20533-20536 CD denotes 6.1
T79456 20538-20547 VBG denotes Targeting
T24060 20548-20551 DT denotes the
T56819 20552-20553 NN denotes S
T25577 20554-20561 NN denotes protein
T96682 20563-20568 CD denotes 6.1.1
T17328 20570-20580 NN denotes Hypothesis
T61727 20580-20581 -COLON- denotes :
T32221 20582-20583 DT denotes A
T25878 20584-20587 NN denotes mAb
T8625 20588-20595 IN denotes against
T32030 20596-20599 DT denotes the
T55531 20600-20607 NN denotes binding
T9970 20608-20614 NN denotes domain
T76093 20615-20617 IN denotes of
T80345 20618-20621 DT denotes the
T93532 20622-20627 NN denotes virus
T16199 20628-20631 MD denotes can
T28417 20632-20639 VB denotes inhibit
T48409 20640-20649 NN denotes SARS-CoV2
T36310 20650-20659 NN denotes infection
T27915 20660-20668 RB denotes Recently
T56144 20668-20669 -COMMA- denotes ,
T55915 20670-20679 NN denotes hybridoma
T72012 20680-20692 NNS denotes supernatants
T47163 20693-20703 VBG denotes containing
T24138 20704-20712 NN denotes antibody
T98139 20713-20724 NNS denotes repertoires
T66535 20725-20729 IN denotes from
T86473 20730-20739 VBN denotes immunized
T66245 20740-20750 JJ denotes transgenic
T17100 20751-20755 NNS denotes mice
T85324 20756-20760 WDT denotes that
T55347 20761-20768 VBP denotes express
T14738 20769-20772 DT denotes the
T52540 20773-20778 JJ denotes human
T35586 20779-20793 NN denotes immunoglobulin
T72563 20794-20799 JJ denotes heavy
T65069 20800-20803 CC denotes and
T5967 20804-20809 JJ denotes light
T98095 20810-20816 NNS denotes chains
T78221 20817-20820 CC denotes and
T28318 20821-20824 NN denotes rat
T19776 20825-20831 NN denotes origin
T32531 20832-20846 NN denotes immunoglobulin
T16968 20847-20855 NN denotes constant
T56920 20856-20863 NNS denotes regions
T36716 20864-20868 VBD denotes were
T74827 20869-20873 VBN denotes used
T21382 20874-20876 TO denotes to
T11788 20877-20883 VB denotes detect
T40665 20884-20894 NNS denotes antibodies
T56747 20895-20899 WDT denotes that
T54239 20900-20903 MD denotes can
T71867 20904-20909 VB denotes cross
T35671 20910-20920 VB denotes neutralize
T77445 20921-20927 NN denotes SARS-S
T34654 20928-20931 CC denotes and
T83470 20932-20940 NN denotes SARS-2-S
T76245 20941-20942 -LRB- denotes [
T33581 20942-20944 CD denotes 26
T80577 20944-20945 -RRB- denotes ]
T78516 20947-20950 CD denotes One
T34464 20951-20959 JJ denotes chimeric
T13041 20960-20965 NN denotes 47D11
T83927 20966-20970 NN denotes H2L2
T57345 20971-20979 NN denotes antibody
T44833 20980-20989 VBD denotes displayed
T94688 20990-20994 PDT denotes such
T52983 20995-20996 DT denotes a
T30646 20997-21015 JJ denotes cross-neutralizing
T37245 21016-21024 NN denotes activity
T11300 21024-21025 -COMMA- denotes ,
T30814 21026-21035 VBD denotes decreased
T23282 21036-21044 NN denotes syncytia
T72581 21045-21054 NN denotes formation
T71888 21055-21062 VBN denotes induced
T44111 21063-21065 IN denotes by
T7869 21066-21072 NN denotes SARS-S
T80909 21073-21076 CC denotes and
T58127 21077-21084 NN denotes SARS2-S
T9479 21084-21085 -COMMA- denotes ,
T96346 21086-21089 CC denotes and
T43362 21090-21095 MD denotes could
T48435 21096-21103 VB denotes protect
T44775 21104-21110 NN denotes VeroE6
T25625 21111-21116 NNS denotes cells
T19104 21117-21124 IN denotes against
T51640 21125-21131 NN denotes SARS-S
T22676 21132-21135 CC denotes and
T37470 21136-21143 NN denotes SARS2-S
T64695 21144-21155 VBD denotes pseudotyped
T26978 21156-21161 NN denotes virus
T79137 21162-21163 -LRB- denotes [
T95558 21163-21165 CD denotes 26
T95168 21165-21166 -RRB- denotes ]
T45371 21168-21170 PRP denotes It
T75403 21171-21174 MD denotes may
T86603 21175-21178 VB denotes lie
T91829 21179-21181 IN denotes in
T48175 21182-21185 PRP-DOLLAR- denotes its
T69338 21186-21193 JJ denotes similar
T68140 21194-21204 NNS denotes affinities
T76951 21205-21208 IN denotes for
T38362 21209-21220 VBG denotes interacting
T39715 21221-21225 IN denotes with
T48378 21226-21229 DT denotes the
T63623 21230-21234 JJ denotes same
T2491 21235-21241 NN denotes domain
T57621 21242-21244 IN denotes of
T77993 21245-21248 DT denotes the
T52886 21249-21251 NN denotes S1
T27554 21252-21259 NN denotes subunit
T41139 21259-21260 -COMMA- denotes ,
T99819 21261-21265 FW denotes i.e.
T40027 21265-21266 -COMMA- denotes ,
T73637 21267-21270 NN denotes S1B
T71055 21270-21271 -COMMA- denotes ,
T88888 21272-21274 IN denotes of
T40209 21275-21279 DT denotes each
T2572 21280-21286 NN denotes SARS-S
T97128 21287-21290 CC denotes and
T91104 21291-21299 NN denotes SARS-2-S
T63608 21302-21307 CD denotes 6.1.2
T11815 21309-21317 NNP denotes Rational
T73902 21317-21318 -COLON- denotes :
T21134 21319-21322 DT denotes The
T30867 21323-21331 JJ denotes chimeric
T42126 21332-21337 NN denotes 47D11
T93924 21338-21342 NN denotes H2L2
T85248 21343-21348 MD denotes might
T92338 21349-21352 RB denotes not
T49873 21353-21355 VB denotes be
T69919 21356-21365 JJ denotes effective
T60557 21366-21368 IN denotes in
T77242 21369-21374 JJ denotes human
T86725 21375-21379 NN denotes lung
T18333 21380-21385 NNS denotes cells
T22947 21386-21388 IN denotes as
T22184 21389-21391 PRP denotes it
T1922 21392-21394 VBZ denotes is
T72123 21395-21397 FW denotes in
T38972 21398-21403 FW denotes vitro
T22398 21404-21409 NN denotes 47D11
T15962 21410-21417 VBD denotes carried
T83196 21418-21419 DT denotes a
T61532 21420-21426 JJR denotes higher
T47874 21427-21435 NN denotes affinity
T77580 21436-21439 IN denotes for
T95631 21440-21451 VBG denotes interacting
T94847 21452-21456 IN denotes with
T20163 21457-21460 DT denotes the
T18520 21461-21463 NN denotes S2
T89003 21464-21471 NN denotes subunit
T41606 21472-21474 IN denotes of
T4784 21475-21481 NN denotes SARS-S
T32288 21482-21486 IN denotes than
T68894 21487-21491 DT denotes that
T97000 21492-21494 IN denotes of
T32517 21495-21504 NN denotes SARS-2-S.
T24633 21505-21507 PRP denotes It
T45480 21508-21510 VBZ denotes is
T10954 21511-21520 JJ denotes important
T96386 21521-21525 IN denotes that
T80967 21526-21529 IN denotes for
T24571 21530-21534 DT denotes both
T18211 21535-21541 NN denotes SARS-S
T39196 21542-21545 CC denotes and
T83081 21546-21554 NN denotes SARS-2-S
T70298 21554-21555 -COMMA- denotes ,
T91479 21556-21559 DT denotes the
T56884 21560-21567 NN denotes binding
T11559 21568-21570 IN denotes of
T2922 21571-21574 DT denotes the
T11592 21575-21580 NN denotes 47D11
T36887 21581-21589 NN denotes antibody
T46706 21590-21592 TO denotes to
T40788 21593-21596 DT denotes the
T37833 21597-21603 NN denotes target
T37378 21604-21605 VBZ denotes –
T15003 21606-21609 DT denotes the
T4372 21610-21613 NN denotes S1B
T31100 21614-21620 NN denotes domain
T82065 21621-21622 NN denotes –
T43926 21623-21627 VBZ denotes does
T69422 21628-21631 RB denotes not
T3419 21632-21637 VB denotes block
T21955 21638-21641 DT denotes the
T12942 21642-21649 NN denotes binding
T83444 21650-21652 IN denotes of
T49120 21653-21656 NN denotes S1B
T55070 21657-21660 CC denotes and
T98634 21661-21663 NN denotes S2
T48321 21664-21666 TO denotes to
T80580 21667-21671 NN denotes ACE2
T18877 21672-21680 NN denotes receptor
T18503 21681-21682 -LRB- denotes [
T33177 21682-21684 CD denotes 26
T92006 21684-21685 -RRB- denotes ]
T53652 21687-21689 IN denotes By
T58622 21690-21698 NN denotes contrast
T35381 21698-21699 -COMMA- denotes ,
T41843 21700-21712 VBG denotes neutralizing
T81589 21713-21723 NNS denotes antibodies
T68196 21724-21728 WDT denotes that
T30816 21729-21741 RB denotes specifically
T53446 21742-21748 NN denotes target
T89813 21749-21755 NN denotes SARS-S
T95236 21756-21761 MD denotes could
T7888 21762-21769 VB denotes compete
T34125 21770-21774 IN denotes with
T82101 21775-21778 NN denotes S1B
T1902 21779-21782 CC denotes and
T24277 21783-21785 NN denotes S2
T37015 21786-21789 IN denotes for
T86465 21790-21797 VBG denotes binding
T1893 21798-21800 TO denotes to
T91196 21801-21805 NN denotes ACE2
T54390 21808-21811 CD denotes 6.2
T7377 21813-21822 VBG denotes Targeting
T2754 21823-21839 JJ denotes pro-inflammatory
T79617 21840-21849 NNS denotes cytokines
T42975 21851-21856 CD denotes 6.2.1
T96891 21858-21868 NN denotes Hypothesis
T41163 21868-21869 -COLON- denotes :
T35174 21870-21871 DT denotes A
T74401 21872-21875 NN denotes mAb
T75556 21876-21883 IN denotes against
T83617 21884-21887 NN denotes IL6
T67953 21888-21891 MD denotes can
T68840 21892-21901 VB denotes attenuate
T2426 21902-21907 NN denotes hyper
T92661 21908-21920 NN denotes inflammation
T86439 21921-21932 NNP denotes Tocilizumab
T21494 21932-21933 -COMMA- denotes ,
T50157 21934-21938 RB denotes also
T26283 21939-21944 VBN denotes known
T43571 21945-21947 IN denotes as
T44785 21948-21957 NN denotes atlizumab
T96810 21957-21958 -COMMA- denotes ,
T58761 21959-21961 VBZ denotes is
T56416 21962-21963 DT denotes a
T79548 21964-21973 JJ denotes humanized
T29074 21974-21984 JJ denotes anti-human
T88685 21985-21988 NN denotes IL6
T26777 21989-21997 NN denotes receptor
T24185 21998-22006 NN denotes antibody
T17221 22007-22015 VBN denotes approved
T32471 22016-22018 IN denotes by
T53882 22019-22022 NNP denotes FDA
T24580 22023-22026 IN denotes for
T33924 22027-22034 JJ denotes several
T90119 22035-22047 JJ denotes inflammatory
T59846 22048-22051 CC denotes and
T31666 22052-22062 JJ denotes autoimmune
T46803 22063-22071 NNS denotes diseases
T80969 22072-22078 JJ denotes severe
T13017 22078-22079 -COMMA- denotes ,
T79015 22080-22084 JJ denotes such
T43255 22085-22087 IN denotes as
T47553 22088-22096 NN denotes cytokine
T34694 22097-22104 NN denotes release
T36705 22105-22113 NN denotes syndrome
T68837 22113-22114 -COMMA- denotes ,
T30269 22115-22125 JJ denotes rheumatoid
T54700 22126-22135 NN denotes arthritis
T81658 22135-22136 -COMMA- denotes ,
T84650 22137-22142 JJ denotes giant
T11095 22143-22147 NN denotes cell
T15987 22148-22157 NN denotes arteritis
T88887 22157-22158 -COMMA- denotes ,
T31599 22159-22172 JJ denotes polyarticular
T93322 22173-22181 JJ denotes juvenile
T49595 22182-22192 JJ denotes idiopathic
T62141 22193-22202 NN denotes arthritis
T76737 22202-22203 -COMMA- denotes ,
T30470 22204-22207 CC denotes and
T13999 22208-22218 JJ denotes systematic
T88238 22219-22227 JJ denotes juvenile
T89892 22228-22238 JJ denotes idiopathic
T97598 22239-22248 NN denotes arthritis
T25454 22250-22252 PRP denotes It
T28665 22253-22255 VBZ denotes is
T15312 22256-22260 JJ denotes safe
T18121 22261-22264 CC denotes and
T2467 22265-22274 JJ denotes effective
T39207 22275-22278 IN denotes for
T89869 22279-22283 DT denotes both
T32842 22284-22290 NNS denotes adults
T38357 22291-22294 CC denotes and
T13891 22295-22303 NNS denotes children
T61388 22304-22307 CD denotes two
T66576 22308-22313 NNS denotes years
T46590 22314-22316 IN denotes of
T15404 22317-22320 NN denotes age
T19164 22321-22324 CC denotes and
T99851 22325-22330 JJR denotes older
T41884 22333-22338 CD denotes 6.2.2
T3706 22340-22349 NNP denotes Rationale
T87509 22349-22350 -COLON- denotes :
T72411 22351-22362 NNP denotes Tocilizumab
T46139 22363-22366 MD denotes can
T80638 22367-22372 VB denotes treat
T14365 22373-22377 NN denotes lung
T88114 22378-22384 NN denotes injury
T76208 22385-22387 IN denotes in
T24628 22388-22396 NNS denotes patients
T15777 22397-22401 IN denotes with
T58130 22402-22410 JJ denotes critical
T31522 22411-22414 CC denotes and
T55163 22415-22421 JJ denotes severe
T92225 22422-22430 NN denotes COVID-19
T21073 22431-22433 IN denotes In
T65150 22434-22437 DT denotes the
T61991 22438-22443 NN denotes study
T18474 22444-22445 -LRB- denotes [
T8341 22445-22447 CD denotes 27
T6430 22447-22448 -RRB- denotes ]
T29393 22448-22449 -COMMA- denotes ,
T77821 22450-22452 CD denotes 21
T79215 22453-22461 NNS denotes patients
T5404 22462-22466 IN denotes with
T75582 22467-22475 NN denotes COVID-19
T89299 22476-22481 WP-DOLLAR- denotes whose
T66055 22482-22491 NN denotes condition
T80340 22492-22495 VBD denotes was
T3490 22496-22502 JJ denotes severe
T44653 22503-22505 CC denotes or
T55941 22506-22514 JJ denotes critical
T85453 22515-22523 VBD denotes received
T98598 22524-22527 CD denotes one
T96881 22528-22530 CC denotes or
T24534 22531-22534 CD denotes two
T70238 22535-22540 NNS denotes doses
T20616 22541-22543 IN denotes of
T68912 22544-22555 NNP denotes Tocilizumab
T98192 22556-22560 CC denotes plus
T20706 22561-22569 JJ denotes standard
T58005 22570-22577 NN denotes therapy
T96625 22579-22587 NNS denotes Patients
T75572 22588-22591 WP denotes who
T31917 22592-22595 VBD denotes had
T15301 22596-22597 DT denotes a
T24848 22598-22602 JJ denotes mean
T84688 22603-22606 NN denotes IL6
T96963 22607-22612 NN denotes level
T6930 22613-22615 IN denotes of
T90933 22616-22620 JJR denotes more
T81944 22621-22625 IN denotes than
T75581 22626-22635 NN denotes 100 pg/ml
T64021 22636-22642 IN denotes before
T9387 22643-22654 NN denotes tocilizumab
T84664 22655-22664 NN denotes treatment
T18203 22665-22671 VBD denotes showed
T60803 22672-22683 NN denotes improvement
T44490 22684-22686 IN denotes in
T81402 22687-22695 JJ denotes clinical
T14228 22696-22704 NNS denotes symptoms
T94537 22705-22708 CC denotes and
T83697 22709-22719 JJ denotes peripheral
T13978 22720-22726 NN denotes oxygen
T35808 22727-22737 NN denotes saturation
T34900 22738-22741 CC denotes and
T75964 22742-22755 NN denotes normalization
T84268 22756-22759 IN denotes for
T65028 22760-22770 NN denotes lymphocyte
T34390 22771-22781 NN denotes proportion
T96610 22782-22785 CC denotes and
T30755 22786-22789 NN denotes CRP
T63070 22790-22796 NNS denotes levels
T31791 22798-22802 RB denotes Also
T31152 22802-22803 -COMMA- denotes ,
T79595 22804-22808 NN denotes lung
T51431 22809-22815 NN denotes lesion
T10130 22816-22823 NN denotes opacity
T31388 22824-22827 VBD denotes was
T1824 22828-22836 VBN denotes absorbed
T60055 22837-22839 IN denotes in
T38598 22840-22842 CD denotes 90
T67288 22842-22843 NN denotes %
T48683 22844-22846 IN denotes of
T41529 22847-22855 NNS denotes patients
T69670 22857-22864 CC denotes Neither
T9277 22865-22872 JJ denotes serious
T15021 22873-22880 JJ denotes adverse
T23626 22881-22888 NNS denotes effects
T98539 22889-22892 CC denotes nor
T65699 22893-22899 NNS denotes deaths
T50204 22900-22908 VBD denotes occurred
T20973 22909-22913 IN denotes with
T14012 22914-22925 NN denotes tocilizumab
T66286 22926-22935 NN denotes treatment
T24269 22937-22942 EX denotes There
T26765 22943-22946 VBP denotes are
T84711 22947-22954 VBG denotes ongoing
T74304 22955-22963 JJ denotes clinical
T68003 22964-22970 NNS denotes trials
T5000 22971-22974 IN denotes for
T64198 22975-22986 NN denotes tocilizumab
T83078 22987-22996 NN denotes treatment
T11331 22997-22999 IN denotes in
T42834 23000-23008 NNS denotes patients
T27205 23009-23013 IN denotes with
T23786 23014-23022 JJ denotes moderate
T45333 23023-23026 CC denotes and
T9137 23027-23033 JJ denotes severe
T27842 23034-23042 NN denotes COVID-19
T92236 23044-23053 RB denotes Currently
T32112 23053-23054 -COMMA- denotes ,
T54987 23055-23058 DT denotes the
T85855 23059-23062 NN denotes use
T69355 23063-23065 IN denotes of
T40115 23066-23077 NNP denotes Tocilizumab
T10850 23078-23080 VBZ denotes is
T78367 23081-23092 VBN denotes recommended
T33042 23093-23096 IN denotes for
T36466 23097-23105 NNS denotes patients
T61983 23106-23110 IN denotes with
T2749 23111-23119 NN denotes COVID-19
T17580 23120-23123 WP denotes who
T69055 23124-23128 VBP denotes have
T71996 23129-23136 VBG denotes warning
T59356 23137-23142 NNS denotes signs
T65527 23143-23145 IN denotes of
T99769 23146-23151 NN denotes hyper
T44301 23152-23164 NN denotes inflammation
T54453 23164-23165 -COMMA- denotes ,
T58078 23166-23168 IN denotes as
T75237 23169-23172 MD denotes can
T7496 23173-23175 VB denotes be
T53845 23176-23184 VBN denotes measured
T78207 23185-23187 IN denotes by
T88455 23188-23191 NN denotes IL6
T77671 23191-23192 -COMMA- denotes ,
T67481 23193-23201 NN denotes ferritin
T99390 23201-23202 -COMMA- denotes ,
T23484 23203-23211 NN denotes platelet
T65701 23212-23218 NNS denotes counts
T30323 23218-23219 -COMMA- denotes ,
T72053 23220-23232 JJ denotes inflammatory
T81575 23233-23240 NNS denotes markers
T96428 23240-23241 -COMMA- denotes ,
T36542 23242-23245 CC denotes and
T88469 23246-23247 NN denotes H
T51141 23248-23253 NN denotes score
T97739 23254-23255 -LRB- denotes [
T29313 23255-23257 CD denotes 28
T54016 23257-23258 -RRB- denotes ]
T24370 23261-23262 CD denotes 7
T36802 23264-23279 NNS denotes Corticosteroids
T3294 23281-23284 CD denotes 7.1
T91345 23286-23296 NN denotes Hypothesis
T83198 23296-23297 -COLON- denotes :
T5476 23298-23313 NNS denotes Corticosteroids
T19383 23314-23317 MD denotes can
T18906 23318-23326 VB denotes modulate
T94029 23327-23339 NN denotes inflammation
T27658 23340-23355 NNS denotes Corticosteroids
T8138 23356-23359 VBP denotes are
T91474 23360-23368 RB denotes commonly
T89187 23369-23373 VBN denotes used
T38824 23374-23377 IN denotes for
T21445 23378-23388 NN denotes modulation
T58316 23389-23391 IN denotes of
T58021 23392-23393 DT denotes a
T37655 23394-23401 NN denotes variety
T87627 23402-23404 IN denotes of
T8391 23405-23417 JJ denotes inflammatory
T71073 23418-23428 NNS denotes conditions
T68994 23430-23432 IN denotes In
T59818 23433-23441 NN denotes addition
T18282 23442-23444 TO denotes to
T76082 23445-23446 DT denotes a
T38966 23447-23452 JJ denotes daily
T35672 23453-23460 NN denotes regimen
T41748 23460-23461 -COMMA- denotes ,
T45789 23462-23466 PRP denotes they
T91069 23467-23470 MD denotes can
T84858 23471-23473 VB denotes be
T11971 23474-23478 VBN denotes used
T91181 23479-23481 IN denotes in
T55573 23482-23485 DT denotes the
T52866 23486-23490 NN denotes form
T8605 23491-23493 IN denotes of
T21111 23494-23499 NN denotes pulse
T43357 23500-23507 NN denotes therapy
T46430 23508-23510 TO denotes to
T90499 23511-23516 VB denotes treat
T36198 23517-23523 NNS denotes flares
T16735 23524-23526 IN denotes of
T37577 23527-23537 JJ denotes autoimmune
T82392 23538-23546 NNS denotes diseases
T8787 23548-23555 RB denotes However
T74715 23555-23556 -COMMA- denotes ,
T63832 23557-23564 NN denotes caution
T88619 23565-23567 IN denotes in
T72548 23568-23571 DT denotes the
T74757 23572-23575 NN denotes use
T50691 23576-23578 IN denotes of
T75348 23579-23594 NNS denotes corticosteroids
T98869 23595-23597 VBZ denotes is
T37602 23598-23604 VBN denotes needed
T93826 23605-23608 IN denotes due
T27767 23609-23611 TO denotes to
T91545 23612-23615 DT denotes the
T30802 23616-23625 JJ denotes potential
T82688 23626-23633 JJ denotes serious
T84923 23634-23638 NN denotes side
T90339 23639-23646 NNS denotes effects
T67748 23647-23657 VBN denotes associated
T22188 23658-23662 IN denotes with
T5158 23663-23677 NN denotes corticosteroid
T29681 23678-23683 NNS denotes drugs
T1981 23684-23687 CC denotes and
T7707 23688-23692 IN denotes that
T73209 23693-23708 NNS denotes corticosteroids
T32353 23709-23718 RB denotes generally
T32990 23719-23727 VBP denotes suppress
T84727 23728-23731 DT denotes the
T72594 23732-23738 JJ denotes immune
T82578 23739-23745 NN denotes system
T98970 23747-23750 DT denotes The
T73202 23751-23757 JJ denotes latter
T49682 23758-23763 VBZ denotes means
T56698 23764-23768 IN denotes that
T44497 23769-23784 NNS denotes corticosteroids
T44722 23785-23793 VBP denotes modulate
T39029 23794-23799 NN denotes hyper
T14674 23800-23812 NN denotes inflammation
T31300 23813-23816 CC denotes and
T40275 23816-23817 -COMMA- denotes ,
T84174 23818-23820 IN denotes on
T84917 23821-23824 DT denotes the
T41471 23825-23830 JJ denotes other
T79253 23831-23835 NN denotes hand
T80094 23835-23836 -COMMA- denotes ,
T14361 23837-23844 VBP denotes inhibit
T92448 23845-23851 JJ denotes immune
T32652 23852-23861 NNS denotes responses
T58197 23862-23866 WDT denotes that
T6432 23867-23870 VBP denotes are
T65734 23871-23876 JJ denotes vital
T7857 23877-23880 IN denotes for
T27355 23881-23884 DT denotes the
T81023 23885-23889 NN denotes host
T39598 23890-23897 NN denotes defense
T97712 23898-23905 IN denotes against
T6736 23906-23909 DT denotes the
T59893 23910-23915 NN denotes virus
T48542 23916-23917 -LRB- denotes [
T9013 23917-23919 CD denotes 29
T33036 23919-23920 -RRB- denotes ]
T37227 23923-23926 CD denotes 7.2
T83170 23928-23937 NNP denotes Rationale
T22490 23937-23938 -COLON- denotes :
T92502 23939-23954 NNS denotes Corticosteroids
T30425 23955-23960 MD denotes might
T17782 23961-23965 VB denotes help
T8496 23966-23976 VB denotes accelerate
T16617 23977-23985 NN denotes recovery
T39745 23986-23990 IN denotes from
T7154 23991-23999 NN denotes COVID-19
T19799 24000-24003 DT denotes The
T20594 24004-24009 NN denotes study
T82079 24010-24011 -LRB- denotes [
T66365 24011-24013 CD denotes 30
T51925 24013-24014 -RRB- denotes ]
T58773 24015-24027 VBD denotes investigated
T62943 24028-24031 DT denotes the
T17766 24032-24038 NN denotes effect
T91507 24039-24041 IN denotes of
T41721 24042-24049 VBN denotes inhaled
T68865 24050-24065 NNS denotes corticosteroids
T72129 24066-24077 NN denotes ciclesonide
T75975 24077-24078 -COMMA- denotes ,
T94153 24079-24088 NN denotes cortisone
T58635 24088-24089 -COMMA- denotes ,
T32129 24090-24102 NN denotes prednisolone
T52544 24102-24103 -COMMA- denotes ,
T7734 24104-24117 NN denotes dexamethasone
T48772 24117-24118 -COMMA- denotes ,
T59239 24119-24122 CC denotes and
T36302 24123-24134 NN denotes fluticasone
T2290 24135-24137 IN denotes on
T42645 24138-24141 DT denotes the
T67274 24142-24153 NN denotes replication
T25492 24154-24156 IN denotes of
T52796 24157-24160 DT denotes the
T27491 24161-24169 NN denotes MERS-CoV
T5267 24171-24176 IN denotes Among
T36393 24177-24180 DT denotes the
T1788 24181-24185 CD denotes four
T60636 24186-24195 NNS denotes compounds
T50162 24195-24196 -COMMA- denotes ,
T78874 24197-24200 DT denotes the
T22199 24201-24205 JJ denotes only
T45806 24206-24217 NN denotes ciclesonide
T86672 24218-24221 VBD denotes was
T12794 24222-24229 JJ denotes capable
T91797 24230-24232 IN denotes of
T13593 24233-24243 VBG denotes inhibiting
T5717 24244-24249 JJ denotes viral
T7401 24250-24261 NN denotes replication
T65340 24263-24267 RB denotes Also
T92623 24267-24268 -COMMA- denotes ,
T81617 24269-24280 NN denotes ciclesonide
T95958 24281-24288 VBD denotes induced
T85366 24289-24290 DT denotes a
T21714 24291-24302 JJ denotes significant
T15429 24303-24313 NN denotes inhibition
T16699 24314-24316 IN denotes of
T25584 24317-24322 JJ denotes viral
T73696 24323-24334 NN denotes replication
T7458 24335-24337 IN denotes of
T20174 24338-24343 JJ denotes other
T58259 24344-24349 JJ denotes human
T40953 24350-24363 NNS denotes coronaviruses
T84867 24363-24364 -COMMA- denotes ,
T83672 24365-24369 JJ denotes such
T19443 24370-24372 IN denotes as
T95806 24373-24382 NN denotes HCoV-229E
T84685 24383-24386 CC denotes and
T17277 24387-24395 NN denotes SARS-CoV
T94349 24395-24396 -COMMA- denotes ,
T72578 24397-24400 CC denotes and
T26171 24401-24408 DT denotes another
T39629 24409-24424 JJ denotes positive-strand
T10581 24425-24428 NN denotes RNA
T42602 24429-24434 NN denotes virus
T70474 24434-24435 -COMMA- denotes ,
T82553 24436-24443 NN denotes rubella
T68058 24444-24449 NN denotes virus
T24019 24449-24450 -COMMA- denotes ,
T62462 24451-24456 IN denotes while
T32300 24457-24460 RB denotes not
T38146 24461-24467 VB denotes affect
T72944 24468-24471 DT denotes the
T97423 24472-24477 JJ denotes viral
T43382 24478-24489 NN denotes replication
T16861 24490-24492 IN denotes of
T53501 24493-24508 JJ denotes negative-strand
T3387 24509-24512 NN denotes RNA
T51732 24513-24520 NNS denotes viruses
T35282 24520-24521 -COMMA- denotes ,
T32607 24522-24526 FW denotes e.g.
T24756 24526-24527 -COMMA- denotes ,
T29751 24528-24537 NN denotes influenza
T16801 24538-24541 CC denotes and
T19789 24542-24553 JJ denotes respiratory
T17323 24554-24563 JJ denotes syncytial
T9582 24564-24569 NN denotes virus
T55931 24571-24574 IN denotes For
T42084 24575-24578 DT denotes the
T92915 24579-24587 NN denotes MERS-CoV
T45016 24587-24588 -COMMA- denotes ,
T62094 24589-24590 DT denotes a
T52727 24591-24604 JJ denotes nonstructural
T37738 24605-24612 NN denotes protein
T44869 24613-24615 CD denotes 15
T12678 24616-24617 -LRB- denotes (
T67952 24617-24622 NN denotes NSP15
T62960 24622-24623 -RRB- denotes )
T99202 24624-24632 VBD denotes appeared
T16450 24633-24635 TO denotes to
T75671 24636-24639 VB denotes act
T10168 24640-24642 IN denotes as
T75263 24643-24646 DT denotes the
T95644 24647-24653 NN denotes target
T19735 24654-24656 IN denotes of
T45429 24657-24668 NN denotes ciclesonide
T28790 24670-24672 DT denotes An
T72966 24673-24678 JJ denotes amino
T10430 24679-24683 NN denotes acid
T13644 24684-24696 NN denotes substitution
T66951 24697-24699 IN denotes in
T16733 24700-24703 DT denotes the
T82047 24704-24709 NN denotes NSP15
T5298 24710-24719 VBD denotes conferred
T82196 24720-24730 NN denotes resistance
T91861 24731-24733 IN denotes of
T16541 24734-24737 DT denotes the
T11735 24738-24745 VBN denotes mutated
T77495 24746-24754 NN denotes MERS-CoV
T54348 24755-24757 TO denotes to
T98167 24758-24769 NN denotes ciclesonide
T36698 24771-24781 NN denotes Mometasone
T83057 24782-24787 MD denotes could
T32973 24788-24792 VB denotes help
T81462 24793-24797 VB denotes deal
T7177 24798-24809 RB denotes effectively
T91822 24810-24814 IN denotes with
T40647 24815-24818 DT denotes the
T69218 24819-24826 VBN denotes mutated
T94051 24827-24835 NN denotes MERS-CoV
T94597 24837-24840 IN denotes For
T52862 24841-24844 DT denotes the
T49143 24845-24854 NN denotes SARS-CoV2
T76216 24854-24855 -COMMA- denotes ,
T48579 24856-24859 DT denotes all
T87735 24860-24865 CD denotes three
T54792 24866-24877 NN denotes ciclesonide
T41003 24877-24878 -COMMA- denotes ,
T64594 24879-24889 NN denotes mometasone
T89636 24889-24890 -COMMA- denotes ,
T45337 24891-24894 CC denotes and
T31426 24895-24904 NN denotes lopinavir
T30995 24905-24909 VBD denotes were
T47275 24910-24914 JJ denotes able
T43506 24915-24917 TO denotes to
T13737 24918-24925 VB denotes inhibit
T48184 24926-24931 JJ denotes viral
T45532 24932-24943 NN denotes replication
T78456 24944-24946 TO denotes to
T84667 24947-24948 DT denotes a
T50127 24949-24956 JJ denotes similar
T63329 24957-24963 NN denotes degree
T13824 24965-24978 RB denotes Interestingly
T97722 24978-24979 -COMMA- denotes ,
T32551 24980-24985 PRP-DOLLAR- denotes their
T29877 24986-24992 NN denotes effect
T26799 24993-24996 VBD denotes was
T38163 24997-25001 RBR denotes more
T71857 25002-25012 JJ denotes noticeable
T13399 25013-25017 IN denotes than
T61277 25018-25024 NN denotes serine
T95334 25025-25033 NN denotes protease
T18879 25034-25044 NNS denotes inhibitors
T2889 25044-25045 -COMMA- denotes ,
T73448 25046-25050 FW denotes e.g.
T12218 25050-25051 -COMMA- denotes ,
T97193 25052-25062 NN denotes nafamostat
T84364 25063-25066 CC denotes and
T56231 25067-25075 NN denotes camostat
T36295 25076-25078 IN denotes in
T50002 25079-25084 NNS denotes cells
T41374 25085-25089 WDT denotes that
T64051 25090-25094 NN denotes Vero
T69995 25095-25100 NNS denotes cells
T3328 25101-25105 WDT denotes that
T80806 25106-25113 VBP denotes express
T14927 25114-25121 NN denotes TMPRSS2
T77594 25123-25125 PRP denotes It
T50088 25126-25135 VBZ denotes indicates
T80437 25136-25139 DT denotes the
T11181 25140-25148 NN denotes tendency
T22059 25149-25151 IN denotes of
T93173 25152-25155 DT denotes the
T10513 25156-25165 NN denotes SARS-CoV2
T35356 25166-25168 TO denotes to
T95799 25169-25174 VB denotes enter
T54387 25175-25178 DT denotes the
T81737 25179-25183 NN denotes cell
T49362 25184-25191 IN denotes through
T16554 25192-25195 DT denotes the
T7152 25196-25215 JJ denotes cathepsin/endosomal
T53710 25216-25223 NN denotes pathway
T21481 25224-25230 RB denotes rather
T71892 25231-25235 IN denotes than
T13882 25236-25243 IN denotes through
T1912 25244-25247 DT denotes the
T96928 25248-25260 NN denotes TMPRSS2/cell
T71956 25261-25268 NN denotes surface
T74893 25269-25276 NN denotes pathway
T35160 25278-25281 DT denotes The
T65117 25282-25287 NN denotes study
T45353 25288-25289 -LRB- denotes [
T58501 25289-25291 CD denotes 31
T88016 25291-25292 -RRB- denotes ]
T88407 25293-25301 VBD denotes included
T16300 25302-25304 CD denotes 46
T33446 25305-25313 NNS denotes patients
T87886 25314-25318 IN denotes with
T58994 25319-25325 JJ denotes severe
T97970 25326-25334 NN denotes COVID-19
T41758 25334-25335 -COMMA- denotes ,
T58135 25336-25338 IN denotes of
T85647 25339-25344 DT denotes these
T95602 25345-25347 CD denotes 26
T73561 25348-25356 NNS denotes patients
T76496 25357-25365 VBD denotes received
T42976 25366-25384 NN denotes methylprednisolone
T32544 25385-25386 -LRB- denotes (
T60914 25386-25397 NN denotes 1–2 mg/kg/d
T95632 25398-25401 IN denotes for
T23094 25402-25410 NNS denotes 5–7 days
T28841 25410-25411 -RRB- denotes )
T83750 25411-25412 -COMMA- denotes ,
T5759 25413-25416 CC denotes and
T23681 25417-25419 CD denotes 20
T13615 25420-25428 NNS denotes patients
T96732 25429-25437 VBD denotes received
T97501 25438-25446 JJ denotes standard
T84414 25447-25454 NN denotes therapy
T2990 25455-25462 IN denotes without
T83484 25463-25481 NN denotes methylprednisolone
T55303 25483-25486 DT denotes The
T42547 25487-25492 JJ denotes first
T58218 25493-25498 NN denotes group
T37085 25499-25507 VBD denotes achieved
T74264 25508-25514 JJR denotes faster
T54798 25515-25526 NN denotes improvement
T77136 25527-25529 IN denotes in
T46765 25530-25538 JJ denotes clinical
T98040 25539-25547 NNS denotes symptoms
T23999 25548-25549 -LRB- denotes (
T37402 25549-25554 NN denotes fever
T65661 25555-25558 CC denotes and
T89758 25559-25569 JJ denotes peripheral
T63703 25570-25576 NN denotes oxygen
T9527 25577-25587 NN denotes saturation
T5300 25587-25588 -RRB- denotes )
T34896 25589-25592 CC denotes and
T9982 25593-25597 NN denotes lung
T64673 25598-25605 NNS denotes lesions
T90980 25606-25614 VBN denotes detected
T16483 25615-25617 IN denotes by
T31403 25618-25620 NN denotes CT
T8195 25621-25628 NN denotes imaging
T7710 25630-25637 RB denotes However
T57863 25637-25638 -COMMA- denotes ,
T19219 25639-25642 CD denotes two
T43356 25643-25649 NNS denotes deaths
T32769 25650-25658 VBD denotes occurred
T5412 25659-25661 IN denotes in
T52171 25662-25665 DT denotes the
T5683 25666-25671 JJ denotes first
T18985 25672-25677 NN denotes group
T72564 25678-25681 CC denotes and
T66890 25682-25685 CD denotes one
T21460 25686-25691 NN denotes death
T49866 25692-25694 IN denotes in
T26278 25695-25698 DT denotes the
T96270 25699-25705 JJ denotes second
T89439 25706-25711 NN denotes group
T61059 25713-25721 RB denotes Moreover
T97295 25721-25722 -COMMA- denotes ,
T66784 25723-25726 DT denotes the
T32526 25727-25730 CD denotes two
T39437 25731-25737 NNS denotes groups
T87016 25738-25741 VBD denotes did
T42838 25742-25745 RB denotes not
T18576 25746-25752 VB denotes differ
T50188 25753-25755 IN denotes in
T80686 25756-25766 NN denotes laboratory
T16685 25767-25777 NNS denotes parameters
T92910 25777-25778 -COMMA- denotes ,
T79314 25779-25788 VBG denotes including
T58552 25789-25792 NNP denotes WBC
T52445 25792-25793 -COMMA- denotes ,
T19300 25794-25804 NN denotes lymphocyte
T50601 25805-25810 NN denotes count
T15065 25810-25811 -COMMA- denotes ,
T27527 25812-25820 NN denotes monocyte
T31332 25821-25826 NN denotes count
T62470 25826-25827 -COMMA- denotes ,
T39782 25828-25831 CC denotes and
T74286 25832-25841 NNS denotes cytokines
T39990 25842-25843 -LRB- denotes (
T86188 25843-25847 NN denotes IL-2
T98181 25847-25848 -COMMA- denotes ,
T95707 25849-25853 NN denotes IL-4
T51521 25853-25854 -COMMA- denotes ,
T13191 25855-25859 NN denotes IL-6
T97649 25859-25860 -COMMA- denotes ,
T67884 25861-25864 CC denotes and
T96461 25865-25870 NN denotes IL-10
T46182 25870-25871 -RRB- denotes )
T71095 25872-25875 CD denotes six
T75519 25876-25880 NNS denotes days
T70281 25881-25886 IN denotes after
T58821 25887-25896 NN denotes treatment
T68602 25898-25903 EX denotes There
T35641 25904-25906 VBZ denotes is
T96551 25907-25908 DT denotes a
T4246 25909-25915 NN denotes report
T68154 25916-25918 IN denotes of
T38317 25919-25922 DT denotes the
T15000 25923-25930 NN denotes patient
T78684 25931-25935 IN denotes with
T75392 25936-25944 NN denotes COVID-19
T66370 25945-25952 VBN denotes treated
T30686 25953-25957 IN denotes with
T52580 25958-25976 NN denotes methylprednisolone
T48202 25977-25982 IN denotes since
T9113 25983-25986 NN denotes day
T95658 25987-25988 CD denotes 8
T45554 25989-25991 IN denotes of
T3986 25992-25995 DT denotes the
T39007 25996-26003 NN denotes disease
T69348 26004-26010 NN denotes course
T97762 26012-26019 RB denotes However
T96472 26019-26020 -COMMA- denotes ,
T86008 26021-26024 PRP-DOLLAR- denotes his
T42849 26025-26034 NN denotes situation
T60930 26035-26043 VBD denotes worsened
T29454 26044-26047 CC denotes and
T36559 26048-26057 VBD denotes developed
T85992 26058-26069 JJ denotes respiratory
T55480 26070-26077 NN denotes failure
T13828 26078-26081 CC denotes and
T63285 26082-26086 VBD denotes died
T37916 26087-26089 IN denotes on
T9153 26090-26093 NN denotes day
T54332 26094-26096 CD denotes 14
T22231 26097-26098 -LRB- denotes [
T45405 26098-26100 CD denotes 32
T54531 26100-26101 -RRB- denotes ]
T33004 26104-26105 CD denotes 8
T58581 26107-26111 NNS denotes Eggs
T97114 26112-26115 IN denotes for
T27689 26116-26126 VBG denotes increasing
T63081 26127-26131 NN denotes ACE2
T72667 26132-26135 CC denotes and
T79511 26136-26142 NN denotes copper
T38004 26143-26146 NN denotes Egg
T27506 26147-26161 NN denotes ovotransferrin
T37276 26162-26170 VBZ denotes contains
T34098 26171-26173 DT denotes an
T97147 26174-26196 JJ denotes angiotensin-converting
T86608 26197-26203 NN denotes enzyme
T66871 26204-26205 -LRB- denotes (
T13854 26205-26208 NN denotes ACE
T64698 26208-26209 -RRB- denotes )
T83677 26210-26220 JJ denotes inhibitory
T66003 26221-26228 NN denotes peptide
T77918 26228-26229 -COMMA- denotes ,
T89508 26230-26235 VBN denotes known
T88322 26236-26238 IN denotes as
T66546 26239-26242 NNP denotes IRW
T45851 26242-26243 -COMMA- denotes ,
T60984 26244-26248 WDT denotes that
T46693 26249-26252 VBZ denotes has
T76296 26253-26258 VBN denotes shown
T28156 26259-26261 TO denotes to
T90573 26262-26270 VB denotes decrease
T38759 26271-26276 NN denotes blood
T21018 26277-26285 NN denotes pressure
T30544 26286-26288 IN denotes in
T99198 26289-26301 JJ denotes hypertensive
T98401 26302-26306 NNS denotes rats
T50903 26307-26308 -LRB- denotes [
T33947 26308-26310 CD denotes 33
T14997 26310-26311 -RRB- denotes ]
T50077 26313-26320 IN denotes Through
T34549 26321-26324 DT denotes the
T35438 26325-26338 NN denotes up-regulation
T84846 26339-26341 IN denotes of
T82446 26342-26346 NN denotes ACE2
T51616 26346-26347 -COMMA- denotes ,
T55154 26348-26358 NN denotes E-cadherin
T8679 26358-26359 -COMMA- denotes ,
T45090 26360-26366 NN denotes ABCB-1
T32702 26366-26367 -COMMA- denotes ,
T32352 26368-26371 CC denotes and
T2901 26372-26377 NN denotes IRF-8
T24097 26377-26378 -COMMA- denotes ,
T97074 26379-26382 NNP denotes IRW
T68802 26383-26386 MD denotes can
T39838 26387-26395 VB denotes decrease
T60149 26396-26399 NN denotes RAS
T50074 26400-26408 NN denotes activity
T49953 26408-26409 -COMMA- denotes ,
T70369 26410-26421 NN denotes hyperplasia
T91445 26421-26422 -COMMA- denotes ,
T20067 26423-26426 CC denotes and
T30801 26427-26435 JJ denotes vascular
T51592 26436-26448 NN denotes inflammation
T28168 26449-26452 CC denotes and
T93235 26453-26456 NN denotes aid
T43180 26457-26469 JJ denotes differential
T82201 26470-26480 NN denotes regulation
T72254 26481-26483 IN denotes of
T87852 26484-26494 NNS denotes leukocytes
T80434 26496-26498 IN denotes On
T8306 26499-26502 DT denotes the
T52921 26503-26508 JJ denotes other
T81543 26509-26513 NN denotes hand
T20825 26513-26514 -COMMA- denotes ,
T78284 26515-26517 IN denotes by
T10667 26518-26521 DT denotes the
T59443 26522-26537 NN denotes down-regulation
T14412 26538-26540 IN denotes of
T13570 26541-26557 JJ denotes pro-inflammatory
T20179 26558-26567 NNS denotes molecules
T42843 26567-26568 -COMMA- denotes ,
T68303 26569-26573 FW denotes e.g.
T5913 26573-26574 -COMMA- denotes ,
T53611 26575-26581 NN denotes ICAM-1
T22569 26582-26585 CC denotes and
T86123 26586-26592 NN denotes VCAM-1
T88206 26592-26593 -COMMA- denotes ,
T14786 26594-26597 NN denotes IRW
T56782 26598-26601 MD denotes can
T84385 26602-26608 VB denotes reduce
T54198 26609-26612 DT denotes the
T53586 26613-26624 NN denotes recruitment
T18273 26625-26627 IN denotes of
T25763 26628-26638 NNS denotes leukocytes
T50471 26639-26642 CC denotes and
T39944 26643-26651 JJ denotes vascular
T95815 26652-26664 NN denotes inflammation
T32229 26666-26672 NN denotes Copper
T37620 26673-26678 MD denotes might
T49191 26679-26683 VB denotes help
T32412 26684-26687 DT denotes the
T49707 26688-26694 JJ denotes immune
T77430 26695-26701 NN denotes system
T78509 26702-26704 TO denotes to
T84428 26705-26711 VB denotes combat
T52262 26712-26717 JJ denotes viral
T25569 26718-26728 NNS denotes infections
T85825 26730-26731 DT denotes A
T86532 26732-26744 NN denotes High-content
T37905 26745-26747 IN denotes of
T38135 26748-26754 NN denotes copper
T5313 26755-26761 VBZ denotes exists
T26683 26762-26764 IN denotes in
T69996 26765-26769 NNS denotes eggs
T88154 26770-26773 CC denotes and
T28753 26774-26783 NNS denotes eggshells
T68700 26784-26786 IN denotes of
T82775 26787-26795 JJ denotes domestic
T68554 26796-26801 NNS denotes birds
T12507 26803-26805 IN denotes In
T63866 26806-26816 JJ denotes particular
T96163 26816-26817 -COMMA- denotes ,
T60294 26818-26821 DT denotes the
T93066 26822-26830 NN denotes eggshell
T75912 26831-26833 IN denotes of
T52328 26834-26840 NN denotes pigeon
T61958 26841-26842 -LRB- denotes (
T56156 26842-26843 CD denotes 4
T26914 26844-26845 NN denotes ±
T94273 26846-26855 NN denotes 0.29 μg/g
T66624 26855-26856 -RRB- denotes )
T87690 26857-26860 CC denotes and
T47055 26861-26864 DT denotes the
T46042 26865-26868 NN denotes egg
T48696 26869-26871 IN denotes of
T59365 26872-26877 NN denotes quail
T45935 26878-26879 -LRB- denotes (
T43374 26879-26883 CD denotes 4.67
T68174 26884-26885 CC denotes ±
T58925 26886-26895 NN denotes 1.08 μg/g
T41203 26895-26896 -RRB- denotes )
T68835 26897-26905 VBZ denotes contains
T5139 26906-26910 JJ denotes high
T58590 26911-26925 NNS denotes concentrations
T50194 26926-26928 IN denotes of
T95116 26929-26935 NN denotes copper
T90276 26936-26937 -LRB- denotes [
T72554 26937-26939 CD denotes 34
T34750 26939-26940 -RRB- denotes ]
T30828 26943-26944 CD denotes 9
T16242 26946-26956 NN denotes Conclusion
T34609 26957-26960 DT denotes The
T89640 26961-26966 JJ denotes novel
T90255 26967-26978 NN denotes coronavirus
T47494 26978-26979 -COMMA- denotes ,
T92057 26980-26989 NN denotes SARS-CoV2
T86476 26989-26990 -COMMA- denotes ,
T90050 26991-26994 MD denotes can
T44793 26995-27000 VB denotes cause
T83762 27001-27002 DT denotes a
T24737 27003-27014 RB denotes potentially
T30756 27015-27020 JJ denotes fatal
T98647 27021-27028 NN denotes disease
T39699 27028-27029 -COMMA- denotes ,
T83416 27030-27038 NN denotes COVID-19
T88854 27038-27039 -COMMA- denotes ,
T23368 27040-27042 IN denotes in
T6658 27043-27049 NNS denotes humans
T83401 27051-27054 DT denotes The
T88396 27055-27064 NN denotes infection
T41360 27065-27067 IN denotes of
T54757 27068-27073 JJ denotes human
T45506 27074-27079 NNS denotes cells
T35377 27080-27082 IN denotes by
T7551 27083-27092 NN denotes SARS-CoV2
T69934 27093-27101 VBZ denotes includes
T86235 27102-27105 CD denotes two
T83907 27106-27116 JJ denotes sequential
T31606 27117-27122 NNS denotes steps
T8581 27122-27123 -COLON- denotes :
T92030 27124-27134 NN denotes attachment
T73554 27135-27137 IN denotes of
T8936 27138-27141 DT denotes the
T8983 27142-27147 NN denotes virus
T66380 27148-27150 TO denotes to
T19797 27151-27154 DT denotes the
T19295 27155-27162 NN denotes surface
T35146 27163-27171 NN denotes receptor
T47614 27172-27174 IN denotes of
T61527 27175-27181 NN denotes target
T54919 27182-27187 NNS denotes cells
T84322 27188-27191 CC denotes and
T41319 27192-27195 DT denotes the
T5207 27196-27202 NN denotes fusion
T80511 27203-27205 IN denotes of
T69288 27206-27211 JJ denotes viral
T56752 27212-27215 CC denotes and
T14937 27216-27220 NN denotes host
T80253 27221-27230 NNS denotes membranes
T25258 27232-27235 DT denotes The
T76019 27236-27242 JJ denotes former
T58724 27243-27251 VBZ denotes requires
T9128 27252-27254 IN denotes at
T32276 27255-27260 JJS denotes least
T24570 27261-27262 DT denotes a
T92436 27263-27279 JJ denotes receptor-binding
T64204 27280-27286 NN denotes domain
T40189 27287-27289 IN denotes on
T26075 27290-27293 DT denotes the
T84125 27294-27303 NN denotes SARS-CoV2
T91232 27304-27309 NN denotes Spike
T75548 27310-27317 NN denotes protein
T15500 27318-27322 WDT denotes that
T13216 27323-27326 MD denotes can
T74634 27327-27335 VB denotes interact
T94971 27336-27340 IN denotes with
T93734 27341-27342 DT denotes a
T75854 27343-27347 NN denotes cell
T13409 27348-27355 NN denotes surface
T62139 27356-27364 NN denotes receptor
T99372 27364-27365 -COMMA- denotes ,
T52645 27366-27369 IN denotes for
T45934 27370-27377 NN denotes example
T7202 27377-27378 -COMMA- denotes ,
T57327 27379-27383 NN denotes ACE2
T94908 27383-27384 -COMMA- denotes ,
T89289 27385-27394 VBN denotes expressed
T98989 27395-27397 IN denotes on
T1718 27398-27403 JJ denotes human
T54799 27404-27409 NNS denotes cells
T35873 27411-27414 DT denotes The
T71668 27415-27421 JJ denotes latter
T77029 27422-27430 VBZ denotes requires
T58629 27431-27433 IN denotes at
T56483 27434-27439 JJS denotes least
T97030 27440-27443 DT denotes the
T96744 27444-27448 NN denotes host
T15927 27449-27457 NN denotes protease
T76016 27457-27458 -LRB- denotes (
T39360 27458-27459 NNS denotes s
T19744 27459-27460 -RRB- denotes )
T6084 27461-27463 TO denotes to
T44730 27464-27471 VB denotes mediate
T91735 27472-27483 JJ denotes proteolytic
T36459 27484-27492 NN denotes cleavage
T4317 27493-27495 IN denotes of
T57535 27496-27499 DT denotes the
T19590 27500-27509 NN denotes SARS-CoV2
T61296 27510-27515 NN denotes Spike
T59765 27516-27523 NN denotes protein
T37338 27524-27528 IN denotes into
T49962 27529-27531 NN denotes S1
T42599 27532-27535 CC denotes and
T28541 27536-27538 NN denotes S2
T69297 27539-27547 NNS denotes subunits
T86274 27548-27551 CC denotes and
T27045 27552-27564 RB denotes consequently
T2068 27565-27572 VBP denotes promote
T89079 27573-27576 DT denotes the
T65082 27577-27583 NN denotes fusion
T32005 27584-27586 IN denotes of
T46413 27587-27592 JJ denotes viral
T37466 27593-27596 CC denotes and
T12807 27597-27601 NN denotes host
T52032 27602-27611 NNS denotes membranes
T8599 27613-27617 RB denotes Also
T75642 27617-27618 -COMMA- denotes ,
T77995 27619-27628 NN denotes SARS-CoV2
T83579 27629-27638 VBZ denotes possesses
T13485 27639-27640 DT denotes a
T30948 27641-27650 JJ denotes polybasic
T88376 27651-27659 NN denotes cleavage
T13257 27660-27664 NN denotes site
T62080 27665-27669 WDT denotes that
T72593 27670-27673 MD denotes can
T68497 27674-27681 VB denotes explain
T75684 27682-27685 DT denotes the
T70730 27686-27690 JJ denotes high
T67108 27691-27704 NN denotes pathogenicity
T52147 27705-27707 IN denotes of
T97526 27708-27717 NN denotes SARS-CoV2
T37933 27717-27718 -COMMA- denotes ,
T70141 27719-27728 NNS denotes N-glycans
T39330 27729-27732 CC denotes and
T24202 27733-27742 NNS denotes O-glycans
T7384 27743-27747 WDT denotes that
T5681 27748-27752 VBP denotes make
T60584 27753-27756 DT denotes the
T39050 27757-27762 JJ denotes dense
T21027 27763-27773 NN denotes decoration
T27410 27774-27776 IN denotes of
T7435 27777-27786 NN denotes SARS-CoV2
T14256 27787-27788 NN denotes S
T13014 27789-27796 NN denotes protein
T24915 27796-27797 -COMMA- denotes ,
T65635 27798-27801 CC denotes and
T97815 27802-27808 JJ denotes cyclic
T48498 27809-27816 NNS denotes regions
T47927 27817-27821 WDT denotes that
T83674 27822-27825 MD denotes can
T49668 27826-27834 VB denotes interact
T28141 27835-27839 IN denotes with
T82773 27840-27852 JJ denotes cell-surface
T16887 27853-27858 NN denotes GRP78
T32660 27860-27869 JJ denotes Essential
T82280 27870-27878 NNS denotes elements
T81648 27879-27883 IN denotes that
T14044 27884-27891 NN denotes process
T34906 27892-27901 NN denotes SARS-CoV2
T11727 27902-27906 NN denotes cell
T51771 27907-27912 NN denotes entry
T42633 27913-27916 CC denotes and
T86737 27917-27925 JJ denotes specific
T22570 27926-27941 NNS denotes characteristics
T8091 27942-27946 WDT denotes that
T39623 27947-27952 VBP denotes allow
T42798 27953-27962 NN denotes SARS-CoV2
T73233 27963-27965 TO denotes to
T53867 27966-27972 VB denotes escape
T40812 27973-27976 DT denotes the
T43928 27977-27983 JJ denotes immune
T80777 27984-27990 NN denotes system
T33950 27991-27995 VBP denotes have
T72049 27996-27999 DT denotes the
T50749 28000-28009 NN denotes potential
T76482 28010-28012 IN denotes as
T86110 28013-28020 NNS denotes targets
T97786 28021-28024 IN denotes for
T96599 28025-28033 NN denotes COVID-19
T67580 28034-28041 NN denotes therapy
T2209 28043-28047 NN denotes Lack
T82418 28048-28050 IN denotes of
T17483 28051-28059 JJ denotes specific
T11435 28060-28070 NNS denotes treatments
T58860 28071-28074 IN denotes for
T97288 28075-28083 NN denotes COVID-19
T14954 28084-28087 CC denotes and
T67635 28088-28091 DT denotes the
T14560 28092-28096 RB denotes very
T29994 28097-28111 JJ denotes time-consuming
T54347 28112-28119 NN denotes process
T43425 28120-28122 IN denotes of
T40405 28123-28130 NN denotes vaccine
T65584 28131-28142 NN denotes development
T26632 28143-28147 VBP denotes lead
T87212 28148-28150 PRP denotes us
T4319 28151-28153 TO denotes to
T17398 28154-28159 VB denotes trust
T39922 28160-28171 JJ denotes traditional
T59832 28172-28179 NNS denotes notions
T79640 28180-28182 IN denotes of
T39982 28183-28195 NN denotes immunization
T68886 28196-28201 VBG denotes using
T59526 28202-28209 JJ denotes passive
T93112 28210-28218 NN denotes transfer
T2403 28219-28221 IN denotes of
T97514 28222-28229 JJ denotes humoral
T67166 28230-28238 NN denotes immunity
T8460 28240-28247 JJ denotes Passive
T78989 28248-28260 NN denotes immunization
T37380 28261-28264 MD denotes can
T3292 28265-28267 VB denotes be
T87394 28268-28272 VBN denotes done
T83285 28273-28278 VBG denotes using
T80590 28279-28285 NN denotes plasma
T40394 28286-28293 NN denotes therapy
T28898 28294-28297 CC denotes and
T56173 28298-28302 NN denotes IVIG
T89662 28303-28310 NN denotes therapy
T43126 28312-28318 NN denotes Plasma
T98086 28319-28323 IN denotes from
T4913 28324-28332 NNS denotes patients
T85558 28333-28342 VBN denotes recovered
T54139 28343-28347 IN denotes from
T65005 28348-28356 NN denotes COVID-19
T70575 28357-28361 WDT denotes that
T50076 28362-28370 VBZ denotes contains
T23714 28371-28381 NNS denotes antibodies
T54709 28382-28389 IN denotes against
T26763 28390-28399 NN denotes SARS-CoV2
T82790 28400-28403 VBZ denotes has
T72786 28404-28409 VBN denotes shown
T96449 28410-28419 JJ denotes promising
T61880 28420-28427 NNS denotes results
T36158 28428-28430 IN denotes in
T98710 28431-28439 NNS denotes patients
T52661 28440-28444 IN denotes with
T93981 28445-28451 JJ denotes severe
T61440 28452-28460 NN denotes COVID-19
T56097 28462-28466 RB denotes Also
T27399 28466-28467 -COMMA- denotes ,
T46672 28468-28476 NN denotes SARS-CoV
T4016 28477-28480 CC denotes and
T5488 28481-28490 NN denotes SARS-CoV2
T49089 28491-28494 VBP denotes are
T63728 28495-28502 RB denotes ideally
T58020 28503-28510 JJ denotes similar
T17353 28511-28513 IN denotes in
T77583 28514-28517 DT denotes the
T84845 28518-28527 NN denotes structure
T63353 28528-28531 CC denotes and
T19500 28532-28535 DT denotes the
T16312 28536-28540 NN denotes cell
T15071 28541-28546 NN denotes entry
T65845 28547-28555 NN denotes receptor
T64776 28556-28559 CC denotes and
T5365 28560-28568 NN denotes protease
T91360 28570-28577 NNS denotes Studies
T61175 28578-28582 VBP denotes show
T3464 28583-28587 IN denotes that
T71594 28588-28593 NN denotes serum
T59411 28594-28598 IN denotes from
T50943 28599-28611 JJ denotes convalescent
T99070 28612-28616 NN denotes SARS
T52714 28617-28625 NNS denotes patients
T30344 28626-28629 CC denotes and
T97752 28630-28635 NN denotes serum
T56749 28636-28640 IN denotes from
T81227 28641-28648 NNS denotes rabbits
T65088 28649-28658 VBN denotes immunized
T9531 28659-28663 IN denotes with
T3496 28664-28668 NNS denotes SARS
T18753 28669-28672 VBP denotes are
T56305 28673-28677 DT denotes both
T22390 28678-28682 JJ denotes able
T89303 28683-28685 TO denotes to
T72802 28686-28696 VB denotes neutralize
T57194 28697-28706 NN denotes SARS-CoV2
T63708 28707-28718 RB denotes efficiently
T61132 28720-28727 RB denotes However
T21857 28727-28728 -COMMA- denotes ,
T14229 28729-28734 NN denotes serum
T89468 28735-28739 IN denotes from
T75820 28740-28744 NNS denotes bats
T4213 28745-28754 VBN denotes immunized
T87498 28755-28759 IN denotes with
T5484 28760-28769 JJ denotes SARS-lice
T47898 28770-28781 NN denotes coronavirus
T5732 28782-28788 NN denotes SL-CoV
T45225 28789-28792 NN denotes Rp3
T42100 28793-28798 MD denotes could
T14407 28799-28802 RB denotes not
T21817 28803-28808 VB denotes exert
T34384 28809-28813 JJ denotes such
T15054 28814-28816 DT denotes an
T64476 28817-28823 NN denotes effect
T80575 28825-28827 PRP denotes It
T5249 28828-28830 VBZ denotes is
T88108 28831-28834 JJ denotes due
T14481 28835-28837 TO denotes to
T48691 28838-28839 DT denotes a
T43979 28840-28850 JJ denotes noticeable
T25730 28851-28857 NN denotes degree
T63462 28858-28860 IN denotes of
T72538 28861-28871 NN denotes difference
T22468 28872-28874 IN denotes in
T50331 28875-28878 DT denotes the
T61223 28879-28881 NN denotes S1
T8313 28882-28888 NN denotes domain
T42013 28889-28891 IN denotes in
T41693 28892-28895 DT denotes the
T41576 28896-28898 NN denotes S1
T33017 28899-28905 NN denotes domain
T6643 28906-28913 IN denotes between
T73200 28914-28917 DT denotes the
T38226 28918-28921 NN denotes bat
T96665 28922-28928 NN denotes SL-CoV
T68744 28929-28932 NN denotes Rp3
T25467 28933-28939 NN denotes strain
T80157 28940-28943 CC denotes and
T9673 28944-28953 NN denotes SARS-CoV2
T92096 28955-28956 DT denotes A
T21466 28957-28967 JJ denotes short-term
T18604 28968-28976 JJ denotes moderate
T45992 28977-28981 NN denotes dose
T31582 28982-28984 IN denotes of
T44685 28985-28989 NN denotes IVIG
T42097 28990-28998 VBN denotes combined
T36053 28999-29003 IN denotes with
T48662 29004-29017 NN denotes moderate-dose
T22507 29018-29020 IN denotes of
T9912 29021-29036 NNS denotes corticosteroids
T83835 29037-29042 MD denotes might
T7774 29043-29050 VB denotes improve
T16718 29051-29058 NN denotes patient
T30604 29059-29067 NNS denotes outcomes
T91513 29069-29076 NNS denotes Studies
T81529 29077-29081 VBP denotes show
T7530 29082-29086 IN denotes that
T31986 29087-29090 DT denotes the
T73402 29091-29096 JJ denotes viral
T42028 29097-29100 NN denotes RNA
T66238 29101-29103 IN denotes of
T77066 29104-29113 NN denotes SARS-CoV2
T7474 29114-29121 VBZ denotes reaches
T81899 29122-29125 PRP-DOLLAR- denotes its
T82598 29126-29130 NN denotes peak
T40173 29131-29137 IN denotes during
T31013 29138-29141 DT denotes the
T16396 29142-29147 JJ denotes first
T75325 29148-29152 NN denotes week
T4182 29153-29156 CC denotes and
T18300 29157-29161 RB denotes then
T56358 29162-29171 RB denotes gradually
T76094 29172-29181 VBZ denotes decreases
T20828 29182-29185 CC denotes and
T83224 29186-29190 IN denotes that
T96146 29191-29194 NN denotes IgG
T47796 29195-29198 CC denotes and
T69933 29199-29202 NN denotes IgM
T32800 29203-29208 VBP denotes begin
T67925 29209-29211 TO denotes to
T47586 29212-29216 VB denotes rise
T31692 29217-29221 IN denotes from
T7968 29222-29225 DT denotes the
T13466 29226-29230 JJ denotes 10th
T6862 29231-29234 NN denotes day
T3983 29235-29237 IN denotes so
T20802 29238-29242 IN denotes that
T89923 29243-29247 JJS denotes most
T68511 29248-29256 NNS denotes patients
T75930 29257-29261 VBP denotes have
T84637 29262-29272 JJ denotes anti-viral
T76069 29273-29283 NNS denotes antibodies
T50453 29284-29286 IN denotes by
T78621 29287-29290 DT denotes the
T91971 29291-29295 JJ denotes 14th
T55876 29296-29299 NN denotes day
T58337 29301-29308 JJ denotes Passive
T80315 29309-29321 NN denotes immunization
T58229 29322-29330 VBZ denotes protects
T77600 29331-29338 IN denotes against
T79174 29339-29346 NN denotes disease
T49092 29346-29347 -COMMA- denotes ,
T77811 29348-29351 CC denotes and
T60601 29352-29354 IN denotes so
T49810 29355-29357 PRP denotes it
T35724 29358-29364 MD denotes should
T59058 29365-29367 VB denotes be
T47054 29368-29380 VBN denotes administered
T78182 29381-29383 RB denotes as
T58224 29384-29389 RB denotes early
T10653 29390-29392 IN denotes as
T65232 29393-29401 JJ denotes possible
T7135 29402-29406 WRB denotes when
T74033 29407-29410 DT denotes the
T73325 29411-29418 NN denotes patient
T59206 29419-29421 VBZ denotes is
T72256 29422-29431 VBN denotes diagnosed
T60314 29433-29441 NN denotes Evidence
T35183 29442-29447 VBZ denotes links
T72324 29448-29456 NN denotes COVID-19
T95206 29457-29459 TO denotes to
T97915 29460-29468 JJ denotes variable
T92397 29469-29476 NNS denotes degrees
T70831 29477-29479 IN denotes of
T73708 29480-29492 NN denotes inflammation
T93832 29494-29509 NNS denotes Corticosteroids
T86571 29510-29515 VBP denotes offer
T20640 29516-29517 DT denotes a
T11737 29518-29524 JJ denotes potent
T13881 29525-29542 JJ denotes anti-inflammatory
T85869 29543-29549 NN denotes option
T39590 29551-29558 RB denotes However
T9841 29558-29559 -COMMA- denotes ,
T82570 29560-29564 PRP denotes they
T33328 29565-29567 VBP denotes do
T52824 29568-29571 RB denotes not
T27396 29572-29579 VB denotes dictate
T37147 29580-29587 JJ denotes precise
T31383 29588-29595 NNS denotes actions
T30144 29596-29599 CC denotes and
T43608 29600-29605 MD denotes might
T71924 29606-29611 VB denotes cause
T87293 29612-29623 NN denotes suppression
T66079 29624-29626 IN denotes of
T8269 29627-29637 JJ denotes anti-viral
T52172 29638-29644 JJ denotes immune
T20124 29645-29654 NNS denotes responses
T85154 29655-29657 RB denotes as
T9965 29658-29662 RB denotes well
T92497 29664-29671 NNS denotes Studies
T44468 29672-29676 VBP denotes show
T92811 29677-29681 IN denotes that
T62828 29682-29685 DT denotes the
T64812 29686-29689 NN denotes use
T90977 29690-29692 IN denotes of
T15178 29693-29708 NNS denotes corticosteroids
T25429 29709-29714 MD denotes might
T69842 29715-29725 VB denotes accelerate
T80684 29726-29734 NN denotes recovery
T88404 29735-29739 IN denotes from
T21137 29740-29748 NN denotes COVID-19
T1899 29750-29755 EX denotes There
T21793 29756-29759 VBP denotes are
T48698 29760-29762 DT denotes no
T88569 29763-29773 JJ denotes controlled
T72804 29774-29782 JJ denotes clinical
T97339 29783-29789 NNS denotes trials
T48573 29790-29794 WDT denotes that
T30904 29795-29799 VBP denotes show
T93994 29800-29807 IN denotes whether
T4378 29808-29811 DT denotes the
T44216 29812-29815 NN denotes use
T95916 29816-29818 IN denotes of
T36033 29819-29834 NNS denotes corticosteroids
T95640 29835-29838 MD denotes can
T86415 29839-29845 VB denotes reduce
T37383 29846-29862 JJ denotes COVID-19-related
T11797 29863-29868 NN denotes death
T74879 29870-29878 RB denotes Moreover
T90599 29878-29879 -COMMA- denotes ,
T98284 29880-29883 DT denotes the
T49609 29884-29900 JJ denotes pro-inflammatory
T24072 29901-29909 NN denotes cytokine
T64274 29910-29913 NN denotes IL6
T39845 29914-29916 VBZ denotes is
T48453 29917-29920 DT denotes the
T6053 29921-29936 JJ denotes best-documented
T54874 29937-29945 NN denotes cytokine
T84071 29946-29948 IN denotes in
T3462 29949-29957 NN denotes COVID-19
T4397 29958-29968 VBD denotes correlated
T53541 29969-29973 IN denotes with
T9169 29974-29982 NN denotes severity
T52339 29982-29983 -COMMA- denotes ,
T9027 29984-29995 NN denotes criticality
T63816 29995-29996 -COMMA- denotes ,
T3842 29997-30002 JJ denotes viral
T33160 30003-30007 NN denotes load
T71418 30007-30008 -COMMA- denotes ,
T44925 30009-30012 CC denotes and
T24005 30013-30022 NN denotes prognosis
T43722 30023-30025 IN denotes of
T77279 30026-30034 NNS denotes patients
T53860 30035-30039 IN denotes with
T83045 30040-30048 NN denotes COVID-19
T91725 30050-30061 NNP denotes Tocilizumab
T13491 30061-30062 -COMMA- denotes ,
T55969 30063-30064 DT denotes a
T88153 30065-30075 JJ denotes monoclonal
T13966 30076-30084 NN denotes antibody
T87639 30085-30092 IN denotes against
T20271 30093-30096 NN denotes IL6
T22072 30096-30097 -COMMA- denotes ,
T26781 30098-30103 MD denotes could
T93033 30104-30110 VB denotes confer
T66151 30111-30119 JJ denotes clinical
T39668 30120-30127 NN denotes benefit
T93255 30128-30130 IN denotes in
T16710 30131-30139 NNS denotes patients
T86610 30140-30144 IN denotes with
T16499 30145-30149 JJ denotes high
T41273 30150-30153 NN denotes IL6
T27148 30154-30160 NNS denotes levels
R0 T2 T0 arg2Of planning,Towards
R1 T2 T1 arg1Of planning,treatment
R10 T11 T12 arg1Of use,of
R100 T99 T107 arg1Of cause,in
R1000 T1007 T1008 arg1Of linked,to
R1001 T1016 T1008 arg2Of residues,to
R1002 T1016 T1009 arg1Of residues,the
R1003 T1016 T1010 arg1Of residues,amino
R1004 T1016 T1011 arg1Of residues,acid
R1005 T1016 T1012 arg1Of residues,asparagine
R10059 T24866 T92743 arg1Of transition,the
R1006 T1016 T1013 arg1Of residues,(
R1007 T1014 T1013 arg2Of Asn,(
R1008 T1015 T1013 arg3Of ),(
R1009 T1016 T1017 arg1Of residues,(
R101 T108 T107 arg2Of humans,in
R1010 T1020 T1017 arg2Of acids,(
R1011 T1027 T1017 arg3Of ),(
R10115 T96902 T81416 arg1Of existed,to
R1012 T1020 T1018 arg1Of acids,Asn-any
R10122 T97737 T30067 arg1Of protease,","
R1013 T1020 T1019 arg1Of acids,amino
R1014 T1022 T1021 arg1Of for,except
R1015 T1020 T1022 arg1Of acids,for
R1016 T1025 T1022 arg2Of or,for
R10165 T74634 T94971 arg1Of interact,with
R1017 T1025 T1023 arg1Of or,proline-
R10178 T33581 T76245 arg2Of 26,[
R1018 T1024 T1025 arg1Of Ser,or
R1019 T1026 T1025 arg2Of Thr,or
R102 T113 T109 arg1Of provide,Here
R1020 T1016 T1028 arg1Of residues,utilizing
R1021 T1031 T1028 arg2Of bond,utilizing
R10212 T80315 T58337 arg1Of immunization,Passive
R1022 T1031 T1029 arg1Of bond,an
R1023 T1031 T1030 arg1Of bond,N-glycosidic
R10231 T49810 T59058 arg1Of it,be
R1024 T1031 T1032 arg1Of bond,","
R10241 T98710 T36158 arg2Of patients,in
R1025 T1034 T1032 arg2Of N-acetylglucosamine,","
R10257 T99923 T37838 arg1Of role,of
R1026 T1034 T1033 arg1Of N-acetylglucosamine,mostly
R1027 T1035 T1036 arg1Of O-glycans,are
R10272 T38342 T45580 arg1Of Rp3,and
R1028 T1037 T1036 arg2Of attached,are
R1029 T1035 T1037 arg2Of O-glycans,attached
R103 T113 T110 arg1Of provide,","
R1030 T1037 T1038 arg1Of attached,to
R1031 T1051 T1038 arg2Of residues,to
R1032 T1051 T1039 arg1Of residues,the
R1033 T1042 T1040 arg1Of serine,amino
R1034 T1042 T1041 arg1Of serine,acid
R10340 T87582 T75308 arg1Of rise,so
R1035 T1051 T1042 arg1Of residues,serine
R10355 T66875 T91226 arg1Of patients,most
R10356 T60936 T17683 arg2Of SARS-2-S,and
R1036 T1042 T1043 arg1Of serine,(
R1037 T1044 T1043 arg2Of Ser,(
R10371 T37833 T46706 arg2Of target,to
R1038 T1045 T1043 arg3Of ),(
R10382 T20179 T13570 arg1Of molecules,pro-inflammatory
R1039 T1042 T1046 arg1Of serine,and
R104 T111 T112 arg1Of we,will
R1040 T1047 T1046 arg2Of threonine,and
R1041 T1051 T1047 arg1Of residues,threonine
R1042 T1047 T1048 arg1Of threonine,(
R1043 T1049 T1048 arg2Of Thr,(
R1044 T1050 T1048 arg3Of ),(
R1045 T1037 T1052 arg1Of attached,by
R1046 T1054 T1052 arg2Of addition,by
R1047 T1054 T1053 arg1Of addition,the
R1048 T1054 T1055 arg1Of addition,of
R10483 T16296 T6873 arg2Of infection,to
R1049 T1058 T1055 arg2Of galactosamine,of
R105 T113 T112 arg2Of provide,will
R1050 T1058 T1056 arg1Of galactosamine,an
R1051 T1058 T1057 arg1Of galactosamine,N-acetyl
R10518 T98095 T5967 arg1Of chains,light
R1052 T1058 T1059 arg1Of galactosamine,(
R1053 T1060 T1059 arg2Of GalNAc,(
R1054 T1061 T1059 arg3Of ),(
R1055 T1089 T1062 arg1Of and,For
R1056 T1063 T1062 arg2Of example,For
R1057 T1089 T1064 arg1Of and,","
R1058 T1065 T1066 arg1Of N-glycans,exist
R10580 T49731 T12498 arg2Of E,(
R1059 T1066 T1067 arg1Of exist,in
R106 T111 T113 arg1Of we,provide
R1060 T1081 T1067 arg2Of and,in
R1061 T1069 T1068 arg1Of virus,Hendra
R1062 T1069 T1070 arg1Of virus,","
R1063 T1071 T1070 arg2Of SARS-CoV,","
R1064 T1070 T1072 arg1Of ",",","
R1065 T1074 T1072 arg2Of virus,","
R1066 T1074 T1073 arg1Of virus,influenza
R10665 T89603 T52542 arg1Of coordination,of
R1067 T1072 T1075 arg1Of ",",","
R1068 T1077 T1075 arg2Of virus,","
R1069 T1077 T1076 arg1Of virus,hepatitis
R10698 T65845 T64776 arg1Of receptor,and
R107 T115 T113 arg2Of overview,provide
R1070 T1075 T1078 arg1Of ",",","
R10701 T32201 T94518 arg1Of treatment,","
R10707 T74893 T71956 arg1Of pathway,surface
R1071 T1079 T1078 arg2Of HIV-1,","
R1072 T1081 T1080 arg1Of and,","
R1073 T1078 T1081 arg1Of ",",and
R10738 T17100 T86473 arg2Of mice,immunized
R1074 T1084 T1081 arg2Of virus,and
R1075 T1083 T1082 arg1Of Nile,West
R10750 T21677 T87902 arg3Of ],[
R1076 T1084 T1083 arg1Of virus,Nile
R1077 T1084 T1085 arg1Of virus,[
R1078 T1086 T1085 arg2Of 6,[
R1079 T1087 T1085 arg3Of ],[
R108 T115 T114 arg1Of overview,an
R1080 T1089 T1088 arg1Of and,","
R10807 T27403 T62199 arg2Of 25,[
R1081 T1066 T1089 arg1Of exist,and
R1082 T1092 T1089 arg2Of occurred,and
R1083 T1090 T1091 arg1Of O-glycans,have
R10830 T45118 T86655 arg1Of levels,antibody
R10836 T71701 T38328 arg1Of sequence,acid
R1084 T1092 T1091 arg2Of occurred,have
R1085 T1090 T1092 arg1Of O-glycans,occurred
R10854 T68835 T90276 arg1Of contains,[
R1086 T1092 T1093 arg1Of occurred,in
R1087 T1096 T1093 arg2Of virus,in
R10873 T83272 T20599 arg1Of polyprotein,replicase
R1088 T1096 T1094 arg1Of virus,the
R1089 T1096 T1095 arg1Of virus,Ebola
R10896 T63070 T65028 arg1Of levels,lymphocyte
R109 T115 T116 arg1Of overview,of
R1090 T1100 T1097 arg1Of protein,The
R1091 T1100 T1098 arg1Of protein,2019-nCoV
R1092 T1100 T1099 arg1Of protein,S
R1093 T1100 T1101 arg1Of protein,includes
R1094 T1106 T1101 arg2Of sequons,includes
R10947 T68894 T97000 arg1Of that,of
R1095 T1106 T1102 arg1Of sequons,13
R1096 T1106 T1103 arg1Of sequons,and
R1097 T1106 T1104 arg1Of sequons,9N-linked
R10976 T8983 T66380 arg1Of virus,to
R1098 T1106 T1105 arg1Of sequons,glycosylation
R1099 T1106 T1107 arg1Of sequons,in
R10991 T86520 T22143 arg1Of immunization,protects
R11 T15 T12 arg2Of agents,of
R110 T118 T116 arg2Of options,of
R1100 T1112 T1107 arg2Of subunit,in
R1101 T1112 T1108 arg1Of subunit,the
R11011 T64893 T64532 arg1Of IFNs,play
R1102 T1112 T1109 arg1Of subunit,S1
R11025 T39838 T50077 arg1Of decrease,Through
R1103 T1109 T1110 arg1Of S1,and
R1104 T1111 T1110 arg2Of S2,and
R1105 T1112 T1111 arg1Of subunit,S2
R1106 T1106 T1113 arg1Of sequons,","
R1107 T1106 T1114 arg1Of sequons,respectively
R1108 T1101 T1115 arg1Of includes,[
R11084 T95952 T16420 arg1Of differences,occur
R1109 T1116 T1115 arg2Of 3,[
R111 T118 T117 arg1Of options,therapeutic
R1110 T1117 T1115 arg3Of ],[
R1111 T1118 T1119 arg1Of All,of
R1112 T1120 T1119 arg2Of these,of
R1113 T1118 T1121 arg1Of All,have
R1114 T1123 T1121 arg2Of occurred,have
R1115 T1123 T1122 arg1Of occurred,previously
R11155 T2209 T82418 arg1Of Lack,of
R1116 T1118 T1123 arg1Of All,occurred
R1117 T1123 T1124 arg1Of occurred,in
R11170 T20946 T7432 arg2Of genomes,of
R11171 T49434 T74174 arg1Of include,in
R1118 T1128 T1124 arg2Of glycoprotein,in
R1119 T1128 T1125 arg1Of glycoprotein,the
R112 T115 T119 arg1Of overview,for
R1120 T1128 T1126 arg1Of glycoprotein,SARS-CoV
R1121 T1128 T1127 arg1Of glycoprotein,S
R1122 T1123 T1129 arg1Of occurred,","
R11221 T70930 T74238 arg3Of ),(
R11228 T45337 T30995 arg1Of and,were
R1123 T1131 T1130 arg1Of for,except
R1124 T1123 T1131 arg1Of occurred,for
R1125 T1134 T1131 arg2Of sequons,for
R1126 T1134 T1132 arg1Of sequons,four-linked
R1127 T1134 T1133 arg1Of sequons,glycosylation
R11270 T42144 T39632 arg1Of responses,immune
R1128 T1134 T1135 arg1Of sequons,in
R11280 T7048 T69120 arg1Of late,early
R1129 T1137 T1135 arg2Of S1,in
R113 T120 T119 arg2Of COVID-19,for
R1130 T1137 T1136 arg1Of S1,the
R1131 T1163 T1138 arg1Of are,Also
R1132 T1163 T1139 arg1Of are,","
R11328 T50007 T39219 arg1Of domain,S1
R1133 T1141 T1140 arg1Of to,due
R11336 T67504 T7728 arg1Of analysis,phylogenetic
R1134 T1163 T1141 arg1Of are,to
R1135 T1143 T1141 arg2Of existence,to
R1136 T1143 T1142 arg1Of existence,the
R1137 T1143 T1144 arg1Of existence,of
R11370 T45006 T20264 arg1Of 2019-nCoV,the
R1138 T1148 T1144 arg2Of proline,of
R1139 T1148 T1145 arg1Of proline,an
R114 T121 T122 arg1Of Plasma,from
R1140 T1148 T1146 arg1Of proline,amino
R1141 T1148 T1147 arg1Of proline,acid
R1142 T1148 T1149 arg1Of proline,in
R1143 T1153 T1149 arg2Of site,in
R1144 T1153 T1150 arg1Of site,the
R11446 T98211 T71821 arg1Of processing,to
R1145 T1153 T1151 arg1Of site,polybasic
R11456 T27148 T86610 arg2Of levels,with
R1146 T1153 T1152 arg1Of site,cleavage
R1147 T1148 T1154 arg1Of proline,","
R1148 T1148 T1155 arg1Of proline,which
R11481 T33016 T77949 arg1Of S,ZXC21
R1149 T1148 T1156 arg1Of proline,makes
R11494 T39437 T18576 arg1Of groups,differ
R115 T123 T122 arg2Of patients,from
R1150 T1160 T1156 arg2Of PRRA,makes
R1151 T1160 T1157 arg1Of PRRA,the
R1152 T1160 T1158 arg2Of PRRA,inserted
R1153 T1160 T1159 arg1Of PRRA,sequence
R11531 T3352 T81337 arg2Of them,of
R11535 T98040 T34896 arg1Of symptoms,and
R1154 T1163 T1161 arg1Of are,","
R1155 T1162 T1163 arg1Of there,are
R1156 T1166 T1163 arg2Of glycans,are
R1157 T1166 T1164 arg1Of glycans,three
R1158 T1166 T1165 arg1Of glycans,O-linked
R1159 T1166 T1167 arg2Of glycans,introduced
R11593 T25388 T9522 arg2Of course,from
R116 T123 T124 arg2Of patients,recovered
R1160 T1167 T1168 arg1Of introduced,to
R1161 T1177 T1168 arg2Of and,to
R1162 T1177 T1169 arg1Of and,the
R1163 T1172 T1170 arg1Of residues,2019-nCoV
R1164 T1172 T1171 arg1Of residues,RBD
R1165 T1177 T1172 arg1Of and,residues
R1166 T1173 T1174 arg1Of S673,","
R11663 T62169 T22492 arg1Of introduced,probably
R1167 T1175 T1174 arg2Of T678,","
R1168 T1177 T1176 arg1Of and,","
R1169 T1174 T1177 arg1Of ",",and
R117 T124 T125 arg1Of recovered,from
R1170 T1178 T1177 arg2Of S686,and
R1171 T1177 T1179 arg1Of and,[
R11715 T78080 T98368 arg1Of and,In
R1172 T1180 T1179 arg2Of 7,[
R1173 T1181 T1179 arg3Of ],[
R1174 T1186 T1182 arg1Of domain,3.1.3
R11743 T95515 T28355 arg1Of virus,the
R1175 T1186 T1183 arg1Of domain,SARS-CoV2
R1176 T1186 T1184 arg1Of domain,receptor
R1177 T1186 T1185 arg1Of domain,binding
R1178 T1186 T1187 arg1Of domain,contains
R1179 T1190 T1187 arg2Of acids,contains
R118 T126 T125 arg2Of COVID-19,from
R1180 T1190 T1188 arg1Of acids,six
R11800 T37602 T98869 arg2Of needed,is
R11805 T88382 T8711 arg1Of strain,the
R1181 T1190 T1189 arg1Of acids,amino
R11811 T44856 T20306 arg2Of therapy,without
R11819 T63285 T37916 arg1Of died,on
R1182 T1190 T1191 arg1Of acids,providing
R1183 T1193 T1191 arg2Of positions,providing
R1184 T1193 T1192 arg1Of positions,favorable
R1185 T1193 T1194 arg1Of positions,for
R11853 T85900 T55417 arg1Of attained,Hence
R11857 T81462 T7177 arg1Of deal,effectively
R1186 T1195 T1194 arg2Of binding,for
R1187 T1195 T1196 arg1Of binding,to
R11871 T83960 T65863 arg1Of pool,a
R1188 T1198 T1196 arg2Of ACE2,to
R1189 T1198 T1197 arg1Of ACE2,human
R119 T126 T127 arg1Of COVID-19,that
R1190 T1216 T1199 arg1Of showed,When
R11905 T59365 T45935 arg1Of quail,(
R1191 T1200 T1199 arg2Of compared,When
R11915 T68058 T82553 arg1Of virus,rubella
R1192 T1200 T1201 arg1Of compared,to
R1193 T1203 T1201 arg2Of SB,to
R11936 T20348 T98671 arg1Of outcome,the
R1194 T1203 T1202 arg1Of SB,SARS-CoV
R1195 T1216 T1204 arg1Of showed,","
R11953 T57783 T33080 arg1Of sequences,in
R1196 T1206 T1205 arg1Of motif,the
R1197 T1206 T1207 arg1Of motif,binding
R1198 T1210 T1207 arg2Of ACE2,binding
R1199 T1210 T1208 arg1Of ACE2,the
R11993 T22774 T85435 arg1Of recovered,from
R12 T15 T13 arg1Of agents,multiple
R120 T126 T128 arg1Of COVID-19,contains
R1200 T1210 T1209 arg1Of ACE2,human
R12004 T7474 T40173 arg1Of reaches,during
R1201 T1210 T1211 arg1Of ACE2,to
R1202 T1215 T1211 arg2Of SB,to
R12027 T81378 T78835 arg1Of degree,of
R1203 T1215 T1212 arg1Of SB,the
R1204 T1215 T1213 arg1Of SB,SARS-CoV
R1205 T1215 T1214 arg1Of SB,2
R1206 T1206 T1216 arg1Of motif,showed
R1207 T1221 T1216 arg2Of affinity,showed
R1208 T1225 T1216 arg3Of as,showed
R12080 T6862 T7968 arg1Of day,the
R1209 T1221 T1217 arg1Of affinity,a
R12091 T60803 T44490 arg1Of improvement,in
R121 T129 T128 arg2Of antibodies,contains
R1210 T1219 T1218 arg1Of higher,relatively
R1211 T1221 T1219 arg1Of affinity,higher
R1212 T1221 T1220 arg1Of affinity,binding
R1213 T1221 T1222 arg1Of affinity,for
R1214 T1224 T1222 arg2Of ACE2,for
R1215 T1224 T1223 arg1Of ACE2,human
R12153 T82446 T51616 arg1Of ACE2,","
R1216 T1226 T1225 arg2Of indicated,as
R1217 T1226 T1227 arg1Of indicated,in
R12170 T62141 T88887 arg2Of arthritis,","
R1218 T1231 T1227 arg2Of constant,in
R1219 T1231 T1228 arg1Of constant,smaller
R122 T129 T130 arg1Of antibodies,against
R1220 T1231 T1229 arg1Of constant,equilibrium
R1221 T1231 T1230 arg1Of constant,dissociation
R1222 T1231 T1232 arg1Of constant,(
R12224 T80577 T76245 arg3Of ],[
R1223 T1233 T1232 arg2Of 2.9 nM,(
R12230 T43412 T19399 arg2Of N,(
R12232 T15065 T39782 arg1Of ",",and
R12235 T13191 T51521 arg2Of IL-6,","
R1224 T1236 T1232 arg3Of ),(
R1225 T1233 T1234 arg1Of 2.9 nM,vs.
R1226 T1235 T1234 arg2Of 7.7 nM,vs.
R1227 T1216 T1237 arg1Of showed,[
R1228 T1238 T1237 arg2Of 3,[
R1229 T1239 T1237 arg3Of ],[
R12291 T25763 T50471 arg1Of leukocytes,and
R123 T131 T130 arg2Of SARS-CoV2,against
R1230 T1241 T1240 arg1Of analysis,Structural
R12304 T58392 T22912 arg2Of particular,In
R1231 T1241 T1242 arg1Of analysis,has
R12315 T73561 T85647 arg1Of patients,these
R1232 T1243 T1242 arg2Of demonstrated,has
R1233 T1241 T1243 arg1Of analysis,demonstrated
R12336 T37933 T39330 arg1Of ",",and
R1234 T1248 T1243 arg2Of take,demonstrated
R12341 T13737 T78456 arg1Of inhibit,to
R1235 T1248 T1244 arg1Of take,that
R1236 T1246 T1245 arg1Of positions,fourteen
R12367 T90848 T44446 arg1Of infections,Nocardia
R1237 T1248 T1247 arg1Of take,critically
R12375 T2642 T10299 arg2Of RNA,were
R1238 T1246 T1248 arg1Of positions,take
R1239 T1249 T1248 arg2Of part,take
R124 T121 T132 arg1Of Plasma,has
R1240 T1248 T1250 arg1Of take,in
R1241 T1253 T1250 arg2Of domain,in
R1242 T1253 T1251 arg1Of domain,the
R1243 T1253 T1252 arg1Of domain,receptor-binding
R12434 T48832 T18888 arg1Of diversity,produce
R1244 T1253 T1254 arg1Of domain,of
R1245 T1257 T1254 arg2Of SB,of
R1246 T1257 T1255 arg1Of SB,the
R1247 T1257 T1256 arg1Of SB,SARS-CoV
R12475 T15987 T11095 arg1Of arteritis,cell
R1248 T1257 T1258 arg1Of SB,that
R12484 T95208 T44068 arg1Of Rational,5.2
R1249 T1257 T1259 arg1Of SB,contain
R125 T133 T132 arg2Of shown,has
R1250 T1281 T1259 arg2Of and,contain
R1251 T1281 T1260 arg1Of and,eight
R1252 T1281 T1261 arg1Of and,conserved
R1253 T1280 T1262 arg1Of positions,(
R12539 T22929 T50644 arg1Of agents,and
R1254 T1277 T1262 arg2Of and,(
R12543 T5300 T23999 arg3Of ),(
R1255 T1279 T1262 arg3Of ),(
R12551 T71668 T35873 arg1Of latter,The
R1256 T1263 T1264 arg1Of T402,","
R1257 T1265 T1264 arg2Of Y436,","
R1258 T1264 T1266 arg1Of ",",","
R12583 T14229 T42100 arg1Of serum,could
R1259 T1267 T1266 arg2Of Y440,","
R12595 T33761 T77477 arg1Of spectrum,of
R126 T121 T133 arg1Of Plasma,shown
R1260 T1266 T1268 arg1Of ",",","
R1261 T1269 T1268 arg2Of N473,","
R1262 T1268 T1270 arg1Of ",",","
R12626 T87404 T95865 arg2Of neutralize,able
R1263 T1271 T1270 arg2Of Y475,","
R1264 T1270 T1272 arg1Of ",",","
R1265 T1273 T1272 arg2Of T486,","
R1266 T1272 T1274 arg1Of ",",","
R1267 T1275 T1274 arg2Of G488,","
R1268 T1277 T1276 arg1Of and,","
R1269 T1274 T1277 arg1Of ",",and
R12695 T56787 T11269 arg1Of assumes,2
R127 T135 T133 arg2Of results,shown
R1270 T1278 T1277 arg2Of Y491,and
R1271 T1280 T1281 arg1Of positions,and
R1272 T1310 T1281 arg2Of substitutions,and
R12726 T37666 T71611 arg1Of diseases,share
R1273 T1283 T1282 arg1Of semi-conserved,six
R12734 T54874 T6053 arg1Of cytokine,best-documented
R1274 T1310 T1283 arg1Of substitutions,semi-conserved
R1275 T1283 T1284 arg1Of semi-conserved,(
R1276 T1296 T1284 arg2Of ",",(
R1277 T1309 T1284 arg3Of ),(
R1278 T1285 T1286 arg1Of R426,to
R12784 T4246 T68154 arg1Of report,of
R1279 T1287 T1286 arg2Of N448,to
R12797 T18879 T2889 arg1Of inhibitors,","
R128 T135 T134 arg1Of results,promising
R1280 T1287 T1288 arg1Of N448,","
R12801 T11788 T21382 arg1Of detect,to
R12802 T14810 T86991 arg2Of ORF3b,","
R12803 T58846 T44828 arg2Of 9,[
R12805 T25315 T50563 arg1Of coronavirus,had
R1281 T1289 T1288 arg2Of Y442,","
R1282 T1289 T1290 arg1Of Y442,to
R12822 T62157 T60868 arg1Of VSV-G,receptors
R1283 T1291 T1290 arg2Of L464,to
R1284 T1287 T1292 arg1Of N448,","
R1285 T1293 T1292 arg2Of L472,","
R12851 T1935 T84543 arg1Of present,but
R1286 T1293 T1294 arg1Of L472,to
R12867 T60636 T5267 arg2Of compounds,Among
R1287 T1295 T1294 arg2Of F495,to
R1288 T1285 T1296 arg1Of R426,","
R1289 T1305 T1296 arg2Of and,","
R129 T133 T136 arg1Of shown,in
R1290 T1297 T1298 arg1Of N479,to
R1291 T1299 T1298 arg2Of Q502,to
R1292 T1299 T1300 arg1Of Q502,","
R1293 T1301 T1300 arg2Of Y484,","
R1294 T1301 T1302 arg1Of Y484,to
R1295 T1303 T1302 arg2Of Q507,to
R1296 T1305 T1304 arg1Of and,","
R1297 T1297 T1305 arg1Of N479,and
R12975 T85498 T10956 arg1Of Antiserum,hinder
R1298 T1306 T1305 arg2Of T487,and
R1299 T1305 T1307 arg1Of and,to
R13 T15 T14 arg1Of agents,immunosuppressive
R130 T137 T136 arg2Of patients,in
R1300 T1308 T1307 arg2Of N510,to
R1301 T1259 T1311 arg1Of contain,with
R1302 T1312 T1311 arg2Of respect,with
R1303 T1317 T1311 arg3Of SB,with
R13035 T34750 T90276 arg3Of ],[
R1304 T1311 T1313 arg1Of with,to
R1305 T1317 T1314 arg1Of SB,the
R1306 T1317 T1315 arg1Of SB,SARS-CoV
R1307 T1317 T1316 arg1Of SB,2
R13076 T87601 T88528 arg1Of patients,convalescent
R1308 T1322 T1318 arg1Of domain,3.1.4
R1309 T1322 T1319 arg1Of domain,SARS-CoV2
R131 T137 T138 arg1Of patients,with
R1310 T1322 T1320 arg1Of domain,receptor
R13100 T41895 T37814 arg2Of antibodies,develop
R1311 T1322 T1321 arg1Of domain,binding
R13112 T96815 T6431 arg2Of rabbits,immunized
R1312 T1322 T1323 arg1Of domain,contains
R1313 T1325 T1323 arg2Of regions,contains
R13130 T30755 T96610 arg2Of CRP,and
R1314 T1325 T1324 arg1Of regions,cyclic
R13146 T26283 T50157 arg1Of known,also
R1315 T1325 T1326 arg1Of regions,that
R13154 T85855 T7496 arg1Of use,be
R1316 T1325 T1327 arg1Of regions,can
R1317 T1328 T1327 arg2Of make,can
R13170 T57783 T83153 arg2Of sequences,in
R1318 T1325 T1328 arg1Of regions,make
R13185 T72256 T59206 arg2Of diagnosed,is
R1319 T1329 T1328 arg2Of interaction,make
R132 T140 T138 arg2Of COVID-19,with
R1320 T1329 T1330 arg1Of interaction,with
R1321 T1332 T1330 arg2Of GRP78,with
R1322 T1332 T1331 arg1Of GRP78,cell-surface
R1323 T1333 T1334 arg1Of Pep42,is
R1324 T1337 T1334 arg2Of oligopeptide,is
R1325 T1337 T1335 arg1Of oligopeptide,a
R1326 T1337 T1336 arg1Of oligopeptide,cyclic
R13264 T44301 T99769 arg1Of inflammation,hyper
R1327 T1337 T1338 arg1Of oligopeptide,that
R13275 T62294 T15497 arg2Of encephalitis,","
R13277 T84322 T73554 arg2Of and,of
R1328 T1347 T1339 arg1Of interact,","
R1329 T1347 T1340 arg1Of interact,with
R133 T140 T139 arg1Of COVID-19,severe
R1330 T1343 T1340 arg2Of character,with
R1331 T1343 T1341 arg1Of character,its
R1332 T1343 T1342 arg1Of character,hydrophobic
R1333 T1347 T1344 arg1Of interact,","
R1334 T1337 T1345 arg1Of oligopeptide,can
R1335 T1347 T1345 arg2Of interact,can
R1336 T1347 T1346 arg1Of interact,selectively
R1337 T1337 T1347 arg1Of oligopeptide,interact
R1338 T1347 T1348 arg1Of interact,with
R1339 T1350 T1348 arg2Of surface,with
R13398 T64809 T8248 arg2Of PON,from
R134 T152 T141 arg1Of improve,Also
R1340 T1350 T1349 arg1Of surface,cell
R1341 T1350 T1351 arg2Of surface,glucose‐regulated
R1342 T1352 T1351 arg3Of protein,glucose‐regulated
R1343 T1352 T1353 arg1Of protein,78
R1344 T1352 T1354 arg1Of protein,(
R13443 T72786 T82790 arg2Of shown,has
R1345 T1355 T1354 arg2Of GRP78,(
R1346 T1356 T1354 arg3Of ),(
R13465 T46803 T33924 arg1Of diseases,several
R1347 T1352 T1357 arg1Of protein,","
R13473 T11269 T5490 arg1Of 2,)
R1348 T1359 T1357 arg2Of member,","
R1349 T1359 T1358 arg1Of member,a
R135 T152 T142 arg1Of improve,","
R1350 T1359 T1360 arg1Of member,of
R1351 T1364 T1360 arg2Of proteins,of
R1352 T1364 T1361 arg1Of proteins,70 kDa
R13520 T75671 T99202 arg2Of act,appeared
R1353 T1364 T1362 arg1Of proteins,heat
R13530 T35146 T66380 arg2Of receptor,to
R1354 T1364 T1363 arg1Of proteins,shock
R1355 T1365 T1366 arg1Of GRP78,","
R1356 T1368 T1367 arg1Of known,also
R1357 T1365 T1368 arg2Of GRP78,known
R13579 T5150 T43666 arg1Of recovery,from
R1358 T1368 T1369 arg1Of known,as
R1359 T1371 T1369 arg2Of or,as
R136 T143 T144 arg1Of IVIG,","
R1360 T1370 T1371 arg1Of BiP,or
R1361 T1372 T1371 arg2Of HSPA5,or
R13617 T60390 T21723 arg1Of cells,primary
R1362 T1389 T1373 arg1Of and,","
R1363 T1389 T1374 arg1Of and,under
R13635 T27754 T31036 arg1Of receptor,the
R13636 T99993 T3009 arg1Of SARS-CoV,and
R1364 T1377 T1374 arg2Of stress,under
R1365 T1377 T1375 arg1Of stress,endoplasmic
R1366 T1377 T1376 arg1Of stress,reticulum
R13660 T25132 T29516 arg1Of degree,in
R1367 T1389 T1378 arg1Of and,","
R1368 T1365 T1379 arg1Of GRP78,can
R1369 T1381 T1379 arg2Of translocated,can
R13690 T46450 T23533 arg1Of sequencing,detect
R137 T143 T145 arg2Of IVIG,combined
R1370 T1365 T1380 arg1Of GRP78,be
R1371 T1381 T1380 arg2Of translocated,be
R1372 T1365 T1381 arg2Of GRP78,translocated
R1373 T1381 T1382 arg1Of translocated,from
R1374 T1385 T1382 arg2Of reticulum,from
R1375 T1385 T1383 arg1Of reticulum,the
R1376 T1385 T1384 arg1Of reticulum,endoplasmic
R13764 T19375 T51998 arg2Of favorable,are
R1377 T1385 T1386 arg1Of reticulum,to
R1378 T1388 T1386 arg2Of membrane,to
R1379 T1388 T1387 arg1Of membrane,the
R138 T145 T146 arg1Of combined,with
R1380 T1381 T1389 arg1Of translocated,and
R1381 T1390 T1389 arg2Of helps,and
R13811 T2304 T44373 arg2Of antibodies,have
R1382 T1365 T1390 arg1Of GRP78,helps
R13827 T81617 T95958 arg1Of ciclesonide,induced
R1383 T1392 T1390 arg2Of maintain,helps
R1384 T1392 T1391 arg1Of maintain,to
R13846 T54336 T58340 arg1Of bats,horseshoe
R1385 T1365 T1392 arg1Of GRP78,maintain
R1386 T1394 T1392 arg2Of integrity,maintain
R1387 T1394 T1393 arg1Of integrity,cellular
R1388 T1392 T1395 arg1Of maintain,under
R1389 T1399 T1395 arg2Of stress,under
R139 T147 T146 arg2Of moderate-dose,with
R1390 T1399 T1396 arg1Of stress,physiologic
R1391 T1396 T1397 arg1Of physiologic,and
R1392 T1398 T1397 arg2Of pathological,and
R1393 T1399 T1398 arg1Of stress,pathological
R1394 T1402 T1401 arg1Of contributes,critically
R13940 T53710 T7152 arg1Of pathway,cathepsin/endosomal
R13941 T73531 T42629 arg1Of cells,E6
R1395 T1400 T1402 arg1Of It,contributes
R1396 T1402 T1403 arg1Of contributes,to
R13961 T64875 T87687 arg1Of patients,convalescent
R1397 T1405 T1403 arg2Of functions,to
R1398 T1405 T1404 arg1Of functions,various
R1399 T1405 T1406 arg1Of functions,ranging
R13996 T9153 T37916 arg2Of day,on
R14 T7 T16 arg1Of and,:
R140 T147 T148 arg1Of moderate-dose,of
R1400 T1406 T1407 arg1Of ranging,from
R14004 T66055 T89299 arg1Of condition,whose
R14005 T54783 T57340 arg2Of levels,having
R1401 T1413 T1407 arg2Of and,from
R14017 T7214 T10678 arg1Of effective,more
R1402 T1409 T1408 arg1Of folding,protein
R14025 T49191 T37620 arg2Of help,might
R1403 T1409 T1410 arg1Of folding,","
R1404 T1411 T1410 arg2Of transportation,","
R1405 T1413 T1412 arg1Of and,","
R1406 T1410 T1413 arg1Of ",",and
R14066 T46450 T28843 arg1Of sequencing,Genome
R1407 T1414 T1413 arg2Of degradation,and
R14075 T71973 T7216 arg1Of production,of
R1408 T1405 T1415 arg1Of functions,to
R1409 T1426 T1415 arg2Of and,to
R141 T149 T148 arg2Of corticosteroids,of
R1410 T1421 T1416 arg1Of ",",cell-signaling
R1411 T1421 T1417 arg1Of ",",","
R1412 T1418 T1419 arg1Of proliferation,","
R1413 T1420 T1419 arg2Of survival,","
R14139 T14954 T26632 arg1Of and,lead
R1414 T1419 T1421 arg1Of ",",","
R1415 T1422 T1421 arg2Of apoptosis,","
R1416 T1421 T1423 arg1Of ",",","
R1417 T1424 T1423 arg2Of inflammation,","
R1418 T1426 T1425 arg1Of and,","
R1419 T1423 T1426 arg1Of ",",and
R14196 T72973 T20341 arg1Of inoculated,with
R142 T152 T150 arg1Of improve,","
R1420 T1427 T1426 arg2Of immunity,and
R1421 T1429 T1428 arg1Of expression,The
R1422 T1429 T1430 arg1Of expression,of
R1423 T1431 T1430 arg2Of GRP78,of
R1424 T1429 T1432 arg1Of expression,decreases
R1425 T1432 T1433 arg1Of decreases,with
R1426 T1434 T1433 arg2Of age,with
R1427 T1445 T1435 arg1Of corresponding,On
R1428 T1439 T1435 arg2Of protein,On
R14281 T83045 T53860 arg2Of COVID-19,with
R1429 T1439 T1436 arg1Of protein,the
R143 T143 T151 arg1Of IVIG,might
R1430 T1439 T1437 arg1Of protein,2019-nCoV
R1431 T1439 T1438 arg1Of protein,spike
R1432 T1445 T1440 arg1Of corresponding,","
R14327 T70918 T21084 arg2Of similar,is
R1433 T1443 T1441 arg1Of bonds,13
R14331 T84428 T78509 arg1Of combat,to
R1434 T1443 T1442 arg1Of bonds,disulfide
R1435 T1443 T1444 arg1Of bonds,are
R14351 T55131 T12529 arg2Of 25,[
R14356 T75820 T89468 arg2Of bats,from
R1436 T1445 T1444 arg2Of corresponding,are
R1437 T1443 T1445 arg1Of bonds,corresponding
R1438 T1445 T1446 arg1Of corresponding,to
R14380 T54347 T67635 arg1Of process,the
R1439 T1450 T1446 arg2Of regions,to
R144 T152 T151 arg2Of improve,might
R1440 T1450 T1447 arg1Of regions,13
R14407 T21718 T64168 arg1Of study,[
R1441 T1450 T1448 arg1Of regions,different
R14410 T94817 T39961 arg1Of terms,of
R1442 T1450 T1449 arg1Of regions,cyclic
R1443 T1450 T1451 arg2Of regions,thought
R1444 T1453 T1451 arg3Of be,thought
R1445 T1453 T1452 arg1Of be,to
R1446 T1450 T1453 arg1Of regions,be
R1447 T1454 T1453 arg2Of similar,be
R1448 T1450 T1454 arg1Of regions,similar
R14488 T29466 T5151 arg2Of antibody,of
R1449 T1454 T1455 arg1Of similar,to
R145 T143 T152 arg1Of IVIG,improve
R1450 T1458 T1455 arg2Of form,to
R1451 T1458 T1456 arg1Of form,the
R1452 T1458 T1457 arg1Of form,cyclic
R1453 T1458 T1459 arg1Of form,of
R1454 T1460 T1459 arg2Of Pep42,of
R1455 T1460 T1461 arg1Of Pep42,[
R1456 T1462 T1461 arg2Of 8,[
R1457 T1463 T1461 arg3Of ],[
R1458 T1470 T1464 arg1Of take,Among
R1459 T1465 T1464 arg2Of these,Among
R14592 T4187 T8453 arg1Of it,be
R146 T154 T152 arg2Of outcomes,improve
R1460 T1470 T1466 arg1Of take,","
R1461 T1469 T1467 arg1Of I-IV,four
R1462 T1469 T1468 arg1Of I-IV,regions
R1463 T1469 T1470 arg1Of I-IV,take
R1464 T1471 T1470 arg2Of place,take
R1465 T1470 T1472 arg1Of take,in
R1466 T1475 T1472 arg2Of surface,in
R1467 T1475 T1473 arg1Of surface,the
R14672 T87007 T67550 arg1Of glycoproteins,membrane
R1468 T1475 T1474 arg1Of surface,outer
R1469 T1475 T1476 arg1Of surface,of
R147 T154 T153 arg1Of outcomes,patient
R1470 T1480 T1476 arg2Of domain,of
R1471 T1480 T1477 arg1Of domain,a
R1472 T1480 T1478 arg1Of domain,putative
R1473 T1480 T1479 arg1Of domain,receptor-binding
R1474 T1480 T1481 arg1Of domain,(
R1475 T1482 T1481 arg2Of RBD,(
R1476 T1483 T1481 arg3Of ),(
R14765 T96891 T68840 arg1Of Hypothesis,attenuate
R14767 T8033 T25177 arg1Of frames,open
R1477 T1480 T1484 arg1Of domain,on
R1478 T1487 T1484 arg2Of spike.,on
R1479 T1487 T1485 arg1Of spike.,the
R14799 T45316 T12863 arg1Of protein,coronavirus
R148 T155 T156 arg1Of Evidence,links
R1480 T1487 T1486 arg1Of spike.,viral
R1481 T1475 T1488 arg1Of surface,","
R1482 T1475 T1489 arg1Of surface,including
R1483 T1496 T1489 arg2Of and,including
R1484 T1490 T1491 arg1Of C361,","
R1485 T1492 T1491 arg2Of C379,","
R1486 T1491 T1493 arg1Of ",",","
R1487 T1494 T1493 arg2Of C391,","
R1488 T1496 T1495 arg1Of and,","
R1489 T1493 T1496 arg1Of ",",and
R14892 T86672 T5267 arg1Of was,Among
R149 T157 T156 arg2Of COVID-19,links
R1490 T1497 T1496 arg2Of C480,and
R14909 T58895 T10929 arg1Of outcomes,the
R1491 T1499 T1498 arg1Of regions,These
R14919 T26456 T39392 arg1Of negative,SARS-CoV2
R1492 T1499 T1500 arg1Of regions,share
R1493 T1502 T1500 arg2Of similarity,share
R1494 T1502 T1501 arg1Of similarity,sequence
R1495 T1500 T1503 arg1Of share,with
R1496 T1504 T1503 arg2Of Pep42,with
R14961 T89813 T53446 arg1Of SARS-S,target
R14968 T11797 T37383 arg1Of death,COVID-19-related
R1497 T1500 T1505 arg1Of share,","
R1498 T1499 T1506 arg1Of regions,ranging
R14983 T27658 T8138 arg1Of Corticosteroids,are
R1499 T1512 T1506 arg2Of %,ranging
R14996 T16892 T44829 arg2Of compared,When
R15 T17 T18 arg1Of Anti-antibodies,","
R150 T156 T158 arg1Of links,to
R1500 T1500 T1506 modOf share,ranging
R15007 T84785 T49412 arg2Of antibodies,of
R1501 T1506 T1507 arg1Of ranging,from
R15014 T34931 T62798 arg1Of PON,Rabbit
R1502 T1509 T1507 arg2Of %,from
R1503 T1509 T1508 arg1Of %,15.38
R15037 T3648 T94095 arg3Of ),(
R1504 T1512 T1510 arg1Of %,to
R15040 T95631 T94847 arg1Of interacting,with
R1505 T1512 T1511 arg1Of %,46.15
R1506 T1528 T1513 arg1Of is,However
R1507 T1528 T1514 arg1Of is,","
R15075 T96461 T67884 arg2Of IL-10,and
R1508 T1516 T1515 arg1Of one,only
R15083 T36542 T96428 arg1Of and,","
R1509 T1516 T1517 arg1Of one,of
R151 T160 T158 arg2Of degrees,to
R1510 T1518 T1517 arg2Of them,of
R1511 T1516 T1519 arg1Of one,","
R1512 T1516 T1520 arg1Of one,i.e.
R1513 T1522 T1520 arg2Of region,i.e.
R1514 T1520 T1521 arg1Of i.e.,","
R1515 T1522 T1523 arg1Of region,IV
R15150 T48431 T54967 arg2Of levels,increased
R1516 T1522 T1524 arg1Of region,(
R1517 T1525 T1524 arg2Of GRAVY = 0.08,(
R1518 T1526 T1524 arg3Of ),(
R1519 T1528 T1527 arg1Of is,","
R152 T160 T159 arg1Of degrees,variable
R1520 T1516 T1528 arg1Of one,is
R1521 T1531 T1528 arg2Of region,is
R1522 T1531 T1529 arg1Of region,a
R1523 T1531 T1530 arg1Of region,hydrophobic
R1524 T1528 T1532 arg1Of is,","
R1525 T1528 T1533 arg1Of is,like
R1526 T1534 T1533 arg2Of Pep42,like
R1527 T1534 T1535 arg1Of Pep42,(
R1528 T1536 T1535 arg2Of GRAVY = 1.1,(
R1529 T1537 T1535 arg3Of ),(
R15297 T78989 T3292 arg1Of immunization,be
R153 T160 T161 arg1Of degrees,of
R1530 T1539 T1538 arg1Of models,Structural
R15307 T34731 T94019 arg1Of strain,the
R1531 T1539 T1540 arg1Of models,evaluate
R1532 T1543 T1540 arg2Of contribution,evaluate
R1533 T1543 T1541 arg1Of contribution,the
R15336 T21018 T38759 arg1Of pressure,blood
R1534 T1543 T1542 arg1Of contribution,energy
R1535 T1543 T1544 arg1Of contribution,for
R1536 T1545 T1544 arg2Of region,for
R1537 T1545 T1546 arg1Of region,IV
R1538 T1545 T1547 arg1Of region,as
R15380 T70143 T94916 arg1Of examples,The
R1539 T1549 T1547 arg2Of part,as
R15396 T25878 T28417 arg1Of mAb,inhibit
R154 T162 T161 arg2Of inflammation,of
R1540 T1549 T1548 arg1Of part,a
R15400 T2430 T34278 arg1Of entry,the
R1541 T1549 T1550 arg1Of part,of
R1542 T1551 T1550 arg2Of region,of
R1543 T1551 T1552 arg1Of region,III
R15437 T2963 T5339 arg1Of Paraoxonases,are
R1544 T1543 T1553 arg1Of contribution,to
R15441 T43996 T48594 arg1Of coronaviruses,The
R1545 T1555 T1553 arg2Of GRP78,to
R15458 T43323 T74931 arg2Of and,at
R1546 T1555 T1554 arg1Of GRP78,the
R15467 T37378 T70298 arg1Of –,","
R1547 T1557 T1556 arg1Of be,to
R1548 T1555 T1556 modOf GRP78,to
R1549 T1555 T1557 arg2Of GRP78,be
R15494 T87261 T96660 arg1Of Studies,show
R155 T163 T164 arg1Of Studies,show
R1550 T1557 T1558 arg1Of be,about
R1551 T1558 T1559 arg1Of about,(
R15514 T64204 T58724 arg2Of domain,requires
R1552 T1562 T1559 arg2Of of,(
R1553 T1564 T1559 arg3Of ),(
R15531 T77671 T99390 arg1Of ",",","
R1554 T1562 T1561 arg1Of of,out
R1555 T1560 T1562 arg1Of −9.8,of
R1556 T1563 T1562 arg2Of −14.0 kcal/mol,of
R1557 T1566 T1565 arg1Of and,","
R15573 T75671 T10168 arg1Of act,as
R1558 T1540 T1566 arg1Of evaluate,and
R1559 T1570 T1566 arg2Of proposes,and
R15596 T26799 T13824 arg1Of was,Interestingly
R15599 T22570 T42633 arg2Of characteristics,and
R156 T171 T164 arg2Of accelerate,show
R1560 T1569 T1567 arg1Of platform,the
R15604 T51771 T42633 arg1Of entry,and
R1561 T1569 T1568 arg1Of platform,docking
R1562 T1569 T1570 arg1Of platform,proposes
R1563 T1571 T1570 arg2Of region,proposes
R15634 T50829 T76607 arg1Of Calu-3,cell
R15638 T51732 T32607 arg1Of viruses,e.g.
R1564 T1571 T1572 arg1Of region,IV
R15646 T15191 T79753 arg1Of revealed,","
R1565 T1570 T1573 arg1Of proposes,as
R1566 T1576 T1573 arg2Of region,as
R1567 T1576 T1574 arg1Of region,the
R1568 T1576 T1575 arg1Of region,best
R1569 T1576 T1577 arg1Of region,binding
R157 T171 T165 arg1Of accelerate,that
R1570 T1577 T1578 arg1Of binding,to
R1571 T1579 T1578 arg2Of GRP78,to
R1572 T1581 T1580 arg1Of region,The
R15724 T69281 T90838 arg1Of identical,almost
R15728 T78691 T18580 arg1Of %,and
R1573 T1581 T1582 arg1Of region,IV
R1574 T1581 T1583 arg1Of region,can
R1575 T1585 T1583 arg2Of linked,can
R1576 T1581 T1584 arg1Of region,be
R1577 T1585 T1584 arg2Of linked,be
R15771 T89944 T11032 arg1Of reduce,[
R1578 T1581 T1585 arg2Of region,linked
R15788 T62294 T79163 arg1Of encephalitis,","
R1579 T1585 T1586 arg1Of linked,to
R158 T167 T166 arg1Of use,the
R1580 T1590 T1586 arg2Of β,to
R1581 T1590 T1587 arg1Of β,the
R1582 T1590 T1588 arg1Of β,substrate-binding
R1583 T1590 T1589 arg1Of β,domain
R15830 T47586 T32800 arg2Of rise,begin
R1584 T1590 T1591 arg1Of β,(
R1585 T1592 T1591 arg2Of SBDB,(
R1586 T1593 T1591 arg3Of ),(
R1587 T1590 T1594 arg1Of β,of
R1588 T1595 T1594 arg2Of GRP78,of
R1589 T1595 T1596 arg1Of GRP78,using
R159 T167 T168 arg1Of use,of
R1590 T1610 T1596 arg2Of and,using
R1591 T1598 T1597 arg1Of H-bonds,five
R1592 T1598 T1599 arg1Of H-bonds,(
R1593 T1600 T1599 arg2Of through,(
R1594 T1609 T1599 arg3Of ),(
R1595 T1607 T1600 arg2Of and,through
R1596 T1601 T1602 arg1Of P479,","
R1597 T1603 T1602 arg2Of N481,","
R15972 T37402 T65661 arg1Of fever,and
R1598 T1602 T1604 arg1Of ",",","
R1599 T1605 T1604 arg2Of E484,","
R16 T19 T18 arg2Of immunoglobulins,","
R160 T169 T168 arg2Of corticosteroids,of
R1600 T1607 T1606 arg1Of and,","
R16005 T53057 T52808 arg1Of domain,conveys
R1601 T1604 T1607 arg1Of ",",and
R1602 T1608 T1607 arg2Of N487,and
R1603 T1598 T1610 arg1Of H-bonds,and
R16030 T95232 T83801 arg1Of IFN,can
R1604 T1613 T1610 arg2Of interactions,and
R1605 T1613 T1611 arg1Of interactions,four
R16058 T66003 T83677 arg1Of peptide,inhibitory
R1606 T1613 T1612 arg1Of interactions,hydrophobic
R1607 T1613 T1614 arg1Of interactions,(
R1608 T1615 T1614 arg2Of through,(
R1609 T1622 T1614 arg3Of ),(
R161 T167 T170 arg1Of use,might
R1610 T1620 T1615 arg2Of and,through
R1611 T1616 T1617 arg1Of T478,","
R1612 T1618 T1617 arg2Of E484,","
R1613 T1620 T1619 arg1Of and,","
R1614 T1617 T1620 arg1Of ",",and
R1615 T1621 T1620 arg2Of F486,and
R1616 T1625 T1623 arg1Of immunization,4
R1617 T1625 T1624 arg1Of immunization,Passive
R1618 T1626 T1627 arg1Of There,are
R1619 T1630 T1627 arg2Of ways,are
R16195 T39838 T68802 arg2Of decrease,can
R162 T171 T170 arg2Of accelerate,might
R1620 T1630 T1628 arg1Of ways,two
R1621 T1630 T1629 arg1Of ways,main
R1622 T1632 T1631 arg1Of induce,to
R1623 T1630 T1631 modOf ways,to
R1624 T1633 T1632 arg2Of protection,induce
R1625 T1633 T1634 arg1Of protection,against
R1626 T1635 T1634 arg2Of infections,against
R1627 T1633 T1636 arg1Of protection,:
R1628 T1640 T1637 arg1Of immunization,active
R1629 T1637 T1638 arg1Of active,and
R163 T167 T171 arg1Of use,accelerate
R1630 T1639 T1638 arg2Of passive,and
R16309 T39437 T32526 arg1Of groups,two
R1631 T1640 T1639 arg1Of immunization,passive
R1632 T1632 T1640 arg1Of induce,immunization
R1633 T1642 T1641 arg1Of immunization,Active
R16336 T81462 T91822 arg1Of deal,with
R1634 T1642 T1643 arg1Of immunization,comes
R1635 T1645 T1643 arg2Of exist,comes
R1636 T1645 T1644 arg1Of exist,to
R1637 T1642 T1645 arg1Of immunization,exist
R16377 T54347 T43425 arg1Of process,of
R1638 T1645 T1646 arg1Of exist,when
R16383 T42812 T56973 arg1Of cysteine,endosomal
R1639 T1654 T1646 arg2Of produce,when
R164 T172 T171 arg2Of recovery,accelerate
R1640 T1648 T1647 arg1Of body,the
R1641 T1652 T1649 arg1Of system,'s
R1642 T1648 T1649 arg2Of body,'s
R16425 T41765 T55852 arg1Of mesylate,","
R1643 T1652 T1650 arg1Of system,own
R1644 T1652 T1651 arg1Of system,immune
R16446 T47874 T45480 modOf affinity,is
R16448 T77475 T98779 arg1Of Rhinolophus,and
R1645 T1652 T1653 arg1Of system,can
R16455 T16242 T30828 arg1Of Conclusion,9
R1646 T1654 T1653 arg2Of produce,can
R1647 T1652 T1654 arg1Of system,produce
R1648 T1655 T1654 arg2Of antibodies,produce
R1649 T1657 T1656 arg1Of following,actively
R165 T172 T173 arg1Of recovery,from
R1650 T1655 T1657 arg1Of antibodies,following
R1651 T1658 T1657 arg2Of exposure,following
R16518 T7214 T95142 arg2Of effective,is
R1652 T1658 T1659 arg1Of exposure,to
R1653 T1662 T1659 arg2Of antigen,to
R1654 T1662 T1660 arg1Of antigen,a
R1655 T1662 T1661 arg1Of antigen,viral
R16551 T73930 T90719 arg2Of day,by
R1656 T1668 T1663 arg1Of is,On
R1657 T1665 T1663 arg2Of contrary,On
R16578 T20679 T44741 arg2Of COVID19,of
R1658 T1665 T1664 arg1Of contrary,the
R1659 T1668 T1666 arg1Of is,","
R16595 T13966 T13491 arg2Of antibody,","
R166 T174 T173 arg2Of COVID-19,from
R1660 T1667 T1668 arg1Of there,is
R16601 T51616 T8679 arg1Of ",",","
R1661 T1670 T1668 arg2Of passive,is
R1662 T1670 T1669 arg1Of passive,a
R16622 T57029 T17052 arg2Of cells,in
R1663 T1670 T1671 arg1Of passive,working
R1664 T1672 T1671 arg2Of mode,working
R16640 T77995 T83579 arg1Of SARS-CoV2,possesses
R16643 T98211 T87109 arg1Of processing,proteolytic
R1665 T1672 T1673 arg1Of mode,of
R1666 T1676 T1673 arg2Of system,of
R1667 T1676 T1674 arg1Of system,the
R16675 T42652 T83308 arg1Of treatment,I
R1668 T1676 T1675 arg1Of system,immune
R16681 T33761 T82586 arg1Of spectrum,similar
R1669 T1676 T1677 arg1Of system,that
R16698 T27008 T45941 arg1Of acted,not
R167 T175 T176 arg1Of There,are
R1670 T1676 T1678 arg1Of system,would
R1671 T1679 T1678 arg2Of appear,would
R1672 T1676 T1679 arg1Of system,appear
R1673 T1679 T1680 arg1Of appear,following
R1674 T1682 T1680 arg2Of transfer,following
R16749 T10805 T51590 arg1Of ",",and
R1675 T1682 T1681 arg1Of transfer,the
R16754 T72732 T85670 arg1Of %,76
R1676 T1682 T1683 arg1Of transfer,of
R16765 T83579 T75642 arg1Of possesses,","
R1677 T1684 T1683 arg2Of antibodies,of
R16771 T13833 T13700 arg2Of and,","
R1678 T1684 T1685 arg1Of antibodies,that
R16785 T37738 T99202 arg1Of protein,appeared
R1679 T1684 T1686 arg1Of antibodies,act
R168 T183 T176 arg2Of trials,are
R1680 T1686 T1687 arg1Of act,directly
R1681 T1689 T1688 arg1Of neutralize,to
R16819 T76496 T58135 arg1Of received,of
R1682 T1686 T1688 modOf act,to
R1683 T1684 T1689 arg1Of antibodies,neutralize
R1684 T1691 T1689 arg2Of infectivity,neutralize
R16846 T57549 T26331 arg1Of produce,[
R1685 T1691 T1690 arg1Of infectivity,viral
R1686 T1694 T1692 arg1Of therapy,4.1
R16863 T14835 T13628 arg2Of infection,","
R16864 T58552 T52445 arg1Of WBC,","
R1687 T1694 T1693 arg1Of therapy,Serum
R169 T176 T177 arg1Of are,","
R16905 T68003 T84711 arg1Of trials,ongoing
R16942 T51771 T14044 arg1Of entry,process
R16949 T63658 T78080 arg2Of SARS-2-S.,and
R16981 T89289 T98989 arg1Of expressed,on
R16983 T14997 T50903 arg3Of ],[
R17 T21 T20 arg1Of and,","
R170 T176 T178 arg1Of are,however
R17029 T86080 T42365 arg1Of IgG,and
R1707 T76019 T58724 arg1Of former,requires
R171 T176 T179 arg1Of are,","
R17122 T2491 T39715 arg2Of domain,with
R17167 T91889 T6021 arg1Of species,two
R17185 T85869 T20640 arg1Of option,a
R172 T183 T180 arg1Of trials,no
R17219 T21718 T77014 arg1Of study,decreased
R17226 T80710 T48141 arg1Of plasma,can
R17282 T82201 T43180 arg1Of regulation,differential
R173 T182 T181 arg1Of clinical,controlled
R17337 T48276 T76904 arg3Of ],[
R174 T183 T182 arg1Of trials,clinical
R17401 T53416 T3946 arg1Of inhibitor,of
R17475 T68140 T76951 arg1Of affinities,for
R175 T183 T184 arg1Of trials,that
R17527 T71562 T20678 arg1Of and,and
R17542 T6163 T48110 arg1Of improved,","
R1755 T46478 T71562 arg2Of L,and
R17566 T56884 T37378 arg1Of binding,–
R17590 T58084 T8820 arg1Of in,and
R176 T183 T185 arg1Of trials,show
R17601 T27842 T27205 arg2Of COVID-19,with
R17630 T71403 T91527 arg1Of difference,may
R17667 T77904 T33747 arg2Of SARS-CoV,neutralize
R177 T192 T185 arg2Of reduce,show
R1770 T77014 T13833 arg1Of decreased,and
R17700 T50860 T3162 arg1Of is,respectively
R17703 T39551 T64424 arg1Of identical,%
R17724 T41916 T9559 arg1Of interact,to
R178 T192 T186 arg1Of reduce,whether
R17857 T93066 T60294 arg1Of eggshell,the
R17888 T21434 T41840 arg1Of possibility,the
R17891 T71668 T77029 arg1Of latter,requires
R179 T188 T187 arg1Of use,the
R17912 T92189 T85187 arg2Of 293 T,","
R17928 T37752 T82417 arg1Of fluid,bronchoalveolar
R17941 T36302 T59239 arg2Of fluticasone,and
R17963 T83162 T88144 arg1Of with,but
R18 T18 T21 arg1Of ",",and
R180 T188 T189 arg1Of use,of
R1800 T89187 T8138 arg2Of used,are
R18015 T52580 T48202 arg1Of methylprednisolone,since
R18020 T36698 T81462 arg1Of Mometasone,deal
R18021 T53882 T17221 arg1Of FDA,approved
R18026 T19443 T83672 arg1Of as,such
R18045 T48684 T8813 arg1Of patients,Most
R18068 T98401 T99198 arg1Of rats,hypertensive
R18077 T74021 T3019 arg1Of and,by
R181 T190 T189 arg2Of corticosteroids,of
R18127 T84414 T2990 arg1Of therapy,without
R18185 T75001 T6150 arg2Of ORF,(
R182 T188 T191 arg1Of use,can
R18211 T53907 T57340 arg1Of sera,having
R1825 T98110 T47759 arg2Of 16,[
R183 T192 T191 arg2Of reduce,can
R18320 T62340 T6873 arg1Of susceptible,to
R18378 T57882 T21828 arg1Of pH,endosomal
R18397 T5371 T88463 arg1Of Hypothesis,4.1.1.1
R184 T188 T192 arg1Of use,reduce
R185 T194 T192 arg2Of death,reduce
R18503 T11435 T82418 arg2Of treatments,of
R18514 T62169 T64814 arg2Of introduced,–
R18532 T41345 T28857 arg1Of infection,","
R18552 T31126 T98810 arg1Of to,due
R18562 T6622 T6733 arg2Of SARS-CoV,and
R18564 T34284 T13934 arg1Of virus,the
R18576 T68058 T70474 arg2Of virus,","
R18584 T17277 T84685 arg2Of SARS-CoV,and
R186 T194 T193 arg1Of death,COVID-19-related
R18642 T69842 T44468 arg2Of accelerate,show
R18662 T34931 T82559 arg1Of PON,differs
R18684 T42839 T91527 arg2Of be,may
R187 T201 T195 arg1Of is,Also
R18775 T82506 T23050 arg1Of share,[
R18787 T82047 T66951 arg2Of NSP15,in
R188 T201 T196 arg1Of is,","
R18836 T45992 T92096 arg1Of dose,A
R189 T200 T197 arg1Of IL6,the
R1890 T7060 T20581 arg1Of accompany,that
R18975 T52544 T59239 arg1Of ",",and
R18986 T65980 T6067 arg1Of saturation,oxygen
R18993 T19745 T66697 arg1Of those,for
R19 T22 T21 arg2Of corticosteroids,and
R190 T200 T198 arg1Of IL6,pro-inflammatory
R19016 T62562 T4817 arg3Of ],[
R19027 T32795 T89944 arg1Of Sera,reduce
R191 T200 T199 arg1Of IL6,cytokine
R19129 T72324 T35183 arg2Of COVID-19,links
R19161 T25890 T44174 arg2Of patients,recovered
R192 T200 T201 arg1Of IL6,is
R19206 T53845 T78207 arg1Of measured,by
R19260 T54700 T68837 arg2Of arthritis,","
R19276 T24185 T56416 arg1Of antibody,a
R193 T204 T201 arg2Of cytokine,is
R19338 T67108 T68497 arg2Of pathogenicity,explain
R19341 T3471 T26060 arg1Of ratio,PaO2/FIO2
R19346 T80777 T43928 arg1Of system,immune
R19355 T71594 T59411 arg1Of serum,from
R19361 T49434 T44828 arg1Of include,[
R194 T204 T202 arg1Of cytokine,the
R19448 T2642 T19318 arg1Of RNA,SARS-CoV2
R19463 T44925 T71418 arg1Of and,","
R19479 T50781 T71821 arg2Of degree,to
R19499 T27640 T74776 arg1Of SARS-CoV,and
R195 T204 T203 arg1Of cytokine,best-documented
R19525 T16685 T79314 arg1Of parameters,including
R19535 T77639 T15138 arg1Of fatalities,further
R196 T204 T205 arg1Of cytokine,in
R19610 T18985 T72564 arg1Of group,and
R19622 T25132 T10566 arg1Of degree,high
R19625 T94564 T47629 arg1Of utilize,","
R19626 T43308 T73327 arg1Of related,previously
R19638 T30470 T76737 arg1Of and,","
R19665 T32201 T34533 arg1Of treatment,ranging
R19666 T47496 T22981 arg1Of SARS-CoV,2003
R197 T216 T205 arg2Of and,in
R19722 T56862 T58084 arg1Of similarity,in
R19763 T20348 T65200 arg1Of outcome,of
R198 T206 T207 arg2Of COVID-19,correlated
R19889 T86672 T50162 arg1Of was,","
R199 T207 T208 arg1Of correlated,with
R1991 T75325 T31013 arg1Of week,the
R19939 T58682 T70573 arg2Of spike,","
R19944 T43956 T66824 arg1Of as,such
R1995 T99202 T55931 arg1Of appeared,For
R19973 T39553 T56433 arg1Of pandemic,of
R2 T2 T3 arg1Of planning,of
R20 T25 T24 arg1Of IVIG,•
R200 T209 T208 arg2Of severity,with
R20075 T38116 T31483 arg1Of ",",","
R201 T209 T210 arg1Of severity,","
R20107 T21817 T61132 arg1Of exert,However
R2013 T44722 T40275 arg1Of modulate,","
R2019 T9709 T71708 arg1Of titer,causes
R202 T211 T210 arg2Of criticality,","
R20207 T57517 T3020 arg1Of plasma,convalescent
R20295 T14128 T5339 arg2Of enzymes,are
R203 T206 T212 arg1Of COVID-19,","
R20369 T75386 T47825 arg1Of require,that
R20385 T33446 T88407 arg2Of patients,included
R20386 T31219 T83162 arg2Of SARS-2-S,with
R204 T214 T212 arg2Of load,","
R20426 T63048 T62400 arg1Of and,","
R20444 T37738 T75671 arg1Of protein,act
R20459 T80684 T69842 arg2Of recovery,accelerate
R2046 T90061 T65200 arg2Of patients,of
R205 T214 T213 arg1Of load,viral
R20551 T60636 T36393 arg1Of compounds,the
R20587 T25878 T16199 arg1Of mAb,can
R20598 T55163 T31522 arg2Of severe,and
R206 T216 T215 arg1Of and,","
R2062 T97128 T40209 arg1Of and,each
R20630 T27396 T33328 arg2Of dictate,do
R20697 T67208 T77083 arg1Of results,in
R207 T212 T216 arg1Of ",",and
R20700 T40275 T56698 arg1Of ",",that
R20734 T80969 T24580 arg2Of severe,for
R2074 T32769 T5412 arg1Of occurred,in
R20768 T42842 T18623 arg3Of ),(
R20783 T13644 T28790 arg1Of substitution,An
R208 T217 T216 arg2Of prognosis,and
R20807 T51386 T32237 arg2Of and,against
R20816 T69082 T76487 arg1Of as,such
R20851 T35011 T71611 arg2Of origin,share
R20864 T81658 T88887 arg1Of ",",","
R20867 T80157 T73200 arg1Of and,the
R209 T217 T218 arg1Of prognosis,of
R20900 T32652 T65734 arg1Of responses,vital
R2092 T61033 T21523 arg2Of reveal,could
R20951 T19573 T35997 arg1Of study,investigated
R21 T25 T26 arg1Of IVIG,","
R210 T219 T218 arg2Of patients,of
R21012 T40034 T51029 arg1Of was,For
R211 T219 T220 arg1Of patients,with
R21122 T87212 T26632 arg2Of us,lead
R21152 T80710 T37520 arg1Of plasma,from
R212 T221 T220 arg2Of COVID-19,with
R2126 T51053 T84303 arg1Of Rp3,the
R21271 T24005 T43722 arg1Of prognosis,of
R213 T222 T223 arg1Of Tocilizumab,","
R21319 T90762 T87578 arg1Of domain,S1
R21330 T7551 T35377 arg2Of SARS-CoV2,by
R21351 T25132 T87365 arg1Of degree,of
R21352 T70278 T74174 arg2Of 2015,in
R21368 T24628 T15777 arg1Of patients,with
R214 T226 T223 arg2Of antibody,","
R21425 T95168 T79137 arg3Of ],[
R2145 T50829 T55102 arg1Of Calu-3,line
R21455 T95212 T84611 arg1Of Hypothesis,:
R215 T226 T224 arg1Of antibody,a
R2152 T51672 T85433 arg1Of infection,[
R21524 T24185 T26777 arg1Of antibody,receptor
R21542 T61968 T81337 arg1Of both,of
R21546 T50104 T2438 arg2Of chloride,by
R21552 T5207 T80511 arg1Of fusion,of
R21561 T52808 T34590 arg1Of conveys,and
R21596 T35511 T75185 arg1Of entry,the
R216 T226 T225 arg1Of antibody,monoclonal
R21604 T21137 T88404 arg2Of COVID-19,from
R21619 T34900 T94537 arg2Of and,and
R217 T226 T227 arg1Of antibody,against
R2170 T52032 T37466 arg2Of membranes,and
R21753 T30838 T21841 arg2Of SARS,with
R21771 T25315 T87395 arg1Of coronavirus,SARS-like
R2179 T50571 T85435 arg2Of COVID-19,from
R218 T228 T227 arg2Of IL6,against
R21833 T62169 T13328 arg1Of introduced,from
R219 T231 T229 arg1Of confer,","
R21959 T36705 T34694 arg1Of syndrome,release
R21977 T81575 T30323 arg2Of markers,","
R22 T25 T27 arg2Of IVIG,combined
R220 T222 T230 arg1Of Tocilizumab,could
R22009 T87875 T62169 arg2Of It,introduced
R22045 T86603 T75403 arg2Of lie,may
R22057 T31095 T77014 arg2Of count,decreased
R22070 T72452 T50493 arg1Of 24–48 h,after
R221 T231 T230 arg2Of confer,could
R22102 T47054 T59058 arg2Of administered,be
R22109 T23466 T51386 arg1Of NP,and
R2213 T35336 T19523 arg2Of COVID-19,from
R22133 T78861 T75685 arg1Of plasma,convalescent
R22138 T71668 T2068 arg1Of latter,promote
R22163 T24869 T29802 arg2Of possible,as
R22174 T82402 T86199 arg1Of site,S2′
R222 T222 T231 arg1Of Tocilizumab,confer
R22208 T42028 T66238 arg1Of RNA,of
R22256 T46450 T48337 arg1Of sequencing,could
R22284 T72350 T85433 arg2Of 25,[
R223 T233 T231 arg2Of benefit,confer
R22355 T70281 T75519 arg1Of after,days
R22357 T10956 T70219 arg1Of hinder,while
R2236 T36698 T83057 arg1Of Mometasone,could
R224 T233 T232 arg1Of benefit,clinical
R22400 T44301 T65527 arg2Of inflammation,of
R22449 T98539 T69670 arg1Of nor,Neither
R22469 T64138 T21425 arg1Of effect,of
R22489 T65117 T45353 arg1Of study,[
R225 T231 T234 arg1Of confer,in
R22588 T69995 T64051 arg2Of cells,Vero
R226 T235 T234 arg2Of patients,in
R22614 T17217 T91679 arg2Of COVID-19,with
R22619 T76795 T90831 arg1Of Nile,West
R2263 T24185 T88685 arg1Of antibody,IL6
R22660 T64776 T16312 arg1Of and,cell
R22662 T84435 T44273 arg1Of treatment,with
R227 T235 T236 arg1Of patients,with
R22776 T82196 T5298 arg2Of resistance,conferred
R22781 T18333 T77242 arg1Of cells,human
R22782 T92497 T44468 arg1Of Studies,show
R228 T239 T236 arg2Of levels,with
R22804 T64654 T32904 arg2Of SARS-CoV,of
R2282 T67481 T77671 arg2Of ferritin,","
R22866 T98647 T83762 arg1Of disease,a
R22872 T18064 T59456 arg1Of and,[
R22891 T16399 T13646 arg3Of ),(
R22893 T52328 T75912 arg2Of pigeon,of
R229 T239 T237 arg1Of levels,high
R22914 T98139 T55347 arg1Of repertoires,express
R22926 T71403 T42839 arg1Of difference,be
R22941 T36198 T16735 arg1Of flares,of
R22992 T14503 T99239 arg2Of HEK,(
R23 T27 T28 arg1Of combined,with
R230 T239 T238 arg1Of levels,IL6
R23015 T91889 T20399 arg1Of species,the
R231 T241 T240 arg1Of elements,Essential
R23123 T29624 T20040 arg1Of reaction,(
R2313 T62340 T89464 arg2Of susceptible,are
R23171 T57882 T70941 arg1Of pH,limit
R23184 T30995 T76216 arg1Of were,","
R232 T241 T242 arg1Of elements,that
R23204 T65005 T50076 arg1Of COVID-19,contains
R23224 T62294 T76795 arg1Of encephalitis,Nile
R233 T247 T242 arg2Of and,that
R23329 T89439 T49866 arg2Of group,in
R23338 T7184 T21860 arg2Of line,of
R23347 T32229 T37620 arg1Of Copper,might
R2337 T41758 T5759 arg1Of ",",and
R2338 T16710 T86610 arg1Of patients,with
R234 T258 T242 arg3Of have,that
R23414 T75829 T39220 arg1Of subunit,the
R23449 T3461 T39714 arg2Of entry,of
R23464 T73342 T89375 arg1Of bats,with
R23478 T60629 T78080 arg1Of SARS-S,and
R235 T246 T243 arg1Of entry,process
R2351 T19375 T89702 arg1Of favorable,more
R23512 T67208 T10629 arg2Of results,shown
R23527 T67511 T16526 arg1Of binding,receptor
R23540 T84364 T36295 arg1Of and,in
R23547 T6188 T99442 arg2Of antibodies,contain
R23596 T45006 T44437 arg2Of 2019-nCoV,of
R236 T246 T244 arg1Of entry,SARS-CoV2
R23607 T66003 T34098 arg1Of peptide,an
R23617 T3419 T37378 arg2Of block,–
R237 T246 T245 arg1Of entry,cell
R23710 T2642 T76428 arg1Of RNA,positive
R23718 T50074 T60149 arg1Of activity,RAS
R2373 T29199 T65675 arg2Of protease,and
R23772 T21537 T6014 arg1Of ACE2,[
R23798 T1819 T13278 arg1Of VSV-G,and
R238 T246 T247 arg1Of entry,and
R23820 T97074 T39838 arg1Of IRW,decrease
R23833 T9970 T8625 arg2Of domain,against
R23835 T26871 T3946 arg2Of CatB/L,of
R23852 T97598 T89892 arg1Of arthritis,idiopathic
R23868 T85972 T29990 arg1Of and,that
R23893 T26978 T64695 arg3Of virus,pseudotyped
R239 T249 T247 arg2Of characteristics,and
R2391 T7888 T30816 arg1Of compete,specifically
R23970 T62169 T28188 arg2Of introduced,been
R24 T29 T28 arg2Of moderate-dose,with
R240 T249 T248 arg1Of characteristics,specific
R24035 T54798 T74264 arg1Of improvement,faster
R24043 T38362 T76951 arg2Of interacting,for
R24045 T84845 T77583 arg1Of structure,the
R24069 T92001 T66778 arg2Of rabbits,from
R24087 T24185 T79548 arg1Of antibody,humanized
R24093 T36698 T32973 arg1Of Mometasone,help
R241 T249 T250 arg1Of characteristics,that
R24105 T44730 T77029 arg3Of mediate,requires
R242 T249 T251 arg1Of characteristics,allow
R24201 T40953 T84867 arg1Of coronaviruses,","
R24256 T7157 T16625 arg1Of bat,being
R24267 T74975 T66580 arg2Of response,in
R24279 T45934 T52645 arg2Of example,for
R243 T252 T251 arg2Of SARS-CoV2,allow
R24341 T43255 T79015 arg1Of as,such
R24390 T37602 T74715 arg1Of needed,","
R244 T254 T251 arg3Of escape,allow
R2443 T57327 T7202 arg2Of ACE2,","
R24447 T14674 T39029 arg1Of inflammation,hyper
R24465 T33036 T48542 arg3Of ],[
R24478 T47054 T7135 arg1Of administered,when
R24484 T85645 T96681 arg1Of IFNs,Type
R245 T254 T253 arg1Of escape,to
R24501 T93066 T75912 arg1Of eggshell,of
R24559 T75815 T75489 arg2Of degree,shows
R24570 T89662 T56173 arg1Of therapy,IVIG
R24587 T40953 T19443 arg1Of coronaviruses,as
R24598 T92082 T32575 arg1Of are,ideally
R246 T252 T254 arg1Of SARS-CoV2,escape
R24626 T80386 T79863 arg3Of ),(
R24639 T67580 T96599 arg1Of therapy,COVID-19
R24659 T36559 T29454 arg2Of developed,and
R247 T257 T254 arg2Of system,escape
R24705 T26799 T97722 arg1Of was,","
R24714 T40665 T71867 arg1Of antibodies,cross
R24725 T26913 T10299 arg1Of patients,were
R2474 T64138 T29390 arg1Of effect,the
R24762 T84414 T96732 arg2Of therapy,received
R248 T257 T255 arg1Of system,the
R24883 T84543 T40034 arg2Of but,was
R24887 T35808 T13978 arg1Of saturation,oxygen
R249 T257 T256 arg1Of system,immune
R24947 T42028 T7474 arg1Of RNA,reaches
R24950 T38357 T99851 arg1Of and,older
R24969 T62247 T55724 arg1Of deficiencies,[
R24971 T25730 T22468 arg1Of degree,in
R24972 T68140 T41139 arg1Of affinities,","
R25 T29 T30 arg1Of moderate-dose,of
R250 T247 T258 arg1Of and,have
R25031 T85369 T77390 arg1Of viral,and
R25043 T98779 T26256 arg2Of and,to
R25082 T22631 T6254 arg2Of help,:
R25087 T23341 T20580 arg2Of transfusion,Following
R251 T260 T258 arg2Of potential,have
R25101 T79439 T5826 arg1Of domain,S2
R25118 T31717 T27996 arg3Of ],[
R25119 T28417 T16199 arg2Of inhibit,can
R25179 T38385 T65035 arg1Of Serum,from
R252 T260 T259 arg1Of potential,the
R25207 T6658 T23368 arg2Of humans,in
R25227 T64673 T9982 arg1Of lesions,lung
R25292 T42278 T9092 arg2Of patient,of
R253 T258 T261 arg1Of have,as
R25309 T58218 T42547 arg1Of group,first
R25333 T65830 T56952 arg1Of patients,with
R25355 T46672 T4016 arg1Of SARS-CoV,and
R25360 T33856 T54452 arg1Of origin,the
R25376 T66546 T88322 arg2Of IRW,as
R254 T262 T261 arg2Of targets,as
R25403 T3490 T44653 arg1Of severe,or
R2541 T50396 T59179 arg2Of patients,accompanied
R25437 T95515 T31802 arg1Of virus,2019-nCoV
R25441 T39838 T24097 arg1Of decrease,","
R25449 T53777 T68425 arg1Of junctions,absolutely
R25456 T32800 T83224 arg2Of begin,that
R2548 T53426 T93176 arg1Of RNA,reaches
R25499 T35438 T50077 arg2Of up-regulation,Through
R255 T262 T263 arg1Of targets,for
R25517 T89003 T94847 arg2Of subunit,with
R256 T265 T263 arg2Of therapy,for
R2563 T82872 T63033 arg1Of immunoglobulin,20 g/d
R25631 T47460 T57607 arg1Of look,A
R25674 T11971 T91181 arg1Of used,in
R257 T265 T264 arg1Of therapy,COVID-19
R2570 T66184 T63565 arg2Of cells,in
R25704 T98139 T47163 arg2Of repertoires,containing
R25745 T40275 T49682 arg2Of ",",means
R258 T267 T266 arg1Of Introduction,1
R25803 T79772 T47524 arg1Of week,first
R2585 T36179 T74019 arg1Of week,second
R25853 T35183 T95206 arg1Of links,to
R2587 T6733 T66580 arg1Of and,in
R25886 T13854 T66871 arg2Of ACE,(
R259 T269 T268 arg1Of generations,Several
R25939 T89678 T20122 arg1Of history,the
R25978 T49089 T56097 arg1Of are,Also
R26 T31 T30 arg2Of corticosteroids,of
R260 T269 T270 arg1Of generations,have
R26006 T80253 T56752 arg2Of membranes,and
R26081 T29994 T14560 arg1Of time-consuming,very
R26094 T18879 T12218 arg1Of inhibitors,","
R261 T272 T270 arg2Of exposed,have
R26123 T16756 T20306 arg1Of receiving,without
R26135 T56862 T17027 arg1Of similarity,90
R262 T269 T271 arg1Of generations,been
R26206 T29701 T86722 arg2Of and,at
R26225 T73202 T49682 arg1Of latter,means
R26263 T97193 T84364 arg1Of nafamostat,and
R26290 T39927 T42920 arg2Of sequence,in
R26291 T98647 T30756 arg1Of disease,fatal
R26292 T59480 T16934 arg1Of inhibition,the
R263 T272 T271 arg2Of exposed,been
R26303 T44667 T25201 arg1Of inhibition,of
R2631 T97802 T80013 arg2Of begin,that
R26320 T95417 T50853 arg1Of IVIG,contains
R26327 T42278 T49696 arg1Of patient,a
R26368 T74776 T82506 arg1Of and,share
R26377 T5389 T55726 arg1Of resemblance,of
R26398 T7828 T86158 arg2Of patients,from
R264 T269 T272 arg2Of generations,exposed
R26413 T6163 T32422 arg1Of improved,After
R26417 T45789 T84858 arg1Of they,be
R26450 T42893 T58084 arg2Of nucleotides,in
R26476 T61880 T72786 arg2Of results,shown
R26497 T1931 T51998 arg1Of branches,are
R26499 T85869 T11737 arg1Of option,potent
R265 T272 T273 arg1Of exposed,to
R26520 T89508 T88322 arg1Of known,as
R26531 T80270 T32817 arg2Of remedy,as
R26551 T71641 T61270 arg1Of protein,S
R26554 T83078 T5000 arg2Of treatment,for
R26598 T58026 T85532 arg3Of ),(
R266 T274 T273 arg2Of COVID-19,to
R26619 T82065 T15003 arg1Of –,the
R26625 T48924 T79954 arg1Of effect,an
R26629 T13833 T79561 arg1Of and,e.g.
R26632 T48662 T22507 arg1Of moderate-dose,of
R2665 T97598 T13999 arg1Of arthritis,systematic
R267 T272 T275 arg1Of exposed,under
R26730 T20946 T69163 arg1Of genomes,the
R26738 T20513 T40582 arg2Of viruses,of
R26741 T97526 T37933 arg1Of SARS-CoV2,","
R268 T277 T275 arg2Of conditions,under
R26850 T48569 T69281 arg1Of isolate,identical
R26862 T45992 T18604 arg1Of dose,moderate
R26875 T27055 T9724 arg1Of effect,patient
R269 T277 T276 arg1Of conditions,different
R26904 T85855 T78367 arg2Of use,recommended
R26919 T28601 T59987 arg2Of entry,reduced
R2693 T54798 T37085 arg2Of improvement,achieved
R26977 T53907 T33747 arg1Of sera,neutralize
R26981 T31105 T21671 arg2Of SARS-2-S,and
R27 T34 T32 arg1Of improve,","
R270 T277 T278 arg1Of conditions,of
R27005 T7566 T88144 arg2Of in,but
R27015 T33160 T63816 arg2Of load,","
R27028 T16710 T93255 arg2Of patients,in
R27054 T7184 T59673 arg1Of line,embryonic
R27076 T17915 T64464 arg3Of ],[
R27084 T42133 T24092 arg1Of outbreak,the
R271 T279 T278 arg2Of life,of
R27124 T96902 T31590 arg1Of existed,","
R27176 T58020 T17353 arg1Of similar,in
R27190 T60580 T19399 arg1Of nucleocapsid,(
R27191 T23626 T98539 arg1Of effects,nor
R272 T272 T280 arg1Of exposed,at
R27208 T45371 T86603 arg1Of It,lie
R27252 T93924 T30867 arg1Of H2L2,chimeric
R27294 T1824 T31388 arg2Of absorbed,was
R273 T282 T280 arg2Of locations,at
R27383 T59200 T13336 arg3Of ],[
R274 T282 T281 arg1Of locations,varying
R27403 T93212 T48141 arg2Of treat,can
R27411 T58244 T74170 arg2Of confirm,will
R27449 T83078 T64198 arg1Of treatment,tocilizumab
R275 T282 T283 arg1Of locations,around
R27501 T51141 T36542 arg2Of score,and
R2751 T85333 T4126 arg1Of identity,of
R2759 T62141 T31599 arg1Of arthritis,polyarticular
R27595 T24866 T7060 arg2Of transition,accompany
R276 T285 T283 arg2Of world,around
R27603 T55893 T84276 arg1Of protein,of
R27614 T14538 T20437 arg1Of similarity,of
R27615 T48129 T64443 arg1Of therapy,accelerate
R27618 T32075 T98023 arg2Of pseudotypes,of
R27621 T86955 T55812 arg1Of risk,in
R27628 T87582 T97802 arg2Of rise,begin
R27649 T51998 T82603 arg1Of are,in
R27652 T26722 T73113 arg2Of plasma,offers
R27664 T29454 T13828 arg1Of and,and
R27687 T81378 T25066 arg2Of degree,is
R277 T285 T284 arg1Of world,the
R27711 T11971 T84858 arg2Of used,be
R27738 T5476 T18906 arg1Of Corticosteroids,modulate
R27739 T61991 T21073 arg2Of study,In
R27740 T76927 T21523 arg1Of sequencing,could
R27741 T39330 T5681 arg1Of and,make
R27747 T94564 T92800 arg1Of utilize,Also
R27749 T42602 T70474 arg1Of virus,","
R27767 T68740 T23496 arg1Of plasma,convalescent
R27770 T75325 T40173 arg2Of week,during
R27782 T5721 T21671 arg1Of SARS-S,and
R278 T287 T286 arg1Of long,As
R27833 T59832 T39922 arg1Of notions,traditional
R27865 T10314 T77548 arg1Of effect,of
R27880 T10954 T45480 arg2Of important,is
R27887 T17221 T24580 arg1Of approved,for
R279 T303 T287 arg1Of increased,long
R27976 T73930 T66178 arg1Of day,the
R28 T25 T33 arg1Of IVIG,might
R280 T288 T287 arg2Of as,long
R2805 T87852 T72254 arg2Of leukocytes,of
R28065 T10303 T7764 arg1Of they,can
R28069 T51053 T84085 arg1Of Rp3,(
R28087 T5376 T64814 arg1Of Hypothesis,–
R281 T291 T288 arg2Of continues,as
R28120 T12723 T39296 arg1Of proteins,structural
R28137 T80710 T77485 arg1Of plasma,Convalescent
R28161 T38385 T98558 arg1Of Serum,4.1.3
R28181 T27914 T8453 arg2Of administered,be
R282 T290 T289 arg1Of COVID-19,the
R28208 T35511 T1792 arg1Of entry,of
R28224 T54792 T41003 arg1Of ciclesonide,","
R28227 T10629 T97483 arg1Of shown,","
R28299 T57882 T2438 arg1Of pH,by
R283 T290 T291 arg1Of COVID-19,continues
R28343 T57783 T5455 arg1Of sequences,genome
R28351 T63640 T96099 arg3Of ],[
R284 T293 T291 arg2Of spread,continues
R28408 T50457 T21885 arg1Of notion,different
R28455 T9385 T93008 arg2Of 90,than
R28465 T23786 T45333 arg1Of moderate,and
R28496 T65635 T24915 arg1Of and,","
R285 T293 T292 arg1Of spread,to
R28532 T25577 T79456 arg2Of protein,Targeting
R28577 T7184 T98832 arg1Of line,human
R286 T290 T293 arg1Of COVID-19,spread
R2860 T91011 T23827 arg3Of ],[
R28624 T52785 T92712 arg1Of and,severe
R28653 T47586 T67925 arg1Of rise,to
R28660 T73696 T7458 arg1Of replication,of
R28676 T89782 T96392 arg1Of serum,from
R287 T303 T294 arg1Of increased,","
R28703 T28149 T84544 arg2Of ",",with
R28733 T9761 T69880 arg1Of replication,reaches
R28796 T28228 T71564 arg1Of Tor2,and
R288 T296 T295 arg1Of power,its
R28808 T44373 T75308 arg2Of have,so
R28844 T93891 T28149 arg2Of envelope,","
R28884 T90573 T50903 arg1Of decrease,[
R28892 T27506 T38004 arg1Of ovotransferrin,Egg
R289 T296 T297 arg1Of power,of
R28920 T43323 T54178 arg1Of and,proteins
R28962 T52934 T16269 arg1Of –,encodes
R28970 T61968 T94564 arg1Of both,utilize
R28995 T9832 T13628 arg1Of sepsis,","
R29 T34 T33 arg2Of improve,might
R290 T299 T297 arg2Of modification,of
R29015 T52866 T91181 arg2Of form,in
R29016 T16756 T15733 modOf receiving,to
R29028 T70141 T37933 arg2Of N-glycans,","
R29067 T86110 T76482 arg2Of targets,as
R29083 T52375 T27748 arg2Of sample,of
R291 T299 T298 arg1Of modification,genome
R29116 T51393 T29543 arg1Of detection,in
R29123 T18064 T9269 arg1Of and,","
R29180 T69102 T88119 arg2Of revealed,after
R292 T296 T300 arg1Of power,would
R29203 T48569 T20680 arg1Of isolate,of
R29264 T44653 T80340 arg2Of or,was
R29265 T85333 T51362 arg1Of identity,high
R29294 T65344 T46398 arg2Of CatB/L,(
R293 T303 T300 arg2Of increased,would
R2931 T49967 T2352 arg1Of transfusion,of
R294 T303 T301 arg1Of increased,probably
R2941 T52732 T71483 arg1Of rates,mutation
R29418 T35671 T71867 arg2Of neutralize,cross
R29456 T69348 T39007 arg1Of course,disease
R29470 T47796 T47586 arg1Of and,rise
R295 T296 T302 arg1Of power,be
R29507 T50104 T55605 arg1Of chloride,ammonium
R29518 T68003 T5000 arg1Of trials,for
R29523 T15000 T78684 arg1Of patient,with
R2953 T72581 T23282 arg1Of formation,syncytia
R29558 T17096 T50493 arg2Of infection,after
R29591 T53624 T2868 arg2Of and,from
R296 T303 T302 arg2Of increased,be
R29604 T88114 T80638 arg2Of injury,treat
R29631 T92397 T70831 arg1Of degrees,of
R297 T296 T303 arg2Of power,increased
R2970 T25963 T66169 arg1Of corticosteroid,moderate-dose
R2971 T41203 T45935 arg3Of ),(
R29719 T59765 T19590 arg1Of protein,SARS-CoV2
R29783 T29960 T25638 arg1Of patient,the
R298 T304 T305 arg1Of What,concerns
R29816 T2491 T63623 arg1Of domain,same
R29860 T27007 T55724 arg2Of 21,[
R29876 T45789 T91069 arg1Of they,can
R29888 T31606 T86235 arg1Of steps,two
R29891 T40602 T14267 arg2Of able,is
R299 T306 T305 arg2Of us,concerns
R29937 T12338 T80948 arg2Of ACE2,express
R29960 T97339 T30904 arg1Of trials,show
R29965 T17280 T32273 arg2Of bats,of
R29995 T53777 T82506 arg2Of junctions,share
R3 T4 T3 arg2Of COVID-19,of
R30 T25 T34 arg1Of IVIG,improve
R300 T307 T305 arg3Of more,concerns
R30007 T49542 T83536 arg1Of activity,more
R30046 T7628 T28138 arg1Of strain,the
R30054 T2522 T48589 arg1Of 1,:
R30062 T42834 T27205 arg1Of patients,with
R30096 T26913 T55829 arg1Of patients,turned
R301 T304 T308 arg1Of What,is
R30131 T77430 T49707 arg1Of system,immune
R30150 T12942 T83444 arg1Of binding,of
R3018 T59480 T64120 arg1Of inhibition,of
R30185 T16420 T17928 arg1Of occur,merely
R302 T327 T308 arg2Of fitted,is
R30204 T17766 T91507 arg1Of effect,of
R30207 T82392 T16735 arg2Of diseases,of
R30216 T55185 T10219 arg2Of avium,","
R30238 T88396 T41360 arg1Of infection,of
R303 T327 T309 arg1Of fitted,that
R30321 T97752 T30344 arg2Of serum,and
R3036 T59765 T61296 arg1Of protein,Spike
R30372 T98349 T84544 arg1Of correlate,with
R3039 T79215 T5404 arg1Of patients,with
R304 T311 T310 arg1Of 2019-nCoV,the
R30421 T88382 T5367 arg2Of strain,from
R30440 T48129 T90120 arg1Of therapy,might
R30475 T65630 T2677 arg2Of tuberculosis,","
R305 T327 T312 arg1Of fitted,","
R30509 T27554 T52886 arg1Of subunit,S1
R30550 T8033 T98349 arg1Of frames,correlate
R3058 T40210 T92515 arg1Of strains,Rp3
R306 T327 T313 arg1Of fitted,by
R30604 T26763 T54709 arg2Of SARS-CoV2,against
R30611 T23558 T93581 arg1Of circumstances,the
R307 T315 T313 arg2Of process,by
R30751 T78997 T69102 arg1Of onset,revealed
R30772 T89187 T91474 arg1Of used,commonly
R30779 T33446 T16300 arg1Of patients,46
R308 T315 T314 arg1Of process,the
R30812 T2068 T86274 arg2Of promote,and
R30813 T93924 T69919 arg1Of H2L2,effective
R30825 T71868 T54079 arg1Of %,and
R30853 T86603 T91829 arg1Of lie,in
R30895 T50396 T53728 arg1Of patients,ten
R309 T315 T316 arg1Of process,of
R30944 T42466 T16443 arg1Of B,cathepsin
R30994 T45532 T48184 arg1Of replication,viral
R31 T36 T34 arg2Of outcomes,improve
R310 T317 T316 arg2Of modification,of
R31050 T75815 T40843 arg1Of degree,in
R31078 T58590 T50194 arg1Of concentrations,of
R31087 T64515 T30704 arg1Of days,14
R31098 T61673 T59345 arg1Of signal,is
R311 T317 T318 arg1Of modification,of
R31135 T11971 T68994 arg1Of used,In
R31165 T64204 T92436 arg1Of domain,receptor-binding
R312 T320 T318 arg2Of structure,of
R31206 T57783 T89898 arg1Of sequences,the
R31230 T39154 T80047 arg1Of domains,main
R31237 T87690 T68835 arg1Of and,contains
R31240 T8679 T32352 arg1Of ",",and
R31293 T53535 T71577 arg2Of activity,blocking
R313 T320 T319 arg1Of structure,genome
R31307 T10629 T44219 arg2Of shown,has
R31347 T98815 T75376 arg1Of COVID-19,demonstrated
R31375 T75582 T5404 arg2Of COVID-19,with
R31379 T18879 T61277 arg1Of inhibitors,serine
R31390 T18384 T4817 arg2Of 16,[
R314 T327 T321 arg1Of fitted,","
R31404 T79253 T84917 arg1Of hand,the
R31420 T69880 T96177 arg1Of reaches,In
R315 T311 T322 arg1Of 2019-nCoV,might
R31512 T17398 T26632 arg3Of trust,lead
R31515 T37666 T30663 arg1Of diseases,that
R31571 T75815 T56235 arg1Of degree,a
R316 T327 T322 arg2Of fitted,might
R31601 T19520 T87934 arg1Of structure,and
R31620 T4274 T67075 arg1Of %,94
R31644 T49266 T10805 arg2Of laboratory,","
R31648 T64598 T35896 arg1Of range,The
R3169 T58899 T90021 arg2Of outbreak,and
R317 T311 T323 arg1Of 2019-nCoV,become
R31752 T53029 T33850 arg2Of outbreaks,of
R31769 T65830 T31198 arg2Of patients,included
R31772 T71701 T52612 arg1Of sequence,of
R318 T327 T323 arg2Of fitted,become
R31825 T40953 T7458 arg2Of coronaviruses,of
R31881 T33015 T53625 arg1Of samples,fecal
R31887 T80253 T14937 arg1Of membranes,host
R319 T327 T324 arg1Of fitted,more
R31914 T40198 T87895 arg2Of 12,[
R31915 T84364 T12218 arg2Of and,","
R31926 T15256 T39714 arg1Of reduction,of
R31979 T9970 T76093 arg1Of domain,of
R31986 T22570 T8091 arg1Of characteristics,that
R32 T36 T35 arg1Of outcomes,patient
R320 T324 T325 arg1Of more,and
R32011 T90447 T61529 arg3Of ),(
R32051 T70519 T48403 arg1Of patients,convalescent
R32057 T20769 T53543 arg2Of neutralize,able
R32091 T45315 T13278 arg2Of MERS-S,and
R321 T326 T325 arg2Of more,and
R32128 T10303 T28508 arg1Of they,enter
R32155 T28738 T95580 arg2Of protein,and
R322 T327 T326 arg1Of fitted,more
R32206 T90255 T34609 arg1Of coronavirus,The
R32244 T97737 T80974 arg1Of protease,their
R32288 T32416 T22714 arg1Of entry,the
R323 T311 T327 arg2Of 2019-nCoV,fitted
R32306 T60314 T35183 arg1Of Evidence,links
R32316 T6733 T17651 arg2Of and,between
R32317 T57345 T30814 arg1Of antibody,decreased
R3232 T12601 T14267 arg1Of serum,is
R32394 T22929 T58621 arg1Of agents,anti-viral
R324 T327 T328 arg1Of fitted,to
R32415 T4274 T73088 arg1Of %,and
R32436 T66546 T45851 arg1Of IRW,","
R32473 T65630 T67405 arg1Of tuberculosis,Mycobacterium
R325 T329 T328 arg2Of humans,to
R32534 T99917 T85323 arg2Of binding,for
R32545 T15191 T44829 arg1Of revealed,When
R32577 T74401 T41163 arg2Of mAb,:
R326 T332 T330 arg1Of affect,to
R32622 T39073 T25723 arg2Of SARS-2-S,and
R32657 T89944 T31387 arg1Of reduce,effectively
R32666 T32201 T47689 arg1Of treatment,immunomodulatory
R3268 T12526 T42165 arg2Of 12,[
R327 T329 T330 modOf humans,to
R32703 T3983 T20802 arg1Of so,that
R32719 T17328 T96682 arg1Of Hypothesis,6.1.1
R32731 T38590 T37156 arg1Of safety,and
R32754 T64776 T19500 arg1Of and,the
R32776 T81462 T32973 arg2Of deal,help
R328 T332 T331 arg1Of affect,profoundly
R32841 T8090 T96099 arg1Of Toronto,[
R32875 T53586 T54198 arg1Of recruitment,the
R32883 T89053 T50644 arg2Of care,and
R329 T333 T332 arg2Of those,affect
R32916 T20067 T28168 arg1Of and,and
R32918 T52998 T62090 arg1Of sequencing,whole-genome
R3294 T31327 T10621 arg2Of 22,[
R32948 T47275 T30995 arg2Of able,were
R33 T39 T37 arg1Of use,•
R330 T333 T334 arg1Of those,who
R33041 T50749 T33950 arg2Of potential,have
R33081 T71924 T9965 arg1Of cause,well
R331 T333 T335 arg1Of those,have
R33107 T33017 T42013 arg2Of domain,in
R33111 T9027 T52339 arg2Of criticality,","
R33115 T93112 T59526 arg1Of transfer,passive
R33132 T55876 T91971 arg1Of day,14th
R33152 T71594 T30344 arg1Of serum,and
R33163 T64285 T67888 arg1Of all,of
R33164 T28601 T66409 arg1Of entry,the
R33193 T71072 T98716 arg1Of effects,anti-inflammatory
R332 T337 T335 arg2Of escaped,have
R33232 T80270 T73367 arg1Of remedy,the
R33240 T80516 T98862 arg1Of IVIG,improve
R33248 T30470 T43255 arg2Of and,as
R33260 T92502 T8496 arg1Of Corticosteroids,accelerate
R33270 T62479 T19773 arg1Of receptor,ACE2
R33275 T59818 T18282 arg1Of addition,to
R333 T337 T336 arg1Of escaped,already
R33352 T86123 T22569 arg2Of VCAM-1,and
R33385 T25454 T15312 arg1Of It,safe
R334 T333 T337 arg1Of those,escaped
R33407 T14361 T80094 arg1Of inhibit,","
R33432 T64274 T24072 arg1Of IL6,cytokine
R33460 T54347 T14954 arg2Of process,and
R335 T340 T337 arg2Of and,escaped
R3351 T49362 T71892 arg1Of through,than
R33522 T39927 T98118 arg1Of sequence,the
R33556 T47949 T53819 arg1Of onset,infection
R33558 T86415 T93994 arg1Of reduce,whether
R336 T339 T338 arg1Of children,–
R33601 T14876 T91231 arg2Of 2019-nCoV,contained
R33669 T85498 T54727 arg1Of Antiserum,that
R33688 T39330 T65635 arg1Of and,and
R33694 T48435 T43362 arg2Of protect,could
R33698 T47796 T32800 arg1Of and,begin
R337 T339 T340 arg1Of children,and
R33735 T64138 T71428 arg2Of effect,evaluate
R33791 T99851 T19164 arg2Of older,and
R338 T342 T340 arg2Of people,and
R33807 T84385 T20825 arg1Of reduce,","
R33815 T7474 T4182 arg1Of reaches,and
R33852 T98862 T88012 arg1Of improve,to
R33869 T76844 T88673 arg2Of species,between
R33893 T62247 T68999 arg2Of deficiencies,in
R339 T342 T341 arg1Of people,young
R33918 T78742 T43059 arg1Of degree,lesser
R33937 T56920 T78221 arg2Of regions,and
R3397 T47874 T83196 arg1Of affinity,a
R33983 T74827 T27915 arg1Of used,Recently
R34 T39 T38 arg1Of use,The
R340 T337 T343 arg1Of escaped,without
R3402 T44174 T26910 arg1Of recovered,from
R34037 T68003 T74304 arg1Of trials,clinical
R34046 T62139 T75854 arg1Of receptor,cell
R34054 T42640 T56297 arg1Of subunit,the
R34056 T48129 T55251 arg1Of therapy,IVIG
R34099 T58224 T78182 arg1Of early,as
R341 T346 T343 arg2Of condition,without
R34116 T49329 T91601 arg1Of outcomes,of
R34129 T11859 T80531 arg2Of and,decreased
R34142 T95515 T37831 arg2Of virus,of
R34146 T53611 T22569 arg1Of ICAM-1,and
R3415 T33017 T41576 arg1Of domain,S1
R34196 T13891 T38357 arg2Of children,and
R342 T346 T344 arg1Of condition,a
R34213 T32529 T86722 arg1Of inhibit,at
R34230 T39553 T90021 arg1Of pandemic,and
R34245 T15127 T87902 arg2Of 10,[
R3429 T73209 T1981 arg2Of corticosteroids,and
R343 T346 T345 arg1Of condition,pre-existing
R34313 T21161 T45933 arg1Of agent,the
R34331 T31059 T77548 arg2Of chloride,of
R34363 T37814 T61939 arg1Of develop,after
R34375 T70918 T20327 arg1Of similar,to
R344 T348 T347 arg1Of one,No
R34441 T17328 T61727 arg1Of Hypothesis,:
R34450 T62247 T52471 arg1Of deficiencies,antibodies
R345 T348 T349 arg1Of one,can
R34529 T10299 T59448 arg1Of were,before
R34537 T77495 T16541 arg1Of MERS-CoV,the
R34556 T89003 T41606 arg1Of subunit,of
R34567 T7654 T71050 arg1Of plasma,from
R346 T350 T349 arg2Of tell,can
R34622 T79253 T41471 arg1Of hand,other
R34637 T94029 T18906 arg2Of inflammation,modulate
R34638 T73342 T79102 arg2Of bats,from
R34640 T59765 T57535 arg1Of protein,the
R34673 T62855 T26039 arg1Of kinetics,viral
R34689 T39551 T99566 arg2Of identical,remain
R347 T348 T350 arg1Of one,tell
R3470 T16685 T50188 arg2Of parameters,in
R3471 T37204 T13336 arg2Of 12,[
R34720 T3419 T43926 arg2Of block,does
R34762 T20124 T52172 arg1Of responses,immune
R34792 T76540 T40602 arg2Of neutralize,able
R348 T351 T350 arg2Of how,tell
R34809 T32129 T58635 arg2Of prednisolone,","
R34814 T35672 T18282 arg2Of regimen,to
R34824 T14267 T39971 arg1Of is,not
R3485 T19375 T86256 arg1Of favorable,therefore
R34870 T63353 T17353 arg2Of and,in
R349 T352 T351 arg1Of much,how
R34990 T99819 T40027 arg1Of i.e.,","
R35 T39 T40 arg1Of use,of
R350 T355 T352 arg1Of takes,much
R35026 T44497 T44722 arg1Of corticosteroids,modulate
R35046 T64285 T38661 arg1Of all,switching
R35060 T73930 T38757 arg1Of day,14th
R35077 T20513 T48639 arg1Of viruses,these
R351 T352 T353 arg1Of much,time
R35124 T95208 T91019 arg1Of Rational,:
R35129 T57882 T24686 arg1Of pH,the
R35135 T36466 T69055 arg1Of patients,have
R35148 T12942 T21955 arg1Of binding,the
R35158 T58635 T52544 arg1Of ",",","
R35190 T62855 T13471 arg1Of kinetics,the
R352 T354 T355 arg1Of it,takes
R35205 T86415 T95640 arg2Of reduce,can
R35214 T86532 T85825 arg1Of High-content,A
R35220 T84785 T86080 arg1Of antibodies,IgG
R35227 T13001 T2287 arg1Of modulation,of
R3528 T98634 T55070 arg2Of S2,and
R353 T357 T355 arg2Of reach,takes
R35318 T2572 T97128 arg1Of SARS-S,and
R35338 T21671 T49586 arg1Of and,utilize
R35363 T5389 T78835 arg2Of resemblance,of
R35365 T21018 T30544 arg1Of pressure,in
R354 T357 T356 arg1Of reach,to
R3544 T77495 T91861 arg2Of MERS-CoV,of
R35442 T18322 T80297 arg1Of patients,with
R35461 T36179 T87676 arg2Of week,during
R35498 T76285 T93115 arg1Of cells,TMPRSS2 + Caco-2
R355 T354 T357 arg1Of it,reach
R35568 T67874 T96660 arg2Of and,show
R35581 T33160 T3842 arg1Of load,viral
R356 T360 T357 arg2Of level,reach
R35623 T20355 T89944 arg2Of entry,reduce
R35699 T88407 T41758 arg1Of included,","
R357 T360 T358 arg1Of level,a
R35710 T37814 T32237 arg1Of develop,against
R35747 T56884 T46706 arg1Of binding,to
R35751 T42652 T1853 arg2Of treatment,to
R35783 T44216 T86415 arg1Of use,reduce
R358 T360 T359 arg1Of level,new
R35818 T27689 T97114 arg2Of increasing,for
R35854 T64598 T57549 arg1Of range,produce
R359 T360 T361 arg1Of level,of
R35953 T1931 T94548 arg1Of branches,for
R36 T41 T40 arg2Of corticosteroids,of
R360 T362 T361 arg2Of perfection,of
R36008 T97752 T56749 arg1Of serum,from
R36020 T74666 T46614 arg1Of polymerase,(
R36023 T10219 T2677 arg1Of ",",","
R36046 T4913 T85558 arg2Of patients,recovered
R36055 T55070 T83444 arg2Of and,of
R36058 T59832 T79640 arg1Of notions,of
R36062 T40953 T58259 arg1Of coronaviruses,human
R36099 T65675 T92132 arg1Of and,entry
R361 T361 T363 arg1Of of,","
R36109 T85972 T67874 arg1Of and,and
R36176 T52785 T6178 arg1Of and,and
R362 T361 T364 arg1Of of,and
R36223 T24248 T42365 arg2Of IgM,and
R36266 T26913 T16466 arg1Of patients,seven
R363 T365 T364 arg2Of that,and
R3636 T91196 T1893 arg2Of ACE2,to
R36361 T71552 T91525 arg1Of efficiency,higher
R36370 T43668 T31501 arg1Of replication,SARS-CoV2
R364 T360 T365 arg1Of level,that
R36473 T86955 T79896 arg1Of risk,of
R36475 T99577 T85900 arg1Of it,attained
R3648 T16845 T94095 arg1Of sequence,(
R365 T373 T365 arg2Of is,that
R36526 T21885 T59931 arg2Of different,is
R36534 T59765 T4317 arg2Of protein,of
R36556 T76296 T46693 arg2Of shown,has
R36595 T55876 T78621 arg1Of day,the
R366 T367 T366 arg1Of development,the
R36619 T88382 T62453 arg1Of strain,SL-CoV
R36622 T91618 T27562 arg2Of plus,of
R36640 T39360 T76016 arg2Of s,(
R36647 T42602 T39629 arg1Of virus,positive-strand
R367 T367 T368 arg1Of development,of
R36734 T53867 T39623 arg3Of escape,allow
R36752 T84435 T6426 arg1Of treatment,plus
R368 T369 T368 arg2Of vaccines,of
R36890 T24144 T18888 arg2Of differences,produce
R369 T367 T370 arg1Of development,for
R36916 T37833 T40788 arg1Of target,the
R36961 T53710 T16554 arg1Of pathway,the
R36970 T25388 T7048 arg1Of course,late
R37 T39 T42 arg1Of use,might
R370 T372 T370 arg2Of immunization,for
R37042 T18877 T80580 arg1Of receptor,ACE2
R37061 T95212 T56020 arg1Of Hypothesis,4.2.1
R37082 T57345 T44833 arg1Of antibody,displayed
R37095 T70941 T36913 arg2Of limit,could
R37097 T98040 T23999 arg1Of symptoms,(
R371 T372 T371 arg1Of immunization,active
R37108 T22398 T15962 arg1Of 47D11,carried
R37128 T36459 T4317 arg1Of cleavage,of
R37154 T50829 T21513 arg1Of Calu-3,both
R37157 T45090 T8679 arg2Of ABCB-1,","
R37164 T55893 T64906 arg1Of protein,S
R37168 T64476 T34384 arg1Of effect,such
R372 T367 T373 arg1Of development,is
R37221 T17683 T50423 arg2Of and,of
R37229 T8033 T31208 arg1Of frames,and
R37231 T98539 T50204 arg1Of nor,occurred
R37239 T77475 T40616 arg1Of Rhinolophus,(
R37253 T11300 T96346 arg1Of ",",and
R3726 T37161 T59345 arg2Of present,is
R373 T376 T373 arg2Of process,is
R37332 T72667 T27689 arg2Of and,increasing
R37356 T50007 T41545 arg1Of domain,the
R37373 T51393 T33598 arg1Of detection,against
R37376 T39598 T81023 arg1Of defense,host
R37384 T81456 T44465 arg1Of and,both
R374 T376 T374 arg1Of process,a
R3741 T32652 T92448 arg1Of responses,immune
R37459 T80531 T13833 arg2Of decreased,and
R37476 T40665 T54239 arg1Of antibodies,can
R3748 T42144 T52542 arg2Of responses,of
R37482 T85613 T46259 arg1Of has,","
R37496 T39927 T60639 arg1Of sequence,between
R375 T376 T375 arg1Of process,long
R37501 T66576 T61388 arg1Of years,two
R37530 T80638 T46139 arg2Of treat,can
R37588 T32795 T88629 arg1Of Sera,from
R376 T386 T377 arg1Of are,Moreover
R37625 T6987 T41127 arg1Of mesylate,camostat
R37635 T72133 T81416 arg2Of extent,to
R37642 T59443 T14412 arg1Of down-regulation,of
R37658 T77029 T86274 arg1Of requires,and
R37668 T37619 T43323 arg2Of N.,and
R37669 T50457 T44962 arg2Of notion,supports
R377 T386 T378 arg1Of are,","
R37706 T4784 T41606 arg2Of SARS-S,of
R37712 T86961 T43097 arg1Of role,the
R3776 T86110 T97786 arg1Of targets,for
R37777 T10243 T94164 arg1Of Study,has
R37793 T96625 T75572 arg1Of Patients,who
R37795 T93826 T27767 arg1Of due,to
R378 T379 T380 arg1Of most,of
R37840 T13628 T43956 arg2Of ",",as
R37865 T80315 T58229 arg1Of immunization,protects
R37867 T51504 T98332 arg1Of subunit,of
R3787 T29624 T74170 arg1Of reaction,will
R379 T385 T380 arg2Of agents,of
R37915 T50002 T41374 arg1Of cells,that
R3792 T65405 T27300 arg2Of mAb,(
R37940 T58590 T5139 arg1Of concentrations,high
R37944 T17027 T88762 arg1Of 90,%
R37965 T27396 T52824 arg1Of dictate,not
R38 T43 T42 arg2Of accelerate,might
R380 T385 T381 arg1Of agents,the
R38001 T51393 T60810 arg1Of detection,among
R38065 T98647 T44793 arg2Of disease,cause
R38076 T7550 T23827 arg1Of infection,[
R381 T383 T382 arg1Of available,best
R382 T385 T383 arg1Of agents,available
R38202 T95152 T64168 arg3Of ],[
R3822 T57517 T2352 arg2Of plasma,of
R38259 T97339 T72804 arg1Of trials,clinical
R38280 T71552 T15191 arg2Of efficiency,revealed
R383 T385 T384 arg1Of agents,anti-viral
R38349 T51053 T40481 arg1Of Rp3,isolate
R38398 T55032 T54166 arg2Of SARS,with
R384 T379 T386 arg1Of most,are
R38432 T18576 T50188 arg1Of differ,in
R385 T388 T386 arg2Of helpful,are
R38579 T81326 T85814 arg1Of isolated,in
R38585 T67947 T51866 arg2Of 90,than
R386 T386 T387 arg1Of are,not
R38640 T65675 T96172 arg1Of and,cell
R38672 T56752 T80511 arg2Of and,of
R38683 T97737 T89215 arg1Of protease,","
R387 T379 T388 arg1Of most,helpful
R38722 T7154 T39745 arg2Of COVID-19,from
R38725 T50457 T59931 arg1Of notion,is
R3874 T2491 T57621 arg1Of domain,of
R38756 T90499 T46430 arg1Of treat,to
R388 T386 T389 arg1Of are,in
R38806 T4240 T2183 arg1Of increase,an
R38807 T30144 T39590 arg1Of and,However
R38821 T32201 T26744 arg1Of treatment,currently
R38873 T9582 T19789 arg1Of virus,respiratory
R389 T391 T389 arg2Of treatment,in
R38913 T28738 T84704 arg1Of protein,nucleocapsid
R38926 T33016 T45981 arg1Of S,","
R38960 T78742 T2565 arg2Of degree,e
R38976 T93891 T12498 arg1Of envelope,(
R38992 T60914 T95632 arg1Of 1–2 mg/kg/d,for
R39 T39 T43 arg1Of use,accelerate
R390 T391 T390 arg1Of treatment,the
R39000 T39598 T27355 arg1Of defense,the
R39033 T51504 T69690 arg1Of subunit,S1
R39066 T32990 T32353 arg1Of suppress,generally
R39074 T22570 T39623 arg1Of characteristics,allow
R391 T391 T392 arg1Of treatment,of
R39175 T82101 T1902 arg1Of S1B,and
R392 T393 T392 arg2Of COVID-19,of
R39227 T82047 T16733 arg1Of NSP15,the
R39248 T64443 T89890 arg1Of accelerate,to
R39252 T82201 T93235 arg1Of regulation,aid
R39297 T22412 T36397 arg1Of CoV,SARS-like
R393 T397 T394 arg1Of trial,A
R39309 T52981 T49738 arg1Of H1N1,in
R39324 T13833 T58632 arg1Of and,","
R39377 T66003 T37276 arg2Of peptide,contains
R3939 T34896 T77136 arg2Of and,in
R39394 T93924 T21134 arg1Of H2L2,The
R39396 T87601 T11172 arg2Of patients,from
R394 T397 T395 arg2Of trial,randomized
R39436 T23714 T50076 arg2Of antibodies,contains
R39441 T77639 T14621 arg2Of fatalities,avoid
R39456 T71073 T8391 arg1Of conditions,inflammatory
R395 T397 T396 arg2Of trial,controlled
R39576 T62139 T94971 arg2Of receptor,with
R396 T397 T398 arg1Of trial,of
R39618 T82190 T9564 arg1Of 2019-nCoV,the
R3964 T96672 T78252 arg1Of variety,a
R39650 T87007 T95580 arg1Of glycoproteins,and
R39672 T75815 T89657 arg1Of degree,noticeable
R397 T401 T398 arg2Of adults,of
R39708 T94273 T56156 arg1Of 0.29 μg/g,4
R39715 T72581 T71888 arg2Of formation,induced
R39732 T42798 T53867 arg1Of SARS-CoV2,escape
R39759 T71577 T97443 arg1Of blocking,through
R398 T401 T399 arg1Of adults,199
R39863 T81104 T21841 arg1Of immunized,with
R39883 T52803 T28508 arg2Of cells,enter
R399 T401 T400 arg2Of adults,hospitalized
R3997 T89003 T18520 arg1Of subunit,S2
R39984 T56787 T34590 arg2Of assumes,and
R3999 T64673 T90980 arg2Of lesions,detected
R4 T2 T5 arg1Of planning,:
R40 T44 T43 arg2Of recovery,accelerate
R400 T401 T402 arg1Of adults,with
R40020 T50471 T18273 arg2Of and,of
R4003 T6426 T52543 arg2Of plus,following
R4008 T48589 T17226 arg2Of :,than
R40089 T85558 T54139 arg1Of recovered,from
R401 T404 T402 arg2Of COVID-19,with
R40101 T35266 T22680 arg2Of cells,In
R40147 T94153 T75975 arg2Of cortisone,","
R40198 T81326 T18272 arg2Of isolated,was
R402 T404 T403 arg2Of COVID-19,confirmed
R4025 T88599 T81348 arg1Of blocker,a
R40258 T91091 T79089 arg1Of day,the
R40262 T60914 T32544 arg2Of 1–2 mg/kg/d,(
R40263 T14835 T62406 arg1Of infection,Parvovirus
R403 T397 T405 arg1Of trial,demonstrated
R40351 T24326 T59786 arg1Of symptoms,worsening
R40363 T45225 T5484 arg1Of Rp3,SARS-lice
R40383 T63832 T88619 arg1Of caution,in
R404 T408 T405 arg2Of difference,demonstrated
R40473 T15927 T97030 arg1Of protease,the
R40479 T71443 T18696 arg2Of COVID-19,with
R40491 T61673 T18285 arg1Of signal,a
R405 T408 T406 arg1Of difference,no
R40504 T89813 T7888 arg1Of SARS-S,compete
R40508 T65980 T11859 arg2Of saturation,and
R40528 T39668 T93033 arg2Of benefit,confer
R40530 T71428 T15733 arg1Of evaluate,to
R40584 T67121 T55726 arg2Of %,of
R406 T408 T407 arg1Of difference,actual
R40601 T49668 T83674 arg2Of interact,can
R40627 T37156 T94632 arg1Of and,of
R40674 T73531 T89464 arg1Of cells,are
R40689 T82201 T72254 arg1Of regulation,of
R407 T408 T409 arg1Of difference,between
R40705 T25315 T82233 arg2Of coronavirus,of
R40741 T79772 T35185 arg1Of week,the
R4076 T13833 T83448 arg1Of and,","
R408 T410 T409 arg2Of patients,between
R40823 T36509 T87404 arg1Of Serum,neutralize
R40867 T7672 T83098 arg1Of study,showed
R409 T410 T411 arg1Of patients,who
R40933 T36542 T78207 arg2Of and,by
R4099 T71072 T2648 arg2Of effects,with
R41 T44 T45 arg1Of recovery,from
R410 T410 T412 arg1Of patients,received
R41002 T86417 T20040 arg3Of ),(
R41003 T51504 T49296 arg1Of subunit,the
R41008 T64338 T85298 arg1Of lacking,","
R41012 T54149 T19053 arg2Of and,through
R41036 T14000 T98332 arg2Of SARS-S,of
R41044 T51047 T56803 arg3Of ),(
R41066 T82598 T81899 arg1Of peak,its
R41067 T95799 T49362 arg1Of enter,through
R41074 T71868 T4274 arg1Of %,%
R41077 T92006 T18503 arg3Of ],[
R411 T414 T412 arg2Of and,received
R41127 T89545 T54246 arg1Of Studies,show
R41132 T20215 T19523 arg1Of recovered,from
R41139 T89464 T41368 arg1Of are,thus
R41169 T20828 T81529 arg2Of and,show
R41187 T86955 T19254 arg2Of risk,reduced
R412 T413 T414 arg1Of lopinavir-ritonavir,and
R4121 T69297 T37338 arg2Of subunits,into
R41247 T48498 T65635 arg2Of regions,and
R41252 T62247 T18422 arg1Of deficiencies,primary
R41260 T60445 T91733 arg1Of immunoglobulin,(
R41269 T90255 T47494 arg1Of coronavirus,","
R41275 T24477 T81104 arg2Of rabbits,immunized
R413 T415 T414 arg2Of patients,and
R41315 T92001 T54331 arg2Of rabbits,immunized
R41319 T90021 T49434 arg2Of and,include
R41346 T32652 T6432 arg1Of responses,are
R41388 T34731 T75489 arg1Of strain,shows
R414 T410 T416 arg1Of patients,who
R41419 T74666 T57901 arg2Of polymerase,and
R41497 T66546 T76296 arg2Of IRW,shown
R415 T410 T417 arg1Of patients,received
R41519 T45580 T60639 arg2Of and,between
R41521 T64285 T6163 arg1Of all,improved
R41529 T8983 T84322 arg1Of virus,and
R41530 T76285 T60629 arg1Of cells,SARS-S
R41534 T48924 T40034 arg1Of effect,was
R416 T419 T417 arg2Of care,received
R41612 T5150 T64443 arg2Of recovery,accelerate
R41615 T51141 T97739 arg1Of score,[
R41655 T49689 T32529 arg1Of Pretreatment,inhibit
R41659 T50853 T84611 arg2Of contains,:
R417 T419 T418 arg1Of care,standard
R41727 T68906 T27996 arg2Of 12,[
R418 T419 T420 arg1Of care,alone
R41813 T90339 T32990 arg1Of effects,suppress
R4189 T76094 T18300 arg1Of decreases,then
R419 T417 T421 arg1Of received,in
R41915 T58895 T63732 arg1Of outcomes,paraclinical
R41949 T36705 T68837 arg1Of syndrome,","
R41959 T41765 T96381 arg1Of mesylate,and
R42 T46 T45 arg2Of COVID-19,from
R420 T428 T421 arg2Of and,in
R42021 T42849 T60930 arg1Of situation,worsened
R42024 T88396 T69934 arg1Of infection,includes
R42046 T15987 T84650 arg1Of arteritis,giant
R42060 T95580 T31208 arg2Of and,and
R42067 T53967 T27300 arg3Of ),(
R42092 T72133 T53199 arg1Of extent,lesser
R421 T423 T422 arg1Of improvement,clinical
R42101 T26913 T47643 arg1Of patients,who
R42123 T70238 T85453 arg2Of doses,received
R42151 T96815 T73609 arg2Of rabbits,from
R42164 T73113 T32817 arg1Of offers,as
R42165 T37245 T44833 arg2Of activity,displayed
R42168 T55337 T23972 arg2Of 11,[
R42193 T68511 T75930 arg1Of patients,have
R422 T423 T424 arg1Of improvement,","
R42203 T7184 T37299 arg1Of line,cell
R42239 T16269 T15815 arg1Of encodes,and
R42253 T45225 T5732 arg1Of Rp3,SL-CoV
R42254 T3009 T92082 arg1Of and,are
R42265 T95468 T30678 arg1Of Rhinolophidae,family
R42281 T76542 T70219 arg2Of affected,while
R42283 T61619 T39961 arg2Of and,of
R423 T426 T424 arg2Of rate,","
R42302 T20124 T8269 arg1Of responses,anti-viral
R42305 T64615 T46489 arg1Of %,94
R4231 T52714 T50943 arg1Of patients,convalescent
R424 T426 T425 arg1Of rate,death
R42425 T64526 T51029 arg2Of SARS-CoV,For
R42427 T85015 T87582 arg1Of and,rise
R42475 T30756 T24737 arg1Of fatal,potentially
R425 T428 T427 arg1Of and,","
R42521 T15178 T90977 arg2Of corticosteroids,of
R4253 T46413 T37466 arg1Of viral,and
R42535 T41843 T35381 arg1Of neutralizing,","
R42573 T22676 T64695 arg2Of and,pseudotyped
R426 T424 T428 arg1Of ",",and
R42612 T75238 T83388 arg2Of shown,have
R42614 T24131 T44437 arg1Of protein,of
R42624 T30344 T72802 arg1Of and,neutralize
R42628 T99631 T37089 arg1Of pseudotypes,SARS-2-S
R42646 T93474 T62375 arg2Of 17,[
R427 T432 T428 arg2Of rate,and
R42735 T75548 T13216 arg1Of protein,can
R42740 T65082 T2068 arg2Of fusion,promote
R42781 T65734 T7857 arg1Of vital,for
R428 T432 T429 arg1Of rate,positive
R42805 T53543 T69045 arg2Of able,is
R42808 T59443 T10667 arg1Of down-regulation,the
R42816 T93176 T85972 arg1Of reaches,and
R42821 T97598 T88238 arg1Of arthritis,juvenile
R42871 T32652 T14361 arg2Of responses,inhibit
R42875 T58244 T28791 arg1Of confirm,seropositive
R42879 T98539 T9277 arg1Of nor,serious
R42896 T97867 T41175 arg2Of IVIG,(
R429 T432 T430 arg1Of rate,virus
R42977 T32769 T57863 arg1Of occurred,","
R42990 T33761 T84821 arg1Of spectrum,a
R43 T51 T47 arg1Of trials,•
R430 T432 T431 arg1Of rate,test
R43001 T53426 T40522 arg1Of RNA,decreases
R43023 T58635 T68865 arg1Of ",",corticosteroids
R43068 T64958 T62199 arg1Of SARS-CoV,[
R431 T432 T433 arg1Of rate,at
R43148 T40210 T28228 arg1Of strains,Tor2
R432 T434 T433 arg2Of day,at
R4320 T52876 T70918 arg1Of It,similar
R4328 T64809 T26023 arg1Of PON,human
R43289 T96521 T30811 arg1Of bats,to
R433 T434 T435 arg1Of day,28
R43315 T92412 T42209 arg1Of replication,viral
R43356 T38146 T24019 arg1Of affect,","
R43366 T43308 T50563 arg2Of related,had
R43374 T54531 T22231 arg3Of ],[
R43398 T96263 T37600 arg1Of Rp3,SL-CoV
R434 T417 T436 arg1Of received,[
R43411 T82559 T99497 arg1Of differs,under
R43418 T4452 T60580 arg1Of proteins,nucleocapsid
R435 T437 T436 arg2Of 1,[
R43573 T60984 T76296 arg1Of that,shown
R436 T438 T436 arg3Of ],[
R4360 T69348 T3986 arg1Of course,the
R43602 T47874 T15962 arg2Of affinity,carried
R43619 T48498 T83674 arg1Of regions,can
R43666 T57029 T24463 arg1Of cells,TMPRSS2 + Caco-2
R43699 T35266 T64338 arg1Of cells,lacking
R437 T441 T439 arg1Of review,Here
R43732 T85869 T13881 arg1Of option,anti-inflammatory
R43774 T54331 T18102 arg1Of immunized,with
R43795 T64812 T69842 arg1Of use,accelerate
R438 T440 T441 arg1Of we,review
R43811 T98769 T44828 arg3Of ],[
R43834 T51998 T40424 arg1Of are,","
R43872 T1899 T21793 arg1Of There,are
R439 T443 T441 arg2Of indicators,review
R43912 T90339 T30802 arg1Of effects,potential
R43951 T46478 T46398 arg1Of L,(
R43963 T58895 T87507 arg1Of outcomes,clinical
R43998 T77430 T32412 arg1Of system,the
R44 T51 T48 arg1Of trials,No
R440 T443 T442 arg1Of indicators,intermediate
R441 T443 T444 arg1Of indicators,of
R44114 T76540 T99887 arg1Of neutralize,efficiently
R44161 T13737 T43506 arg1Of inhibit,to
R44193 T68579 T52733 arg1Of IFN,5
R442 T446 T444 arg2Of pathogenesis,of
R44206 T82716 T22399 arg1Of Development,6
R44220 T74286 T39782 arg2Of cytokines,and
R44226 T72732 T56803 arg2Of %,(
R44270 T97128 T88888 arg2Of and,of
R44280 T38146 T32300 arg1Of affect,not
R443 T446 T445 arg1Of pathogenesis,the
R44320 T25625 T48435 arg2Of cells,protect
R44335 T14361 T84174 arg1Of inhibit,on
R444 T446 T447 arg1Of pathogenesis,of
R44421 T98040 T46765 arg1Of symptoms,clinical
R44438 T6788 T81456 arg2Of SARS-2-S,and
R4444 T31666 T59846 arg2Of autoimmune,and
R44466 T72802 T22390 arg2Of neutralize,able
R445 T448 T447 arg2Of COVID-19,of
R44540 T75325 T16396 arg1Of week,first
R44574 T39782 T79314 arg2Of and,including
R44599 T96617 T22931 arg1Of antibody,the
R446 T443 T449 arg1Of indicators,that
R44629 T42976 T76496 arg2Of methylprednisolone,received
R44640 T10431 T43810 arg2Of 16,[
R44663 T53057 T14573 arg1Of domain,the
R447 T443 T450 arg1Of indicators,have
R44712 T66003 T77918 arg1Of peptide,","
R44752 T42902 T4517 arg1Of reason,an
R4477 T92225 T55163 arg1Of COVID-19,severe
R448 T452 T450 arg2Of potential,have
R44862 T7628 T45580 arg2Of strain,and
R449 T452 T451 arg1Of potential,the
R44930 T78772 T31833 arg1Of IFN,I
R44939 T63329 T50127 arg1Of degree,similar
R44940 T58581 T97114 arg1Of Eggs,for
R44966 T38146 T72578 arg2Of affect,and
R44975 T10130 T1824 arg2Of opacity,absorbed
R44977 T9153 T54332 arg1Of day,14
R44986 T92057 T47494 arg2Of SARS-CoV2,","
R45 T51 T49 arg2Of trials,controlled
R450 T452 T453 arg1Of potential,of
R45006 T80516 T69063 arg1Of IVIG,might
R45063 T27914 T10896 arg1Of administered,when
R451 T455 T453 arg2Of considered,of
R4510 T91321 T75450 arg1Of help,that
R45141 T84385 T56782 arg2Of reduce,can
R452 T455 T454 arg2Of considered,being
R45223 T40210 T39551 arg1Of strains,identical
R45246 T17546 T58982 arg2Of bats,to
R45292 T58244 T13336 arg1Of confirm,[
R453 T455 T456 arg1Of considered,for
R45343 T52328 T61958 arg1Of pigeon,(
R45347 T97422 T55724 arg3Of ],[
R45357 T36705 T47553 arg1Of syndrome,cytokine
R454 T458 T456 arg2Of treatment,for
R45413 T58229 T77600 arg1Of protects,against
R45433 T71857 T38163 arg1Of noticeable,more
R45491 T42028 T73402 arg1Of RNA,viral
R455 T458 T457 arg1Of treatment,the
R45507 T59987 T61995 modOf reduced,to
R45534 T64274 T98284 arg1Of IL6,the
R45567 T13828 T96472 arg1Of and,","
R45591 T37378 T96386 arg2Of –,that
R456 T458 T459 arg1Of treatment,of
R45638 T60636 T1788 arg1Of compounds,four
R45642 T22917 T47400 arg2Of dose,to
R45661 T90933 T64021 arg1Of more,before
R45666 T76626 T19053 arg1Of play,through
R45693 T34533 T96539 arg1Of ranging,to
R457 T460 T459 arg2Of COVID-19,of
R45703 T39330 T7384 arg1Of and,that
R45757 T81589 T68196 arg1Of antibodies,that
R45761 T36459 T44730 arg2Of cleavage,mediate
R45762 T90182 T48589 arg2Of 640,:
R45763 T78080 T53436 arg1Of and,both
R458 T464 T461 arg1Of entry,2
R45807 T32795 T18675 arg1Of Sera,could
R45826 T47874 T32288 arg1Of affinity,than
R45843 T56483 T58629 arg1Of least,at
R45855 T89662 T28898 arg2Of therapy,and
R459 T464 T462 arg1Of entry,SARS-CoV2
R4590 T7828 T20215 arg2Of patients,recovered
R45922 T32201 T83276 arg1Of treatment,an
R45963 T31415 T96381 arg2Of E-64d,and
R45973 T16617 T39745 arg1Of recovery,from
R46 T51 T50 arg1Of trials,clinical
R460 T464 T463 arg1Of entry,cell
R46015 T35672 T38966 arg1Of regimen,daily
R46087 T61320 T4817 arg1Of was,[
R46099 T16845 T48942 arg2Of sequence,","
R461 T464 T465 arg1Of entry,is
R4610 T37752 T87849 arg1Of fluid,The
R46110 T49962 T42599 arg1Of S1,and
R46140 T28611 T53543 arg1Of Serum,able
R46142 T14621 T50380 arg1Of avoid,to
R46163 T50829 T68094 arg1Of Calu-3,cancer
R462 T467 T465 arg2Of complex,is
R4625 T84214 T64350 arg2Of S1B,of
R46266 T39845 T90599 arg1Of is,","
R463 T465 T466 arg1Of is,not
R46320 T13076 T79043 arg1Of Hypothesis,4.1.3.1
R464 T464 T467 arg1Of entry,complex
R46464 T54707 T29802 arg1Of early,as
R46469 T15256 T39475 arg1Of reduction,a
R46480 T81644 T34209 arg1Of presence,the
R465 T468 T469 arg1Of Fig.,1
R46504 T37912 T2287 arg2Of responses,of
R46515 T42640 T2907 arg2Of subunit,with
R466 T468 T470 arg1Of Fig.,is
R46612 T65830 T55004 arg1Of patients,ten
R46656 T28781 T80297 arg2Of and,with
R46659 T91321 T90120 arg2Of help,might
R46662 T82559 T8248 arg1Of differs,from
R46683 T28898 T83285 arg2Of and,using
R46687 T47949 T61939 arg2Of onset,after
R467 T473 T470 arg2Of illustration,is
R46705 T87507 T10805 arg1Of clinical,","
R46721 T10314 T96902 arg1Of effect,existed
R46727 T75671 T16450 arg1Of act,to
R46737 T79439 T56787 arg1Of domain,assumes
R468 T473 T471 arg1Of illustration,a
R46848 T49143 T52862 arg1Of SARS-CoV2,the
R46861 T89333 T78823 arg1Of Rational,4.1.4.2
R46891 T42133 T31651 arg2Of outbreak,of
R46895 T29466 T94716 arg1Of antibody,monoclonal
R469 T473 T472 arg1Of illustration,schematic
R46910 T64698 T66871 arg3Of ),(
R46916 T87875 T46333 arg1Of It,has
R46944 T55185 T3443 arg1Of avium,Mycobacterium
R47 T51 T52 arg1Of trials,exist
R470 T473 T474 arg1Of illustration,of
R47010 T74458 T38190 arg1Of residues,most
R47040 T26688 T69861 arg1Of methylprednisolone,1600 mg/d
R4705 T13076 T75604 arg1Of Hypothesis,:
R47055 T58925 T68174 arg2Of 1.08 μg/g,±
R471 T477 T474 arg2Of proteins,of
R47106 T67776 T67888 arg2Of patients,of
R47112 T87582 T15243 arg1Of rise,from
R47188 T29624 T34558 arg1Of reaction,chain
R472 T477 T475 arg1Of proteins,the
R47262 T21718 T80531 arg1Of study,decreased
R47267 T37655 T58021 arg1Of variety,a
R47275 T55924 T10680 arg1Of proteases,Two
R473 T477 T476 arg1Of proteins,minimum
R47300 T47242 T45981 arg2Of S,","
R47308 T9133 T51866 arg1Of greater,than
R47359 T86423 T81091 arg2Of infection,for
R47369 T73531 T60353 arg1Of cells,","
R47378 T89439 T26278 arg1Of group,the
R47382 T67121 T9133 arg1Of %,greater
R47395 T15927 T96744 arg1Of protease,host
R47396 T4602 T44962 arg1Of It,supports
R474 T477 T478 arg2Of proteins,required
R47400 T82065 T43926 arg1Of –,does
R47434 T42133 T26029 arg1Of outbreak,of
R4744 T13257 T68497 arg1Of site,explain
R475 T480 T479 arg1Of mediate,to
R4750 T93112 T68886 arg2Of transfer,using
R47508 T97598 T30470 arg2Of arthritis,and
R47510 T82402 T63048 arg1Of site,and
R47571 T2491 T48378 arg1Of domain,the
R47598 T18322 T82834 arg1Of patients,receiving
R476 T478 T479 modOf required,to
R47614 T43993 T64840 arg2Of is,and
R47659 T43668 T32529 arg2Of replication,inhibit
R47680 T9527 T89758 arg1Of saturation,peripheral
R477 T484 T480 arg2Of entry,mediate
R47705 T77066 T66238 arg2Of SARS-CoV2,of
R47706 T14876 T55260 arg1Of 2019-nCoV,the
R478 T484 T481 arg1Of entry,the
R47808 T76343 T40337 arg1Of shed,on
R47877 T41916 T92667 arg1Of interact,with
R47881 T2153 T23050 arg2Of 18,[
R47891 T74458 T20437 arg2Of residues,of
R479 T484 T482 arg1Of entry,SARS-CoV2
R47953 T36459 T37338 arg1Of cleavage,into
R47959 T54874 T48453 arg1Of cytokine,the
R47977 T7550 T93874 arg2Of infection,after
R48 T52 T53 arg1Of exist,on
R480 T484 T483 arg1Of entry,cell
R48015 T68140 T99819 arg1Of affinities,i.e.
R48027 T7888 T34125 arg1Of compete,with
R48042 T56686 T68640 arg1Of differ,in
R48043 T63329 T78456 arg2Of degree,to
R481 T493 T485 arg1Of glycoprotein,The
R48104 T31794 T72017 arg1Of antibodies,against
R48113 T62455 T20341 arg2Of SARS-S,with
R482 T493 T486 arg1Of glycoprotein,trimeric
R48219 T6862 T31692 arg2Of day,from
R4822 T54336 T40616 arg2Of bats,(
R48240 T37738 T44869 arg1Of protein,15
R483 T486 T487 arg1Of trimeric,","
R4830 T18906 T19383 arg2Of modulate,can
R48307 T13257 T62080 arg1Of site,that
R48317 T37655 T58316 arg2Of variety,of
R48338 T24185 T58761 arg2Of antibody,is
R48343 T36887 T11592 arg1Of antibody,47D11
R48367 T95644 T10168 arg2Of target,as
R48373 T52676 T45640 arg2Of antibodies,of
R4839 T71403 T17651 arg1Of difference,between
R484 T488 T487 arg2Of transmembrane,","
R48403 T66184 T20519 arg2Of cells,inoculated
R48435 T37655 T87627 arg1Of variety,of
R48454 T37092 T65035 arg2Of patients,from
R48455 T86961 T56787 arg2Of role,assumes
R48458 T60930 T29454 arg1Of worsened,and
R48472 T45316 T34405 arg1Of protein,the
R48474 T65972 T95142 arg1Of Serum,is
R48482 T96346 T9479 arg1Of and,","
R48496 T85015 T97802 arg1Of and,begin
R485 T493 T488 arg1Of glycoprotein,transmembrane
R48507 T81904 T58859 arg1Of plasma,or
R48523 T17683 T12207 arg1Of and,both
R48533 T76542 T16218 arg1Of affected,not
R48539 T23714 T54709 arg1Of antibodies,against
R48542 T76343 T34741 arg2Of shed,:
R48546 T67884 T97649 arg1Of and,","
R48556 T69995 T3328 arg1Of cells,that
R48595 T44833 T11300 arg1Of displayed,","
R486 T493 T489 arg1Of glycoprotein,spike
R48610 T40522 T18711 arg1Of decreases,gradually
R48680 T17436 T17683 arg1Of SARS-S,and
R48681 T61991 T18474 arg1Of study,[
R487 T493 T490 arg1Of glycoprotein,(
R48701 T30704 T43796 arg1Of 14,more
R4871 T84785 T24248 arg1Of antibodies,IgM
R4872 T62980 T21998 arg3Of ],[
R48722 T32448 T6092 arg1Of protease,","
R48725 T31686 T72559 arg2Of CRP,in
R48726 T29681 T1981 arg1Of drugs,and
R48731 T59356 T69055 arg2Of signs,have
R4874 T85333 T86629 arg1Of identity,sequence
R48761 T64532 T15939 arg2Of play,:
R48789 T21027 T39050 arg1Of decoration,dense
R48790 T6178 T68999 arg1Of and,in
R488 T491 T490 arg2Of S,(
R48861 T97174 T19399 arg3Of ),(
R48879 T66624 T61958 arg3Of ),(
R489 T492 T490 arg3Of ),(
R48932 T14481 T5249 arg2Of to,is
R49 T55 T53 arg2Of use,on
R490 T493 T494 arg1Of glycoprotein,of
R49022 T54874 T39845 arg2Of cytokine,is
R49023 T53624 T75369 arg1Of and,the
R49039 T81543 T8306 arg1Of hand,the
R4907 T85855 T10850 arg1Of use,is
R49090 T93033 T93255 arg1Of confer,in
R491 T496 T494 arg2Of virus,of
R49171 T97970 T58994 arg1Of COVID-19,severe
R49184 T49689 T57406 arg1Of Pretreatment,could
R49189 T80575 T14481 arg1Of It,to
R492 T496 T495 arg1Of virus,the
R49206 T32990 T98869 modOf suppress,is
R49211 T1922 T22947 arg2Of is,as
R49235 T69281 T37427 arg2Of identical,was
R493 T493 T497 arg1Of glycoprotein,","
R49322 T74757 T72548 arg1Of use,the
R49359 T20519 T7566 arg1Of inoculated,in
R49394 T11805 T99442 arg1Of Plasma,contain
R494 T498 T497 arg2Of SARS-2-S,","
R49421 T1824 T60055 arg1Of absorbed,in
R49422 T37602 T93826 arg1Of needed,due
R49427 T44262 T25723 arg1Of SARS-S,and
R49439 T14257 T38116 arg2Of E,","
R4945 T52445 T15065 arg1Of ",",","
R49475 T58827 T61529 arg2Of P,(
R495 T500 T499 arg1Of includes,","
R49507 T96263 T84085 arg2Of Rp3,(
R49535 T99130 T66496 arg1Of role,a
R49580 T52785 T43956 arg1Of and,as
R496 T493 T500 arg1Of glycoprotein,includes
R49635 T13833 T52543 arg1Of and,following
R497 T504 T500 arg2Of subunits,includes
R49718 T26913 T26456 arg1Of patients,negative
R49728 T74893 T13882 arg2Of pathway,through
R49745 T37912 T72730 arg1Of responses,inflammatory
R49757 T75930 T3983 arg2Of have,so
R49758 T86423 T93402 arg1Of infection,lung
R4977 T88016 T45353 arg3Of ],[
R49772 T66370 T30686 arg1Of treated,with
R4978 T40695 T18064 arg2Of ORF6,and
R49789 T26913 T3255 arg1Of patients,all
R498 T504 T501 arg1Of subunits,two
R49835 T35357 T53693 arg1Of groups,control
R49840 T63388 T43810 arg3Of ],[
R49869 T82233 T8820 arg2Of of,and
R49876 T50457 T13974 arg1Of notion,","
R499 T504 T502 arg1Of subunits,main
R49902 T75930 T50453 arg1Of have,by
R49926 T14538 T63048 arg2Of similarity,and
R49957 T54149 T85138 arg1Of and,the
R49961 T85333 T85613 arg2Of identity,has
R49971 T55924 T2463 arg1Of proteases,for
R5 T6 T7 arg1Of Rationale,and
R50 T55 T54 arg1Of use,the
R500 T504 T503 arg1Of subunits,functional
R50003 T25963 T65524 arg1Of corticosteroid,short-term
R50015 T99923 T40693 arg1Of role,the
R50036 T74458 T87029 arg1Of residues,essential
R50098 T55153 T65675 arg1Of receptor,and
R501 T504 T505 arg1Of subunits,:
R50103 T12601 T95726 arg1Of serum,Bat
R5011 T32075 T45315 arg1Of pseudotypes,MERS-S
R50111 T36509 T11172 arg1Of Serum,from
R50117 T3228 T74238 arg2Of BALF,(
R50127 T86256 T90160 arg1Of therefore,and
R502 T507 T505 arg2Of and,:
R50238 T53586 T84385 arg2Of recruitment,reduce
R5025 T21027 T5681 arg2Of decoration,make
R50258 T13615 T96732 arg1Of patients,received
R503 T506 T507 arg1Of S1,and
R5031 T20998 T79456 arg1Of 6.1,Targeting
R50313 T82190 T94548 arg2Of 2019-nCoV,for
R50332 T4452 T18709 arg1Of proteins,in
R50369 T21718 T18993 arg1Of study,The
R50386 T89099 T91733 arg3Of ),(
R504 T508 T507 arg2Of S2,and
R50435 T72133 T58350 arg1Of extent,a
R505 T510 T509 arg1Of former,The
R50503 T98303 T59456 arg3Of ],[
R50505 T45506 T41360 arg2Of cells,of
R50526 T21482 T58268 arg1Of S,the
R50529 T9969 T12001 arg1Of Hypothesis,5.1
R50549 T66003 T97147 arg1Of peptide,angiotensin-converting
R50584 T13257 T13485 arg1Of site,a
R5059 T24633 T10954 arg1Of It,important
R50591 T42602 T26171 arg1Of virus,another
R506 T515 T511 arg1Of consists,","
R50628 T50396 T89276 arg1Of patients,the
R50655 T88887 T30470 arg1Of ",",and
R50669 T66548 T59987 arg1Of Sera,reduced
R50675 T59040 T57582 arg1Of was,In
R507 T515 T512 arg1Of consists,in
R50736 T2209 T14954 arg1Of Lack,and
R50751 T95232 T95927 arg1Of IFN,Recombinant
R50792 T63048 T35396 arg2Of and,","
R50799 T27914 T50400 arg1Of administered,so
R508 T513 T512 arg2Of turn,in
R50810 T12723 T18237 arg1Of proteins,including
R50828 T51592 T20067 arg2Of inflammation,and
R50831 T96302 T22068 arg1Of Rational,4.1.3.2
R50864 T31415 T14631 arg1Of E-64d,","
R50898 T98095 T52540 arg1Of chains,human
R509 T515 T514 arg1Of consists,","
R50943 T64274 T39845 arg1Of IL6,is
R50945 T29960 T20464 arg1Of patient,is
R50948 T75548 T26075 arg1Of protein,the
R50965 T66286 T14012 arg1Of treatment,tocilizumab
R50969 T26321 T17226 arg1Of higher,than
R51 T55 T56 arg1Of use,of
R510 T510 T515 arg1Of former,consists
R51061 T82578 T84727 arg1Of system,the
R511 T515 T516 arg1Of consists,of
R5113 T86955 T75238 arg2Of risk,shown
R51130 T31332 T27527 arg1Of count,monocyte
R51148 T22631 T69063 arg2Of help,might
R51174 T31208 T64104 arg1Of and,","
R51176 T88144 T44086 arg1Of but,","
R512 T520 T516 arg2Of domains,of
R513 T520 T517 arg1Of domains,the
R51321 T61440 T52661 arg2Of COVID-19,with
R51347 T71403 T46096 arg1Of difference,The
R51354 T13014 T27410 arg2Of protein,of
R51383 T11435 T17483 arg1Of treatments,specific
R514 T520 T518 arg1Of domains,four
R51409 T3048 T18696 arg1Of patients,with
R51413 T51053 T13194 arg1Of Rp3,coronavirus
R51417 T67890 T83630 arg1Of engage,MERS-S
R51462 T67108 T52147 arg1Of pathogenicity,of
R51479 T50396 T61149 arg1Of patients,all
R51483 T73531 T71726 arg1Of cells,Vero
R51485 T27554 T57621 arg2Of subunit,of
R51498 T48832 T43993 arg1Of diversity,is
R515 T520 T519 arg1Of domains,core
R51502 T45806 T22199 arg1Of ciclesonide,only
R51539 T69995 T80806 arg1Of cells,express
R51576 T55154 T51616 arg2Of E-cadherin,","
R51585 T46091 T48884 arg2Of length,of
R516 T520 T521 arg1Of domains,","
R51607 T41916 T94564 arg3Of interact,utilize
R51680 T31332 T15065 arg2Of count,","
R517 T528 T521 arg2Of and,","
R5174 T70369 T49953 arg2Of hyperplasia,","
R51750 T27055 T98703 arg1Of effect,serum
R51784 T65005 T70575 arg1Of COVID-19,that
R518 T522 T523 arg1Of S1A,","
R51801 T72014 T69872 arg1Of Rationale,4.1.2.2
R51824 T14927 T80806 arg2Of TMPRSS2,express
R51826 T82065 T3419 arg1Of –,block
R51838 T13575 T75386 arg2Of TMPRSS2,require
R51850 T94537 T18203 arg2Of and,showed
R5188 T51732 T35282 arg1Of viruses,","
R51882 T5376 T34741 arg1Of Hypothesis,:
R519 T524 T523 arg2Of S1B,","
R51965 T67108 T70730 arg1Of pathogenicity,high
R51991 T5967 T65069 arg2Of light,and
R51996 T73531 T80948 arg1Of cells,express
R52 T57 T56 arg2Of corticosteroids,of
R520 T523 T525 arg1Of ",",","
R52004 T45225 T47898 arg1Of Rp3,coronavirus
R52070 T13628 T15497 arg1Of ",",","
R52082 T19573 T94687 arg1Of study,A
R521 T526 T525 arg2Of S1C,","
R52117 T33747 T42258 arg1Of neutralize,to
R52150 T89678 T33850 arg1Of history,of
R522 T528 T527 arg1Of and,","
R5221 T76927 T61033 arg1Of sequencing,reveal
R52277 T82559 T47798 arg1Of differs,[
R523 T525 T528 arg1Of ",",and
R52362 T19745 T44026 arg2Of those,than
R524 T529 T528 arg2Of S1D,and
R52418 T58218 T55303 arg1Of group,The
R52481 T90762 T47778 arg1Of domain,of
R52486 T77887 T97770 arg1Of fusion,the
R525 T520 T530 arg1Of domains,","
R52507 T49668 T28141 arg1Of interact,with
R52512 T65082 T89079 arg1Of fusion,the
R52514 T63733 T48926 arg2Of entry,for
R52555 T7060 T54246 arg2Of accompany,show
R526 T520 T531 arg1Of domains,that
R52625 T10513 T93173 arg1Of SARS-CoV2,the
R52641 T29466 T64967 arg1Of antibody,human
R52673 T9153 T22231 arg1Of day,[
R52690 T20594 T58773 arg1Of study,investigated
R52693 T64812 T25429 arg1Of use,might
R527 T520 T532 arg1Of domains,contribute
R5275 T64958 T68614 arg2Of SARS-CoV,for
R52755 T48373 T85015 arg1Of IgG,and
R52768 T27754 T79207 arg1Of receptor,","
R528 T532 T533 arg1Of contribute,to
R52803 T51590 T95692 arg1Of and,","
R52856 T49810 T35724 arg1Of it,should
R52864 T96870 T42442 arg1Of improvement,of
R52889 T75548 T84125 arg1Of protein,SARS-CoV2
R5289 T45789 T90499 arg1Of they,treat
R529 T535 T533 arg2Of attachment,to
R52903 T15429 T85366 arg1Of inhibition,a
R52910 T75386 T88073 arg2Of require,indicating
R52920 T68610 T26256 arg1Of belonging,to
R52958 T40665 T11788 arg2Of antibodies,detect
R52999 T66055 T80340 arg1Of condition,was
R53 T55 T58 arg1Of use,for
R530 T535 T534 arg1Of attachment,the
R53013 T53426 T36950 arg1Of RNA,viral
R53041 T58078 T92236 arg1Of as,Currently
R53047 T74097 T73088 arg2Of 88,and
R53068 T96963 T31917 arg2Of level,had
R53099 T62960 T12678 arg3Of ),(
R531 T535 T536 arg1Of attachment,to
R53187 T96963 T24848 arg1Of level,mean
R532 T539 T536 arg2Of receptor,to
R53204 T55480 T85992 arg1Of failure,respiratory
R53215 T70143 T26901 arg1Of examples,recent
R533 T539 T537 arg1Of receptor,the
R53333 T58821 T70281 arg2Of treatment,after
R53372 T66875 T44373 arg1Of patients,have
R53389 T81227 T65088 arg2Of rabbits,immunized
R534 T539 T538 arg1Of receptor,surface
R53417 T89003 T20163 arg1Of subunit,the
R53418 T76285 T1792 arg2Of cells,of
R53455 T16685 T80686 arg1Of parameters,laboratory
R53458 T39437 T66784 arg1Of groups,the
R53466 T53491 T57582 arg2Of and,In
R53477 T90762 T35597 arg1Of domain,the
R53482 T2594 T83675 arg1Of peak,its
R535 T539 T540 arg1Of receptor,of
R53501 T52514 T30811 arg2Of men,to
R53561 T93832 T86571 arg1Of Corticosteroids,offer
R53572 T90762 T16269 arg2Of domain,encodes
R536 T542 T540 arg2Of cells,of
R53600 T90499 T11971 arg3Of treat,used
R53615 T16816 T41175 arg3Of ),(
R537 T542 T541 arg1Of cells,target
R53709 T18784 T21998 arg1Of bats,[
R53724 T27754 T36069 arg1Of receptor,entry
R5373 T90933 T6930 arg2Of more,of
R53731 T68554 T82775 arg1Of birds,domestic
R53734 T24534 T96881 arg2Of two,or
R53752 T80909 T71888 arg1Of and,induced
R53767 T86465 T1893 arg1Of binding,to
R53769 T88396 T35377 arg1Of infection,by
R53774 T82196 T54348 arg1Of resistance,to
R538 T547 T543 arg1Of coordinates,Then
R53814 T29466 T20950 arg1Of antibody,a
R53841 T76285 T63658 arg1Of cells,SARS-2-S.
R53873 T54783 T85409 arg1Of levels,high
R539 T547 T544 arg1Of coordinates,","
R53908 T51998 T44026 arg1Of are,than
R53920 T71641 T52612 arg2Of protein,of
R53923 T15359 T76304 arg2Of suffice,would
R53932 T74757 T88619 arg2Of use,in
R53989 T89696 T11399 arg1Of immunity,anti-viral
R53992 T58895 T49266 arg1Of outcomes,laboratory
R54 T59 T58 arg2Of COVID-19,for
R540 T546 T545 arg1Of latter,the
R54019 T9709 T49785 arg1Of titer,that
R54048 T92082 T75604 arg2Of are,:
R54057 T74286 T39990 arg1Of cytokines,(
R541 T546 T547 arg1Of latter,coordinates
R54102 T93532 T80345 arg1Of virus,the
R54150 T45806 T12794 arg1Of ciclesonide,capable
R542 T549 T547 arg2Of fusion,coordinates
R54223 T78367 T10850 arg2Of recommended,is
R5424 T2677 T52785 arg1Of ",",and
R54251 T68140 T69338 arg1Of affinities,similar
R54258 T31606 T83907 arg1Of steps,sequential
R543 T549 T548 arg1Of fusion,the
R5432 T17705 T6178 arg2Of infections,and
R54321 T42313 T79163 arg2Of HIV,","
R54339 T25625 T44775 arg1Of cells,VeroE6
R544 T549 T550 arg1Of fusion,of
R54403 T2182 T41175 arg1Of immunoglobulins,(
R54495 T48924 T5764 arg1Of effect,such
R545 T554 T550 arg2Of membranes,of
R54546 T85900 T40490 arg1Of attained,","
R54555 T57657 T37520 arg2Of patients,from
R54575 T15359 T64840 arg1Of suffice,and
R54593 T38563 T93829 arg1Of patients,with
R546 T554 T551 arg1Of membranes,viral
R54614 T49688 T48117 arg1Of RaTG13,[
R54619 T9761 T67170 arg1Of replication,SARS-CoV2
R54652 T85333 T77820 arg1Of identity,a
R54661 T37752 T74238 arg1Of fluid,(
R54662 T81737 T54387 arg1Of cell,the
R54690 T93112 T2403 arg1Of transfer,of
R547 T551 T552 arg1Of viral,and
R54748 T98095 T72563 arg1Of chains,heavy
R5477 T32520 T18229 arg2Of –,of
R548 T553 T552 arg2Of cellular,and
R54859 T56862 T61033 arg2Of similarity,reveal
R54860 T91091 T15243 arg2Of day,from
R54861 T11797 T86415 arg2Of death,reduce
R54869 T20946 T80745 arg1Of genomes,viral
R54888 T9709 T69880 arg2Of titer,reaches
R549 T554 T553 arg1Of membranes,cellular
R5494 T56884 T91479 arg1Of binding,the
R54949 T87850 T56623 arg1Of effect,cytopathic
R54968 T3323 T79102 arg1Of Serum,from
R55 T62 T60 arg1Of correlates,•
R550 T556 T555 arg1Of binding,Receptor
R55007 T19302 T20680 arg2Of coronaviruses,of
R55027 T45992 T31582 arg1Of dose,of
R551 T556 T557 arg1Of binding,activates
R55122 T12601 T40602 arg1Of serum,able
R55160 T18879 T73448 arg1Of inhibitors,e.g.
R552 T558 T557 arg2Of proteases,activates
R55206 T6862 T13466 arg1Of day,10th
R55214 T24171 T61844 arg1Of stability,more
R5522 T3048 T91601 arg2Of patients,of
R55232 T86520 T85504 arg1Of immunization,Passive
R55235 T45109 T21998 arg2Of 13,[
R55247 T92397 T95206 arg2Of degrees,to
R55274 T37666 T64366 arg1Of diseases,human
R5528 T4246 T96551 arg1Of report,a
R55295 T14229 T21817 arg1Of serum,exert
R553 T558 T559 arg1Of proteases,that
R55306 T75548 T74634 arg1Of protein,interact
R55335 T60390 T29104 arg1Of cells,human
R554 T558 T560 arg1Of proteases,can
R55406 T39553 T54973 arg1Of pandemic,the
R55425 T57345 T78516 arg1Of antibody,One
R55440 T17782 T30425 arg2Of help,might
R55450 T83272 T70573 arg1Of polyprotein,","
R55476 T4913 T98086 arg2Of patients,from
R555 T561 T560 arg2Of carry,can
R55504 T20355 T32181 arg1Of entry,the
R55505 T52375 T27295 arg1Of sample,a
R55511 T12942 T48321 arg1Of binding,to
R5554 T60803 T94537 arg1Of improvement,and
R55546 T49586 T41218 arg1Of utilize,that
R5555 T4182 T7530 arg1Of and,that
R55554 T8038 T49447 arg1Of infections,difficile
R55573 T42633 T81648 arg2Of and,that
R55576 T33177 T18503 arg2Of 26,[
R556 T558 T561 arg1Of proteases,carry
R55603 T57882 T36913 arg1Of pH,could
R55612 T24144 T88673 arg1Of differences,between
R55615 T7672 T46997 arg1Of study,The
R55634 T83960 T50853 arg2Of pool,contains
R55663 T25851 T93008 arg1Of more,than
R55692 T53416 T14631 arg2Of inhibitor,","
R557 T564 T561 arg2Of cleavage,carry
R55726 T96146 T47796 arg1Of IgG,and
R558 T561 T562 arg1Of carry,out
R5580 T25730 T48691 arg1Of degree,a
R55812 T3419 T69422 arg1Of block,not
R55825 T67952 T12678 arg2Of NSP15,(
R55856 T38342 T51508 arg1Of Rp3,SL-CoV
R55870 T59832 T68886 arg1Of notions,using
R5589 T45992 T21466 arg1Of dose,short-term
R559 T564 T563 arg1Of cleavage,proteolytic
R55934 T7654 T81207 arg1Of plasma,Convalescent
R55984 T80157 T96665 arg1Of and,SL-CoV
R55992 T16892 T48251 arg1Of compared,with
R56 T61 T62 arg1Of IL6,correlates
R560 T564 T565 arg1Of cleavage,of
R56002 T83416 T39699 arg2Of COVID-19,","
R56025 T51672 T69307 arg2Of infection,after
R56055 T66963 T20040 arg2Of PCR,(
R56074 T71701 T19117 arg1Of sequence,amino
R56076 T52998 T20323 arg1Of sequencing,and
R56085 T22917 T88178 arg1Of dose,double
R56090 T18784 T87528 arg2Of bats,to
R561 T568 T565 arg2Of protein,of
R56134 T32769 T49866 arg1Of occurred,in
R56159 T50204 T20973 arg1Of occurred,with
R56160 T70519 T51594 arg1Of patients,SARS
R562 T568 T566 arg1Of protein,the
R56229 T31606 T69934 arg2Of steps,includes
R563 T568 T567 arg1Of protein,S
R56313 T62141 T93322 arg1Of arthritis,juvenile
R56320 T36613 T59179 arg1Of and,accompanied
R564 T573 T569 arg1Of occurs,In
R5640 T27491 T52796 arg1Of MERS-CoV,the
R56468 T4016 T49089 arg1Of and,are
R565 T570 T569 arg2Of coronaviruses,In
R56550 T81737 T95799 arg2Of cell,enter
R566 T573 T571 arg1Of occurs,","
R56648 T9113 T95658 arg1Of day,8
R56670 T96381 T89506 arg1Of and,","
R56677 T50829 T39137 arg1Of Calu-3,human
R56679 T79772 T62926 arg2Of week,during
R567 T572 T573 arg1Of cleavage,occurs
R56727 T80948 T60658 arg1Of express,and
R56743 T98192 T20616 arg2Of plus,of
R568 T573 T574 arg1Of occurs,at
R56840 T64138 T54708 arg1Of effect,main
R569 T576 T574 arg2Of sites,at
R56902 T69919 T49873 arg2Of effective,be
R56923 T99130 T64532 arg2Of role,play
R5694 T58501 T45353 arg2Of 31,[
R56950 T20067 T91445 arg1Of and,","
R56953 T87404 T56983 arg1Of neutralize,efficiently
R56955 T68511 T89923 arg1Of patients,most
R56978 T8033 T31588 arg1Of frames,that
R57 T62 T63 arg1Of correlates,with
R570 T576 T575 arg1Of sites,two
R57039 T13882 T71892 arg2Of through,than
R57053 T53416 T42969 arg1Of inhibitor,an
R57057 T27055 T14991 arg1Of effect,in
R5706 T71857 T26799 arg2Of noticeable,was
R57062 T36509 T31307 arg1Of Serum,is
R57077 T52580 T30686 arg2Of methylprednisolone,with
R57082 T52981 T27857 arg1Of H1N1,A
R57097 T48498 T47927 arg1Of regions,that
R571 T576 T577 arg1Of sites,:
R57108 T17217 T80666 arg1Of COVID-19,severe
R57112 T59987 T35673 arg1Of reduced,and
R57154 T52732 T35366 arg2Of rates,with
R57168 T77880 T81456 arg1Of SARS-S,and
R57198 T25723 T75386 arg1Of and,require
R572 T580 T577 arg2Of junction,:
R57258 T90933 T81944 arg1Of more,than
R57291 T52934 T45076 arg1Of –,which
R57298 T59239 T91507 arg2Of and,of
R573 T580 T578 arg1Of junction,the
R57304 T58899 T16664 arg1Of outbreak,the
R5731 T70238 T24534 arg1Of doses,two
R57317 T41345 T46256 arg1Of infection,2009
R57386 T93176 T62926 arg1Of reaches,during
R57398 T86415 T30904 arg2Of reduce,show
R574 T580 T579 arg1Of junction,S1/S2
R57443 T9970 T55531 arg1Of domain,binding
R57449 T16845 T23620 arg1Of sequence,almost
R57493 T7628 T53721 arg1Of strain,which
R575 T574 T581 arg1Of at,and
R57525 T84685 T19443 arg2Of and,as
R57531 T39367 T35171 arg1Of therapy,standard
R576 T582 T581 arg2Of at,and
R57612 T92502 T17782 arg1Of Corticosteroids,help
R57671 T62141 T49595 arg1Of arthritis,idiopathic
R577 T573 T582 arg1Of occurs,at
R57726 T58682 T42366 arg1Of spike,the
R57766 T18211 T39196 arg1Of SARS-S,and
R57772 T14128 T35148 arg1Of enzymes,mammalian
R57789 T64812 T90977 arg1Of use,of
R57799 T45371 T75403 arg1Of It,may
R578 T584 T582 arg2Of S2′,at
R57803 T28541 T42599 arg2Of S2,and
R5782 T59949 T47798 arg2Of 20,[
R57869 T96337 T43810 arg1Of proteases,[
R57872 T54919 T47614 arg2Of cells,of
R579 T584 T583 arg1Of S2′,the
R57903 T63070 T34390 arg1Of levels,proportion
R57912 T46042 T47055 arg1Of egg,the
R57926 T49873 T22947 arg1Of be,as
R58 T71 T63 arg2Of and,with
R580 T584 T585 arg1Of S2′,","
R58032 T57783 T32904 arg1Of sequences,of
R58043 T45337 T48579 arg1Of and,all
R58046 T77390 T55259 arg2Of and,of
R58063 T48832 T76304 arg1Of diversity,would
R58092 T8195 T16483 arg2Of imaging,by
R58093 T77495 T11735 arg2Of MERS-CoV,mutated
R581 T587 T585 arg2Of region,","
R58114 T14011 T36351 arg2Of rabbits,immunized
R58115 T74051 T6180 arg2Of DPP4,and
R58146 T10243 T43431 arg1Of Study,shown
R58171 T87582 T54813 arg1Of rise,to
R582 T587 T586 arg1Of region,a
R58214 T53882 T32471 arg2Of FDA,by
R58217 T44722 T31300 arg1Of modulate,and
R58250 T17328 T16199 modOf Hypothesis,can
R58251 T82402 T47005 arg1Of site,cleavage
R5826 T68579 T83488 arg1Of IFN,Recombinant
R583 T587 T588 arg1Of region,close
R5834 T63733 T62543 arg1Of entry,cell
R58356 T10243 T21860 arg1Of Study,of
R58389 T63733 T50860 arg1Of entry,is
R584 T588 T589 arg1Of close,to
R58409 T40210 T14942 arg1Of strains,bat
R58460 T64204 T32276 arg1Of domain,least
R58480 T31794 T58025 arg2Of antibodies,contains
R58487 T30704 T66398 arg1Of 14,or
R585 T593 T589 arg2Of peptide,to
R58532 T11181 T35356 modOf tendency,to
R586 T593 T590 arg1Of peptide,the
R58615 T15000 T68154 arg2Of patient,of
R58662 T27506 T37276 arg1Of ovotransferrin,contains
R587 T593 T591 arg1Of peptide,viral
R58716 T37470 T22676 arg2Of SARS2-S,and
R58721 T67580 T97786 arg2Of therapy,for
R58725 T89333 T87452 arg1Of Rational,:
R58749 T14554 T48251 arg2Of serum,with
R58753 T95232 T46872 arg1Of IFN,I
R588 T593 T592 arg1Of peptide,fusion
R58839 T74401 T75556 arg1Of mAb,against
R5884 T29466 T27300 arg1Of antibody,(
R58848 T21735 T80547 arg2Of disease,against
R58851 T37245 T52983 arg1Of activity,a
R58884 T57397 T80510 arg2Of 2019-nCoV,against
R589 T593 T594 arg1Of peptide,[
R58901 T45316 T47778 arg2Of protein,of
R58904 T81378 T54103 arg1Of degree,a
R58905 T37089 T60207 arg2Of SARS-2-S,and
R58949 T85900 T87895 arg1Of attained,[
R58957 T48589 T94835 arg1Of :,on
R58960 T53492 T25066 arg1Of There,is
R58970 T67166 T97514 arg1Of immunity,humoral
R59 T64 T65 arg1Of severity,","
R590 T595 T594 arg2Of 2,[
R59047 T33217 T69082 arg2Of and,as
R59048 T89678 T44003 arg2Of history,at
R59071 T14554 T63812 arg1Of serum,patient
R591 T596 T594 arg3Of ],[
R59105 T44856 T63670 arg1Of therapy,convalescent
R59110 T29313 T97739 arg2Of 28,[
R59126 T27754 T80074 arg1Of receptor,same
R59147 T34284 T28857 arg2Of virus,","
R59149 T88599 T30022 arg1Of blocker,of
R59163 T1902 T34125 arg2Of and,with
R59166 T14481 T88108 arg1Of to,due
R592 T598 T597 arg1Of cleavage,Proteolytic
R59200 T34731 T43891 arg1Of strain,SARS-CoV
R59227 T64443 T91321 arg2Of accelerate,help
R59263 T15927 T77029 arg2Of protease,requires
R59273 T21817 T42100 arg2Of exert,could
R593 T598 T599 arg1Of cleavage,of
R59317 T30144 T9841 arg1Of and,","
R59330 T60390 T43867 arg1Of cells,the
R594 T602 T599 arg2Of protein,of
R59428 T18985 T5683 arg1Of group,first
R59437 T54700 T30269 arg1Of arthritis,rheumatoid
R59452 T82559 T83097 arg1Of differs,in
R59467 T45806 T13593 arg1Of ciclesonide,inhibiting
R595 T602 T600 arg1Of protein,the
R59510 T82280 T81648 arg1Of elements,that
R59552 T59443 T78284 arg2Of down-regulation,by
R59565 T1832 T7555 arg1Of manner,a
R59576 T9137 T45333 arg2Of severe,and
R596 T602 T601 arg1Of protein,S
R59603 T49810 T47054 arg2Of it,administered
R59690 T78772 T74739 arg2Of IFN,with
R597 T598 T603 arg1Of cleavage,causes
R59705 T15154 T63966 arg1Of consists,:
R598 T605 T603 arg2Of changes,causes
R5982 T41345 T49738 arg2Of infection,in
R59825 T82872 T91618 arg2Of immunoglobulin,plus
R59827 T32201 T52317 arg2Of treatment,is
R59832 T15429 T16699 arg1Of inhibition,of
R59863 T77279 T53860 arg1Of patients,with
R59867 T61673 T89124 arg1Of signal,for
R59897 T35438 T34549 arg1Of up-regulation,the
R599 T605 T604 arg1Of changes,conformational
R59901 T95952 T83153 arg1Of differences,in
R59902 T76626 T64464 arg1Of play,[
R59905 T8090 T85814 arg2Of Toronto,in
R59919 T24326 T75376 arg2Of symptoms,demonstrated
R59931 T48841 T27337 arg1Of CoVs,bat
R59988 T32229 T49191 arg1Of Copper,help
R6 T8 T7 arg2Of hypothesis,and
R60 T66 T65 arg2Of criticality,","
R600 T603 T606 arg1Of causes,so
R60032 T20179 T14412 arg2Of molecules,of
R60061 T79439 T64378 arg1Of domain,the
R601 T611 T606 arg2Of revert,so
R60119 T36466 T17580 arg1Of patients,who
R60124 T81644 T58244 arg2Of presence,confirm
R60141 T49967 T59448 arg2Of transfusion,before
R60151 T21460 T66890 arg1Of death,one
R60172 T50829 T99828 arg1Of Calu-3,lung
R60175 T44497 T14361 arg1Of corticosteroids,inhibit
R60177 T9113 T48202 arg2Of day,since
R602 T606 T607 arg1Of so,that
R60201 T21537 T99917 arg2Of ACE2,binding
R60224 T71868 T74097 arg1Of %,88
R60239 T48892 T85015 arg2Of IgM,and
R60276 T8313 T61223 arg1Of domain,S1
R60299 T72578 T94349 arg1Of and,","
R603 T608 T609 arg1Of they,can
R60303 T71701 T55756 arg1Of sequence,the
R60332 T50644 T28925 arg2Of and,with
R60341 T39154 T15378 arg2Of domains,of
R60347 T30604 T7774 arg2Of outcomes,improve
R60363 T64490 T84543 arg2Of absent,but
R60391 T12131 T99269 arg1Of count,lymphocyte
R604 T611 T609 arg2Of revert,can
R60475 T92600 T77635 arg1Of entry,SARS-2-S
R60499 T22184 T1922 arg1Of it,is
R605 T611 T610 arg1Of revert,not
R60526 T75815 T92988 arg1Of degree,of
R60583 T34145 T59456 arg2Of 25,[
R60586 T65701 T99390 arg2Of counts,","
R60594 T83081 T39196 arg2Of SARS-2-S,and
R60596 T38135 T37905 arg2Of copper,of
R606 T608 T611 arg1Of they,revert
R6060 T4681 T2648 arg1Of associated,with
R60630 T74458 T68062 arg1Of residues,the
R60648 T16845 T14679 arg1Of sequence,same
R60659 T88154 T26683 arg2Of and,in
R60685 T32416 T89272 arg2Of entry,","
R607 T611 T612 arg1Of revert,to
R60719 T36351 T2907 arg1Of immunized,with
R60741 T48569 T45372 arg1Of isolate,an
R60748 T11646 T91858 arg1Of inhibition,of
R60777 T77430 T49191 arg2Of system,help
R60787 T14786 T56782 arg1Of IRW,can
R60794 T80777 T53867 arg2Of system,escape
R60797 T20124 T66079 arg2Of responses,of
R608 T615 T612 arg2Of structure,to
R60809 T85498 T58025 arg1Of Antiserum,contains
R60813 T45992 T7774 arg1Of dose,improve
R60823 T44730 T6084 arg1Of mediate,to
R60884 T51771 T11727 arg1Of entry,cell
R60896 T32416 T31064 arg1Of entry,SARS-2-S
R60898 T85613 T32040 arg1Of has,In
R609 T615 T613 arg1Of structure,the
R60939 T90119 T59846 arg1Of inflammatory,and
R6095 T27008 T42258 modOf acted,to
R61 T65 T67 arg1Of ",",","
R610 T615 T614 arg1Of structure,original
R61000 T24202 T39330 arg2Of O-glycans,and
R61072 T88599 T55852 arg2Of blocker,","
R61089 T7048 T81312 arg1Of late,to
R61094 T78997 T33297 arg1Of onset,symptom
R611 T615 T616 arg1Of structure,and
R61124 T17398 T4319 arg1Of trust,to
R61171 T7401 T13593 arg2Of replication,inhibiting
R612 T615 T617 arg1Of structure,profound
R61217 T53624 T48926 arg1Of and,for
R61251 T2749 T61983 arg2Of COVID-19,with
R61252 T89439 T96270 arg1Of group,second
R6126 T92915 T55931 arg2Of MERS-CoV,For
R61261 T45118 T26321 arg1Of levels,higher
R613 T620 T617 arg2Of prime,profound
R614 T617 T618 arg1Of profound,enough
R61440 T58005 T98192 arg2Of therapy,plus
R61441 T58078 T32112 arg1Of as,","
R615 T620 T619 arg1Of prime,to
R6150 T50749 T72049 arg1Of potential,the
R61511 T16801 T16861 arg2Of and,of
R6154 T59356 T65527 arg1Of signs,of
R61551 T14228 T81402 arg1Of symptoms,clinical
R61578 T85869 T86571 arg2Of option,offer
R616 T623 T620 arg2Of subunit,prime
R61660 T65005 T54139 arg2Of COVID-19,from
R61697 T64476 T21817 arg2Of effect,exert
R617 T623 T621 arg1Of subunit,the
R61732 T19744 T76016 arg3Of ),(
R61734 T43382 T97423 arg1Of replication,viral
R61751 T22412 T89375 arg2Of CoV,with
R618 T623 T622 arg1Of subunit,S2
R619 T623 T624 arg1Of subunit,for
R61909 T3461 T40063 arg1Of entry,of
R62 T69 T67 arg2Of load,","
R620 T626 T624 arg2Of fusion,for
R62047 T82578 T32990 arg2Of system,suppress
R62097 T59040 T21310 arg1Of was,","
R621 T626 T625 arg1Of fusion,the
R62122 T71892 T21481 arg1Of than,rather
R62126 T49953 T20067 arg1Of ",",and
R62128 T65972 T7214 arg1Of Serum,effective
R62130 T75829 T95765 arg1Of subunit,S2
R62163 T88382 T66860 arg1Of strain,bat
R622 T626 T627 arg1Of fusion,of
R623 T631 T627 arg2Of membranes,of
R62325 T87007 T28810 arg1Of glycoproteins,(
R62361 T36887 T2922 arg1Of antibody,the
R62362 T17766 T58773 arg2Of effect,investigated
R62385 T6595 T61951 arg1Of useful,for
R624 T631 T628 arg1Of membranes,viral
R62417 T51290 T72721 arg1Of %,96
R62438 T39598 T7857 arg2Of defense,for
R62451 T8313 T22468 arg2Of domain,in
R62455 T95815 T39944 arg1Of inflammation,vascular
R62464 T78989 T8460 arg1Of immunization,Passive
R625 T628 T629 arg1Of viral,and
R62516 T26978 T79137 arg1Of virus,[
R62555 T51504 T18102 arg2Of subunit,with
R626 T630 T629 arg2Of cellular,and
R627 T631 T630 arg1Of membranes,cellular
R62701 T68842 T84996 arg1Of Serum,4.1.4
R62745 T38661 T32422 arg2Of switching,After
R62752 T34900 T84268 arg1Of and,for
R62759 T81474 T56686 arg1Of they,differ
R62774 T66440 T79549 arg1Of domain,the
R62783 T15927 T76016 arg1Of protease,(
R628 T634 T632 arg1Of Proteins,Fig.
R62865 T50829 T67184 arg1Of Calu-3,the
R629 T632 T633 arg1Of Fig.,1
R62931 T28717 T99239 arg3Of ),(
R62932 T33016 T24341 arg1Of S,SARSr-CoV
R62948 T7401 T5717 arg1Of replication,viral
R63 T69 T68 arg1Of load,viral
R630 T634 T635 arg2Of Proteins,required
R63011 T17100 T66535 arg2Of mice,from
R63068 T53586 T18273 arg1Of recruitment,of
R631 T635 T636 arg1Of required,for
R63116 T78221 T14738 arg1Of and,the
R63159 T75386 T81091 arg1Of require,for
R63165 T43431 T15543 arg1Of shown,","
R63178 T45992 T83835 arg1Of dose,might
R632 T639 T636 arg2Of entry,for
R63232 T10956 T21969 arg2Of hinder,could
R63247 T64875 T5869 arg1Of patients,SARS
R63281 T10634 T47481 arg1Of disorders,autoimmune
R633 T639 T637 arg1Of entry,the
R6332 T30434 T28810 arg3Of ),(
R63324 T63732 T51590 arg2Of paraclinical,and
R63345 T18121 T28665 arg2Of and,is
R63354 T32276 T9128 arg1Of least,at
R63361 T99566 T15154 arg2Of remain,consists
R6337 T86188 T98181 arg1Of IL-2,","
R63382 T77279 T43722 arg2Of patients,of
R634 T639 T638 arg1Of entry,SARS-CoV2-cell
R6341 T70941 T77508 arg1Of limit,significantly
R63472 T77475 T16732 arg1Of Rhinolophus,the
R635 T642 T640 arg1Of characteristics,3
R63506 T69348 T45554 arg2Of course,of
R63519 T56686 T90671 arg1Of differ,However
R63553 T47054 T77811 arg2Of administered,and
R636 T642 T641 arg1Of characteristics,Certain
R63665 T92502 T30425 arg1Of Corticosteroids,might
R63671 T48287 T91679 arg1Of patients,with
R637 T642 T643 arg1Of characteristics,of
R6370 T72554 T90276 arg2Of 34,[
R63773 T83272 T61529 arg1Of polyprotein,(
R638 T644 T643 arg2Of SARS-CoV2,of
R63810 T79174 T77600 arg2Of disease,against
R63818 T37752 T31054 arg1Of fluid,lavage
R63842 T54798 T77136 arg1Of improvement,in
R63866 T35511 T70941 arg2Of entry,limit
R63867 T37161 T63565 arg1Of present,in
R63884 T10513 T22059 arg2Of SARS-CoV2,of
R6389 T35672 T76082 arg1Of regimen,a
R639 T646 T645 arg1Of SARS-CoV2,3.1
R63916 T58635 T41721 arg2Of ",",inhaled
R63993 T7214 T72082 arg1Of effective,than
R64 T71 T70 arg1Of and,","
R640 T646 T647 arg1Of SARS-CoV2,has
R64010 T78772 T62356 arg1Of IFN,recombinant
R64025 T22917 T27562 arg1Of dose,of
R64051 T13001 T54149 arg2Of modulation,and
R64065 T99631 T60794 arg1Of pseudotypes,both
R64073 T74757 T50691 arg1Of use,of
R64079 T27148 T41273 arg1Of levels,IL6
R641 T648 T647 arg2Of acquired,has
R64105 T75392 T66370 arg2Of COVID-19,treated
R642 T646 T648 arg1Of SARS-CoV2,acquired
R6420 T1902 T37015 arg1Of and,for
R64276 T83832 T16280 arg1Of Hypotheses,:
R64279 T16296 T68175 arg1Of infection,SARS-CoV2
R6429 T90324 T31483 arg2Of M,","
R643 T651 T648 arg2Of glycoprotein,acquired
R64318 T65699 T98539 arg2Of deaths,nor
R64331 T90339 T91545 arg1Of effects,the
R64377 T55924 T40938 arg1Of proteases,are
R644 T651 T649 arg1Of glycoprotein,an
R6445 T24980 T93829 arg2Of COVID19,with
R64474 T76985 T20072 arg1Of Analysis,collected
R645 T651 T650 arg1Of glycoprotein,S
R64524 T63832 T37602 arg2Of caution,needed
R64570 T42466 T71562 arg1Of B,and
R64586 T65117 T35160 arg1Of study,The
R64588 T75548 T40189 arg2Of protein,on
R646 T651 T652 arg1Of glycoprotein,that
R64616 T3726 T74021 arg1Of SARS-S,and
R6462 T44785 T43571 arg2Of atlizumab,as
R6463 T49873 T60557 arg1Of be,in
R64658 T96870 T83098 arg2Of improvement,showed
R647 T654 T653 arg1Of underwent,highly
R64711 T26722 T71269 arg1Of plasma,convalescent
R64712 T53777 T56482 arg1Of junctions,same
R648 T651 T654 arg1Of glycoprotein,underwent
R64820 T96891 T41163 arg1Of Hypothesis,:
R64833 T82392 T37577 arg1Of diseases,autoimmune
R64835 T67890 T53624 arg2Of engage,and
R64854 T82065 T4372 arg1Of –,S1B
R64885 T11181 T50088 arg2Of tendency,indicates
R649 T657 T654 arg2Of and,underwent
R64970 T24866 T9522 arg1Of transition,from
R64973 T80950 T3009 arg2Of SARS-CoV2,and
R65 T67 T71 arg1Of ",",and
R650 T657 T655 arg1Of and,genetic
R65037 T70555 T85532 arg2Of H1N1pdm09,(
R651 T656 T657 arg1Of variation,and
R65190 T13615 T23681 arg1Of patients,20
R65194 T19573 T22655 arg1Of study,pilot
R652 T658 T657 arg2Of glycosylation,and
R65208 T31383 T37147 arg1Of actions,precise
R65213 T8033 T13269 arg1Of frames,reading
R65223 T92397 T97915 arg1Of degrees,variable
R65241 T81904 T53621 arg1Of plasma,convalescent
R65268 T91348 T96539 arg2Of deficiencies,to
R65283 T92755 T44041 arg1Of studies,Meta-analysis
R65288 T40210 T9407 arg1Of strains,SARS-CoV
R65296 T70659 T80018 arg1Of Ebola,African
R653 T662 T659 arg1Of site,3.1.1
R65301 T58761 T96810 arg1Of is,","
R65371 T13644 T5298 arg1Of substitution,conferred
R65396 T8349 T48117 arg2Of 3,[
R654 T662 T660 arg1Of site,Polybasic
R65488 T67274 T2290 arg2Of replication,on
R655 T662 T661 arg1Of site,cleavage
R65523 T94051 T40647 arg1Of MERS-CoV,the
R65549 T18888 T62259 arg1Of produce,to
R65562 T20594 T19799 arg1Of study,The
R656 T670 T663 arg1Of is,As
R65601 T70238 T20616 arg1Of doses,of
R65615 T95799 T13882 arg1Of enter,through
R65636 T87394 T3292 arg2Of done,be
R65646 T72012 T36716 arg1Of supernatants,were
R6567 T79226 T33377 arg1Of similar,in
R65672 T89437 T56176 arg3Of ],[
R657 T664 T663 arg2Of evidenced,As
R65706 T19573 T26265 arg1Of study,has
R65720 T5759 T83750 arg1Of and,","
R65744 T35988 T97443 arg2Of increasing,through
R65755 T72804 T88569 arg1Of clinical,controlled
R65763 T25454 T28665 arg1Of It,is
R658 T664 T665 arg1Of evidenced,by
R65883 T72802 T89303 arg1Of neutralize,to
R65884 T32075 T1819 arg1Of pseudotypes,VSV-G
R65895 T24185 T29074 arg1Of antibody,anti-human
R65896 T22966 T35366 arg1Of regions,with
R65897 T39845 T74879 arg1Of is,Moreover
R659 T667 T665 arg2Of analysis,by
R65903 T79958 T26331 arg2Of 12,[
R65914 T43996 T94005 arg1Of coronaviruses,possess
R65917 T86961 T18963 arg1Of role,of
R65938 T85613 T62529 arg1Of has,with
R66 T72 T71 arg2Of prognosis,and
R660 T667 T666 arg1Of analysis,sequence
R66017 T95799 T35356 arg1Of enter,to
R66024 T73708 T70831 arg2Of inflammation,of
R66056 T96870 T5017 arg1Of improvement,clinical
R661 T670 T668 arg1Of is,","
R6618 T73325 T72256 arg2Of patient,diagnosed
R66187 T94273 T26914 arg1Of 0.29 μg/g,±
R66191 T51732 T3387 arg1Of viruses,RNA
R662 T669 T670 arg1Of there,is
R66219 T39782 T70281 arg1Of and,after
R66257 T87807 T47759 arg3Of ],[
R663 T673 T670 arg2Of insertion,is
R66336 T23341 T23846 arg1Of transfusion,of
R66376 T13365 T15815 arg2Of contains,and
R664 T673 T671 arg1Of insertion,a
R66400 T58020 T49089 arg2Of similar,are
R66473 T59893 T6736 arg1Of virus,the
R665 T673 T672 arg1Of insertion,residue
R66576 T97339 T21793 arg2Of trials,are
R66579 T26456 T55829 arg2Of negative,turned
R66581 T28841 T32544 arg3Of ),(
R666 T673 T674 arg2Of insertion,formed
R66606 T11181 T80437 arg1Of tendency,the
R66611 T70519 T80239 arg2Of patients,from
R66632 T69297 T49962 arg1Of subunits,S1
R66652 T55062 T19426 arg3Of ),(
R66672 T5207 T41319 arg1Of fusion,the
R66698 T53907 T27008 arg1Of sera,acted
R66699 T81543 T80434 arg2Of hand,On
R667 T674 T675 arg1Of formed,of
R66734 T98815 T69048 arg1Of COVID-19,who
R66754 T33856 T40337 arg2Of origin,on
R66763 T43308 T56176 arg1Of related,[
R66768 T11646 T70471 arg1Of inhibition,complete
R66797 T59239 T48772 arg1Of and,","
R668 T678 T675 arg2Of acids,of
R66809 T14228 T44490 arg2Of symptoms,in
R66835 T74827 T56144 arg1Of used,","
R669 T678 T676 arg1Of acids,four
R66912 T72581 T30814 arg2Of formation,decreased
R66943 T85855 T54987 arg1Of use,the
R66954 T24269 T26765 arg1Of There,are
R66955 T52032 T12807 arg1Of membranes,host
R66967 T9912 T22507 arg2Of corticosteroids,of
R67 T72 T73 arg1Of prognosis,of
R670 T678 T677 arg1Of acids,amino
R67016 T47738 T84690 arg1Of plasma,convalescent
R67028 T70419 T13646 arg2Of S,(
R6704 T78533 T51548 arg1Of role,primary
R67089 T37466 T32005 arg2Of and,of
R671 T678 T679 arg1Of acids,(
R67132 T70238 T98598 arg1Of doses,one
R67139 T74827 T36716 arg2Of used,were
R67158 T62855 T64125 arg1Of kinetics,replication
R67161 T22676 T19104 arg2Of and,against
R67187 T72256 T7135 arg2Of diagnosed,when
R672 T681 T679 arg2Of nucleotides,(
R67204 T53417 T66297 arg2Of COVID-19,with
R67236 T71708 T47272 arg1Of causes,in
R67249 T37156 T95987 arg1Of and,contain
R6725 T37245 T30646 arg1Of activity,cross-neutralizing
R673 T682 T679 arg3Of ),(
R67300 T86465 T37015 arg2Of binding,for
R67328 T63866 T12507 arg2Of particular,In
R67339 T65584 T40405 arg1Of development,vaccine
R67342 T73696 T16699 arg2Of replication,of
R6737 T64598 T32273 arg1Of range,of
R67370 T64615 T78691 arg1Of %,%
R674 T681 T680 arg1Of nucleotides,12
R67482 T67884 T39990 arg2Of and,(
R675 T674 T683 arg1Of formed,at
R67530 T89289 T52645 arg1Of expressed,for
R67593 T13828 T97762 arg1Of and,However
R676 T685 T683 arg2Of boundary,at
R67632 T15429 T95958 arg2Of inhibition,induced
R67675 T62139 T89289 arg2Of receptor,expressed
R67688 T87293 T71924 arg2Of suppression,cause
R6769 T74327 T15313 arg1Of membranes,host-cell
R67692 T75964 T34900 arg2Of normalization,and
R677 T685 T684 arg1Of boundary,the
R67701 T28611 T20769 arg1Of Serum,neutralize
R6776 T91345 T83198 arg1Of Hypothesis,:
R67798 T39579 T91622 arg1Of decrease,a
R678 T670 T686 arg1Of is,between
R6780 T7888 T95236 arg2Of compete,could
R67825 T63329 T84667 arg1Of degree,a
R67837 T72012 T74827 arg2Of supernatants,used
R67841 T2963 T18623 arg1Of Paraoxonases,(
R67856 T72564 T5412 arg2Of and,in
R67857 T58244 T57534 arg1Of confirm,for
R679 T690 T686 arg2Of subunits,between
R67917 T74893 T96928 arg1Of pathway,TMPRSS2/cell
R67933 T1832 T14991 arg2Of manner,in
R67960 T51640 T22676 arg1Of SARS-S,and
R68 T74 T73 arg2Of COVID-19,of
R680 T690 T687 arg1Of subunits,S1
R6800 T51386 T55833 arg1Of and,the
R68003 T43357 T8605 arg2Of therapy,of
R6804 T36310 T48409 arg1Of infection,SARS-CoV2
R68043 T66365 T82079 arg2Of 30,[
R68061 T1922 T38972 arg1Of is,vitro
R68071 T42902 T84855 arg1Of reason,apparent
R681 T687 T688 arg1Of S1,and
R68118 T9582 T16801 arg2Of virus,and
R6815 T47054 T60601 arg1Of administered,so
R68163 T83272 T7216 arg2Of polyprotein,of
R682 T689 T688 arg2Of S2,and
R68217 T83073 T87404 arg2Of SARS-CoV2,neutralize
R68253 T18576 T61059 arg1Of differ,Moreover
R68265 T9169 T53541 arg2Of severity,with
R68271 T30323 T36542 arg1Of ",",and
R68274 T83224 T20828 arg2Of that,and
R68299 T91627 T62375 arg3Of ],[
R683 T690 T689 arg1Of subunits,S2
R68308 T41087 T46398 arg3Of ),(
R6831 T71552 T68477 arg1Of efficiency,in
R68311 T40394 T80590 arg1Of therapy,plasma
R68332 T9527 T65661 arg2Of saturation,and
R68379 T86991 T18064 arg1Of ",",and
R684 T690 T691 arg1Of subunits,of
R6844 T14128 T4681 arg2Of enzymes,associated
R68452 T47460 T44003 arg1Of look,at
R68459 T16887 T28141 arg2Of GRP78,with
R68462 T52714 T99070 arg1Of patients,SARS
R68469 T21434 T32751 arg2Of possibility,poses
R68489 T27055 T56518 arg1Of effect,The
R685 T695 T691 arg2Of S.,of
R68501 T15256 T59040 arg2Of reduction,was
R68506 T35357 T13795 arg2Of groups,were
R68576 T69297 T28541 arg1Of subunits,S2
R686 T695 T692 arg1Of S.,the
R68604 T11280 T11917 arg2Of SARS-S,of
R6863 T41408 T28737 arg2Of coronavirus,of
R68664 T49873 T85248 arg2Of be,might
R68691 T44685 T42097 arg2Of IVIG,combined
R687 T695 T693 arg1Of S.,SARS-CoV
R6870 T11815 T63608 arg1Of Rational,6.1.2
R6871 T96386 T80967 arg1Of that,for
R68735 T67504 T20323 arg2Of analysis,and
R68776 T49689 T74739 arg1Of Pretreatment,with
R68783 T56677 T12498 arg3Of ),(
R688 T695 T694 arg1Of S.,2
R68805 T54707 T25991 arg1Of early,as
R6883 T74021 T3764 arg1Of and,both
R68832 T67776 T16788 arg1Of patients,the
R68842 T37092 T20625 arg1Of patients,convalescent
R68866 T41843 T53652 arg1Of neutralizing,By
R68878 T30995 T94597 arg1Of were,For
R689 T696 T697 arg1Of It,defines
R68969 T95631 T77580 arg2Of interacting,for
R68981 T75975 T58635 arg1Of ",",","
R68983 T79226 T92082 arg2Of similar,are
R68991 T95558 T79137 arg2Of 26,[
R69 T82 T75 arg1Of confer,•
R690 T695 T697 arg2Of S.,defines
R69010 T78989 T37380 arg1Of immunization,can
R69030 T39782 T62470 arg1Of and,","
R69068 T32529 T93874 arg1Of inhibit,after
R69085 T51053 T85900 arg2Of Rp3,attained
R691 T702 T698 arg1Of site,a
R69132 T70519 T68000 arg1Of patients,three
R69157 T39437 T87016 arg1Of groups,did
R69166 T87850 T71708 arg2Of effect,causes
R692 T702 T699 arg1Of site,polybasic
R69236 T24131 T37699 arg1Of protein,the
R6925 T45806 T78874 arg1Of ciclesonide,the
R69272 T24661 T37156 arg2Of effect,and
R69283 T69785 T73262 arg1Of combination,of
R693 T702 T700 arg1Of site,furin
R69341 T11788 T74827 arg3Of detect,used
R69371 T82402 T5992 arg1Of site,a
R69387 T22929 T68950 arg1Of agents,regular
R694 T702 T701 arg1Of site,cleavage
R69428 T65675 T87934 arg2Of and,and
R69453 T27491 T25492 arg2Of MERS-CoV,of
R69456 T24628 T76208 arg2Of patients,in
R695 T702 T703 arg1Of site,of
R69542 T49542 T61619 arg1Of activity,and
R69581 T22143 T80547 arg1Of protects,against
R696 T704 T703 arg2Of RRAR,of
R69603 T5207 T84322 arg2Of fusion,and
R69633 T21695 T91858 arg2Of entry,of
R69637 T97339 T48573 arg1Of trials,that
R69640 T94005 T64690 arg1Of possess,commonly
R69683 T47874 T61532 arg1Of affinity,higher
R697 T702 T705 arg1Of site,for
R69719 T79617 T2754 arg1Of cytokines,pro-inflammatory
R6977 T95116 T50194 arg2Of copper,of
R69779 T13014 T7435 arg1Of protein,SARS-CoV2
R69781 T84385 T78284 arg1Of reduce,by
R698 T708 T705 arg2Of SARS-CoV,for
R69810 T95468 T98779 arg2Of Rhinolophidae,and
R69829 T77594 T50088 arg1Of It,indicates
R69842 T72014 T36633 arg1Of Rationale,:
R69846 T5488 T4016 arg2Of SARS-CoV2,and
R69868 T75489 T84749 arg1Of shows,","
R6989 T76094 T4182 arg2Of decreases,and
R699 T708 T706 arg1Of SARS-CoV,the
R69901 T3009 T79226 arg1Of and,similar
R69904 T10314 T25862 arg1Of effect,the
R69912 T77887 T18963 arg2Of fusion,of
R6992 T36887 T11559 arg2Of antibody,of
R6993 T37814 T10621 arg1Of develop,[
R6996 T98095 T35586 arg1Of chains,immunoglobulin
R7 T7 T9 arg1Of and,for
R70 T76 T77 arg1Of Tocilizumab,","
R700 T708 T707 arg1Of SARS-CoV,human
R70060 T50396 T42442 arg2Of patients,of
R70066 T33265 T15244 arg1Of concentration,same
R70070 T52249 T13795 arg1Of There,were
R7008 T64476 T15054 arg1Of effect,an
R70086 T34654 T35671 arg2Of and,neutralize
R701 T708 T709 arg1Of SARS-CoV,2
R702 T702 T710 arg1Of site,that
R70225 T45118 T95987 arg2Of levels,contain
R70229 T95815 T50471 arg2Of inflammation,and
R70294 T52375 T62671 arg1Of sample,fecal
R703 T702 T711 arg1Of site,was
R70326 T90061 T66297 arg1Of patients,with
R70338 T15000 T38317 arg1Of patient,the
R70394 T60580 T57901 arg1Of nucleocapsid,and
R704 T712 T711 arg2Of absent,was
R70416 T97492 T51383 arg1Of replication,SARS-CoV2
R705 T702 T712 arg1Of site,absent
R70505 T94051 T91822 arg2Of MERS-CoV,with
R70515 T70659 T20739 arg1Of Ebola,Western
R70559 T12723 T37519 arg1Of proteins,","
R70591 T16420 T18957 arg1Of occur,in
R706 T712 T713 arg1Of absent,in
R70600 T87850 T52777 arg1Of effect,the
R70624 T34731 T54296 arg1Of strain,Tor2
R707 T721 T713 arg2Of and,in
R70728 T21695 T17052 arg1Of entry,in
R70730 T38972 T72123 arg1Of vitro,in
R70734 T71072 T63688 arg1Of effects,anti-oxidant
R70744 T79240 T30106 arg2Of Rp3,","
R70763 T8195 T31403 arg1Of imaging,CT
R70781 T2594 T93176 arg2Of peak,reaches
R70792 T8033 T52748 arg1Of frames,five
R708 T715 T714 arg1Of SARS-CoV,human
R7081 T94273 T61958 arg2Of 0.29 μg/g,(
R70872 T42652 T87892 arg1Of treatment,type
R709 T715 T716 arg1Of SARS-CoV,","
R70932 T80516 T22631 arg1Of IVIG,help
R70938 T13966 T88153 arg1Of antibody,monoclonal
R70941 T75489 T22912 arg1Of shows,In
R70976 T25963 T99668 arg1Of corticosteroid,a
R70993 T36802 T24370 arg1Of Corticosteroids,7
R71 T79 T77 arg2Of anti-IL6,","
R710 T719 T716 arg2Of CoVs,","
R7103 T58859 T16756 arg2Of or,receiving
R711 T719 T717 arg1Of CoVs,bat
R71138 T71906 T11963 arg2Of MERS-CoV,of
R71140 T47738 T82834 arg2Of plasma,receiving
R712 T719 T718 arg1Of CoVs,SARS-like
R71223 T37738 T12678 arg1Of protein,(
R71234 T88396 T83401 arg1Of infection,The
R71243 T65088 T9531 arg1Of immunized,with
R71258 T73325 T59206 arg1Of patient,is
R71267 T60390 T53491 arg2Of cells,and
R71283 T44373 T90719 arg1Of have,by
R71284 T58581 T33004 arg1Of Eggs,8
R713 T721 T720 arg1Of and,","
R71339 T62855 T20327 arg2Of kinetics,to
R71366 T92495 T36003 arg1Of epidemic,in
R71375 T32520 T74591 arg1Of –,SARS-CoV
R714 T716 T721 arg1Of ",",and
R71444 T97288 T58860 arg2Of COVID-19,for
R71489 T53777 T48942 arg1Of junctions,","
R715 T725 T721 arg2Of while,and
R71573 T2068 T27045 arg1Of promote,consequently
R71574 T73531 T62340 arg1Of cells,susceptible
R716 T725 T722 arg1Of while,pangolin
R71640 T25315 T43308 arg1Of coronavirus,related
R71645 T15312 T18121 arg1Of safe,and
R71664 T21445 T58316 arg1Of modulation,of
R71674 T85855 T75237 arg1Of use,can
R71679 T41035 T6014 arg2Of 16,[
R71697 T3462 T63816 arg1Of COVID-19,","
R717 T725 T723 arg1Of while,SARS-like
R71721 T21695 T75023 arg1Of entry,SARS-2-S
R71731 T68271 T69307 arg1Of 48 h,after
R71752 T53535 T94566 arg1Of activity,CatB/L
R718 T725 T724 arg1Of while,CoV
R71875 T38342 T27996 arg1Of Rp3,[
R7189 T1832 T3238 arg1Of manner,dose-dependent
R719 T702 T726 arg1Of site,might
R71902 T91321 T21434 arg2Of help,possibility
R72 T79 T78 arg1Of anti-IL6,an
R720 T727 T726 arg2Of be,might
R72037 T13257 T83579 arg2Of site,possesses
R72062 T11181 T22059 arg1Of tendency,of
R721 T690 T726 modOf subunits,might
R72130 T68842 T82613 arg1Of Serum,from
R72167 T96672 T75647 arg1Of variety,of
R722 T702 T727 arg1Of site,be
R72223 T9113 T45554 arg1Of day,of
R7224 T7628 T18272 arg1Of strain,was
R72270 T94385 T31311 arg2Of 24 h,at
R723 T728 T727 arg2Of present,be
R72360 T51521 T67884 arg1Of ",",and
R724 T702 T728 arg1Of site,present
R72409 T17094 T86991 arg1Of NSP3,","
R72412 T72578 T65340 arg1Of and,Also
R72421 T6071 T23827 arg2Of 25,[
R72430 T76094 T56358 arg1Of decreases,gradually
R72431 T25132 T56803 arg1Of degree,(
R72465 T14525 T24485 arg1Of 1,)
R725 T728 T729 arg1Of present,in
R72524 T44216 T4378 arg1Of use,the
R72528 T41408 T98581 arg1Of coronavirus,the
R72554 T59345 T43431 arg2Of is,shown
R726 T731 T729 arg2Of species,in
R72618 T20769 T43055 arg1Of neutralize,efficiently
R72696 T83617 T75556 arg2Of IL6,against
R72699 T60390 T3411 arg1Of cells,lung
R727 T731 T730 arg1Of species,other
R7270 T35146 T19295 arg1Of receptor,surface
R72739 T91345 T3294 arg1Of Hypothesis,7.1
R72743 T18576 T87016 arg2Of differ,did
R72772 T59356 T71996 arg1Of signs,warning
R72776 T7184 T85187 arg1Of line,","
R72778 T22570 T86737 arg1Of characteristics,specific
R728 T727 T732 arg1Of be,[
R72806 T92755 T75238 arg1Of studies,shown
R72835 T87293 T66079 arg1Of suppression,of
R72853 T79511 T72667 arg2Of copper,and
R72877 T35438 T84846 arg1Of up-regulation,of
R72889 T90255 T44793 arg1Of coronavirus,cause
R7289 T77811 T49092 arg1Of and,","
R72891 T57549 T49538 arg1Of produce,","
R729 T733 T732 arg2Of 3,[
R72901 T65734 T6432 arg2Of vital,are
R72922 T88154 T68700 arg1Of and,of
R72924 T57657 T22774 arg2Of patients,recovered
R72933 T50601 T19300 arg1Of count,lymphocyte
R72949 T73739 T6758 arg2Of samples,of
R72983 T78367 T54453 arg1Of recommended,","
R73 T82 T80 arg1Of confer,","
R730 T734 T732 arg3Of ],[
R73040 T3323 T16328 arg1Of Serum,4.1.2
R73050 T59443 T5913 arg1Of down-regulation,","
R73057 T33017 T41693 arg1Of domain,the
R73092 T11646 T87218 arg1Of inhibition,the
R731 T760 T735 arg1Of take,After
R73101 T23558 T99497 arg2Of circumstances,under
R73123 T53426 T81080 arg1Of RNA,the
R73124 T78691 T87988 arg1Of %,100
R732 T737 T735 arg2Of introduction,After
R73215 T57345 T43362 arg1Of antibody,could
R73246 T32769 T7710 arg1Of occurred,However
R73275 T65661 T23999 arg2Of and,(
R73284 T43126 T72786 arg1Of Plasma,shown
R733 T737 T736 arg1Of introduction,the
R73328 T52934 T18957 arg2Of –,in
R73378 T13644 T66951 arg1Of substitution,in
R73394 T89396 T64464 arg2Of 24,[
R734 T737 T738 arg1Of introduction,of
R73412 T14011 T88629 arg2Of rabbits,from
R73426 T13966 T55969 arg1Of antibody,a
R73449 T13737 T47275 arg2Of inhibit,able
R73472 T93924 T49873 arg1Of H2L2,be
R735 T739 T738 arg2Of mutation,of
R73525 T29877 T32551 arg1Of effect,their
R73540 T45337 T47275 arg1Of and,able
R73544 T15927 T56483 arg1Of protease,least
R73596 T78772 T67333 arg1Of IFN,type
R736 T737 T740 arg1Of introduction,to
R737 T747 T740 arg2Of site,to
R73729 T65134 T94632 arg2Of plasma,of
R73746 T9969 T15939 arg1Of Hypothesis,:
R7377 T37156 T64844 arg1Of and,that
R73778 T46091 T84416 arg1Of length,greater
R738 T747 T741 arg1Of site,the
R73808 T21460 T72564 arg2Of death,and
R73815 T4246 T35641 arg2Of report,is
R73869 T20355 T50423 arg1Of entry,of
R73891 T21817 T14407 arg1Of exert,not
R739 T747 T742 arg1Of site,residue
R73905 T27554 T77993 arg1Of subunit,the
R73916 T25577 T56819 arg1Of protein,S
R73941 T35997 T26265 arg2Of investigated,has
R73965 T68140 T88888 arg1Of affinities,of
R7397 T12037 T52317 arg1Of IVIG,is
R73986 T86955 T72067 arg1Of risk,a
R74 T76 T81 arg1Of Tocilizumab,can
R740 T747 T743 arg1Of site,insertion
R741 T743 T744 arg1Of insertion,and
R74118 T3048 T6238 arg1Of patients,ten
R74139 T57345 T83927 arg1Of antibody,H2L2
R74181 T36033 T95916 arg2Of corticosteroids,of
R74189 T33265 T81647 arg2Of concentration,at
R742 T745 T744 arg2Of furin,and
R74216 T31126 T42839 arg2Of to,be
R7429 T54874 T84071 arg1Of cytokine,in
R74296 T53867 T73233 arg1Of escape,to
R74298 T44667 T68477 arg2Of inhibition,in
R743 T747 T745 arg1Of site,furin
R74345 T48569 T77212 arg1Of isolate,which
R74391 T52732 T42165 arg1Of rates,[
R744 T747 T746 arg1Of site,cleavage
R74424 T98598 T96881 arg1Of one,or
R74425 T31483 T43323 arg1Of ",",and
R74451 T40210 T87890 arg1Of strains,SL-CoV
R74499 T8160 T57534 arg2Of SARS-CoV,for
R745 T760 T748 arg1Of take,","
R74510 T26901 T85352 arg1Of recent,most
R74536 T87212 T17398 arg1Of us,trust
R74556 T68835 T12507 arg1Of contains,In
R74572 T95232 T3712 arg1Of IFN,type
R746 T751 T749 arg1Of cleavage,the
R74668 T83470 T34654 arg2Of SARS-2-S,and
R747 T751 T750 arg1Of cleavage,S1/S2
R74716 T48435 T19104 arg1Of protect,against
R7472 T24005 T44925 arg2Of prognosis,and
R74727 T54079 T29543 arg2Of and,in
R74735 T62479 T92667 arg2Of receptor,with
R74746 T64875 T96392 arg2Of patients,from
R74784 T68840 T67953 arg2Of attenuate,can
R748 T751 T752 arg1Of cleavage,of
R74845 T46489 T18580 arg2Of 94,and
R749 T756 T752 arg2Of S,of
R74916 T17100 T66245 arg1Of mice,transgenic
R74963 T79215 T85453 arg1Of patients,received
R74972 T13120 T76540 arg2Of SARS-CoV,neutralize
R74990 T39367 T58859 arg2Of therapy,or
R74996 T76626 T65875 arg1Of play,in
R75 T82 T81 arg2Of confer,can
R750 T756 T753 arg1Of S,the
R75080 T33217 T24128 arg1Of and,","
R751 T756 T754 arg1Of S,SARS-CoV
R75113 T18879 T13399 arg2Of inhibitors,than
R75140 T27008 T40921 arg2Of acted,why
R75166 T81456 T2463 arg2Of and,for
R75181 T30814 T11300 arg2Of decreased,","
R752 T756 T755 arg1Of S,2
R75209 T90339 T67748 arg2Of effects,associated
R753 T751 T757 arg1Of cleavage,did
R75326 T85453 T21073 arg1Of received,In
R754 T760 T757 arg2Of take,did
R75414 T64598 T68610 arg1Of range,belonging
R75498 T52981 T99958 arg1Of H1N1,influenza
R755 T760 T758 arg1Of take,not
R75502 T10263 T91733 arg2Of 10 g/d,(
R7552 T54792 T87735 arg1Of ciclesonide,three
R75542 T59987 T3889 arg1Of reduced,","
R75547 T35627 T29701 arg1Of 24,and
R75573 T49329 T94835 arg2Of outcomes,on
R756 T760 T759 arg1Of take,longer
R75655 T60984 T46693 arg1Of that,has
R7566 T65117 T88407 arg1Of study,included
R75667 T80710 T93212 arg1Of plasma,treat
R757 T751 T760 arg1Of cleavage,take
R75716 T54390 T7377 arg1Of 6.2,Targeting
R7573 T53426 T78293 arg1Of RNA,of
R75777 T51011 T23410 arg1Of ACE2,human
R75797 T95865 T31307 arg2Of able,is
R758 T761 T760 arg2Of place,take
R75826 T96963 T15301 arg1Of level,a
R75887 T32300 T62462 arg1Of not,while
R75892 T15927 T44730 arg1Of protease,mediate
R75895 T84414 T97501 arg1Of therapy,standard
R75896 T64776 T63353 arg2Of and,and
R759 T774 T762 arg1Of remained,However
R75916 T69842 T25429 arg2Of accelerate,might
R75925 T49089 T27399 arg1Of are,","
R75974 T59040 T81391 arg1Of was,","
R76 T76 T82 arg1Of Tocilizumab,confer
R760 T774 T763 arg1Of remained,","
R761 T768 T764 arg1Of entry,the
R76104 T41529 T48683 arg2Of patients,of
R76106 T56862 T82233 arg1Of similarity,of
R76164 T13644 T72966 arg1Of substitution,amino
R76165 T42902 T43993 arg2Of reason,is
R7618 T71973 T28149 arg1Of production,","
R76194 T42976 T32544 arg1Of methylprednisolone,(
R762 T768 T765 arg1Of entry,SARS-CoV
R76205 T72564 T52171 arg1Of and,the
R76207 T82578 T72594 arg1Of system,immune
R7624 T17705 T68317 arg1Of infections,recurrent
R76244 T48832 T88085 arg1Of diversity,This
R76248 T25388 T44741 arg1Of course,of
R76274 T66430 T64168 arg2Of 23,[
R76291 T45532 T13737 arg2Of replication,inhibit
R763 T768 T766 arg1Of entry,2
R76318 T58899 T11963 arg1Of outbreak,of
R76331 T68835 T96163 arg1Of contains,","
R76335 T84385 T88206 arg1Of reduce,","
R76339 T18576 T42838 arg1Of differ,not
R764 T768 T767 arg1Of entry,S
R76424 T53029 T21640 arg1Of outbreaks,viral
R76438 T42640 T11917 arg1Of subunit,of
R765 T768 T769 arg2Of entry,raised
R76504 T69785 T56133 arg1Of combination,yielded
R76507 T32652 T58197 arg1Of responses,that
R76529 T59818 T68994 arg2Of addition,In
R76550 T58130 T31522 arg1Of critical,and
R76562 T46042 T48696 arg1Of egg,of
R76565 T65232 T10653 arg2Of possible,as
R766 T769 T770 arg1Of raised,for
R76601 T5371 T65084 arg1Of Hypothesis,:
R76622 T36509 T95865 arg1Of Serum,able
R76627 T13682 T79896 arg2Of mortality,of
R76656 T27658 T89187 arg2Of Corticosteroids,used
R76662 T9673 T80157 arg2Of SARS-CoV2,and
R7667 T25878 T32221 arg1Of mAb,A
R76677 T27148 T16499 arg1Of levels,high
R76678 T41003 T45337 arg1Of ",",and
R767 T772 T770 arg2Of cells,for
R76701 T55480 T36559 arg2Of failure,developed
R76744 T80157 T38226 arg1Of and,bat
R76746 T43431 T94164 arg2Of shown,has
R76759 T36302 T2290 arg1Of fluticasone,on
R76769 T92225 T58130 arg1Of COVID-19,critical
R76774 T14674 T44722 arg2Of inflammation,modulate
R76775 T4016 T58020 arg1Of and,similar
R76777 T69842 T92811 arg1Of accelerate,that
R7678 T59345 T43613 arg1Of is,that
R76787 T25730 T63462 arg1Of degree,of
R76790 T82402 T47763 arg1Of site,","
R768 T772 T771 arg1Of cells,VeroE6
R76811 T26283 T43571 arg1Of known,as
R76838 T4182 T20828 arg1Of and,and
R76856 T47054 T58224 arg1Of administered,early
R76858 T64274 T49609 arg1Of IL6,pro-inflammatory
R76876 T61673 T37161 arg1Of signal,present
R76879 T93532 T76093 arg2Of virus,of
R769 T768 T773 arg1Of entry,and
R76986 T75548 T15500 arg1Of protein,that
R77 T83 T82 arg2Of benefit,confer
R770 T768 T774 arg1Of entry,remained
R77066 T23258 T6150 arg3Of ),(
R77067 T48832 T15359 arg1Of diversity,suffice
R771 T775 T774 arg2Of high,remained
R77190 T66576 T19164 arg1Of years,and
R77199 T20348 T98862 arg2Of outcome,improve
R772 T768 T775 arg1Of entry,high
R77219 T63733 T54619 arg1Of entry,that
R773 T775 T776 arg1Of high,in
R77316 T54016 T97739 arg3Of ],[
R77322 T87934 T33377 arg2Of and,in
R77326 T47242 T58714 arg1Of S,ZC45
R77337 T10634 T57537 arg2Of disorders,from
R77343 T48662 T36053 arg2Of moderate-dose,with
R77344 T73531 T83400 arg1Of cells,which
R77360 T38357 T89869 arg1Of and,both
R7737 T56920 T32531 arg1Of regions,immunoglobulin
R77390 T97339 T48698 arg1Of trials,no
R774 T778 T776 arg2Of cells,in
R77408 T50200 T31121 arg1Of inhibit,effectively
R7741 T44216 T95916 arg1Of use,of
R77420 T12131 T18383 arg2Of count,in
R7749 T78861 T21425 arg2Of plasma,of
R77496 T52375 T30106 arg1Of sample,","
R775 T778 T777 arg1Of cells,BHK
R77514 T47874 T96386 arg1Of affinity,that
R77534 T24185 T17221 arg2Of antibody,approved
R7755 T52934 T30016 arg1Of –,the
R7756 T32529 T5100 arg1Of inhibit,effectively
R77580 T9527 T63703 arg1Of saturation,oxygen
R77595 T48569 T18234 arg1Of isolate,","
R776 T778 T779 arg1Of cells,that
R77637 T12179 T10629 arg1Of IVIG,shown
R777 T778 T780 arg1Of cells,express
R77711 T28149 T88926 arg1Of ",",the
R77720 T31426 T45337 arg2Of lopinavir,and
R778 T782 T780 arg2Of ACE,express
R77806 T40665 T56747 arg1Of antibodies,that
R77868 T48841 T69082 arg1Of CoVs,as
R779 T782 T781 arg1Of ACE,human
R77915 T87404 T8130 arg1Of neutralize,to
R77927 T59832 T17398 arg2Of notions,trust
R77955 T56133 T27079 arg1Of yielded,","
R7798 T59480 T65875 arg2Of inhibition,in
R78 T82 T84 arg1Of confer,in
R780 T786 T783 arg1Of seems,Therefore
R78022 T66055 T55941 arg1Of condition,critical
R78024 T95707 T98181 arg2Of IL-4,","
R78087 T43356 T32769 arg1Of deaths,occurred
R781 T786 T784 arg1Of seems,","
R78116 T62169 T46333 arg2Of introduced,has
R78190 T47874 T77580 arg1Of affinity,for
R782 T785 T786 arg1Of it,seems
R78212 T25963 T44273 arg2Of corticosteroid,with
R78219 T80909 T44111 arg2Of and,by
R78223 T87394 T83285 modOf done,using
R78283 T73209 T7707 arg1Of corticosteroids,that
R783 T792 T786 arg2Of depend,seems
R78306 T53799 T10621 arg3Of ],[
R78333 T32842 T38357 arg1Of adults,and
R78348 T33947 T50903 arg2Of 33,[
R784 T792 T787 arg1Of depend,that
R78407 T74021 T40063 arg2Of and,of
R78424 T64673 T34896 arg2Of lesions,and
R78431 T96672 T61951 arg2Of variety,for
R78448 T35997 T92410 arg1Of investigated,recently
R78454 T12723 T40582 arg1Of proteins,of
R78491 T71403 T31126 arg1Of difference,to
R785 T789 T788 arg1Of transmissibility,SARS-CoV2
R78514 T44685 T31582 arg2Of IVIG,of
R78526 T78533 T51847 arg1Of role,a
R78533 T42834 T11331 arg2Of patients,in
R7854 T69934 T92030 arg1Of includes,attachment
R78542 T99923 T52808 arg2Of role,conveys
R78547 T67511 T37838 arg2Of binding,of
R78599 T64594 T41003 arg2Of mometasone,","
R786 T789 T790 arg1Of transmissibility,does
R7863 T9582 T17323 arg1Of virus,syncytial
R78642 T84664 T9387 arg1Of treatment,tocilizumab
R7867 T40781 T11032 arg3Of ],[
R787 T792 T790 arg2Of depend,does
R78762 T21495 T91380 arg1Of 2TMPRSS2,serine
R78785 T24756 T16801 arg1Of ",",and
R788 T792 T791 arg1Of depend,not
R78842 T98095 T78221 arg1Of chains,and
R78843 T41378 T26910 arg2Of COVID-19,from
R78893 T12982 T36003 arg2Of 2014,in
R78894 T72909 T77083 arg2Of case,in
R789 T789 T792 arg1Of transmissibility,depend
R7895 T65134 T56352 arg1Of plasma,convalescent
R78959 T50200 T83801 arg2Of inhibit,can
R78982 T92600 T25201 arg2Of entry,of
R78999 T5376 T58124 arg1Of Hypothesis,4.1.2.1
R79 T85 T84 arg2Of patients,in
R790 T792 T793 arg1Of depend,on
R79010 T55829 T74721 arg1Of turned,","
R79029 T31095 T40148 arg1Of count,lymphocyte
R791 T796 T793 arg2Of cleavage,on
R79137 T51592 T30801 arg1Of inflammation,vascular
R79151 T56884 T11559 arg1Of binding,of
R79160 T50860 T7846 arg1Of is,","
R792 T796 T794 arg1Of cleavage,the
R79215 T51290 T94095 arg2Of %,(
R79224 T58895 T27596 arg2Of outcomes,in
R79226 T15191 T24898 arg1Of revealed,to
R79228 T79215 T77821 arg1Of patients,21
R79231 T93033 T26781 arg2Of confer,could
R79272 T48431 T27422 arg1Of levels,immunoglobulin
R79286 T50002 T64051 arg1Of cells,Vero
R793 T796 T795 arg1Of cleavage,S1/S2
R79302 T57345 T48435 arg1Of antibody,protect
R794 T800 T797 arg1Of site,A
R79405 T2430 T76542 arg3Of entry,affected
R79425 T56445 T77065 arg2Of SARS,with
R7945 T50002 T36295 arg2Of cells,in
R79461 T72012 T55915 arg1Of supernatants,hybridoma
R795 T800 T798 arg1Of site,polybasic
R79509 T29624 T58244 arg1Of reaction,confirm
R79527 T74401 T35174 arg1Of mAb,A
R79540 T60445 T6426 arg2Of immunoglobulin,plus
R79576 T22917 T27854 arg1Of dose,the
R79578 T12834 T40616 arg3Of ),(
R79591 T68554 T68700 arg2Of birds,of
R796 T800 T799 arg1Of site,cleavage
R79602 T84704 T19426 arg1Of nucleocapsid,(
R79646 T33015 T18709 arg2Of samples,in
R79664 T84543 T33679 arg1Of but,at
R79687 T92225 T15777 arg2Of COVID-19,with
R797 T800 T801 arg1Of site,explains
R79700 T52785 T60726 arg1Of and,","
R79733 T18753 T61175 arg2Of are,show
R79737 T64515 T20072 arg2Of days,collected
R79769 T47496 T66659 arg1Of SARS-CoV,the
R79793 T51998 T26826 arg1Of are,Moreover
R79797 T37752 T91231 arg1Of fluid,contained
R798 T803 T801 arg2Of virus,explains
R79812 T21368 T74776 arg2Of SARS-CoV2,and
R79816 T96617 T96372 arg1Of antibody,SARS-CoV
R79824 T2467 T18121 arg2Of effective,and
R79844 T68837 T81658 arg1Of ",",","
R79868 T53057 T2720 arg1Of domain,S1
R79879 T87875 T28188 arg1Of It,been
R799 T803 T802 arg1Of virus,a
R79904 T33950 T76482 arg1Of have,as
R79916 T84664 T64021 arg2Of treatment,before
R79940 T99202 T45016 arg1Of appeared,","
R79941 T66286 T20973 arg2Of treatment,with
R8 T11 T9 arg2Of use,for
R80 T85 T86 arg1Of patients,with
R800 T803 T804 arg1Of virus,that
R80027 T86423 T10997 arg1Of infection,a
R80044 T2304 T45012 arg1Of antibodies,anti-viral
R80079 T66440 T94564 arg2Of domain,utilize
R801 T803 T805 arg1Of virus,is
R80156 T64776 T15071 arg1Of and,entry
R80184 T69933 T47796 arg2Of IgM,and
R80185 T26744 T6595 arg1Of currently,useful
R80186 T36613 T83510 arg2Of and,by
R80187 T82587 T48117 arg3Of ],[
R80199 T19375 T58982 arg1Of favorable,to
R802 T806 T805 arg2Of highly-pathogenic,is
R80207 T53777 T5709 arg1Of junctions,cleavage
R80214 T17766 T62943 arg1Of effect,the
R80215 T48287 T93212 arg2Of patients,treat
R8023 T21482 T53333 arg1Of S,protein
R80234 T68579 T93217 arg1Of IFN,type
R80254 T49688 T33217 arg2Of RaTG13,and
R803 T803 T806 arg1Of virus,highly-pathogenic
R80345 T27754 T14629 arg1Of receptor,i.e.
R80362 T81543 T52921 arg1Of hand,other
R80380 T52785 T79863 arg2Of and,(
R804 T806 T807 arg1Of highly-pathogenic,for
R80403 T78002 T54161 arg1Of entry,the
R80450 T8341 T18474 arg2Of 27,[
R80452 T85645 T76626 arg1Of IFNs,play
R80466 T43382 T38146 arg2Of replication,affect
R80485 T43126 T82790 arg1Of Plasma,has
R805 T808 T807 arg2Of humans,for
R80539 T92030 T73554 arg1Of attachment,of
R80549 T45806 T86672 arg1Of ciclesonide,was
R806 T801 T809 arg1Of explains,while
R80609 T65176 T33598 arg2Of NP,against
R80630 T4452 T74666 arg1Of proteins,polymerase
R80634 T53907 T70648 arg1Of sera,bat
R80643 T7184 T99239 arg1Of line,(
R80657 T76296 T28156 modOf shown,to
R80683 T4213 T87498 arg1Of immunized,with
R80686 T66576 T46590 arg1Of years,of
R807 T811 T809 arg2Of is,while
R80780 T66003 T89508 arg2Of peptide,known
R808 T810 T811 arg1Of it,is
R80801 T14361 T40275 arg2Of inhibit,","
R80817 T24131 T85613 arg1Of protein,has
R80841 T75548 T91232 arg1Of protein,Spike
R80889 T85498 T76542 arg2Of Antiserum,affected
R80891 T46450 T27748 arg1Of sequencing,of
R80894 T58622 T53652 arg2Of contrast,By
R80896 T81904 T11852 arg1Of plasma,alone
R809 T812 T811 arg2Of low-pathogenic,is
R80908 T32529 T57406 arg2Of inhibit,could
R80924 T85289 T43666 arg2Of COVID-19,from
R81 T88 T86 arg2Of and,with
R810 T810 T812 arg1Of it,low-pathogenic
R81037 T18576 T97295 arg1Of differ,","
R81041 T91091 T92830 arg1Of day,10th
R81045 T18048 T78293 arg2Of 2019-nCoV,of
R81075 T51998 T48884 arg1Of are,of
R811 T812 T813 arg1Of low-pathogenic,for
R81126 T83960 T68527 arg1Of pool,large
R81151 T68894 T32288 arg2Of that,than
R81194 T55941 T44653 arg2Of critical,or
R812 T815 T813 arg2Of species,for
R81217 T31829 T42165 arg3Of ],[
R81229 T76069 T84637 arg1Of antibodies,anti-viral
R81252 T43126 T98086 arg1Of Plasma,from
R81263 T42633 T33950 arg1Of and,have
R813 T815 T814 arg1Of species,other
R81304 T38357 T39207 arg2Of and,for
R81333 T28753 T88154 arg2Of eggshells,and
R81373 T81644 T22237 arg1Of presence,if
R814 T833 T816 arg1Of developed,For
R81402 T27055 T61320 arg1Of effect,was
R81415 T58682 T13646 arg1Of spike,(
R8147 T18064 T18237 arg2Of and,including
R81496 T50601 T52445 arg2Of count,","
R815 T817 T816 arg2Of example,For
R81506 T48569 T23533 arg2Of isolate,detect
R81516 T7157 T47566 arg1Of bat,an
R81517 T48498 T49668 arg1Of regions,interact
R81532 T46182 T39990 arg3Of ),(
R81579 T25577 T24060 arg1Of protein,the
R81582 T65117 T76496 arg1Of study,received
R816 T833 T818 arg1Of developed,","
R81607 T92600 T81647 arg1Of entry,at
R81621 T48924 T64490 arg1Of effect,absent
R81635 T29877 T26799 arg1Of effect,was
R817 T822 T819 arg2Of tools,using
R81725 T58218 T37085 arg1Of group,achieved
R81734 T47986 T23106 arg1Of %,80–98
R81743 T69880 T97012 arg1Of reaches,","
R81779 T9013 T48542 arg2Of 29,[
R81797 T97267 T51386 arg2Of RBD,and
R818 T833 T819 modOf developed,using
R81820 T17027 T57735 arg1Of 90,about
R8185 T96625 T18203 arg1Of Patients,showed
R81856 T13257 T30948 arg1Of site,polybasic
R81876 T1935 T31311 arg1Of present,at
R81898 T27396 T30144 arg1Of dictate,and
R819 T821 T820 arg1Of genetic,reverse
R81932 T52981 T85532 arg1Of H1N1,(
R81984 T97737 T81238 arg2Of protease,of
R81985 T1824 T31791 arg1Of absorbed,Also
R82 T87 T88 arg1Of COVID-19,and
R820 T822 T821 arg1Of tools,genetic
R82007 T74975 T1853 arg1Of response,to
R82049 T98167 T54348 arg2Of ciclesonide,to
R82064 T72909 T84121 arg1Of case,of
R82088 T18877 T18503 arg1Of receptor,[
R821 T833 T823 arg1Of developed,","
R82123 T67748 T22188 arg1Of associated,with
R82137 T64532 T16405 arg1Of play,in
R82140 T31699 T72940 arg1Of Rationale,4.2.2
R82170 T38106 T28810 arg2Of M,(
R82193 T77887 T55259 arg1Of fusion,of
R82198 T76927 T41253 arg1Of sequencing,RNA
R822 T827 T824 arg1Of type,an
R82228 T89464 T12529 arg1Of are,[
R82243 T58590 T68835 arg2Of concentrations,contains
R82268 T82570 T71924 arg1Of they,cause
R82274 T90573 T28156 arg1Of decrease,to
R82277 T48569 T37427 arg1Of isolate,was
R823 T827 T825 arg1Of type,avian
R82327 T69996 T88154 arg1Of eggs,and
R82331 T43975 T56176 arg2Of 14,[
R8236 T55893 T47180 arg1Of protein,the
R824 T827 T826 arg1Of type,paramyxovirus
R82408 T37738 T52727 arg1Of protein,nonstructural
R82420 T83832 T35613 arg1Of Hypotheses,4.1.4.1
R82422 T96617 T57549 arg2Of antibody,produce
R8244 T63070 T84268 arg2Of levels,for
R82456 T52934 T55882 arg1Of –,S
R82494 T68602 T35641 arg1Of There,is
R82498 T4187 T38504 arg1Of it,should
R825 T827 T828 arg1Of type,7
R82541 T39579 T72559 arg1Of decrease,in
R8259 T25467 T80157 arg1Of strain,and
R826 T827 T829 arg1Of type,(
R827 T830 T829 arg2Of APMV-7,(
R82740 T63081 T72667 arg1Of ACE2,and
R82759 T45337 T89636 arg1Of and,","
R828 T831 T829 arg3Of ),(
R82801 T76019 T25258 arg1Of former,The
R82814 T37666 T75647 arg2Of diseases,of
R82868 T86439 T26283 arg2Of Tocilizumab,known
R82882 T85645 T4789 arg1Of IFNs,I
R829 T827 T832 arg1Of type,was
R82903 T29701 T26971 arg1Of and,both
R82929 T73696 T25584 arg1Of replication,viral
R82941 T75851 T54040 arg2Of 80 mg/d,(
R82963 T90848 T52785 arg2Of infections,and
R82985 T80638 T76208 arg1Of treat,in
R82994 T61991 T65150 arg1Of study,the
R83 T90 T88 arg2Of IL6,and
R830 T833 T832 arg2Of developed,was
R83087 T37156 T35997 arg2Of and,investigated
R83092 T7184 T56471 arg1Of line,kidney
R83097 T35266 T74423 arg1Of cells,293 T
R831 T827 T833 arg2Of type,developed
R83120 T2182 T55819 arg1Of immunoglobulins,4.2
R83125 T86439 T21494 arg1Of Tocilizumab,","
R83132 T34284 T92495 arg1Of virus,epidemic
R83152 T89187 T38824 arg1Of used,for
R83183 T11868 T46614 arg3Of ),(
R832 T833 T834 arg1Of developed,by
R83211 T98716 T88373 arg2Of anti-inflammatory,and
R83234 T47460 T14621 arg1Of look,avoid
R83237 T95644 T19735 arg1Of target,of
R83256 T44793 T90050 arg2Of cause,can
R83284 T52803 T77477 arg2Of cells,of
R833 T835 T834 arg2Of mutating,by
R83353 T72578 T92623 arg1Of and,","
R8336 T82402 T7278 arg1Of site,similar
R83390 T51141 T88469 arg1Of score,H
R834 T843 T835 arg2Of site,mutating
R83427 T2901 T32352 arg2Of IRF-8,and
R83433 T67274 T25492 arg1Of replication,of
R8345 T37092 T20197 arg1Of patients,SARS
R83493 T94954 T26331 arg3Of ],[
R83498 T21161 T31651 arg1Of agent,of
R83499 T73993 T11032 arg2Of 16,[
R835 T843 T836 arg1Of site,the
R83525 T51011 T72017 arg2Of ACE2,against
R83532 T91725 T13491 arg1Of Tocilizumab,","
R83550 T49586 T50457 arg2Of utilize,notion
R83564 T51998 T36143 arg1Of are,","
R836 T843 T837 arg1Of site,fusion
R83600 T6987 T3019 arg2Of mesylate,by
R83662 T25730 T14481 arg2Of degree,to
R83692 T67274 T42645 arg1Of replication,the
R837 T843 T838 arg1Of site,(
R83702 T18888 T15359 arg2Of produce,suffice
R83757 T30604 T16718 arg1Of outcomes,patient
R8377 T76069 T75930 arg2Of antibodies,have
R83793 T13644 T10430 arg1Of substitution,acid
R838 T839 T838 arg2Of F,(
R83808 T55829 T20580 arg1Of turned,Following
R83809 T44925 T84071 arg2Of and,in
R839 T840 T838 arg3Of ),(
R83908 T72129 T75975 arg1Of ciclesonide,","
R83925 T48626 T96099 arg2Of 15,[
R83938 T83170 T37227 arg1Of Rationale,7.2
R83956 T13966 T87639 arg1Of antibody,against
R84 T90 T89 arg1Of IL6,high
R840 T843 T841 arg1Of site,protein
R84017 T58127 T80909 arg2Of SARS2-S,and
R84018 T59365 T48696 arg2Of quail,of
R84032 T35146 T47614 arg1Of receptor,of
R8404 T37245 T94688 arg1Of activity,such
R84051 T68140 T48175 arg1Of affinities,its
R84073 T96891 T67953 arg1Of Hypothesis,can
R84082 T68140 T71055 arg1Of affinities,","
R841 T843 T842 arg1Of site,cleavage
R84108 T77482 T6733 arg1Of SARS-CoV2,and
R84172 T75582 T89299 arg2Of COVID-19,whose
R842 T835 T844 arg1Of mutating,[
R84216 T21445 T38824 arg2Of modulation,for
R84230 T81589 T7888 arg2Of antibodies,compete
R84268 T50074 T49953 arg1Of activity,","
R84281 T80575 T5249 arg1Of It,is
R84283 T45225 T87498 arg2Of Rp3,with
R843 T845 T844 arg2Of 4,[
R84305 T84704 T76152 arg1Of nucleocapsid,the
R84332 T3706 T87509 arg1Of Rationale,:
R84362 T23533 T48337 arg2Of detect,could
R84379 T48841 T84276 arg2Of CoVs,of
R84386 T60580 T93490 arg1Of nucleocapsid,SARS-CoV
R844 T846 T844 arg3Of ],[
R845 T849 T847 arg1Of APMV-7,The
R84505 T51053 T28667 arg1Of Rp3,SARS-like
R84591 T70143 T49434 arg1Of examples,include
R846 T849 T848 arg2Of APMV-7,constructed
R84668 T77475 T46544 arg1Of Rhinolophus,genus
R84671 T32973 T83057 arg2Of help,could
R847 T849 T850 arg1Of APMV-7,showed
R84704 T40522 T60597 arg1Of decreases,then
R84710 T95958 T72578 arg1Of induced,and
R84750 T23533 T51658 arg1Of detect,","
R84751 T89053 T22041 arg1Of care,supportive
R84762 T26439 T83961 arg1Of trees,phylogenomic
R848 T852 T850 arg2Of cleavage,showed
R84803 T76844 T38511 arg1Of species,the
R84805 T7157 T64813 arg1Of bat,individual
R8489 T50781 T76662 arg1Of degree,some
R84898 T66548 T80239 arg1Of Sera,from
R849 T852 T851 arg1Of cleavage,furin
R84902 T12794 T91797 arg1Of capable,of
R84932 T53845 T7496 arg2Of measured,be
R84947 T91360 T61175 arg1Of Studies,show
R84997 T32448 T68064 arg1Of protease,transmembrane
R85 T94 T92 arg1Of coronavirus,The
R850 T850 T853 arg1Of showed,and
R85039 T31118 T87365 arg2Of similarity,of
R8504 T67208 T45168 arg1Of results,promising
R85056 T20769 T27081 arg1Of neutralize,to
R85080 T93066 T87690 arg1Of eggshell,and
R85093 T23094 T95632 arg2Of 5–7 days,for
R851 T854 T853 arg2Of increased,and
R85149 T66440 T64350 arg1Of domain,of
R85160 T69288 T56752 arg1Of viral,and
R85163 T73637 T99819 arg2Of S1B,i.e.
R8517 T59443 T42843 arg1Of down-regulation,","
R85170 T32448 T20678 arg2Of protease,and
R85183 T98539 T15021 arg1Of nor,adverse
R85187 T39196 T24571 arg1Of and,both
R852 T849 T854 arg1Of APMV-7,increased
R85206 T50450 T57480 arg2Of antibodies,of
R8521 T64598 T96367 arg1Of range,","
R85229 T76540 T35003 arg1Of neutralize,to
R85256 T8313 T50331 arg1Of domain,the
R85296 T44216 T95640 arg1Of use,can
R853 T856 T854 arg2Of and,increased
R85301 T93924 T85248 arg1Of H2L2,might
R85317 T66003 T86608 arg1Of peptide,enzyme
R85360 T91889 T33080 arg2Of species,in
R854 T855 T856 arg1Of replication,and
R85443 T49089 T63728 arg1Of are,ideally
R85448 T38357 T66576 arg1Of and,years
R85482 T78367 T58078 arg1Of recommended,as
R85485 T39579 T36613 arg2Of decrease,and
R855 T858 T856 arg2Of formation,and
R8551 T99869 T6180 arg1Of LDLR,and
R85515 T96381 T73262 arg2Of and,of
R85549 T50829 T53491 arg1Of Calu-3,and
R856 T858 T857 arg1Of formation,syncytium
R85602 T49873 T92338 arg1Of be,not
R8563 T68140 T91829 arg2Of affinities,in
R85642 T8038 T29310 arg1Of infections,Clostridium
R85646 T51393 T69102 arg2Of detection,revealed
R85690 T52866 T55573 arg1Of form,the
R857 T854 T859 arg1Of increased,in
R85705 T67288 T38598 arg1Of %,90
R85714 T22390 T18753 arg2Of able,are
R858 T861 T859 arg2Of cultures,in
R85800 T42893 T28737 arg1Of nucleotides,of
R85824 T57345 T34464 arg1Of antibody,chimeric
R859 T861 T860 arg1Of cultures,cell
R85915 T56231 T84364 arg2Of camostat,and
R85928 T43308 T34259 arg1Of related,","
R85967 T48841 T65227 arg1Of CoVs,SARS-like
R85975 T30344 T22390 arg1Of and,able
R85994 T83484 T2990 arg2Of methylprednisolone,without
R85999 T14991 T61320 arg2Of in,was
R86 T94 T93 arg1Of coronavirus,novel
R860 T871 T862 arg1Of exhibit,However
R86001 T40210 T87202 arg1Of strains,The
R86004 T72411 T46139 arg1Of Tocilizumab,can
R86011 T80270 T23573 arg1Of remedy,only
R86044 T43055 T92493 arg1Of efficiently,very
R861 T871 T863 arg1Of exhibit,","
R86134 T62479 T6335 arg1Of receptor,the
R86136 T12115 T23050 arg3Of ],[
R8614 T25890 T71050 arg2Of patients,from
R86142 T44793 T23368 arg1Of cause,in
R86147 T97737 T24041 arg1Of protease,main
R86154 T95952 T47685 arg1Of differences,The
R86157 T45506 T54757 arg1Of cells,human
R86184 T40259 T38116 arg1Of P,","
R86188 T2182 T56180 arg1Of immunoglobulins,Intravenous
R862 T864 T865 arg2Of chicken,exposed
R86212 T46803 T90119 arg1Of diseases,inflammatory
R86230 T65584 T43425 arg2Of development,of
R86253 T66440 T81034 arg1Of domain,same
R86274 T35011 T4369 arg1Of origin,an
R863 T865 T866 arg1Of exposed,to
R86356 T80684 T88404 arg1Of recovery,from
R86364 T73202 T98970 arg1Of latter,The
R86398 T48924 T1935 arg1Of effect,present
R864 T868 T866 arg2Of virus,to
R86414 T39982 T79640 arg2Of immunization,of
R865 T868 T867 arg1Of virus,the
R86526 T21718 T31198 arg1Of study,included
R86586 T45316 T32427 arg1Of protein,spike
R866 T864 T869 arg1Of chicken,did
R86622 T28508 T7764 arg2Of enter,can
R867 T871 T869 arg2Of exhibit,did
R86711 T39196 T80967 arg2Of and,for
R868 T871 T870 arg1Of exhibit,not
R86835 T71073 T87627 arg2Of conditions,of
R869 T864 T871 arg1Of chicken,exhibit
R86911 T54246 T44838 arg1Of show,consistently
R86934 T18121 T39207 arg1Of and,for
R86954 T15154 T15378 arg1Of consists,of
R86976 T65635 T52147 arg2Of and,of
R87 T94 T95 arg1Of coronavirus,","
R870 T872 T871 arg2Of infection,exhibit
R87076 T9965 T85154 arg1Of well,as
R871 T874 T873 arg1Of Glycosylation,3.1.2
R87106 T23141 T45488 arg1Of differences,in
R87111 T72538 T63462 arg2Of difference,of
R8712 T96732 T5759 arg2Of received,and
R87137 T73561 T58135 arg2Of patients,of
R87180 T13257 T88376 arg1Of site,cleavage
R87187 T3462 T4397 arg2Of COVID-19,correlated
R872 T875 T876 arg1Of Glycosylation,and
R87204 T74893 T1912 arg1Of pathway,the
R87206 T28611 T66778 arg1Of Serum,from
R87209 T88382 T71117 arg1Of strain,Rp3
R87244 T73113 T50380 modOf offers,to
R87251 T62157 T53624 arg1Of VSV-G,and
R8726 T98139 T85324 arg1Of repertoires,that
R87268 T56920 T19776 arg1Of regions,origin
R87272 T42812 T96337 arg1Of cysteine,proteases
R873 T882 T876 arg2Of ",",and
R8733 T8195 T90980 arg1Of imaging,detected
R87330 T83272 T15921 arg1Of polyprotein,the
R87348 T89317 T28925 arg1Of combined,with
R874 T882 T877 arg1Of ",",its
R87454 T29624 T31150 arg1Of reaction,Polymerase
R87462 T63285 T13828 arg2Of died,and
R87480 T96424 T23241 arg1Of serum,rabbit
R87485 T46803 T31666 arg1Of diseases,autoimmune
R875 T879 T878 arg1Of products,related
R87525 T55924 T43316 arg1Of proteases,main
R87538 T85855 T53845 arg2Of use,measured
R87567 T32517 T97000 arg2Of SARS-2-S.,of
R876 T879 T880 arg1Of products,","
R87600 T22966 T13365 arg2Of regions,contains
R8765 T51925 T82079 arg3Of ],[
R87653 T28611 T69045 arg1Of Serum,is
R87665 T25454 T2467 arg1Of It,effective
R877 T879 T881 arg1Of products,i.e.
R8771 T34731 T82008 arg1Of strain,human
R87714 T25132 T89215 arg2Of degree,","
R87740 T17626 T48238 arg2Of 2019-nCoV,of
R87747 T84428 T49191 arg3Of combat,help
R87768 T39927 T35947 arg1Of sequence,nucleotide
R878 T879 T882 arg1Of products,","
R87834 T22143 T4169 arg1Of protects,and
R879 T883 T882 arg2Of glycans,","
R87904 T11646 T56133 arg2Of inhibition,yielded
R87937 T21027 T27410 arg1Of decoration,of
R87952 T39551 T74931 arg1Of identical,at
R87967 T52866 T8605 arg1Of form,of
R87983 T35671 T54239 arg2Of neutralize,can
R87985 T83960 T57480 arg1Of pool,of
R88 T96 T95 arg2Of SARS-CoV2,","
R880 T885 T884 arg1Of introduce,","
R8803 T33017 T6643 arg1Of domain,between
R88041 T14538 T36374 arg1Of similarity,the
R88065 T64204 T24570 arg1Of domain,a
R88068 T57194 T72802 arg2Of SARS-CoV2,neutralize
R88085 T92915 T42084 arg1Of MERS-CoV,the
R88091 T40034 T41819 arg1Of was,","
R881 T876 T885 arg1Of and,introduce
R88130 T96902 T22680 arg1Of existed,In
R882 T886 T885 arg2Of changes,introduce
R88200 T75386 T85073 arg1Of require,partially
R8823 T47054 T35724 arg2Of administered,should
R88239 T52981 T56433 arg2Of H1N1,of
R88261 T96963 T84688 arg1Of level,IL6
R88271 T43382 T16861 arg1Of replication,of
R88299 T63070 T30755 arg1Of levels,CRP
R883 T886 T887 arg1Of changes,to
R88306 T86532 T5313 arg1Of High-content,exists
R8839 T87394 T37380 arg2Of done,can
R884 T890 T887 arg2Of envelope,to
R88402 T68497 T72593 arg2Of explain,can
R88405 T39598 T97712 arg1Of defense,against
R88441 T12794 T86672 arg2Of capable,was
R88451 T8033 T6150 arg1Of frames,(
R88472 T7628 T93675 arg1Of strain,Tor2
R88474 T52732 T87135 arg1Of rates,high
R885 T890 T888 arg1Of envelope,the
R88503 T36198 T90499 arg2Of flares,treat
R88560 T77445 T34654 arg1Of SARS-S,and
R88561 T64424 T25851 arg1Of %,more
R88593 T16617 T8496 arg2Of recovery,accelerate
R886 T890 T889 arg1Of envelope,viral
R88677 T81264 T51845 arg1Of Rationale,4.1.1.2
R887 T886 T891 arg1Of changes,that
R8876 T37814 T87676 arg1Of develop,during
R88768 T35357 T16756 arg1Of groups,receiving
R88773 T89944 T18675 arg2Of reduce,could
R8879 T62139 T13409 arg1Of receptor,surface
R888 T886 T892 arg1Of changes,make
R8881 T18322 T55812 arg2Of patients,in
R88823 T47586 T31692 arg1Of rise,from
R88827 T90255 T89640 arg1Of coronavirus,novel
R88840 T92412 T64120 arg2Of replication,of
R88878 T86532 T37905 arg1Of High-content,of
R88883 T34590 T14525 arg1Of and,1
R889 T894 T892 arg2Of virus,make
R88924 T32352 T84846 arg2Of and,of
R88979 T47738 T87902 arg1Of plasma,[
R89 T99 T97 arg1Of cause,","
R890 T894 T893 arg1Of virus,the
R89002 T18753 T3464 arg1Of are,that
R89041 T25569 T52262 arg1Of infections,viral
R89048 T54783 T45640 arg1Of levels,of
R89055 T98181 T51521 arg1Of ",",","
R89076 T88455 T77671 arg1Of IL6,","
R89083 T18753 T56305 arg1Of are,both
R89087 T13014 T14256 arg1Of protein,S
R891 T894 T895 arg2Of virus,fitted
R89109 T24477 T82613 arg2Of rabbits,from
R89140 T4169 T15590 arg1Of and,","
R8917 T40665 T35671 arg1Of antibodies,neutralize
R89182 T25963 T54040 arg1Of corticosteroid,(
R892 T895 T896 arg1Of fitted,for
R8921 T89782 T72082 arg2Of serum,than
R89241 T27842 T23786 arg1Of COVID-19,moderate
R89244 T84845 T63353 arg1Of structure,and
R89296 T14229 T89468 arg1Of serum,from
R893 T897 T896 arg2Of interaction,for
R8931 T92103 T32040 arg2Of particular,In
R89343 T15241 T19426 arg2Of N,(
R8936 T97074 T68802 arg1Of IRW,can
R89371 T33761 T47763 arg2Of spectrum,","
R89374 T75308 T98992 arg1Of so,that
R8938 T72452 T96177 arg2Of 24–48 h,In
R89388 T18879 T95334 arg1Of inhibitors,protease
R894 T897 T898 arg1Of interaction,with
R89421 T78002 T48418 arg1Of entry,of
R89495 T25315 T40001 arg1Of coronavirus,that
R895 T902 T898 arg2Of membrane,with
R89519 T69934 T8581 arg1Of includes,:
R89530 T34533 T57537 arg1Of ranging,from
R89583 T90021 T49803 arg1Of and,","
R896 T902 T899 arg1Of membrane,the
R89636 T55250 T72973 arg2Of cells,inoculated
R89642 T35671 T76245 arg1Of neutralize,[
R89644 T63688 T88373 arg1Of anti-oxidant,and
R89670 T90339 T84923 arg1Of effects,side
R89677 T75392 T78684 arg2Of COVID-19,with
R897 T902 T900 arg1Of membrane,host
R89732 T3036 T10896 arg2Of diagnosed,when
R89736 T47496 T66697 arg2Of SARS-CoV,for
R89760 T28678 T12529 arg3Of ],[
R898 T902 T901 arg1Of membrane,cell
R89839 T27198 T76904 arg2Of 19,[
R89880 T89464 T60658 arg2Of are,and
R89881 T85855 T69355 arg1Of use,of
R89899 T68912 T98192 arg1Of Tocilizumab,plus
R899 T902 T903 arg1Of membrane,[
R8993 T65701 T23484 arg1Of counts,platelet
R89938 T91104 T97128 arg2Of SARS-2-S,and
R89954 T67288 T60055 arg2Of %,in
R89986 T38563 T60810 arg2Of patients,among
R9 T11 T10 arg1Of use,the
R90 T94 T98 arg1Of coronavirus,can
R900 T904 T903 arg2Of 5,[
R90018 T94116 T9665 arg2Of ACE2,","
R90019 T71443 T93206 arg1Of COVID-19,severe
R9002 T3706 T41884 arg1Of Rationale,6.2.2
R90023 T59443 T68303 arg1Of down-regulation,e.g.
R90026 T82280 T32660 arg1Of elements,Essential
R90058 T7628 T81326 arg2Of strain,isolated
R9006 T3461 T49107 arg1Of entry,the
R90071 T21161 T53102 arg1Of agent,causative
R901 T905 T903 arg3Of ],[
R90100 T55250 T7566 arg2Of cells,in
R90123 T31208 T94005 arg2Of and,possess
R90147 T20323 T76343 arg1Of and,shed
R9016 T68740 T23846 arg2Of plasma,of
R90193 T28168 T39838 arg2Of and,decrease
R902 T909 T906 arg1Of are,Generally
R90200 T82196 T91861 arg1Of resistance,of
R90208 T62139 T93734 arg1Of receptor,a
R90227 T80157 T68744 arg1Of and,Rp3
R90242 T98862 T22631 arg2Of improve,help
R90293 T64204 T40189 arg1Of domain,on
R903 T909 T907 arg1Of are,","
R90351 T5476 T19383 arg1Of Corticosteroids,can
R90367 T73561 T95602 arg1Of patients,26
R904 T908 T909 arg1Of glycans,are
R90411 T56686 T39710 arg1Of differ,","
R90414 T11435 T58860 arg1Of treatments,for
R90433 T51732 T53501 arg1Of viruses,negative-strand
R90434 T24131 T72545 arg1Of protein,S
R90438 T75820 T4213 arg2Of bats,immunized
R90450 T10130 T31388 arg1Of opacity,was
R9046 T68174 T45935 arg2Of ±,(
R9047 T87029 T85323 arg1Of essential,for
R90482 T88114 T14365 arg1Of injury,lung
R90486 T87601 T76648 arg1Of patients,SARS
R90497 T95644 T75263 arg1Of target,the
R905 T910 T909 arg2Of oligosaccharides,are
R90538 T46803 T80969 arg1Of diseases,severe
R906 T910 T911 arg2Of oligosaccharides,linked
R90604 T73531 T47272 arg2Of cells,in
R90654 T66055 T3490 arg1Of condition,severe
R90661 T16685 T92910 arg1Of parameters,","
R90666 T59893 T97712 arg2Of virus,against
R90684 T14786 T84385 arg1Of IRW,reduce
R90696 T43356 T19219 arg1Of deaths,two
R907 T911 T912 arg1Of linked,to
R90719 T21885 T2868 arg1Of different,from
R90752 T20678 T96337 arg2Of and,proteases
R90774 T35808 T34900 arg1Of saturation,and
R90780 T97492 T50200 arg2Of replication,inhibit
R908 T915 T912 arg2Of decoration,to
R90818 T13593 T91797 arg2Of inhibiting,of
R90827 T48153 T29701 arg2Of 48 h,and
R909 T915 T913 arg1Of decoration,the
R90910 T1824 T31152 arg1Of absorbed,","
R90913 T70918 T68614 arg1Of similar,for
R9092 T82570 T33328 arg1Of they,do
R90985 T70941 T35988 arg2Of limit,increasing
R90990 T98139 T24138 arg1Of repertoires,antibody
R91 T99 T98 arg2Of cause,can
R910 T915 T914 arg1Of decoration,dense
R91008 T34963 T62199 arg3Of ],[
R91010 T18877 T48321 arg2Of receptor,to
R91021 T93924 T42126 arg1Of H2L2,47D11
R91035 T77150 T24898 arg2Of us,to
R91050 T71924 T30144 arg2Of cause,and
R9107 T86756 T47798 arg3Of ],[
R91084 T67288 T48683 arg1Of %,of
R911 T915 T916 arg1Of decoration,of
R91106 T90255 T90050 arg1Of coronavirus,can
R91107 T91348 T92790 arg1Of deficiencies,antibody
R91116 T20072 T88119 arg1Of collected,after
R91140 T51386 T48238 arg1Of and,of
R91161 T65675 T72009 arg1Of and,the
R91166 T57345 T13041 arg1Of antibody,47D11
R91188 T78002 T10956 arg2Of entry,hinder
R91193 T1931 T19375 arg1Of branches,favorable
R912 T919 T916 arg2Of glycoprotein,of
R91222 T29681 T5158 arg1Of drugs,corticosteroid
R91228 T96625 T31917 arg1Of Patients,had
R91259 T33950 T81648 arg3Of have,that
R91296 T39927 T7432 arg1Of sequence,of
R913 T919 T917 arg1Of glycoprotein,the
R91325 T42849 T63285 arg1Of situation,died
R914 T919 T918 arg1Of glycoprotein,spike
R91436 T12582 T28781 arg2Of influenza,and
R9144 T30344 T18753 arg1Of and,are
R91466 T21495 T6092 arg2Of 2TMPRSS2,","
R91476 T82716 T5151 arg1Of Development,of
R915 T926 T920 arg1Of shown,In
R91506 T78221 T55347 arg2Of and,express
R91543 T20594 T82079 arg1Of study,[
R9155 T33856 T37831 arg1Of origin,of
R91588 T27914 T4169 arg2Of administered,and
R916 T921 T920 arg2Of particular,In
R91610 T10485 T64338 arg2Of 2TMPRSS2,lacking
R9162 T91725 T26781 arg1Of Tocilizumab,could
R91675 T54799 T98989 arg2Of cells,on
R917 T926 T922 arg1Of shown,","
R91702 T59040 T88073 modOf was,indicating
R91747 T12601 T76540 arg1Of serum,neutralize
R91756 T86439 T58761 arg1Of Tocilizumab,is
R91771 T50007 T40843 arg2Of domain,in
R91773 T25878 T8625 arg1Of mAb,against
R91783 T45981 T33217 arg1Of ",",and
R918 T924 T923 arg1Of oligosaccharides,these
R91823 T49143 T94597 arg2Of SARS-CoV2,For
R91830 T42028 T76094 arg1Of RNA,decreases
R91845 T48684 T37814 arg1Of patients,develop
R91863 T14942 T71564 arg2Of bat,and
R91887 T67108 T75684 arg1Of pathogenicity,the
R9189 T61880 T96449 arg1Of results,promising
R919 T924 T925 arg1Of oligosaccharides,have
R91907 T45789 T11971 arg2Of they,used
R91937 T42602 T38146 arg1Of virus,affect
R92 T94 T99 arg1Of coronavirus,cause
R920 T926 T925 arg2Of shown,have
R92060 T6163 T27596 arg1Of improved,in
R921 T924 T926 arg1Of oligosaccharides,shown
R92110 T4397 T53541 arg1Of correlated,with
R92120 T63816 T44925 arg1Of ",",and
R92122 T81575 T72053 arg1Of markers,inflammatory
R92127 T62157 T44853 arg1Of VSV-G,primary
R92175 T15404 T46590 arg2Of age,of
R92187 T98401 T30544 arg2Of rats,in
R92198 T72411 T80638 arg1Of Tocilizumab,treat
R922 T928 T927 arg1Of influence,to
R92204 T45337 T13737 arg1Of and,inhibit
R92213 T9970 T32030 arg1Of domain,the
R9222 T50457 T82487 arg1Of notion,which
R92245 T2670 T46614 arg2Of P,(
R92270 T96891 T42975 arg1Of Hypothesis,6.2.1
R9228 T94051 T69218 arg2Of MERS-CoV,mutated
R92294 T56920 T28318 arg1Of regions,rat
R923 T926 T927 modOf shown,to
R92327 T2565 T61995 arg1Of e,to
R92357 T42278 T77065 arg1Of patient,with
R92376 T69785 T12695 arg1Of combination,A
R92393 T35808 T83697 arg1Of saturation,peripheral
R924 T930 T928 arg2Of folding,influence
R92400 T65972 T73609 arg1Of Serum,from
R92430 T24633 T45480 arg1Of It,is
R92448 T66488 T20769 arg2Of SARS-CoV2,neutralize
R92489 T40115 T69355 arg2Of Tocilizumab,of
R925 T930 T929 arg1Of folding,the
R92508 T73098 T54079 arg2Of RBD,and
R92565 T99390 T30323 arg1Of ",",","
R92577 T3471 T11859 arg1Of ratio,and
R92578 T58224 T10653 arg1Of early,as
R92582 T32448 T62149 arg1Of protease,the
R92599 T50457 T87111 arg1Of notion,the
R926 T930 T931 arg1Of folding,of
R92607 T52934 T98573 arg1Of –,gene
R92610 T24185 T43255 arg1Of antibody,as
R92669 T12179 T44219 arg1Of IVIG,has
R92697 T45429 T19735 arg2Of ciclesonide,of
R927 T935 T931 arg2Of and,of
R92709 T54178 T24944 arg1Of proteins,the
R92720 T36466 T61983 arg1Of patients,with
R92728 T38362 T39715 arg1Of interacting,with
R92749 T99631 T68393 arg1Of pseudotypes,SARS-S
R92776 T82506 T81238 arg1Of share,of
R928 T935 T932 arg1Of and,the
R92859 T29751 T24756 arg2Of influenza,","
R92880 T82598 T7474 arg2Of peak,reaches
R92888 T53777 T18098 arg1Of junctions,the
R929 T934 T933 arg1Of protein,S
R92901 T62139 T99372 arg1Of receptor,","
R92905 T31198 T13700 arg1Of included,","
R92907 T94817 T83097 arg2Of terms,in
R93 T103 T99 arg2Of disease,cause
R930 T934 T935 arg1Of protein,and
R93053 T53710 T49362 arg2Of pathway,through
R93097 T16845 T31417 arg1Of sequence,the
R931 T937 T935 arg2Of process,and
R93142 T45405 T22231 arg2Of 32,[
R93157 T2430 T98023 arg1Of entry,of
R93190 T51732 T24756 arg1Of viruses,","
R932 T937 T936 arg1Of process,proteolytic
R9329 T7566 T98702 arg1Of in,not
R93295 T6735 T32751 arg1Of It,poses
R933 T928 T938 arg1Of influence,so
R93335 T97737 T35396 arg1Of protease,","
R93364 T78989 T87394 arg2Of immunization,done
R93366 T72012 T47163 arg1Of supernatants,containing
R93374 T51998 T18117 arg1Of are,","
R934 T941 T938 arg2Of facilitate,so
R93413 T75348 T50691 arg2Of corticosteroids,of
R93465 T79617 T7377 arg2Of cytokines,Targeting
R9347 T3036 T20464 arg2Of diagnosed,is
R93481 T11805 T86158 arg1Of Plasma,from
R935 T938 T939 arg1Of so,that
R93501 T42640 T15332 arg1Of subunit,S1
R936 T940 T941 arg1Of they,facilitate
R9363 T85498 T21969 arg1Of Antiserum,could
R93633 T75829 T89124 arg2Of subunit,for
R9364 T77430 T84428 arg1Of system,combat
R937 T945 T941 arg2Of entry,facilitate
R93722 T27053 T18623 arg2Of PON,(
R93727 T36219 T76343 arg2Of light,shed
R93749 T74634 T13216 arg2Of interact,can
R93750 T27754 T64684 arg1Of receptor,primary
R93763 T76496 T41758 arg2Of received,","
R93772 T82570 T43608 arg1Of they,might
R9378 T4452 T94659 arg2Of proteins,of
R938 T945 T942 arg1Of entry,the
R93865 T79787 T87895 arg3Of ],[
R93882 T89603 T54149 arg1Of coordination,and
R93896 T37752 T9092 arg1Of fluid,of
R93897 T41765 T77261 arg1Of mesylate,camostat
R939 T945 T943 arg1Of entry,virus
R93906 T4681 T76904 arg1Of associated,[
R93910 T89696 T16405 arg2Of immunity,in
R93919 T24144 T72744 arg1Of differences,functional
R93944 T78367 T33042 arg1Of recommended,for
R93961 T42652 T81934 arg1Of treatment,IFN
R93975 T54799 T1718 arg1Of cells,human
R93978 T37602 T8787 arg1Of needed,However
R9398 T8983 T8936 arg1Of virus,the
R94 T103 T100 arg1Of disease,a
R940 T945 T944 arg1Of entry,cell
R94081 T24171 T61619 arg2Of stability,and
R94093 T73739 T88720 arg1Of samples,serum
R94096 T47460 T73113 arg1Of look,offers
R941 T954 T946 arg1Of gains,Moreover
R94118 T37738 T62094 arg1Of protein,a
R94130 T46042 T87690 arg2Of egg,and
R94172 T93033 T22072 arg1Of confer,","
R94197 T8038 T10219 arg1Of infections,","
R942 T954 T947 arg1Of gains,","
R94218 T7734 T52544 arg2Of dexamethasone,","
R94229 T22569 T5913 arg2Of and,","
R94232 T4187 T27914 arg2Of it,administered
R94262 T68003 T26765 arg2Of trials,are
R94278 T63832 T98869 arg1Of caution,is
R943 T949 T948 arg1Of virus,a
R94308 T61440 T93981 arg1Of COVID-19,severe
R94310 T53845 T58078 arg2Of measured,as
R94349 T29877 T71857 arg1Of effect,noticeable
R9435 T36310 T28417 arg2Of infection,inhibit
R94363 T51053 T99794 arg1Of Rp3,name
R94369 T75581 T81944 arg2Of 100 pg/ml,than
R94383 T91513 T81529 arg1Of Studies,show
R94399 T25569 T84428 arg2Of infections,combat
R944 T949 T950 arg1Of virus,with
R94411 T31383 T27396 arg2Of actions,dictate
R94493 T42849 T36559 arg1Of situation,developed
R945 T953 T950 arg2Of glycoprotein,with
R94505 T48129 T91321 arg1Of therapy,help
R94510 T19520 T59896 arg1Of structure,the
R9452 T14361 T48542 arg1Of inhibit,[
R94533 T72563 T65069 arg1Of heavy,and
R94556 T92661 T68840 arg2Of inflammation,attenuate
R94582 T32352 T32702 arg1Of and,","
R94590 T82506 T61038 arg1Of share,","
R946 T953 T951 arg1Of glycoprotein,the
R94604 T6188 T80510 arg1Of antibodies,against
R94657 T35357 T15563 arg1Of groups,no
R94676 T98139 T66535 arg1Of repertoires,from
R947 T953 T952 arg2Of glycoprotein,glycosylated
R94705 T27914 T38504 arg2Of administered,should
R94736 T98647 T39699 arg1Of disease,","
R94776 T27008 T78461 arg1Of acted,efficiently
R94792 T91348 T18270 arg1Of deficiencies,primary
R948 T949 T954 arg1Of virus,gains
R94809 T71857 T13399 arg1Of noticeable,than
R9487 T68271 T33679 arg2Of 48 h,at
R949 T957 T954 arg2Of feature,gains
R94930 T51393 T49412 arg1Of detection,of
R94945 T33129 T59040 arg1Of there,was
R94949 T7774 T83835 arg2Of improve,might
R94996 T20271 T87639 arg2Of IL6,against
R95 T102 T101 arg1Of fatal,potentially
R950 T957 T955 arg1Of feature,an
R95003 T7184 T41284 arg1Of line,the
R9501 T80157 T6643 arg2Of and,between
R95020 T24277 T1902 arg2Of S2,and
R951 T957 T956 arg1Of feature,extra
R95106 T19573 T23972 arg1Of study,[
R95128 T98710 T52661 arg1Of patients,with
R95143 T43374 T68174 arg1Of 4.67,±
R952 T957 T958 arg1Of feature,for
R95215 T35011 T95969 arg1Of origin,idiopathic
R95276 T43382 T72944 arg1Of replication,the
R953 T960 T958 arg2Of escape,for
R95339 T96728 T23972 arg3Of ],[
R95354 T12723 T45488 arg2Of proteins,in
R954 T960 T959 arg1Of escape,an
R95414 T92755 T83388 arg1Of studies,have
R95470 T83078 T11331 arg1Of treatment,in
R95481 T16887 T82773 arg1Of GRP78,cell-surface
R95496 T75851 T15835 arg1Of 80 mg/d,methylprednisolone
R955 T960 T961 arg1Of escape,from
R95545 T25132 T68838 arg1Of degree,a
R95558 T44793 T88854 arg1Of cause,","
R95568 T18333 T86725 arg1Of cells,lung
R956 T964 T961 arg2Of responses,from
R95610 T81644 T94659 arg1Of presence,of
R95633 T21482 T15154 arg1Of S,consists
R9566 T63406 T85433 arg3Of ],[
R9567 T81264 T56248 arg1Of Rationale,:
R95673 T14835 T99835 arg1Of infection,B19
R95689 T50450 T98962 arg1Of antibodies,human
R957 T964 T962 arg1Of responses,the
R95761 T78742 T89272 arg1Of degree,","
R95770 T33446 T87886 arg1Of patients,with
R958 T964 T963 arg1Of responses,immune
R95893 T71641 T55072 arg1Of protein,their
R959 T968 T965 arg1Of are,Therefore
R95901 T15429 T21714 arg1Of inhibition,significant
R95905 T90339 T82688 arg1Of effects,serious
R95907 T52375 T93555 arg1Of sample,bat
R95922 T4240 T36613 arg1Of increase,and
R95994 T42133 T76932 arg1Of outbreak,SARS-CoV
R96 T103 T102 arg1Of disease,fatal
R960 T968 T966 arg1Of are,","
R96008 T29960 T3036 arg2Of patient,diagnosed
R96060 T8496 T17782 arg2Of accelerate,help
R96077 T55876 T50453 arg2Of day,by
R96084 T83170 T22490 arg1Of Rationale,:
R96087 T79253 T84174 arg2Of hand,on
R96088 T96963 T6930 arg1Of level,of
R96095 T10571 T28781 arg1Of SARS-CoV,and
R961 T967 T968 arg1Of glycans,are
R96158 T42028 T31986 arg1Of RNA,the
R962 T971 T968 arg2Of target,are
R96220 T26439 T82603 arg2Of trees,in
R96241 T64812 T62828 arg1Of use,the
R96279 T34284 T70659 arg1Of virus,Ebola
R963 T971 T969 arg1Of target,a
R96321 T48435 T96346 arg2Of protect,and
R9633 T55893 T62529 arg2Of protein,with
R96381 T98211 T68640 arg2Of processing,in
R964 T971 T970 arg1Of target,good
R9640 T82201 T28168 arg2Of regulation,and
R96417 T68579 T64716 arg1Of IFN,I
R96435 T9169 T52339 arg1Of severity,","
R96440 T47586 T3983 arg1Of rise,so
R96444 T42144 T13645 arg1Of responses,anti-viral
R96446 T11971 T41748 arg1Of used,","
R96452 T7869 T80909 arg1Of SARS-S,and
R965 T971 T972 arg1Of target,for
R96502 T40210 T16130 arg1Of strains,human
R96557 T71924 T43608 arg2Of cause,might
R96558 T36459 T91735 arg1Of cleavage,proteolytic
R966 T974 T972 arg2Of design,for
R9661 T98815 T56952 arg2Of COVID-19,with
R967 T974 T973 arg1Of design,vaccine
R96735 T40210 T99566 arg1Of strains,remain
R96775 T89813 T95236 arg1Of SARS-S,could
R968 T977 T975 arg1Of types,Two
R96809 T21817 T21857 arg1Of exert,","
R96826 T42097 T36053 arg1Of combined,with
R96832 T33265 T93940 arg1Of concentration,the
R96842 T53845 T75237 arg2Of measured,can
R96844 T28601 T72671 arg1Of entry,SARS-S
R96845 T80013 T67874 arg2Of that,and
R96846 T15987 T81658 arg2Of arteritis,","
R969 T977 T976 arg1Of types,main
R96928 T11971 T91069 arg2Of used,can
R96954 T36466 T33042 arg2Of patients,for
R96957 T26688 T91618 arg1Of methylprednisolone,plus
R96985 T77130 T92988 arg2Of difference,of
R97 T103 T104 arg1Of disease,","
R970 T977 T978 arg1Of types,of
R9700 T7654 T34096 arg1Of plasma,4.1.1
R9702 T27754 T9665 arg1Of receptor,","
R97056 T21027 T60584 arg1Of decoration,the
R97074 T43323 T13349 arg1Of and,","
R97077 T83579 T8599 arg1Of possesses,Also
R971 T979 T978 arg2Of glycans,of
R97104 T27842 T9137 arg1Of COVID-19,severe
R97110 T54347 T29994 arg1Of process,time-consuming
R97116 T84385 T80434 arg1Of reduce,On
R97129 T82065 T31100 arg1Of –,domain
R97152 T35146 T19797 arg1Of receptor,the
R97154 T43357 T21111 arg1Of therapy,pulse
R97168 T34390 T96610 arg1Of proportion,and
R97198 T97970 T87886 arg2Of COVID-19,with
R972 T977 T980 arg1Of types,are
R97280 T7676 T26029 arg2Of 2002–2003,of
R973 T981 T980 arg2Of N-linked,are
R9730 T96521 T13328 arg2Of bats,from
R97353 T58005 T20706 arg1Of therapy,standard
R9737 T49120 T55070 arg1Of S1B,and
R974 T977 T981 arg2Of types,N-linked
R9744 T64615 T69539 arg2Of %,in
R97441 T36179 T56543 arg1Of week,the
R975 T984 T981 arg3Of glycans,N-linked
R97536 T37156 T92380 arg1Of and,the
R9754 T48498 T97815 arg1Of regions,cyclic
R97543 T38661 T47400 arg1Of switching,to
R976 T984 T982 arg1Of glycans,and
R97607 T65082 T32005 arg1Of fusion,of
R97670 T39668 T66151 arg1Of benefit,clinical
R977 T984 T983 arg1Of glycans,O-linked
R97705 T67166 T2403 arg2Of immunity,of
R97711 T96302 T46108 arg1Of Rational,:
R97731 T1981 T22188 arg2Of and,with
R97743 T91725 T93033 arg1Of Tocilizumab,confer
R97799 T20519 T83162 arg1Of inoculated,with
R978 T985 T986 arg1Of Both,are
R97819 T17221 T13017 arg1Of approved,","
R97853 T6180 T50860 arg2Of and,is
R97859 T64338 T71577 modOf lacking,blocking
R97873 T64840 T33948 arg1Of and,","
R979 T987 T986 arg2Of released,are
R98 T105 T104 arg2Of COVID-19,","
R980 T985 T987 arg2Of Both,released
R98023 T18333 T60557 arg2Of cells,in
R9808 T71701 T29516 arg2Of sequence,in
R98083 T26913 T47829 arg1Of patients,the
R981 T987 T988 arg1Of released,from
R98182 T66003 T66871 arg1Of peptide,(
R982 T989 T988 arg2Of glycoproteins,from
R98214 T52934 T13365 arg1Of –,contains
R98220 T85453 T29393 arg1Of received,","
R98228 T44793 T86476 arg1Of cause,","
R98234 T82506 T62375 arg1Of share,[
R98284 T76985 T6758 arg1Of Analysis,of
R98291 T73325 T74033 arg1Of patient,the
R98296 T40953 T20174 arg1Of coronaviruses,other
R983 T1000 T990 arg1Of perform,Whereas
R98342 T56920 T16968 arg1Of regions,constant
R98361 T80777 T40812 arg1Of system,the
R98383 T15140 T84085 arg3Of ),(
R9839 T78533 T76626 arg2Of role,play
R984 T992 T990 arg2Of fulfill,Whereas
R98402 T27914 T54707 arg1Of administered,early
R98406 T52676 T58628 arg1Of antibodies,cross-reactive
R98416 T72802 T63708 arg1Of neutralize,efficiently
R98431 T52876 T21084 arg1Of It,is
R98484 T49329 T20257 arg1Of outcomes,clinical
R985 T991 T992 arg1Of enzymes,fulfill
R98500 T42849 T86008 arg1Of situation,his
R98509 T21018 T90573 arg2Of pressure,decrease
R98567 T74327 T77390 arg2Of membranes,and
R98576 T42602 T10581 arg1Of virus,RNA
R98591 T25066 T42920 arg1Of is,in
R986 T994 T992 arg2Of construction,fulfill
R98630 T96424 T15191 arg1Of serum,revealed
R9864 T42798 T39623 arg2Of SARS-CoV2,allow
R98693 T95468 T38088 arg1Of Rhinolophidae,the
R987 T994 T993 arg1Of construction,the
R98700 T51771 T34906 arg1Of entry,SARS-CoV2
R98709 T6178 T84121 arg2Of and,of
R98776 T41345 T7553 arg1Of infection,virus
R988 T994 T995 arg1Of construction,of
R9880 T4240 T18383 arg1Of increase,in
R98807 T7157 T22237 arg2Of bat,if
R98822 T92661 T2426 arg1Of inflammation,hyper
R98847 T43308 T87528 arg1Of related,to
R98878 T8313 T42013 arg1Of domain,in
R98880 T95232 T50200 arg1Of IFN,inhibit
R989 T996 T995 arg2Of N-glycans,of
R98900 T13257 T72593 arg1Of site,can
R98915 T25730 T43979 arg1Of degree,noticeable
R98942 T75519 T71095 arg1Of days,six
R98943 T81227 T56749 arg2Of rabbits,from
R98961 T54919 T61527 arg1Of cells,target
R98966 T40170 T30022 arg2Of TMPRSS2,of
R98967 T41408 T54378 arg1Of coronavirus,novel
R98978 T81378 T67673 arg1Of degree,significant
R99 T99 T106 arg1Of cause,","
R990 T1000 T997 arg1Of perform,","
R99006 T5365 T64776 arg2Of protease,and
R9904 T10130 T51431 arg1Of opacity,lesion
R99041 T95806 T84685 arg1Of HCoV-229E,and
R99048 T81589 T41843 arg1Of antibodies,neutralizing
R99082 T45934 T94908 arg1Of example,","
R991 T999 T998 arg1Of methods,chemical
R99138 T10130 T79595 arg1Of opacity,lung
R99172 T6431 T54166 arg1Of immunized,with
R992 T999 T1000 arg1Of methods,perform
R99263 T62294 T72325 arg1Of encephalitis,virus
R99271 T27754 T49586 arg2Of receptor,utilize
R99275 T45934 T7202 arg1Of example,","
R99280 T58229 T77811 arg1Of protects,and
R993 T1002 T1000 arg2Of release,perform
R99309 T52785 T73958 arg1Of and,","
R99315 T40522 T85972 arg2Of decreases,and
R99347 T5313 T26683 arg1Of exists,in
R99384 T10243 T47759 arg1Of Study,[
R99391 T42902 T40921 arg1Of reason,why
R994 T1002 T1001 arg1Of release,the
R99403 T38308 T74021 arg2Of SARS-2-S,and
R9941 T10629 T23275 arg1Of shown,Also
R99410 T52714 T59411 arg2Of patients,from
R99421 T68393 T60207 arg1Of SARS-S,and
R99439 T3496 T9531 arg2Of SARS,with
R99441 T23141 T31126 arg2Of differences,to
R99456 T72786 T36158 arg1Of shown,in
R99461 T48841 T43941 arg1Of CoVs,","
R99492 T40394 T28898 arg1Of therapy,and
R99494 T47986 T4126 arg2Of %,of
R995 T1002 T1003 arg1Of release,of
R9958 T8340 T6014 arg3Of ],[
R99597 T31699 T6254 arg1Of Rationale,:
R99599 T82570 T27396 arg1Of they,dictate
R996 T1004 T1003 arg2Of O-glycans,of
R99609 T12942 T3419 arg2Of binding,block
R99613 T39154 T8893 arg1Of domains,two
R99617 T31059 T48002 arg1Of chloride,ammonium
R99688 T96337 T40938 arg2Of proteases,are
R997 T1005 T1006 arg1Of N-glycans,are
R9970 T48589 T89317 arg2Of :,combined
R99722 T75489 T5367 arg1Of shows,from
R99727 T7628 T18229 arg1Of strain,of
R99734 T89053 T63224 arg1Of care,standard
R99739 T54079 T69539 arg1Of and,in
R99770 T69281 T30703 arg1Of identical,to
R998 T1007 T1006 arg2Of linked,are
R99800 T55858 T54040 arg3Of ),(
R99853 T21161 T30703 arg2Of agent,to
R99891 T6430 T18474 arg3Of ],[
R99899 T99631 T48418 arg2Of pseudotypes,of
R999 T1005 T1007 arg2Of N-glycans,linked
R9994 T48431 T7060 arg1Of levels,accompany
R99987 T11815 T73902 arg1Of Rational,: